Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
gsea,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.6767210315212142,2.2494076520176978,0.0,0.0,0.0,67/128,18.58%,AURKB;ERCC6L;SGO2;KIF4A;KIF2C;BUB1;BUB1B;NDC80;KIF11;CENPF;PLK1;CDCA8;TUBG1;KIF18A;TTK;CENPE;SEH1L;KNTC1;DYNC1LI1;CENPH;SPC24;NUSAP1;SKA2;TACC3;SPDL1;KIF2A;CENPU;XPO1;DSN1;PPP1CC;STIL;INTS13;NUP43;INCENP;MAD2L1;GPSM2;WDR62;RAN;CENPQ;CENPK;ESPL1;MAPRE1;CENPN;NUP133;ENST00000632578.1;RANBP2;CKAP5;DYNC1I2;CENPA;NUF2;ZWINT;NUP107;BUB3;CENPM;NUP85;RMDN1;NUP37;DLGAP5;CENPI;CCNB1;BIRC5;TBCE;ZW10;EML4;AHCTF1;RPS27;BCCIP
gsea,ncRNA export from nucleus (GO:0097064),0.7474383625716736,2.2133013235027352,0.0,0.0,0.0,26/38,17.62%,NDC1;NUP188;SSB;NUP50;SEH1L;NUP62;NUP153;NUP205;XPOT;NUP210;NUP43;POM121C;NUP58;NPM1;NUP35;RAN;NUP133;TPR;RANBP2;NUP107;NUP85;NOL6;NUP37;NUP214;NUP93;NUP88
gsea,mitotic spindle organization (GO:0007052),0.6404909199797261,2.177127565013146,0.0,0.0,0.0,72/157,18.01%,AURKB;ERCC6L;SGO2;TPX2;KIF4A;KIF2C;BUB1;BUB1B;NDC80;KIF11;CENPF;PLK1;CDCA8;TUBG1;KIF18A;TTK;CENPE;SEH1L;KNTC1;DYNC1LI1;CENPH;SMC1A;PRC1;SPC24;SKA2;SPDL1;KIF2A;CENPU;XPO1;DSN1;PPP1CC;STIL;INTS13;NUP43;INCENP;STAG1;MAD2L1;KIFC1;GPSM2;WDR62;RAN;CENPQ;CENPK;MAPRE1;CENPN;NUP133;ENST00000632578.1;RANBP2;CKAP5;DYNC1I2;CENPA;NUF2;OFD1;ZWINT;SMC3;NUP107;BUB3;CENPM;NUP85;RMDN1;NUP37;DLGAP5;CENPI;CCNB1;BIRC5;RHOA;TBCE;MZT1;ZW10;EML4;AHCTF1;RPS27
gsea,mitotic sister chromatid segregation (GO:0000070),0.6408004442324314,2.173570707582015,0.0,0.0,0.0,51/102,20.04%,SGO2;KIF2C;CEP55;NDC80;RAD21;NCAPD2;PLK1;CDCA8;TUBG1;KIF18A;CENPE;SEH1L;NUP62;SPAG5;SMC1A;PRC1;CDK1;NCAPD3;NCAPG;NUSAP1;KNSTRN;KIF22;KIF18B;CHMP2B;SPDL1;PDS5A;NCAPG2;DSN1;NCAPH;KIFC1;CDCA5;NCAPH2;RAN;CENPK;SMC2;ESPL1;TENT4A;VPS4B;ZWINT;PDCD6IP;DLGAP5;KIF14;CCNB1;RB1;ZW10;CDC23;EML4;CHMP4C;HASPIN;INO80;PHF8
gsea,mitotic spindle checkpoint signaling (GO:0071174),0.7521286673208616,2.1697707210775756,0.0,0.0,0.0,11/21,12.37%,BUB1;BUB1B;TRIP13;CENPF;PLK1;TTK;KNTC1;MAD2L1;TPR;ZWINT;BUB3
gsea,spindle assembly checkpoint signaling (GO:0071173),0.7521286673208616,2.1697707210775756,0.0,0.0,0.0,11/21,12.37%,BUB1;BUB1B;TRIP13;CENPF;PLK1;TTK;KNTC1;MAD2L1;TPR;ZWINT;BUB3
gsea,mitotic spindle assembly checkpoint signaling (GO:0007094),0.7521286673208616,2.1697707210775756,0.0,0.0,0.0,11/21,12.37%,BUB1;BUB1B;TRIP13;CENPF;PLK1;TTK;KNTC1;MAD2L1;TPR;ZWINT;BUB3
gsea,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.7598649090622605,2.1561697360324628,0.0,0.0,0.0,12/22,12.37%,BUB1;BUB1B;TRIP13;CENPF;PLK1;TTK;KNTC1;FBXO5;MAD2L1;TPR;ZWINT;BUB3
gsea,regulation of DNA replication (GO:0006275),0.6897243348718628,2.1352723671709226,0.0,0.0,0.0,13/53,8.33%,DSCC1;DHX9;CDC6;PCNA;NUCKS1;KAT7;PDS5A;FBXO5;GMNN;ORC3;DNA2;PPP2CA;STN1
gsea,mitotic nuclear division (GO:0140014),0.6487550764775277,2.1310330347115225,0.0,0.0,0.0,27/74,12.13%,SGO2;TPX2;NDC80;KIF11;PLK1;CDCA8;TUBG1;KIF18A;NUP62;SPAG5;SMC1A;NUSAP1;KNSTRN;UBE2C;KIF18B;KIF2A;NCAPG2;DSN1;STAG1;KIFC1;RAN;CENPK;ESPL1;ENST00000632578.1;OFD1;ZWINT;SMC3
gsea,regulation of cell cycle process (GO:0010564),0.48748002478799557,2.1210708180407853,0.0,0.0,0.0,25/106,12.20%,AURKB;BUB1;KIF20A;KIF11;PLK1;MKI67;KIF20B;SPAG5;PRC1;CHEK1;KNSTRN;RMI2;BORA;FBXO5;NEK2;PLK4;HMGA2;PRMT5;MYO19;PKMYT1;RACGAP1;TXLNG;DBF4B;CDC25C;TIPIN
gsea,DNA replication (GO:0006260),0.6300646426374842,2.093678246317979,0.0,0.0022685321310725605,0.02,57/108,19.35%,CDK2;ORC1;MCM6;CDC6;BRCA1;NAP1L1;CHEK1;CLSPN;FAM111A;FAM111B;POLE;CDK1;DONSON;MCM2;TOPBP1;PCLAF;RMI2;MCM3;KAT7;EXO1;MCM5;RFC3;POLE2;RFC5;MCM10;FEN1;RFC2;RPA3;ORC3;DNA2;RPA1;GRWD1;TIMELESS;RPA2;ORC6;RBBP8;RFC1;WDHD1;DUT;TIPIN;PNKP;CDC7;CDC45;POLA1;IGHMBP2;MCM7;MCM4;HUS1;RFC4;TICRR;TOP1;MCM8;POLD1;ORC4;ORC2;PIF1;RAD50
gsea,tRNA transport (GO:0051031),0.7420490926361132,2.0781343005042023,0.0,0.0031410444891773913,0.03,25/37,17.62%,NDC1;NUP188;SSB;NUP50;SEH1L;NUP62;NUP153;NUP205;XPOT;NUP210;NUP43;POM121C;NUP58;NUP35;RAN;NUP133;TPR;RANBP2;NUP107;NUP85;NOL6;NUP37;NUP214;NUP93;NUP88
gsea,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.752268283547813,2.070516107290871,0.0,0.004537064262145121,0.04,25/34,17.62%,NDC1;NUP188;SSB;NUP50;SEH1L;NUP62;NUP153;NUP205;XPOT;NUP210;NUP43;POM121C;NUP58;NUP35;RAN;NUP133;TPR;RANBP2;NUP107;NUP85;NOL6;NUP37;NUP214;NUP93;NUP88
gsea,tRNA export from nucleus (GO:0006409),0.752268283547813,2.070516107290871,0.0,0.004537064262145121,0.04,25/34,17.62%,NDC1;NUP188;SSB;NUP50;SEH1L;NUP62;NUP153;NUP205;XPOT;NUP210;NUP43;POM121C;NUP58;NUP35;RAN;NUP133;TPR;RANBP2;NUP107;NUP85;NOL6;NUP37;NUP214;NUP93;NUP88
gsea,regulation of cell cycle G2/M phase transition (GO:1902749),0.6426630249650228,2.0632501108772097,0.0,0.004253497745761051,0.04,38/85,24.51%,TPX2;CDK2;CENPF;PLK1;TUBG1;TUBB;YWHAE;CDK1;HSP90AA1;HAUS7;NEK2;GTSE1;PLK4;CNTRL;HAUS6;HAUS3;NPM1;CSNK1E;MAPRE1;HAUS2;ENST00000632578.1;CKAP5;DYNC1I2;TUBB4B;HMMR;OFD1;TUBA4A;NEDD1;CEP72;KIF14;HAUS8;CDK5RAP2;CETN2;PAFAH1B1;AURKA;CEP250;CEP78;HAUS1
gsea,mitotic G2/M transition checkpoint (GO:0044818),0.6503395132981312,2.0631726098012666,0.0,0.004003291996010401,0.04,13/45,4.83%,DTL;ORC1;PLK1;CDC6;BRCA1;CHEK1;CLSPN;CDK1;DONSON;TOPBP1;HMGA2;TAOK3;RINT1
gsea,sister chromatid segregation (GO:0000819),0.774161426546004,2.0499214124868295,0.0,0.003780886885120934,0.04,19/34,9.06%,SGO2;NDC80;PLK1;CDCA8;TUBG1;KIF18A;TOP2A;SPAG5;SMC1A;NUSAP1;KNSTRN;KIF18B;NCAPG2;DSN1;KIFC1;CHAMP1;RAN;CENPK;ESPL1
gsea,mitotic metaphase plate congression (GO:0007080),0.5912483141765078,2.047038534450098,0.0,0.00501464997394987,0.04,24/51,18.25%,KIF2C;CEP55;NDC80;CDCA8;KIF18A;CENPE;SEH1L;NUP62;KIF22;CHMP2B;SPDL1;KIFC1;CHAMP1;CDCA5;NUF2;VPS4B;RMDN1;PDCD6IP;KIF14;CCNB1;ZW10;CDC23;EML4;CHMP4C
gsea,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.6955713455647803,2.0399523227195404,0.0,0.004763917475252377,0.04,11/33,4.83%,DTL;PLK1;BRCA1;CHEK1;CLSPN;CDK1;DONSON;TOPBP1;HMGA2;TAOK3;RINT1
gsea,RNA export from nucleus (GO:0006405),0.5496611245407416,2.039130840692134,0.0,0.00453706426214512,0.04,41/106,18.95%,NDC1;NUP188;NUP50;SEH1L;NUP62;CPSF3;SRRM1;NCBP1;NUP153;THOC3;GLE1;THOC1;NUP205;UPF2;U2AF1;NUP210;NUP43;EIF4E;SLBP;POM121C;NUP58;CPSF2;NUP35;RAN;SRSF1;HNRNPA2B1;SRSF7;NUP133;TPR;SARNP;FYTTD1;RANBP2;NUP107;NUP85;NUP37;SRSF4;NUP214;NUP93;NUP88;XPO5;THOC7
gsea,regulation of generation of precursor metabolites and energy (GO:0043467),0.6268375683877507,2.037525649169856,0.0,0.004330834068411251,0.04,22/50,17.62%,NDC1;NUP188;NUP50;SEH1L;NUP62;NUP153;NUP205;NUP210;NUP43;POM121C;NUP58;PNPT1;NUP35;NUP133;TPR;RANBP2;NUP107;NUP85;NUP37;NUP214;NUP93;NUP88
gsea,DNA metabolic process (GO:0006259),0.5425142410433614,2.031484710213554,0.0,0.004734327925716647,0.05,103/277,19.61%,RAD21;CDK2;ORC1;POLQ;PRKDC;MCM6;TOP2A;CDC6;PCNA;BRCA1;SMC1A;CHEK1;NEIL3;POLE;UBE2A;CDK1;MCM2;TOPBP1;RAD54L;XRCC2;TYMS;RMI2;UBE2V2;MCM3;XRCC5;EXO1;MCM5;HMGB1;PDS5A;RECQL;RFC3;POLE2;KPNA2;RFC5;MCM10;HELLS;MSH2;FEN1;RFC2;PARP1;GMNN;NOC3L;RPA3;ORC3;SUPV3L1;UBE2T;INIP;ERCC5;DNA2;NPM1;SMUG1;RPA1;POLD3;STN1;RAN;TIMELESS;RPA2;CSNK1E;PARP2;ORC6;RBBP8;RFC1;RAD51AP1;PARK7;PRIM2;FANCL;PSME4;WDHD1;DDB2;DDX21;TRRAP;PTGES3;UNG;GTF2H1;PNKP;MMS19;MBD4;CDC7;CDC45;FANCA;RPS27A;POLA1;IGHMBP2;ASF1A;MCM7;FANCC;RAD51;MCM4;HUS1;RFC4;CHD1L;TICRR;TOP1;UHRF2;ACD;MCM8;POLD1;ORC4;ORC2;RAD50;INO80;VCP;LIG1
gsea,centromere complex assembly (GO:0034508),0.7547674868911545,2.027406252623858,0.0,0.005104197294913261,0.06,18/37,15.19%,CENPF;CENPE;CENPH;MIS18BP1;SMARCA5;CENPU;HELLS;OIP5;NPM1;CENPQ;CENPK;CENPN;HJURP;CENPA;CENPM;MIS18A;DLGAP5;CENPI
gsea,regulation of mitotic cell cycle phase transition (GO:1901990),0.5377581593873818,2.0220655208218696,0.0,0.005444477114574145,0.07,75/188,22.35%,TPX2;BUB1B;CDK2;CENPF;ANAPC1;PLK1;TUBG1;CENPE;KNTC1;CDC6;TUBB;E2F1;YWHAE;CDK1;UBE2C;CDC26;HSP90AA1;FBXO5;HAUS7;PSMD14;ANLN;NEK2;PSMD6;PSMB2;PLK4;CNTRL;PSMD5;HAUS6;HAUS3;MAD2L1;PSMD1;PSMA5;PSMD11;CSNK1E;PSMA4;MAPRE1;HAUS2;PSMA3;ENST00000632578.1;PSME4;CDC27;CKAP5;DYNC1I2;APPL1;TUBB4B;HMMR;PSMD7;OFD1;BUB3;TUBA4A;ENST00000629691.2;NEDD1;RPS27A;CEP72;KIF14;ANAPC2;PSMC6;HAUS8;PSMA1;CCNB1;ZW10;CDC23;PSMD10;PSMB3;CDK5RAP2;INO80;CETN2;TFAP4;CDC20;PSME1;ANAPC10;PAFAH1B1;PSMC3;AURKA;SKP1
gsea,telomere maintenance via telomerase (GO:0007004),0.6184427655716712,2.0193452258334186,0.0,0.005758581563491884,0.08,15/29,22.75%,CDK2;HSP90AA1;GAR1;RPA1;RFC1;PTGES3;PPP6C;HSP90AB1;ACD;DKC1;PIF1;RAD50;PPP6R3;TERF2IP;WRAP53
gsea,mitotic DNA damage checkpoint signaling (GO:0044773),0.6203457173924872,2.0180142450345935,0.0,0.005545300764844037,0.08,20/59,16.19%,DTL;CDK2;PLK1;PRKDC;BRCA1;CHEK1;CLSPN;CDK1;DONSON;TOPBP1;MDC1;HMGA2;RFWD3;TAOK3;RINT1;RPA2;TIPIN;UIMC1;HUS1;TICRR
gsea,regulation of purine nucleotide metabolic process (GO:1900542),0.6423468968235512,2.0005110959762686,0.0,0.006319482365130704,0.09,21/43,17.62%,NDC1;NUP188;NUP50;SEH1L;NUP62;NUP153;NUP205;NUP210;NUP43;POM121C;NUP58;NUP35;NUP133;TPR;RANBP2;NUP107;NUP85;NUP37;NUP214;NUP93;NUP88
gsea,pore complex assembly (GO:0046931),0.6311991358120003,2.0004169335318833,0.0,0.006101569180126197,0.09,10/19,21.71%,NDC1;PDZD11;NUP153;NUP205;ANO6;TPR;NUP107;NUP93;AHCTF1;RTN4
gsea,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.6042499284153063,1.9958289418179633,0.0,0.006351889967003169,0.1,67/149,24.51%,TPX2;DTL;CDK2;CENPF;PLK1;TUBG1;CDC25A;TUBB;YWHAE;CDK1;HSP90AA1;FBXO5;HAUS7;PSMD14;NEK2;PSMD6;PSMB2;PLK4;CNTRL;PSMD5;HAUS6;HAUS3;PSMD1;PSMA5;PSMD11;CSNK1E;PSMA4;MAPRE1;HAUS2;PSMA3;ENST00000632578.1;PSME4;DBF4B;CKAP5;DYNC1I2;TUBB4B;HMMR;VPS4B;PSMD7;OFD1;CDC25C;TUBA4A;ENST00000629691.2;CDC7;NEDD1;CEP72;KIF14;PSMC6;HAUS8;PSMA1;CCNB1;PSMD10;BRD4;PSMB3;CDK5RAP2;CETN2;USP47;PSME1;RAB11A;PAFAH1B1;PSMC3;AURKA;SKP1;CEP250;CUL1;CEP78;HAUS1
gsea,mRNA transport (GO:0051028),0.5321769622154032,1.9947699977758702,0.0,0.006146990290648228,0.1,38/104,17.62%,NDC1;NUP188;NUP50;SEH1L;NUP62;CPSF3;SRRM1;NCBP1;NUP153;THOC3;GLE1;THOC1;NUP205;UPF2;U2AF1;NUP210;NUP43;EIF4E;SLBP;POM121C;NUP58;CPSF2;NUP35;SRSF1;HNRNPA2B1;SRSF7;NUP133;TPR;SARNP;FYTTD1;RANBP2;NUP107;NUP85;NUP37;SRSF4;NUP214;NUP93;NUP88
gsea,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.5542673093146132,1.988308024952755,0.0,0.005954896844065471,0.1,38/99,17.62%,NDC1;NUP188;NUP50;SEH1L;NUP62;CPSF3;SRRM1;NCBP1;NUP153;THOC3;GLE1;THOC1;NUP205;UPF2;U2AF1;NUP210;NUP43;EIF4E;SLBP;POM121C;NUP58;CPSF2;NUP35;SRSF1;HNRNPA2B1;SRSF7;NUP133;TPR;SARNP;FYTTD1;RANBP2;NUP107;NUP85;NUP37;SRSF4;NUP214;NUP93;NUP88
gsea,mitotic chromosome condensation (GO:0007076),0.7240487749343604,1.9877190492538561,0.0,0.005774445424548335,0.1,12/27,9.34%,NCAPD2;PLK1;CDK1;NCAPD3;NCAPG;NUSAP1;NCAPG2;NCAPH;CDCA5;NCAPH2;SMC2;TENT4A
gsea,protein sumoylation (GO:0016925),0.598110153781373,1.9822919888553623,0.0,0.006004937994015602,0.1,22/55,17.62%,NDC1;NUP188;NUP50;SEH1L;NUP62;NUP153;NUP205;NUP210;NUP43;POM121C;NUP58;NUP35;NUP133;TPR;RANBP2;NUP107;NUP85;NUP37;PIAS1;NUP214;NUP93;NUP88
gsea,base-excision repair (GO:0006284),0.6386337072303665,1.9746130478826693,0.0,0.00661115078198289,0.11,26/48,20.22%,POLQ;PCNA;NEIL3;POLE;RFC3;RFC5;HMGA2;FEN1;RFC2;PARP1;RPA3;ERCC5;DNA2;HUWE1;SMUG1;RPA1;POLD3;RPA2;RFC1;UNG;PNKP;MBD4;RFC4;POLD1;LIG1;USP47
gsea,ciliary basal body-plasma membrane docking (GO:0097711),0.5537134713158017,1.967170163022067,0.0,0.006805596393217681,0.12,33/95,24.51%,PLK1;TUBG1;TUBB;YWHAE;CDK1;HSP90AA1;HAUS7;NEK2;PLK4;CNTRL;HAUS6;HAUS3;CSNK1E;MAPRE1;HAUS2;ENST00000632578.1;CKAP5;DYNC1I2;TUBB4B;OFD1;TUBA4A;NEDD1;CEP72;HAUS8;CDK5RAP2;CETN2;RAB11A;PAFAH1B1;TCTN3;CEP250;TCTN1;CEP78;HAUS1
gsea,regulation of microtubule cytoskeleton organization (GO:0070507),0.6085303529521252,1.966730127156904,0.0,0.006989531430872213,0.12,12/37,26.70%,CAMSAP3;SKA2;CYLD;SKA3;MAPRE1;ROCK1;PRKAA1;MARK2;MAPRE2;GSK3B;PHLDB2;CLASP1
gsea,telomere maintenance via telomere lengthening (GO:0010833),0.5900835741675668,1.966332346918956,0.0,0.00680559639321768,0.12,17/36,22.75%,CDK2;HSP90AA1;GAR1;RPA1;STN1;RFC1;PTGES3;PPP6C;RAD51;HSP90AB1;ACD;DKC1;PIF1;RAD50;PPP6R3;TERF2IP;WRAP53
gsea,telomere organization (GO:0032200),0.6424928545208121,1.9607801222819654,0.0,0.006980098864838648,0.13,18/47,24.50%,PRKDC;PCNA;XRCC5;PARP1;RPA3;DNA2;RPA1;POLD3;STN1;RPA2;PTGES3;HUS1;ACD;POLD1;RAD50;TERF2IP;RECQL4;ATR
gsea,regulation of mitotic spindle organization (GO:0060236),0.604416829531289,1.9580658085073142,0.0,0.0074861560325394485,0.14,13/35,19.57%,TPX2;PLK1;NUP62;TACC3;CHMP2B;BORA;GPSM2;TPR;VPS4B;PDCD6IP;HNRNPU;CHMP4C;DRG1
gsea,mRNA export from nucleus (GO:0006406),0.5440794617696314,1.9572392440734094,0.0,0.007303566861014097,0.14,38/107,14.51%,NDC1;NUP188;NUP50;SEH1L;NUP62;CPSF3;SRRM1;NCBP1;NUP153;THOC3;IWS1;GLE1;THOC1;NUP205;UPF2;U2AF1;NUP210;NUP43;EIF4E;SLBP;POM121C;NUP58;PCID2;CPSF2;DDX19A;NUP35;SRSF1;HNRNPA2B1;SRSF7;NUP133;TPR;SARNP;FYTTD1;RANBP2;NUP107;NUP85;NUP37;SRSF4
gsea,spindle assembly (GO:0051225),0.5443759673613523,1.9549554550777808,0.0,0.0074537484306669835,0.15,33/84,28.50%,TPX2;KIF11;SMC1A;KIF2A;HAUS7;NEK2;HAUS6;HAUS3;STAG1;KIFC1;GOLGA8A;MAPRE1;HAUS2;HDAC3;OFD1;SMC3;NEK7;HAUS8;RHOA;MZT1;BCCIP;INO80;RAB11A;MAPRE2;GOLGA8B;HAUS1;TUBGCP3;ABRAXAS2;CLASP1;SAC3D1;NEK6;FLNA;KPNB1
gsea,DNA repair (GO:0006281),0.49879904153836585,1.9526315790091244,0.0,0.007280405443907287,0.15,88/298,16.19%,USP1;RAD21;TRIP13;POLQ;BAZ1B;PRKDC;FANCI;PCNA;BRCA1;SMC1A;CHEK1;NEIL3;FAM111A;POLE;UBE2A;CDK1;TOPBP1;SMARCA5;RAD54L;XRCC2;NUCKS1;RMI2;UBE2V2;XRCC5;EXO1;MDC1;PDS5A;RECQL;RFC3;POLE2;NSD2;KPNA2;RFC5;HMGA2;RFWD3;MSH2;FEN1;RFC2;PARP1;ASCC3;RPA3;UBE2T;INIP;ERCC5;CDCA5;DNA2;RNF8;NPM1;HUWE1;SMUG1;RPA1;POLD3;RAD23B;TRAIP;TIMELESS;RPA2;CSNK1E;PARP2;RBBP8;SETX;TENT4A;RAD51AP1;PARK7;FANCL;PSME4;WDHD1;XRCC4;DDB2;TRRAP;UNG;GTF2H1;PNKP;MMS19;UIMC1;MBD4;FANCA;RPS27A;POLA1;IGHMBP2;ASF1A;FANCC;RAD51;MGME1;ASCC1;HUS1;RFC4;CHD1L;TICRR
gsea,regulation of carbohydrate catabolic process (GO:0043470),0.630880808495083,1.9466008899101885,0.0,0.0077336322650200925,0.16,21/43,17.62%,NDC1;NUP188;NUP50;SEH1L;NUP62;NUP153;NUP205;NUP210;NUP43;POM121C;NUP58;NUP35;NUP133;TPR;RANBP2;NUP107;NUP85;NUP37;NUP214;NUP93;NUP88
gsea,regulation of nuclear division (GO:0051783),0.6076803994140727,1.9454655962643752,0.0,0.007864244721051544,0.17,8/20,11.87%,MKI67;KIF20B;BORA;FBXO5;NEK2;PRMT5;PKMYT1;CDC25C
gsea,chromosome condensation (GO:0030261),0.7088659217952016,1.930942411246662,0.0,0.010652237832862458,0.18,14/45,9.34%,NCAPD2;PLK1;TOP2A;CDK1;NCAPD3;NCAPG;NUSAP1;NCAPG2;INCENP;NCAPH;CDCA5;NCAPH2;SMC2;TENT4A
gsea,regulation of gene silencing by miRNA (GO:0060964),0.5741904665942514,1.9235264040320479,0.022222222222222223,0.01071519432123635,0.18,28/67,17.62%,NDC1;DHX9;NUP188;NUP50;SEH1L;NUP62;NUP153;IPO8;NUP205;NUP210;NUP43;POM121C;NUP58;TNRC6A;NUP35;PUM2;NUP133;POLR2B;TPR;RANBP2;NUP107;NUP85;NUP37;ELAVL1;NUP214;NUP93;POLR2K;NUP88
gsea,telomere maintenance (GO:0000723),0.5752470310317234,1.9227169631852579,0.0,0.010491961106210592,0.18,21/56,24.50%,PRKDC;PCNA;XRCC5;PARP1;RPA3;DNA2;RPA1;POLD3;STN1;RPA2;SMC6;PTGES3;RAD51;HUS1;SMC5;ACD;POLD1;RAD50;TERF2IP;RECQL4;ATR
gsea,DNA geometric change (GO:0032392),0.6378648064887524,1.922451659434511,0.022222222222222223,0.010277839450981803,0.18,15/26,27.72%,DHX9;HMGB1;RECQL;ASCC3;SUPV3L1;DNA2;HNRNPA2B1;MTERF1;PIF1;RAD50;RECQL4;DDX11;DDX1;HMGB3;DHX36
gsea,protein-DNA complex assembly (GO:0065004),0.5715804217143219,1.9208777145927838,0.02,0.010344506517690876,0.19,50/143,19.59%,ORC1;MCM6;CDC6;NAP1L1;MCM2;SMARCA5;MCM3;MCM5;PSMD14;PSMD6;PSMB2;PSMD5;CHAF1B;PARP1;GMNN;RPA3;ORC3;CHAF1A;PSMD1;ERCC5;NPM1;RPA1;GRWD1;RAD23B;PSMA5;RPA2;PSMD11;PSMA4;ORC6;ANP32B;PSMA3;PSME4;DDB2;PSMD7;GTF2H1;ENST00000629691.2;RPS27A;ASF1A;MCM7;RAD51;PSMC6;MCM4;CHD1L;PSMA1;PSMD10;MCM8;PSMB3;ORC4;ORC2;CETN2
gsea,double-strand break repair via nonhomologous end joining (GO:0006303),0.5241834413136283,1.9185978362197453,0.0,0.010675445322694401,0.19,20/62,21.63%,POLQ;PRKDC;BRCA1;UBE2V2;XRCC5;MDC1;HMGB1;PSMD14;NSD2;RNF8;XRCC4;NHEJ1;UIMC1;PAXIP1;POLA1;CYREN;SMC5;RAD50;POLM;SMARCAL1
gsea,regulation of spindle assembly (GO:0090169),0.6114797480609265,1.9182926207177398,0.0,0.010470148297257972,0.19,12/25,19.57%,PLK1;SPAG5;RNF4;CHMP2B;SENP6;GPSM2;TPR;VPS4B;PDCD6IP;HNRNPU;CHMP4C;DRG1
gsea,G2/M transition of mitotic cell cycle (GO:0000086),0.5341212376092115,1.9174999352326154,0.0,0.01027259832938518,0.19,49/130,24.51%,CDK2;PLK1;TUBG1;CDC25A;TUBB;YWHAE;CDK1;HSP90AA1;BORA;PHLDA1;FOXM1;HAUS7;PPME1;NEK2;ARPP19;PLK4;CNTRL;MELK;HAUS6;HAUS3;CCNB2;PKMYT1;CSNK1E;MAPRE1;HAUS2;ENST00000632578.1;CKAP5;DYNC1I2;TUBB4B;OFD1;CDC25C;DNM2;TUBA4A;NEDD1;CEP72;HAUS8;CCNB1;CDK5RAP2;CETN2;PPP1R12A;PAFAH1B1;AURKA;SKP1;CEP250;NES;CUL1;CEP78;ENSA;HAUS1
gsea,regulation of telomere maintenance via telomerase (GO:0032210),0.5889768314309235,1.9086072496990423,0.0,0.011090601529688073,0.2,24/52,21.47%,AURKB;CCT8;XRCC5;NEK2;MAPKAPK5;NAF1;CCT7;STN1;CCT2;CCT6A;CCT5;PNKP;CCT3;CCT4;NEK7;HNRNPU;HNRNPC;MAPK1;EXOSC10;ACD;PIF1;NAT10;GNL3L;TENT4B
gsea,protein localization to chromosome (GO:0034502),0.5869685553779257,1.9074888722586278,0.0,0.010888954229148288,0.2,16/34,26.51%,RAD21;PLK1;XRCC5;MSH2;RPA1;RPA2;XRCC4;CENPA;FAM47E;RB1;ACD;MCM8;HASPIN;TERF2IP;ATR;TNKS2
gsea,double-strand break repair (GO:0006302),0.5022342923654074,1.9021925221974902,0.0,0.011666736674087453,0.2,56/164,25.02%,RAD21;TRIP13;POLQ;BAZ1B;PRKDC;BRCA1;SMARCA5;XRCC2;NUCKS1;UBE2V2;XRCC5;MDC1;HMGB1;RECQL;PSMD14;NSD2;KPNA2;RFWD3;FEN1;PARP1;ENST00000647028.2;RPA3;ERCC5;CDCA5;DNA2;RNF8;RPA1;RPA2;PARP2;RBBP8;SETX;TENT4A;RAD51AP1;XRCC4;SMC6;NHEJ1;UIMC1;PAXIP1;POLA1;RAD51;CYREN;HUS1;SMC5;MCM8;RAD50;INO80;VCP;POLM;SMARCAL1;TDP2;RECQL4;NABP2;MAPK8;UBE2N;PPP5C;DDX1
gsea,regulation of posttranscriptional gene silencing (GO:0060147),0.6060293178666473,1.8981644517715122,0.0,0.01149911114716091,0.2,26/55,17.62%,NDC1;NUP188;NUP50;SEH1L;NUP62;NUP153;IPO8;NUP205;NUP210;NUP43;POM121C;NUP58;TNRC6A;NUP35;PUM2;NUP133;POLR2B;TPR;RANBP2;NUP107;NUP85;NUP37;NUP214;NUP93;POLR2K;NUP88
gsea,regulation of gene silencing by RNA (GO:0060966),0.6060293178666473,1.8981644517715122,0.0,0.01149911114716091,0.2,26/55,17.62%,NDC1;NUP188;NUP50;SEH1L;NUP62;NUP153;IPO8;NUP205;NUP210;NUP43;POM121C;NUP58;TNRC6A;NUP35;PUM2;NUP133;POLR2B;TPR;RANBP2;NUP107;NUP85;NUP37;NUP214;NUP93;POLR2K;NUP88
gsea,protein K11-linked ubiquitination (GO:0070979),0.5598373395400943,1.8896452011668463,0.02564102564102564,0.011996305506688794,0.21,12/29,21.16%,ANAPC1;UBE2A;RNF4;UBE2C;CDC26;UBE2T;UBE2E3;CDC27;ANAPC2;CDC23;RNF26;ANAPC10
gsea,negative regulation of cell cycle process (GO:0010948),0.5584807469933227,1.8858104062324796,0.0,0.013838045999542619,0.22,13/64,9.09%,AURKB;E2F8;E2F7;BRCA1;E2F1;CHEK1;SUZ12;FBXO5;NEK2;CBX5;EZH2;ESPL1;RBBP8
gsea,"base-excision repair, gap-filling (GO:0006287)",0.6312633505592404,1.8819964476595146,0.0,0.014280595710358413,0.24,19/35,19.61%,PCNA;POLE;RFC3;RFC5;FEN1;RFC2;PARP1;RPA3;SMUG1;RPA1;POLD3;RPA2;RFC1;UNG;PNKP;MBD4;RFC4;POLD1;LIG1
gsea,peptidyl-lysine modification (GO:0018205),0.5083119269043376,1.8781292190940073,0.0,0.015367475726620571,0.26,26/106,17.62%,NDC1;NUP188;NUP50;SEH1L;NUP62;NUP153;PLOD2;NUP205;NUP210;NUP43;SENP6;POM121C;NUP58;NUP35;GCSH;NUP133;PARK7;TPR;RANBP2;NUP107;NUP85;NUP37;PIAS1;NUP214;NUP93;NUP88
gsea,histone exchange (GO:0043486),0.6904814679013769,1.8777089710831156,0.0,0.015123547540483737,0.26,17/38,15.19%,CENPH;MIS18BP1;SMARCA5;CENPU;ANP32E;OIP5;RNF8;NPM1;CENPQ;CENPK;ACTR6;CENPN;HJURP;CENPA;CENPM;MIS18A;CENPI
gsea,double-strand break repair via homologous recombination (GO:0000724),0.5836258195668917,1.875622860920219,0.0,0.015312591884739784,0.27,34/97,19.49%,RAD21;POLQ;MCM6;GINS2;BRCA1;MCM2;RAD54L;XRCC2;NUCKS1;MCM3;MCM5;RECQL;PSMD14;RFWD3;FEN1;PARP1;ENST00000647028.2;RPA3;ERCC5;RPA1;RPA2;RBBP8;RAD51AP1;SMC6;CDC7;CDC45;MCM7;RAD51;MCM4;HUS1;SMC5;MCM8;RAD50;INO80
gsea,regulation of cellular response to heat (GO:1900034),0.5637717467488067,1.8747537618006864,0.0,0.015077013548051478,0.27,32/79,17.62%,NDC1;NUP188;NUP50;SEH1L;NUP62;DNAJC2;YWHAE;BAG2;NUP153;HSPA8;HSP90AA1;NUP205;NUP210;NUP43;RPA3;POM121C;NUP58;RPA1;NUP35;RPA2;NUP133;TPR;RANBP2;PTGES3;NUP107;NUP85;NUP37;HSP90AB1;MAPK1;NUP214;NUP93;NUP88
gsea,chromatin remodeling at centromere (GO:0031055),0.7652234644563743,1.8729321006211972,0.0,0.014848573948838577,0.27,15/32,15.19%,CENPH;MIS18BP1;SMARCA5;CENPU;HELLS;OIP5;NPM1;CENPQ;CENPK;CENPN;HJURP;CENPA;CENPM;MIS18A;CENPI
gsea,cell cycle G2/M phase transition (GO:0044839),0.5298149168878566,1.8722338732174528,0.0,0.014830105573280319,0.27,49/131,24.51%,CDK2;PLK1;TUBG1;CDC25A;TUBB;YWHAE;CDK1;HSP90AA1;BORA;PHLDA1;FOXM1;HAUS7;PPME1;NEK2;ARPP19;PLK4;CNTRL;MELK;HAUS6;HAUS3;CCNB2;PKMYT1;CSNK1E;MAPRE1;HAUS2;ENST00000632578.1;CKAP5;DYNC1I2;TUBB4B;OFD1;CDC25C;DNM2;TUBA4A;NEDD1;CEP72;HAUS8;CCNB1;CDK5RAP2;CETN2;PPP1R12A;PAFAH1B1;AURKA;SKP1;CEP250;NES;CUL1;CEP78;ENSA;HAUS1
gsea,pre-replicative complex assembly (GO:0036388),0.6189140896992298,1.8707987048329977,0.018867924528301886,0.015012344985039002,0.28,33/64,21.56%,ORC1;MCM6;CDC6;MCM2;MCM3;MCM5;PSMD14;PSMD6;PSMB2;PSMD5;GMNN;ORC3;PSMD1;PSMA5;PSMD11;PSMA4;ORC6;PSMA3;PSME4;PSMD7;ENST00000629691.2;RPS27A;MCM7;PSMC6;MCM4;PSMA1;PSMD10;MCM8;PSMB3;ORC4;ORC2;PSME1;PSMC3
gsea,regulation of DNA recombination (GO:0000018),0.5699318367527241,1.8669343745199722,0.0,0.014992038431436051,0.29,12/42,21.27%,CHEK1;KPNA2;SHLD2;THOC1;MSH2;RPA2;RAD51AP1;PPP4R2;RAD51;RAD50;KPNA1;TERF2IP
gsea,cellular response to topologically incorrect protein (GO:0035967),0.5384986313979931,1.8575511094015427,0.0,0.016916768177426808,0.32,7/32,12.79%,HSPA9;HSPA8;HSPA14;TM7SF3;HSPA13;HSPA5;STUB1
gsea,CENP-A containing nucleosome assembly (GO:0034080),0.7591526325401361,1.8567824649177957,0.0,0.01644685795027606,0.32,14/30,15.19%,CENPH;MIS18BP1;SMARCA5;CENPU;OIP5;NPM1;CENPQ;CENPK;CENPN;HJURP;CENPA;CENPM;MIS18A;CENPI
gsea,CENP-A containing chromatin organization (GO:0061641),0.7591526325401361,1.8567824649177957,0.0,0.01644685795027606,0.32,14/30,15.19%,CENPH;MIS18BP1;SMARCA5;CENPU;OIP5;NPM1;CENPQ;CENPK;CENPN;HJURP;CENPA;CENPM;MIS18A;CENPI
gsea,RNA-dependent DNA biosynthetic process (GO:0006278),0.5983232275651376,1.855633915075932,0.0,0.016221558526299674,0.32,15/30,22.75%,CDK2;HSP90AA1;GAR1;RPA1;RFC1;PTGES3;PPP6C;HSP90AB1;ACD;DKC1;PIF1;RAD50;PPP6R3;TERF2IP;WRAP53
gsea,establishment of mitotic spindle orientation (GO:0000132),0.6841318295119145,1.8522255639251288,0.0,0.016922023464216937,0.34,13/24,21.28%,NDC80;PLK1;NSFL1C;SPDL1;MAD2L1;GPSM2;HTT;ENST00000632578.1;CENPA;ZW10;ITGB1;CDK5RAP2;PAFAH1B1
gsea,regulation of DNA repair (GO:0006282),0.5336154359610734,1.8509193812400366,0.0,0.016696396484694044,0.34,8/45,7.00%,USP1;DHX9;PCNA;BRCA1;UBE2V2;KAT7;SMCHD1;RNF8
gsea,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.649492499353914,1.8502521096134283,0.0,0.01665580169919064,0.35,17/36,17.24%,AURKB;CCT8;XRCC5;NEK2;MAPKAPK5;NAF1;CCT7;HNRNPA2B1;CCT2;CCT6A;CCT5;PNKP;CCT3;CCT4;NEK7;MAPK1;ACD
gsea,DNA-dependent DNA replication (GO:0006261),0.5966193451667104,1.8469723931984385,0.02040816326530612,0.017323336273645004,0.36,65/129,21.56%,CDK2;ORC1;MCM6;CDC6;GINS2;GINS1;POLE;MCM2;TOPBP1;MCM3;MCM5;RECQL;RFC3;POLE2;PSMD14;RFC5;GINS3;PSMD6;PSMB2;MCM10;PSMD5;RFC2;GMNN;NOC3L;RPA3;ORC3;PSMD1;DNA2;RPA1;POLD3;PSMA5;RPA2;PSMD11;PSMA4;ORC6;RFC1;PSMA3;PRIM2;PSME4;WDHD1;DDX21;PSMD7;PNKP;ENST00000629691.2;CDC7;CDC45;RPS27A;POLA1;MCM7;RAD51;MGME1;PSMC6;MCM4;RFC4;PSMA1;PSMD10;MCM8;PSMB3;POLD1;ORC4;ORC2;PRIM1;PSME1;BAZ1A;PSMC3
gsea,cellular response to unfolded protein (GO:0034620),0.5978974151431768,1.8466242890542275,0.0,0.017101242218854687,0.36,8/27,12.47%,HSPD1;HSPA9;HSPA8;HSPA14;TM7SF3;HSPA13;ABCB10;HSPA5
gsea,regulation of exit from mitosis (GO:0007096),0.5330081465148668,1.8435733637833638,0.0,0.017918532275813644,0.36,17/39,21.16%,BUB1B;ANAPC1;KNTC1;UBE2C;CDC26;ANLN;NEK2;MAD2L1;CDCA5;CDC27;BUB3;RPS27A;ANAPC2;ZW10;CDC23;CDC20;ANAPC10
gsea,postreplication repair (GO:0006301),0.6074671162272491,1.8426052223479226,0.0,0.01769455062236597,0.36,16/46,9.13%,DTL;PCNA;BRCA1;USP10;UBE2A;PCLAF;UBE2V2;RFC3;RFC5;MSH2;RFC2;RPA3;RPA1;POLD3;RPA2;RFC1
gsea,positive regulation of telomere maintenance via telomerase (GO:0032212),0.6590220322877299,1.8396170002779901,0.0,0.018484335882813455,0.38,16/33,17.24%,AURKB;CCT8;XRCC5;NEK2;MAPKAPK5;NAF1;CCT7;CCT2;CCT6A;CCT5;PNKP;CCT3;CCT4;NEK7;MAPK1;ACD
gsea,replication fork processing (GO:0031297),0.577520823779401,1.8353352116605623,0.0,0.018756887620331657,0.38,9/39,8.12%,PCNA;FAM111A;NUCKS1;ETAA1;THOC1;RFWD3;ENST00000647028.2;DNA2;TRAIP
gsea,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.5661281781588766,1.8350020022418203,0.020833333333333332,0.018530901022496337,0.38,39/84,22.07%,AURKB;BUB1B;CDK2;ANAPC1;PLK1;CDK1;UBE2C;CDC26;FBXO5;PSMD14;PSMD6;PSMB2;PSMD5;PTTG1;MAD2L1;PSMD1;PSMA5;PSMD11;PSMA4;PSMA3;PSME4;CDC27;PSMD7;BUB3;ENST00000629691.2;RPS27A;ANAPC2;PSMC6;PSMA1;CCNB1;RB1;CDC23;PSMD10;PSMB3;CDC20;PSME1;ANAPC10;PSMC3;AURKA
gsea,DNA recombination (GO:0006310),0.5597879318034764,1.8339615491535446,0.020833333333333332,0.018310295057942808,0.38,14/39,23.09%,RAD21;RAD54L;XRCC2;EXO1;HMGB1;RECQL;MSH2;SUPV3L1;RPA1;IGHMBP2;RAD51;RAD50;RECQL4;RHNO1
gsea,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.6202193715633961,1.832140782208982,0.0,0.018575274861488255,0.38,13/32,18.75%,ORC1;E2F7;CDC6;PCNA;DHFR;E2F1;TYMS;FBXO5;CDC45;POLA1;RB1;BRD4;CDK17
gsea,RNA transport (GO:0050658),0.4730231486191251,1.8287882517923257,0.0,0.019150631711147427,0.38,18/76,10.64%,NUP188;NUP62;SRRM1;NCBP1;NUP153;THOC3;THOC1;U2AF1;EIF4E;SLBP;POM121C;PNPT1;SRSF1;HNRNPA2B1;SRSF7;TPR;SARNP;CKAP5
gsea,DNA integrity checkpoint signaling (GO:0031570),0.6015366682935592,1.8283989180295244,0.0,0.01893050950757102,0.38,14/39,15.95%,CDC6;E2F1;CHEK1;CLSPN;DONSON;DNA2;TIMELESS;TIPRL;INTS7;TIPIN;CDC45;CDC5L;HUS1;MAP3K20
gsea,regulation of telomere capping (GO:1904353),0.5666579319606367,1.8250953842244988,0.0,0.019798098598451434,0.4,11/23,26.51%,AURKB;NEK2;HNRNPD;MAPKAPK5;PNKP;NEK7;MAPK1;RAD50;NABP2;SMG6;TNKS2
gsea,mitotic cell cycle phase transition (GO:0044772),0.49201560734069255,1.8220837235076326,0.0,0.020034452303629578,0.41,71/209,24.51%,CDK2;ANAPC1;PLK1;TUBG1;CDC25A;TUBB;CDKN3;E2F1;YWHAE;POLE;CDK1;UBE2C;TACC3;HSP90AA1;BORA;PHLDA1;FOXM1;HAUS7;PPME1;NEK2;ARPP19;PLK4;CNTRL;MELK;CCNF;HAUS6;HAUS3;EIF4E;CCND3;CCNB2;CDK6;PKMYT1;CSNK1E;MAPRE1;HAUS2;ENST00000632578.1;CDC27;CKAP5;DYNC1I2;TUBB4B;OFD1;CDC25C;DNM2;TUBA4A;CDC7;PPP6C;NEDD1;CEP72;HAUS8;CCNB1;RB1;CUL2;CDC23;CDK5RAP2;CUL5;E2F3;CETN2;PHF8;GSPT1;PPP1R12A;PAFAH1B1;BCAT1;AURKA;SKP1;CEP250;NES;CUL1;CEP78;ENSA;CUL4B;HAUS1
gsea,chromosome organization (GO:0051276),0.4532909428384511,1.8177312793624658,0.02127659574468085,0.02071926013046272,0.41,21/106,11.98%,NDC80;CDCA8;TOP2A;CENPH;COPS3;COPS4;NUCKS1;HMGA2;RFWD3;MSH2;PARP1;COPS8;RAD23B;GPS1;EZH2;NUP133;DDB2;PHF19;NUF2;HDAC3;SUV39H1
gsea,regulation of signal transduction by p53 class mediator (GO:1901796),0.414150751953249,1.8176616784988255,0.0,0.020491575953204888,0.41,26/156,9.09%,AURKB;TPX2;CDK2;PAK1IP1;PIP4K2A;BRCA1;CHEK1;CDK1;TOPBP1;RMI2;EXO1;RFC3;RFC5;RFC2;MAPKAPK5;PRMT5;RPA3;SUPT16H;DNA2;RPA1;NOP2;SSRP1;RPA2;RFFL;RNF34;RBBP8
gsea,regulation of cell cycle phase transition (GO:1901987),0.5131330213104811,1.8094999037022792,0.0,0.022192162151796785,0.46,41/95,26.21%,BUB1B;ANAPC1;PLK1;CDK1;UBE2C;CDC26;FBXO5;PSMD14;PSMD6;PSMB2;GTSE1;PSMD5;MAD2L1;PSMD1;PSMA5;PSMD11;PSMA4;PSMA3;PSME4;DBF4B;CDC27;PSMD7;BUB3;ENST00000629691.2;ANAPC2;PSMC6;PSMA1;CCNB1;CDC23;PSMD10;PSMB3;TFAP4;CDC20;PSME1;ANAPC10;PSMC3;SKP1;CUL1;PSMA6;PSMD13;DBF4
gsea,mitotic spindle assembly (GO:0090307),0.5749869758993883,1.8039733068287302,0.022727272727272728,0.025173388809321313,0.46,15/44,18.58%,AURKB;TPX2;KIF4A;KIF11;SMC1A;PRC1;KIF2A;STAG1;KIFC1;RACGAP1;OFD1;SMC3;RHOA;MZT1;BCCIP
gsea,nuclear export (GO:0051168),0.467448696987752,1.8017941283954448,0.0,0.025050386723971467,0.47,24/84,18.95%,CSE1L;NUP188;NUP62;SRRM1;NCBP1;NUP153;THOC3;XPO1;XPO7;THOC1;U2AF1;EIF4E;POM121C;RAN;SRSF1;SRSF7;TPR;SARNP;STRADB;SRSF4;NUP214;XPO4;XPO5;THOC7
gsea,establishment of mitotic spindle localization (GO:0040001),0.6558156624243073,1.7963657211351673,0.0,0.026506007005163604,0.48,15/29,21.28%,NDC80;PLK1;NSFL1C;NUSAP1;SPDL1;MAD2L1;GPSM2;HTT;ESPL1;ENST00000632578.1;CENPA;ZW10;ITGB1;CDK5RAP2;PAFAH1B1
gsea,positive regulation of cell cycle process (GO:0090068),0.5873465847150751,1.793053493869515,0.0,0.02651346928191055,0.48,33/101,23.09%,AURKB;NDC80;RAD21;CIT;KIF20B;E2F8;E2F7;NUP62;DYNC1LI1;CDC6;SPAG5;NSFL1C;NUSAP1;PLK4;FEN1;MAD2L1;PCID2;GPSM2;RACGAP1;TPR;DBF4B;CDC7;KIF14;MAP3K20;CCNB1;RHOA;INO80;PHIP;RANBP1;AURKA;ECT2;PLSCR1;RHNO1
gsea,positive regulation of DNA biosynthetic process (GO:2000573),0.615955731686819,1.7885093487691535,0.0,0.028625601324049624,0.53,26/61,18.87%,AURKB;DSCC1;CCT8;PCNA;XRCC5;HSP90AA1;RFC3;RFC5;NEK2;RFC2;MAPKAPK5;NAF1;CCT7;CCT2;CCT6A;CCT5;PTGES3;PNKP;CCT3;CCT4;NEK7;RFC4;HSP90AB1;MAPK1;ACD;DKC1
gsea,regulation of DNA metabolic process (GO:0051052),0.4758876132272402,1.7882557219255921,0.0,0.02861128279597637,0.53,21/46,32.78%,USP1;NUCKS1;UBE2V2;KAT7;XRCC5;KPNA2;THOC1;HNRNPD;YLPM1;TICRR;SUB1;PIF1;KPNA1;TERF2IP;UBE2N;SMG6;SMG5;PARG;WDR70;NBN;CDT1
gsea,cytoskeleton-dependent cytokinesis (GO:0061640),0.531473752356753,1.780665101767524,0.020833333333333332,0.03107201585590295,0.54,21/72,18.03%,AURKB;KIF4A;CEP55;KIF20A;CIT;PLK1;NUSAP1;CKAP2;ANLN;INCENP;ROCK2;RACGAP1;ESPL1;SNX9;STAMBP;CENPA;USP8;PDCD6IP;RHOA;ROCK1;RAB35
gsea,positive regulation of telomere maintenance (GO:0032206),0.49210779646579056,1.7784194913887135,0.0,0.031577967264530035,0.55,15/32,32.02%,AURKB;NEK2;HNRNPD;MAPKAPK5;NAF1;HNRNPA2B1;PNKP;NEK7;MAPK1;RAD50;NABP2;TNKS2;DHX36;GNL3;NBN
gsea,regulation of mitotic cell cycle (GO:0007346),0.45731259529146806,1.7766304599693432,0.0,0.03193913554836812,0.56,58/178,21.56%,BUB1B;ANAPC1;PLK1;MKI67;KIF20B;CDK1;UBE2C;CDC26;BORA;FBXO5;PSMD14;NEK2;CYLD;PSMD6;PSMB2;PSMD5;RNF20;INTS13;TTLL12;IQGAP1;PRMT5;EIF4E;MAD2L1;PTPN3;SRA1;PSMD1;PKMYT1;PSMA5;PSMD11;FOXA1;PSMA4;PSMA3;PSME4;CDC27;PSMD7;CDC25C;BUB3;GBF1;ENST00000629691.2;NEK7;HNRNPU;LGMN;DLGAP5;ANAPC2;PSMC6;PSMA1;CCNB1;RB1;CKS1B;CDC23;ZNF268;PSMD10;PSMB3;TFAP4;CDC20;PSME1;ANAPC10;PSMC3
gsea,negative regulation of endocytosis (GO:0045806),-0.5918063476094435,-1.7729488963893187,0.0,1.0,0.52,5/25,8.44%,SNX33;NR1H3;UNC119;LGALS3;NR1H2
gsea,regulation of protein tyrosine kinase activity (GO:0061097),-0.6496970529147528,-1.772541366968448,0.0,0.9030251167954114,0.52,12/39,20.69%,GAS6;SH3BP5L;MVP;UNC119;APP;GPRC5B;RAP2C;SH3BP5;PDGFB;NEDD9;HYAL2;EFNA1
gsea,interleukin-12-mediated signaling pathway (GO:0035722),0.5208421544430878,1.7658462969197108,0.0,0.03562929876449256,0.62,10/46,12.38%,LMNB1;HSPA9;SNRPA1;BOLA2;P4HB;CAPZA1;MSN;HNRNPA2B1;JAK1;RAP1B
gsea,regulation of hematopoietic stem cell differentiation (GO:1902036),0.5042930050618519,1.763617564458391,0.0,0.035679825750849985,0.62,27/71,25.83%,PRKDC;PSMD14;PSMD6;PSMB2;N4BP2L2;PSMD5;PSMD1;PSMA5;PSMD11;PSMA4;PSMA3;PSME4;PSMD7;ENST00000629691.2;GATA2;PUS7;PSMC6;PSMA1;PSMD10;RUNX1;PSMB3;EIF2AK2;PSME1;PSMC3;PSMA6;METTL3;PSMD13
gsea,recombinational repair (GO:0000725),0.5110992657657841,1.7612838556015409,0.0,0.03612201162554,0.62,26/79,23.09%,POLQ;BRCA1;XRCC2;NUCKS1;RECQL;PSMD14;RFWD3;FEN1;PARP1;ENST00000647028.2;RPA3;ERCC5;RPA1;RPA2;RBBP8;RAD51AP1;SMC6;RAD51;HUS1;SMC5;MCM8;RAD50;INO80;RECQL4;NABP2;RHNO1
gsea,DNA replication-independent nucleosome assembly (GO:0006336),0.6870569411728957,1.7607047614630644,0.0,0.03590762287469138,0.62,16/39,15.19%,CENPH;MIS18BP1;SMARCA5;CENPU;ASF1B;OIP5;NPM1;CENPQ;CENPK;CENPN;HJURP;CENPA;CENPM;MIS18A;ASF1A;CENPI
gsea,regulation of cellular response to stress (GO:0080135),0.4755916647209583,1.760486180591014,0.0,0.03582568667373081,0.62,37/118,18.14%,NDC1;NUP188;NUP50;SEH1L;NUP62;DNAJC2;YWHAE;BAG2;NUP153;HSPA8;HSP90AA1;NUP205;NUP210;NUP43;RPA3;POM121C;NUP58;NPM1;ROCK2;PNPT1;RPA1;NUP35;RPA2;NUP133;TPR;RANBP2;ING2;PTGES3;NUP107;NUP85;NUP37;HSP90AB1;MAPK1;NUP214;NUP93;NUP88;ARMT1
gsea,error-prone translesion synthesis (GO:0042276),0.7306864209438645,1.760409149603319,0.0,0.03561807458132619,0.62,11/21,16.10%,PCNA;RFC3;POLE2;RFC5;RFC2;RPA3;RPA1;RPA2;RFC1;RPS27A;RFC4
gsea,mitotic cytokinesis (GO:0000281),0.5323056117662468,1.7599704918472057,0.06,0.03591842540864887,0.62,16/49,11.60%,KIF4A;CEP55;KIF20A;CIT;PLK1;NUSAP1;CKAP2;ANLN;INCENP;ROCK2;RACGAP1;ESPL1;SNX9;STAMBP;CENPA;USP8
gsea,positive regulation of protein targeting to membrane (GO:0090314),-0.5689610524406246,-1.7586519053887328,0.0,0.7272538045237985,0.6,9/24,18.97%,CIB1;FIS1;ERBB2;MTCL1;ENST00000638355.1;PDZK1;MYO1C;AKT2;ITGAM
gsea,"protein localization to chromosome, centromeric region (GO:0071459)",0.6962028356030875,1.7583118302260476,0.0,0.03621326521161702,0.62,10/17,18.73%,AURKB;TTK;CDK1;SPDL1;CHAMP1;CENPA;BUB3;RB1;ZW10;HASPIN
gsea,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.5656831127885844,1.756861192461466,0.0,0.03625526805841419,0.63,12/26,18.52%,PLK1;CENPE;CDC6;UBE2C;FBXO5;ESPL1;CDC27;DLGAP5;CCNB1;RB1;CDC23;CDK5RAP2
gsea,cellular response to interleukin-12 (GO:0071349),0.5007044977336225,1.7563515082489807,0.0,0.035928644021851905,0.63,10/48,12.38%,LMNB1;HSPA9;SNRPA1;BOLA2;P4HB;CAPZA1;MSN;HNRNPA2B1;JAK1;RAP1B
gsea,DNA synthesis involved in DNA repair (GO:0000731),0.6141700594971206,1.7558636615141583,0.0,0.03572938106439283,0.64,18/43,19.52%,DTL;PCNA;USP10;POLE;PCLAF;RFC3;RFC5;RFC2;RPA3;RPA1;POLD3;RPA2;RFC1;RPS27A;POLA1;RFC4;POLD1;VCP
gsea,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.6864039892098034,1.7533679694328383,0.0,0.03637681611949982,0.64,14/24,19.61%,PCNA;POLE;RFC3;RFC5;RFC2;RPA3;RPA1;POLD3;RPA2;RFC1;RPS27A;RFC4;POLD1;LIG1
gsea,regulation of double-strand break repair via homologous recombination (GO:0010569),0.4978791961022493,1.7520161167808614,0.021739130434782608,0.0368934962369169,0.65,13/46,15.36%,POLQ;CHEK1;RMI2;SHLD2;PARP1;SMCHD1;TIMELESS;RPA2;RAD51AP1;ACTR2;MMS19;PPP4R2;RAD51
gsea,DNA replication initiation (GO:0006270),0.7024905576177969,1.7508716805738682,0.0,0.03704611601873277,0.66,28/38,20.18%,CDK2;ORC1;MCM6;CDC6;POLE;MCM2;TOPBP1;MCM3;MCM5;POLE2;MCM10;GMNN;NOC3L;RPA3;ORC3;RPA1;RPA2;ORC6;PRIM2;CDC7;CDC45;POLA1;MCM7;MCM4;MCM8;ORC4;ORC2;PRIM1
gsea,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.7411616558548546,1.750395365744844,0.0,0.03684409081845434,0.66,8/24,11.94%,HSD17B12;ELOVL6;FAR1;ELOVL5;ACOT7;TECR;ACSL3;ELOVL7
gsea,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.6942958650372775,1.7499438630771036,0.0,0.03676185402148354,0.66,12/23,21.12%,DTL;CDC25A;CDK1;FBXO5;NPM1;DBF4B;VPS4B;CDC25C;CDC7;CCNB1;BRD4;RAB11A
gsea,protein localization to chromatin (GO:0071168),0.5377738217446998,1.7489230935579712,0.0,0.036565661977118726,0.66,6/21,18.17%,RAD21;PLK1;MSH2;TASOR;FAM47E;MCM8
gsea,nuclear membrane reassembly (GO:0031468),0.5225865399817275,1.7454253955529515,0.043478260869565216,0.0374021852198686,0.67,21/54,18.25%,NDC1;NUP188;SEH1L;NSFL1C;CDK1;CHMP2B;NUP205;NUP43;CCNB2;LBR;NUP35;PPP2CA;RAN;NUP133;NUP107;NUP85;NUP37;CCNB1;NUP93;AHCTF1;CHMP4C
gsea,regulation of histone acetylation (GO:0035065),0.49030540650217114,1.7423017946322712,0.0,0.038905326047894415,0.68,8/33,13.25%,BRCA1;CHEK1;IWS1;SETD5;PARK7;RPS6KA4;GLYR1;PAXIP1
gsea,regulation of glycolytic process (GO:0006110),0.5338527210958707,1.7349531957071573,0.0,0.042745894701201964,0.71,26/71,23.50%,NDC1;NUP188;NUP50;SEH1L;NUP62;NUP153;NUP205;NUP210;NUP43;POM121C;NUP58;NUP35;NUP133;TPR;RANBP2;NUP107;NUP85;NUP37;NUP214;NUP93;NUP88;ARNT;PRKAA1;HIF1A;PGAM1;NUP155
gsea,regulation of mitotic nuclear division (GO:0007088),0.48807599683641284,1.7325693153961501,0.0,0.043176488593036765,0.71,16/57,22.07%,MKI67;KIF20B;NUP62;CHEK1;NUSAP1;BORA;FBXO5;NEK2;PRMT5;PKMYT1;CDC25C;CCNB1;CDK5RAP2;BMP4;PHIP;AURKA
gsea,protein import into nucleus (GO:0006606),0.5157654549764286,1.7305584132721354,0.0,0.04326810064631078,0.72,36/76,28.50%,CSE1L;NUP188;NUP50;NUP62;IPO9;NUP153;NXT2;IPO11;KPNA2;IPO8;KPNA4;POM121C;NUP35;RAN;NUP133;TPR;RANBP2;APPL1;NUP107;IPO7;NUP85;NUP214;TNPO3;NUP93;NUP88;E2F3;KPNA1;KPNA3;RPL23;NUP155;IPO4;PHB2;NUP62CL;TNPO1;HEATR3;KPNB1
gsea,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.5617282698970105,1.7302209656781276,0.0,0.04335823508582232,0.72,17/43,24.83%,PCNA;FAM111A;POLE;DONSON;NUCKS1;ETAA1;THOC1;RFWD3;ENST00000647028.2;TRAIP;TIMELESS;TIPIN;RAD51;POLD1;SMARCAL1;ATR;DDX11
gsea,positive regulation of protein localization to nucleus (GO:1900182),0.48184882250654915,1.728469688823538,0.0,0.04388248554346761,0.72,17/68,12.77%,PLK1;CCT8;CDK1;KAT7;GTSE1;TFRC;CCT7;FERMT2;RAN;CCT2;CCT6A;PARK7;TPR;CCT5;HDAC3;CCT3;CCT4
gsea,regulation of cytokinesis (GO:0032465),0.49628963568166296,1.7237998830578423,0.0,0.04634287067762516,0.72,22/84,22.86%,AURKB;KIF20A;CIT;PLK1;KIF20B;E2F8;E2F7;CDC6;PRC1;PLK4;MYO19;RACGAP1;PIK3C3;KIF14;PIK3R4;RHOA;AHCTF1;CHMP4C;CETN2;RAB11A;AURKA;ECT2
gsea,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.6868770273318859,1.7227291830706244,0.0,0.046513839915849974,0.72,11/20,21.12%,DTL;CDC25A;CDK1;FBXO5;DBF4B;VPS4B;CDC25C;CDC7;CCNB1;BRD4;RAB11A
gsea,regulation of protein targeting to membrane (GO:0090313),-0.5478642403242135,-1.7224011486862092,0.0,0.7810837689069801,0.71,10/29,18.97%,CIB1;FIS1;ERBB2;MTCL1;INPP5K;ENST00000638355.1;PDZK1;MYO1C;AKT2;ITGAM
gsea,chaperone-mediated protein complex assembly (GO:0051131),0.6082919712485301,1.7220805336083382,0.018518518518518517,0.046469462872439485,0.72,9/22,19.18%,HSPD1;HSP90AA1;HSPA4;CCT2;MKKS;PTGES3;PSMG2;HSP90AB1;PSMG1
gsea,regulation of response to DNA damage stimulus (GO:2001020),0.533628718688236,1.7207058307673626,0.0,0.04642577384520589,0.73,11/41,13.07%,USP1;UBE2V2;FBXO5;ETAA1;HMGA2;RFWD3;WDR76;BCLAF1;RPA2;ING2;CRY1
gsea,regulation of ATP metabolic process (GO:1903578),0.5605290167270466,1.7194475379128789,0.0,0.04648745843982539,0.73,25/56,23.50%,NDC1;NUP188;NUP50;SEH1L;NUP62;NUP153;NUP205;NUP210;NUP43;POM121C;NUP58;NUP35;NUP133;TPR;RANBP2;NUP107;NUP85;NUP37;NUP214;NUP93;NUP88;HIF1A;PGAM1;COX7A2L;NUP155
gsea,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.5441356587090479,1.715011008088309,0.0392156862745098,0.04862624598512785,0.73,28/66,25.83%,AURKB;CHEK1;PSMD14;PSMD6;PSMB2;PSMD5;PSMD1;PSMA5;PSMD11;PSMA4;PSMA3;PSME4;PSMD7;ENST00000629691.2;PSMC6;PSMA1;PSMD10;PSMB3;CHMP4C;USP47;PSME1;PSMC3;AURKA;SKP1;NABP2;CUL1;PSMA6;PSMD13
gsea,membrane lipid biosynthetic process (GO:0046467),0.4774891875011937,1.7125185373154816,0.0,0.049907706883596324,0.74,10/58,15.13%,B3GNT5;ELOVL6;HACD3;ELOVL5;CERS2;CERS6;ELOVL7;PLPP1;SPTLC1;SAMD8
gsea,nucleotide-excision repair (GO:0006289),0.4355558579402114,1.7119217117101018,0.021739130434782608,0.04994182014872524,0.74,33/105,19.61%,PCNA;COPS3;POLE;COPS4;RFC3;AQR;RFC5;RFC2;PARP1;RPA3;ERCC5;COPS8;RPA1;POLD3;RAD23B;GPS1;RPA2;RFC1;POLR2B;DDB2;GTF2H1;PNKP;MMS19;RPS27A;POLA1;FANCC;HUS1;RFC4;CHD1L;POLR2K;POLD1;CETN2;LIG1
gsea,positive regulation of double-strand break repair (GO:2000781),0.5232523817614219,1.7103586640193325,0.0,0.05068645671963616,0.74,14/40,24.83%,PRKDC;FOXM1;SHLD2;PARP1;SMCHD1;TIMELESS;RAD51AP1;ACTR2;PNKP;MMS19;SPIRE1;WRAP53;FUS;DDX11
gsea,cellular response to ketone (GO:1901655),0.5548733179777977,1.7058561074176777,0.0,0.05333571099277264,0.74,10/39,25.50%,ROCK2;MSN;LARP1;ADCY3;RNA5SP498;SFRP1;GOLPH3;AKR1C2;NR3C1;SPP1
gsea,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.5213989361492849,-1.7015342666937192,0.05,0.7566954993292937,0.75,22/39,27.22%,NDUFA1;NDUFA2;NDUFB10;NDUFA13;NDUFA10;NDUFS7;NDUFB4;NDUFS4;NDUFB7;NDUFA11;NDUFA8;NDUFB9;NDUFS3;NDUFC2;NDUFAF1;NDUFB2;NDUFB1;NDUFB8;NDUFB3;NDUFS5;NDUFS6;NDUFB6
gsea,cellular response to DNA damage stimulus (GO:0006974),0.4105209957813869,1.6998753316319886,0.0,0.05654649944364691,0.74,79/350,16.19%,DTL;POLQ;BAZ1B;PRKDC;TOP2A;BRCA1;SMC1A;E2F1;USP10;CHEK1;FAM111A;UBE2A;CDK1;TOPBP1;RAD54L;PCLAF;XRCC2;RMI2;XRCC5;EXO1;PDS5A;RECQL;RFC3;ETAA1;POLE2;RFC5;MCM10;RFWD3;TAOK3;MSH2;FEN1;RFC2;PARP1;WDR76;UBA1;FBXO45;UBE2T;INIP;RNF8;NPM1;RPA1;CASP2;CBX5;UBA6;TRAIP;TIMELESS;CSNK1E;PARP2;RBBP8;SETX;RAD51AP1;PARK7;FANCL;PSME4;USP16;WDHD1;DDB2;TRRAP;SMC6;SUV39H1;UNG;GTF2H1;PNKP;MMS19;CRY1;MBD4;FANCA;POLA1;IGHMBP2;ASF1A;MCM7;FANCC;RAD51;DCUN1D5;HUS1;UFL1;RFC4;CHD1L;TICRR
gsea,G1/S transition of mitotic cell cycle (GO:0000082),0.4724345006451175,1.6975601210351126,0.0,0.05752467608281807,0.74,26/85,21.40%,CDK2;ORC1;CDC6;CDC25A;PCNA;CDKN3;DHFR;E2F1;POLE;TYMS;FBXO5;EIF4E;CDK6;CDC7;CDC45;PPP6C;POLA1;RB1;CUL2;BRD4;CDK17;CUL5;E2F3;PHF8;GSPT1;BCAT1
gsea,positive regulation of telomerase activity (GO:0051973),0.5921040033938842,1.6806331086467914,0.0,0.06923954591360597,0.78,15/34,18.87%,AURKB;XRCC5;HSP90AA1;NEK2;MAPKAPK5;NAF1;CCT2;PTGES3;PNKP;CCT4;NEK7;HSP90AB1;MAPK1;ACD;DKC1
gsea,translesion synthesis (GO:0019985),0.5960413233722838,1.6771575533002305,0.02127659574468085,0.07099363144004056,0.8,17/42,19.52%,DTL;PCNA;USP10;PCLAF;RFC3;POLE2;RFC5;RFC2;RPA3;RPA1;POLD3;RPA2;RFC1;RPS27A;RFC4;POLD1;VCP
gsea,tRNA aminoacylation (GO:0043039),0.5752910096746292,1.6769679270737312,0.021739130434782608,0.07077820248946388,0.8,9/38,17.13%,PPA1;FARSB;EEF1E1;AIMP1;GATC;MARS2;IARS2;LARS2;WARS2
gsea,peptidyl-tyrosine phosphorylation (GO:0018108),-0.525835486481752,-1.6756108467218591,0.02040816326530612,0.836012303991859,0.77,7/69,16.18%,PTPN6;MAPK3;EGFR;ERBB2;ABI1;PTK2B;PDGFB
gsea,DNA strand elongation involved in DNA replication (GO:0006271),0.758784646551399,1.6738222385060928,0.0,0.07230342834780203,0.82,13/18,19.61%,GINS2;PCNA;GINS1;POLE;MCM3;RFC3;GINS3;POLD3;POLA1;MCM7;MCM4;RFC4;LIG1
gsea,regulation of primary metabolic process (GO:0080090),0.4382705761180415,1.673162131872298,0.0,0.07246522356721925,0.82,45/130,27.60%,ELOVL6;PSMD14;PSMD6;PSMB2;PSMD5;SIN3A;PSMD1;ROCK2;PSMA5;IDI1;PSMD11;PSMA4;PSMA3;HMGCS1;PSME4;CERS2;PSMD7;HDAC3;CYP51A1;PLPP1;ENST00000629691.2;LDLR;SQLE;FASN;PSMC6;DHCR7;PSMA1;GGPS1;PSMD10;TBL1XR1;PSMB3;SCD;SC5D;ACACA;PSME1;NCOA6;PSMC3;PPARD;MVD;FDPS;PSMA6;PSMD13;ADIPOR1;ODC1;AZIN1
gsea,midbody abscission (GO:0061952),0.5156505251612717,1.672567553904343,0.0,0.07224402325108,0.82,6/17,18.25%,CEP55;KIF20A;CHMP2B;VPS4B;PDCD6IP;CHMP4C
gsea,positive regulation of myeloid cell differentiation (GO:0045639),0.5357835132092424,1.6690736328421512,0.0,0.07438894946475437,0.82,9/37,20.97%,PRKDC;ABCB10;PITHD1;PRMT1;STAT1;STAT5B;ARNT;ANKRD54;HIF1A
gsea,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.4692872621831115,1.667582814850271,0.04081632653061224,0.07462688458769733,0.82,27/75,25.83%,PRKDC;PSMD14;PSMD6;PSMB2;PSMD5;PSMD1;PSMA5;PSMD11;PSMA4;PSMA3;PSME4;PSMD7;KITLG;ENST00000629691.2;GATA2;PUS7;PSMC6;PSMA1;PSMD10;RUNX1;PSMB3;EIF2AK2;PSME1;PSMC3;PSMA6;METTL3;PSMD13
gsea,error-free translesion synthesis (GO:0070987),0.6862935114654396,1.6674210772855163,0.0,0.0742089688904284,0.82,12/22,19.52%,PCNA;RFC3;RFC5;RFC2;RPA3;RPA1;RPA2;RFC1;RPS27A;RFC4;POLD1;VCP
gsea,negative regulation of phosphate metabolic process (GO:0045936),-0.5643134864750199,-1.6673433643617361,0.0,0.7824962169520198,0.78,6/22,11.21%,CDKN2B;TESK1;INHA;PRKRIP1;CDKN2A;INPP5K
gsea,mitotic nuclear membrane organization (GO:0101024),0.5084317776182449,1.6635392854913336,0.044444444444444446,0.07559730047601262,0.83,20/51,18.25%,NDC1;NUP188;SEH1L;CDK1;CHMP2B;NUP205;NUP43;CCNB2;LBR;NUP35;PPP2CA;RAN;NUP133;NUP107;NUP85;NUP37;CCNB1;NUP93;AHCTF1;CHMP4C
gsea,mitotic nuclear membrane reassembly (GO:0007084),0.5084317776182449,1.6635392854913336,0.044444444444444446,0.07559730047601262,0.83,20/51,18.25%,NDC1;NUP188;SEH1L;CDK1;CHMP2B;NUP205;NUP43;CCNB2;LBR;NUP35;PPP2CA;RAN;NUP133;NUP107;NUP85;NUP37;CCNB1;NUP93;AHCTF1;CHMP4C
gsea,regulation of phosphatase activity (GO:0010921),0.6016697242495141,1.6631693594922414,0.022222222222222223,0.07545533719191684,0.83,8/28,22.00%,URI1;HSP90B1;HTT;TIPRL;SH2D4A;PPP1R26;PPP6R3;SH3RF2
gsea,regulation of telomerase activity (GO:0051972),0.5293447156554475,1.6612543849893409,0.0,0.07622267960403803,0.83,20/46,24.89%,AURKB;XRCC5;HSP90AA1;NEK2;MAPKAPK5;NAF1;CCT2;PTGES3;PNKP;CCT4;NEK7;HSP90AB1;MAPK1;ACD;DKC1;PIF1;PARP4;WRAP53;NABP2;SMG6
gsea,very long-chain fatty acid metabolic process (GO:0000038),0.680043533507887,1.656685096690058,0.0,0.0778812620362924,0.83,6/33,11.94%,ELOVL6;HACD3;ELOVL5;ABCD3;TECR;ELOVL7
gsea,"RNA splicing, via transesterification reactions (GO:0000375)",0.5692962734308583,1.648410428104294,0.023809523809523808,0.08498040759425762,0.83,12/25,18.40%,SRRM1;SF3B3;SMNDC1;SCAF11;SF3B1;BCAS2;SNRNP40;SRSF4;LSM1;TXNL4A;DBR1;WDR83
gsea,regulation of double-strand break repair (GO:2000779),0.4625638229052648,1.6483988049057514,0.02127659574468085,0.08442498009364155,0.83,13/42,24.83%,CHEK1;FOXM1;SHLD2;TIMELESS;RPA2;RAD51AP1;ACTR2;PPP4R2;RAD51;SPIRE1;TERF2IP;WRAP53;DDX11
gsea,regulation of phosphorylation (GO:0042325),0.3982865526592646,1.647619127866937,0.043478260869565216,0.08440707214964785,0.83,31/125,18.57%,NDC1;NUP188;NUP50;SEH1L;NUP62;NUP153;NUP205;CORO1C;FN1;NUP210;NUP43;POM121C;NUP58;NUP35;PPP2CA;NUP133;TPR;BCL10;RANBP2;PTGES3;NUP107;NUP85;NUP37;MCM7;NUP214;BTBD10;NUP93;NUP88;ROCK1;ITGA6;BMP4
gsea,RNA 3'-end processing (GO:0031123),0.4255853214528038,1.642266694209555,0.0,0.08869228847935301,0.83,19/69,16.83%,CPSF3;SRRM1;NCBP1;THOC3;THOC1;U2AF1;PAPOLA;SUPV3L1;CPSF2;PNPT1;SRSF1;SRSF7;TENT4A;SARNP;CSTF2;NUDT21;SRSF4;CSTF3;CSTF1
gsea,nucleosome assembly (GO:0006334),0.581443674877421,1.6422274463115116,0.0,0.08838550187601939,0.83,9/58,14.44%,NAP1L1;SMARCA5;ASF1B;CHAF1B;CHAF1A;NPM1;GRWD1;ANP32B;ASF1A
gsea,termination of RNA polymerase II transcription (GO:0006369),0.5248364368770608,1.6389898299734724,0.0392156862745098,0.09146374770502744,0.84,13/34,16.83%,CPSF3;NCBP1;TTF2;PAPOLA;SLBP;CPSF2;SNRPF;SETX;SNRPD3;CSTF2;NUDT21;CSTF3;CSTF1
gsea,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.524787108837854,1.6368341552338845,0.022727272727272728,0.09269394581142057,0.84,6/28,9.82%,ZNF326;KAT7;THOC1;SETD5;SUPT16H;WDR43
gsea,purine-containing compound biosynthetic process (GO:0072522),0.5700200039620623,1.6327797658217362,0.021739130434782608,0.09579197942151679,0.86,7/26,12.62%,HPRT1;GART;DCK;PNP;ADK;SHMT1;PPAT
gsea,chromatin assembly (GO:0031497),0.5407880643617287,1.6311759550863403,0.0,0.09646932887386062,0.87,8/73,9.40%,NAP1L1;SMARCA5;HMGA2;CHAF1B;CHAF1A;NPM1;GRWD1;ANP32B
gsea,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.4349164542020867,1.627254829832903,0.022727272727272728,0.09975905272045792,0.87,19/65,20.28%,CDK2;E2F8;E2F7;PRKDC;PCNA;E2F1;CDK1;CNOT9;GTSE1;RFWD3;CASP2;RPA2;CDC25C;PRMT1;CNOT7;CCNB1;CNOT11;MUC1;CNOT10
gsea,mitotic cell cycle checkpoint signaling (GO:0007093),0.6158805830308839,1.6250678198946484,0.0,0.10099168968700804,0.87,4/23,1.56%,AURKB;BUB1;BUB1B;CHEK1
gsea,regulation of chromosome organization (GO:0033044),0.51929647672539,1.6245388604804383,0.02127659574468085,0.10053911726912992,0.87,10/22,28.10%,BUB1;RMI2;XRCC5;HNRNPD;YLPM1;RB1;PIF1;TERF2IP;SMG6;SMG5
gsea,neuron projection extension (GO:1990138),0.5067381470608822,1.6196619111246695,0.0,0.10399283269148481,0.87,4/33,5.21%,EIF2AK4;HSP90AA1;ALCAM;IQGAP1
gsea,positive regulation of transferase activity (GO:0051347),0.4116034879374694,1.6149894855877451,0.0,0.10781714528406677,0.88,28/148,19.35%,AURKB;DSCC1;PLK1;PCNA;XRCC5;HSP90AA1;RFC3;RYK;RFC5;NEK2;RFC2;HNRNPD;MAPKAPK5;NAF1;HNRNPA2B1;CCT2;LMO4;PTGES3;PNKP;CCT4;NEK7;DCUN1D5;RFC4;HSP90AB1;MAPK1;ACD;DKC1;RAD50
gsea,aerobic respiration (GO:0009060),-0.5131843259542106,-1.614494082284372,0.047619047619047616,1.0,0.9,9/21,15.21%,BLOC1S1;SURF1;UQCRH;NDUFS7;UQCR10;UQCRB;SDHC;SIRT3;UQCRC1
gsea,response to light stimulus (GO:0009416),0.4496121489872701,1.6122765127011531,0.04081632653061224,0.10970949366415972,0.89,8/61,13.07%,USP1;DTL;COPS3;UBE2A;PCLAF;ERCC5;DDB2;CRY1
gsea,mitotic cytokinetic process (GO:1902410),0.4898939332165167,1.6031679941946628,0.0,0.11842552765682983,0.89,7/20,18.25%,CEP55;KIF20A;CHMP2B;VPS4B;PDCD6IP;RHOA;CHMP4C
gsea,glutamine family amino acid metabolic process (GO:0009064),0.503610329474565,1.6019760086775356,0.02127659574468085,0.1189358988719471,0.89,9/37,12.91%,GOT2;GCLM;FPGS;GLS;DDAH2;SLC39A8;DDAH1;GOT1;ALDH18A1
gsea,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.5402877802561132,1.6012818503649553,0.023255813953488372,0.1180170480423866,0.89,17/37,18.49%,PCNA;RFC3;RFC5;RFC2;PARP1;RPA3;ERCC5;RPA1;POLD3;RPA2;RFC1;DDB2;GTF2H1;RPS27A;RFC4;CHD1L;POLD1
gsea,"nucleotide-excision repair, DNA incision (GO:0033683)",0.5402877802561132,1.6012818503649553,0.023255813953488372,0.1180170480423866,0.89,17/39,18.49%,PCNA;RFC3;RFC5;RFC2;PARP1;RPA3;ERCC5;RPA1;POLD3;RPA2;RFC1;DDB2;GTF2H1;RPS27A;RFC4;CHD1L;POLD1
gsea,establishment of spindle orientation (GO:0051294),0.5561079222229703,1.600238288698169,0.06818181818181818,0.11836165890894376,0.89,13/30,21.28%,NDC80;PLK1;NSFL1C;SPDL1;MAD2L1;GPSM2;HTT;ENST00000632578.1;CENPA;ZW10;ITGB1;CDK5RAP2;PAFAH1B1
gsea,protein depolymerization (GO:0051261),0.5532565784315616,1.6000526331586007,0.05357142857142857,0.11767350972924062,0.89,10/28,14.97%,KIF2C;KIF18A;KIF18B;TWF1;KIF2A;MICAL3;CKAP5;KATNB1;VPS4B;KIF14
gsea,regulation of stem cell differentiation (GO:2000736),0.4677758084247594,1.5994302652576338,0.021739130434782608,0.11793744501078965,0.89,32/91,25.83%,PRKDC;PSMD14;PSMD6;PSMB2;PSMD5;PSMD1;PSMA5;PSMD11;PSMA4;SMYD5;PSMA3;PSME4;PSMD7;NUDT21;ENST00000629691.2;GATA2;PUS7;HNRNPU;PSMC6;PSMA1;PSMD10;RUNX1;PSMB3;NOTCH1;EIF2AK2;NSUN2;PSME1;PSMC3;PTN;PSMA6;METTL3;PSMD13
gsea,nucleosome organization (GO:0034728),0.4567444315418293,1.5985638574452263,0.01818181818181818,0.11827657179936935,0.89,13/94,14.44%,NAP1L1;SMARCA5;ANP32E;CHAF1B;CHAF1A;SUPT16H;RNF8;NPM1;GRWD1;ACTR6;ANP32B;BPTF;ASF1A
gsea,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.4229900456009365,1.5972119777831113,0.045454545454545456,0.1187885915907086,0.89,17/100,15.12%,KIF4A;KIF2C;KIF11;KIF18A;CENPE;DYNC1LI1;KIF22;KIF2A;CAPZA1;AP1S2;RACGAP1;AP1S3;DYNC1I2;DNM2;LGMN;AP1B1;SAR1B
gsea,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.4229900456009365,1.5972119777831113,0.045454545454545456,0.1187885915907086,0.89,17/98,15.12%,KIF4A;KIF2C;KIF11;KIF18A;CENPE;DYNC1LI1;KIF22;KIF2A;CAPZA1;AP1S2;RACGAP1;AP1S3;DYNC1I2;DNM2;LGMN;AP1B1;SAR1B
gsea,regulation of centrosome duplication (GO:0010824),0.538303890567224,1.5968894951663375,0.021739130434782608,0.11834816778714137,0.89,8/32,20.11%,CHMP2B;STIL;CCNF;NPM1;VPS4B;PDCD6IP;CHMP4C;NAT10
gsea,positive regulation of peptidase activity (GO:0010952),-0.5094921684226289,-1.5953504813404173,0.02127659574468085,1.0,0.92,6/22,7.79%,APH1A;DDRGK1;NDUFA13;PRSS22;GRN;VSIR
gsea,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.5109450179550683,1.5939871747547478,0.04081632653061224,0.12066551807300561,0.91,19/58,17.88%,DTL;CDC25A;CDK1;UBE2C;FBXO5;ADAM17;CCND3;CDCA5;ESPL1;DBF4B;CDC27;VPS4B;CDC25C;CDC7;DLGAP5;CCNB1;RB1;CDC23;BRD4
gsea,protein import (GO:0017038),0.44882852039244364,1.5937064969884147,0.046511627906976744,0.12021952958298496,0.91,27/89,17.62%,CSE1L;NUP188;NUP50;NUP62;IPO9;NUP153;NXT2;HSP90AA1;IPO11;PXMP2;IPO8;ABCD3;HSPA4;POM121C;RAN;NUP133;PEX19;TPR;APPL1;NUP107;IPO7;NUP85;PEX13;NUP214;TNPO3;NUP93;NUP88
gsea,regulation of mitotic spindle assembly (GO:1901673),0.542264367095941,1.5928132528758983,0.0,0.1202322029468457,0.91,8/19,19.57%,PLK1;CHMP2B;TPR;VPS4B;PDCD6IP;HNRNPU;CHMP4C;DRG1
gsea,glucose metabolic process (GO:0006006),0.5392250831538289,1.5914921099864994,0.0,0.12054553611412093,0.91,20/62,25.69%,GOT2;GAPDH;ALDOA;PC;GPI;SLC39A14;PGK1;GOT1;CRY1;PGM1;SORD;ENO1;TPI1;ENO2;ADPGK;PGAM1;PPARD;SLC25A13;MDH1;SLC25A12
gsea,positive regulation of signaling receptor activity (GO:2000273),0.5865928218300306,1.5908829905857966,0.0,0.12063106573912219,0.91,6/37,20.97%,ADAM17;HFE;PARK7;ITGB1;HDAC2;HIF1A
gsea,histone modification (GO:0016570),0.41127988494114653,1.5896200491812431,0.0,0.12116192923007216,0.91,18/114,13.04%,AURKB;CDK2;BAZ1B;UBE2A;MSL3;NSD1;NSD3;INCENP;RBM14;SIN3A;HUWE1;EZH2;PARP2;PARK7;USP16;RPS6KA4;TRRAP;PRMT1
gsea,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.4654113608065944,1.589383250235701,0.0,0.12072536210577452,0.91,4/25,7.03%,KAT7;THOC1;SUPT16H;LEO1
gsea,interstrand cross-link repair (GO:0036297),0.5318485350899743,1.5891027017513988,0.021739130434782608,0.1204406626561875,0.91,18/55,19.52%,USP1;FANCI;NEIL3;NUCKS1;RFWD3;RPA3;UBE2T;RNF8;RPA1;RPA2;RAD51AP1;FANCL;FANCA;RPS27A;FANCC;RAD51;MCM8;VCP
gsea,protein complex oligomerization (GO:0051259),0.43192600161854244,1.5844260893971533,0.06818181818181818,0.12418383956226242,0.94,20/90,18.60%,LRRC8D;POLQ;UGDH;JMJD6;PNPT1;EHD4;DNM1L;WDCP;OPA1;BCL10;NUDT21;PRMT1;ALS2;PDCD6IP;MCU;ELAVL1;STOML2;MICU1;ZNHIT6;ATL2
gsea,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.40558763036032375,1.5832625545099213,0.045454545454545456,0.12482992314832429,0.94,17/103,15.12%,KIF4A;KIF2C;KIF11;KIF18A;CENPE;DYNC1LI1;KIF22;KIF2A;CAPZA1;AP1S2;RACGAP1;AP1S3;DYNC1I2;DNM2;LGMN;AP1B1;SAR1B
gsea,DNA damage checkpoint signaling (GO:0000077),0.5282744389799562,1.5797622222759,0.0,0.12822033204668631,0.94,12/32,25.92%,E2F1;CHEK1;CLSPN;DONSON;TIPRL;INTS7;CDC5L;HUS1;MAP3K20;RHNO1;ATR;PRPF19
gsea,response to UV (GO:0009411),0.39184049912434615,1.5785744081532997,0.0,0.1284061203080119,0.94,13/99,7.02%,AURKB;USP1;DTL;CDC25A;PCNA;UBE2A;PCLAF;EIF2AK4;MSH2;FEN1;PARP1;ERCC5;NPM1
gsea,negative regulation of protein dephosphorylation (GO:0035308),0.5224138630248256,1.5781227943473624,0.04081632653061224,0.12823176361957525,0.94,10/22,28.12%,YWHAE;ARPP19;TIPRL;FKBP1A;MFHAS1;YWHAB;GSK3B;ENSA;BOD1L1;PPP1R8
gsea,peptidyl-tyrosine modification (GO:0018212),-0.4952271323968081,-1.5750630009557338,0.06,1.0,0.93,6/56,16.18%,PTPN6;EGFR;ERBB2;ABI1;PTK2B;PDGFB
gsea,regulation of supramolecular fiber organization (GO:1902903),0.4963080722650761,1.5744889971630778,0.019230769230769232,0.1312660581812248,0.94,4/23,12.97%,CAMSAP3;HSPA8;PARK7;CAMSAP2
gsea,signal transduction in response to DNA damage (GO:0042770),0.43042170086476134,1.5742517620619427,0.0,0.13093683894034436,0.94,12/52,15.95%,E2F7;E2F1;USP10;CHEK1;CLSPN;DONSON;TIPRL;INTS7;PAXIP1;CDC5L;HUS1;MAP3K20
gsea,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.49914909019841225,1.571193704457635,0.022727272727272728,0.13385514978577365,0.94,5/18,16.35%,DHX9;SRSF1;DDX5;HNRNPM;PQBP1
gsea,DNA duplex unwinding (GO:0032508),0.46025798899254744,1.5694206658561087,0.06818181818181818,0.1353401592012052,0.94,23/51,25.02%,DHX9;MCM6;MCM2;RECQL;PARP1;ASCC3;SUPV3L1;RPA1;RAD23B;DDB2;GTF2H1;RPS27A;MCM7;RAD51;MCM4;CHD1L;PIF1;RAD50;CETN2;RECQL4;CUL4B;DDX11;DDX1
gsea,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.3747061751929983,1.5662049951225845,0.023255813953488372,0.13862476345569552,0.94,19/74,20.28%,E2F8;E2F7;PCNA;E2F1;USP10;CDK1;CNOT9;FOXM1;GTSE1;CASP2;CDC25C;PRMT1;PAXIP1;CNOT7;CCNB1;CNOT11;TFAP4;MUC1;CNOT10
gsea,microtubule polymerization or depolymerization (GO:0031109),0.6348117147967349,1.5652523194400985,0.038461538461538464,0.13868138772709906,0.94,7/27,14.97%,KIF2C;KIF18A;KIF18B;KIF2A;CKAP5;KATNB1;KIF14
gsea,regulation of cellular amide metabolic process (GO:0034248),0.4412039188859786,1.5645166102525516,0.05555555555555555,0.13853016008529392,0.94,15/32,33.15%,PUM3;MAPKAPK5;EIF4E;GEMIN5;NOLC1;SAMD8;ROCK1;METAP1;PGAM1;CYFIP1;MTPN;ATXN2;METTL18;EIF2A;TCOF1
gsea,import into nucleus (GO:0051170),0.4745163139527315,1.5630631406047804,0.06666666666666667,0.13913663737245038,0.94,29/77,19.73%,CSE1L;NUP188;NUP50;NUP62;SNRPD1;IPO9;NUP153;NXT2;IPO11;IPO8;POM121C;DDX20;SNRPF;GEMIN5;RAN;NUP133;TPR;SNRPD3;APPL1;NUP107;IPO7;NUP85;SNUPN;NUP214;TNPO3;NUP93;NUP88;E2F3;GEMIN4
gsea,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.43992144961575774,1.5620483142954549,0.0,0.1393266316882856,0.94,21/75,19.35%,PCNA;RFC3;RFC5;FEN1;RFC2;PARP1;RPA3;ERCC5;DNA2;RPA1;POLD3;RPA2;RFC1;DDB2;GTF2H1;RPS27A;PNRC2;RFC4;CHD1L;POLD1;RAD50
gsea,visual system development (GO:0150063),-0.5033720149810733,-1.561147205690921,0.06666666666666667,1.0,0.93,8/41,29.71%,PBX2;SH3PXD2B;PBX1;ITGAM;SIPA1L3;SALL2;C3;FOXC1
gsea,cilium assembly (GO:0060271),0.36496155636292554,1.559776540380115,0.04878048780487805,0.14203279672645303,0.94,49/314,24.51%,PLK1;TUBG1;TUBB;YWHAE;CDK1;HSP90AA1;HAUS7;NEK2;PLK4;CNTRL;HAUS6;HAUS3;RAB8A;EHD4;CSNK1E;MAPRE1;HAUS2;TMEM138;SNX10;ENST00000632578.1;CKAP5;DYNC1I2;TUBB4B;MKKS;OFD1;ACTR2;RABL2B;GBF1;IFT74;TUBA4A;ACTR3;NEDD1;CEP72;CFAP298;HAUS8;TMEM107;IFT122;CDK5RAP2;NOTCH1;EXOC2;CETN2;IFT57;RAB11A;PAFAH1B1;TCTN3;CEP250;TCTN1;CEP78;HAUS1
gsea,histone mRNA metabolic process (GO:0008334),0.5002138224304953,1.5568616710289471,0.023255813953488372,0.14484746950340915,0.95,9/28,16.86%,SSB;CPSF3;NCBP1;SLBP;CPSF2;SNRPF;SNRPD3;LSM1;EXOSC10
gsea,negative regulation of double-strand break repair (GO:2000780),0.517641042070402,1.5562863385323726,0.07317073170731707,0.14487160639027735,0.95,5/32,6.30%,POLQ;RMI2;SHLD2;HMGA2;SMCHD1
gsea,regulation of cell communication (GO:0010646),0.5375430604067575,1.5552274459906887,0.020833333333333332,0.14496255568607513,0.95,5/38,14.77%,NUP62;GRK6;CDC42SE2;NCLN;CRK
gsea,regulation of protein localization to membrane (GO:1905475),-0.5397485282065267,-1.5548169273113048,0.0,1.0,0.93,8/30,15.79%,GSN;MMP14;VAMP8;CLN3;CRIPT;PDZK1;CDK5;ZDHHC7
gsea,protein K63-linked deubiquitination (GO:0070536),0.4697305144163339,1.553342879825337,0.022222222222222223,0.14632032245418014,0.95,9/32,17.49%,PSMD14;CYLD;STAMBP;USP16;STAMBPL1;USP8;UIMC1;OTUD4;USP25
gsea,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.41749545678180816,1.5513560074991024,0.02127659574468085,0.1466326565881684,0.95,30/115,26.80%,PSMD14;PSMD6;PSMB2;PSMD5;PSMD1;PSMA5;PSMD11;PSMA4;PSMA3;PSME4;BCL10;PSMD7;ENST00000629691.2;PSMC6;PSMA1;PSMD10;NRAS;PSMB3;PRKACB;MUC1;PSME1;PDPK1;PSMC3;SKP1;KRAS;CUL1;PAK2;PSMA6;PSMD13;RAF1
gsea,cellular response to lectin (GO:1990858),0.41749545678180816,1.5513560074991024,0.02127659574468085,0.1466326565881684,0.95,30/115,26.80%,PSMD14;PSMD6;PSMB2;PSMD5;PSMD1;PSMA5;PSMD11;PSMA4;PSMA3;PSME4;BCL10;PSMD7;ENST00000629691.2;PSMC6;PSMA1;PSMD10;NRAS;PSMB3;PRKACB;MUC1;PSME1;PDPK1;PSMC3;SKP1;KRAS;CUL1;PAK2;PSMA6;PSMD13;RAF1
gsea,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.41749545678180816,1.5513560074991024,0.02127659574468085,0.1466326565881684,0.95,30/119,26.80%,PSMD14;PSMD6;PSMB2;PSMD5;PSMD1;PSMA5;PSMD11;PSMA4;PSMA3;PSME4;BCL10;PSMD7;ENST00000629691.2;PSMC6;PSMA1;PSMD10;NRAS;PSMB3;PRKACB;MUC1;PSME1;PDPK1;PSMC3;SKP1;KRAS;CUL1;PAK2;PSMA6;PSMD13;RAF1
gsea,regulation of protein localization to nucleus (GO:1900180),0.486063430650988,1.5501722662983408,0.046511627906976744,0.14730189885704809,0.95,9/47,10.10%,PLK1;CDK1;KAT7;GTSE1;TFRC;SIN3A;FERMT2;PARK7;TPR
gsea,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.5034125650583618,1.546616585656003,0.023809523809523808,0.15056974986717012,0.95,7/29,15.66%,PRKDC;SHLD2;HMGA2;SMCHD1;ACTR2;PNKP;CYREN
gsea,tRNA aminoacylation for protein translation (GO:0006418),0.5149817277426265,1.5404863455200024,0.0,0.1560101954140472,0.95,10/43,22.80%,PPA1;FARSB;EEF1E1;AIMP1;MARS2;IARS2;LARS2;WARS2;AIMP2;EARS2
gsea,mismatch repair (GO:0006298),0.49981343274594353,1.5401909385376273,0.02,0.1553353186243429,0.95,7/29,8.49%,PCNA;EXO1;MSH2;RPA3;RPA1;POLD3;RPA2
gsea,protein export from nucleus (GO:0006611),0.520273355050947,1.5396929528472847,0.09803921568627451,0.15505203103415754,0.95,10/27,18.89%,CSE1L;XPO1;XPO7;RAN;TPR;STRADB;NUP214;XPO4;XPO5;STYX
gsea,establishment of protein localization to organelle (GO:0072594),0.41627114140294064,1.5389321462752366,0.10204081632653061,0.1550270126755502,0.95,22/76,17.62%,CSE1L;NUP188;NUP50;NUP62;IPO9;NUP153;NXT2;IPO11;IPO8;POM121C;RAN;NUP133;PEX19;TPR;APPL1;NUP107;IPO7;NUP85;NUP214;TNPO3;NUP93;NUP88
gsea,negative regulation of G0 to G1 transition (GO:0070317),0.46612919801652763,1.5387717737160516,0.08,0.15455700220111182,0.95,9/38,15.36%,BRCA1;E2F1;CHEK1;SUZ12;CBX5;EZH2;RBBP8;CDC7;RAD51
gsea,carbohydrate catabolic process (GO:0016052),0.6294192330435804,1.5378616052318363,0.07272727272727272,0.15504098201851257,0.95,12/41,23.10%,GAPDH;ALDOA;HKDC1;LDHA;GPI;PGK1;PGM1;ENO1;TPI1;PKM;ENO2;PGAM1
gsea,nucleus organization (GO:0006997),0.4345230033881863,1.5368334266785464,0.044444444444444446,0.1553944509784704,0.95,13/48,18.25%,CEP55;NDC1;SEH1L;CHMP2B;NUP205;PITPNB;NUP35;NUP133;TPR;VPS4B;PDCD6IP;NUP93;CHMP4C
gsea,hexose biosynthetic process (GO:0019319),0.5549951058849327,1.5363709844533784,0.09090909090909091,0.15536831581567,0.95,18/44,25.69%,GOT2;GAPDH;ALDOA;PC;GPI;SLC39A14;PGK1;GOT1;CRY1;PGM1;SORD;ENO1;TPI1;ENO2;PGAM1;SLC25A13;MDH1;SLC25A12
gsea,positive regulation of erythrocyte differentiation (GO:0045648),0.5134185224229019,1.5360354124379765,0.0196078431372549,0.15471805378342582,0.95,8/27,20.97%,PRKDC;ABCB10;PRMT1;STAT1;STAT5B;ARNT;ANKRD54;HIF1A
gsea,Fc-epsilon receptor signaling pathway (GO:0038095),0.4106670750607073,1.5346876637606888,0.0425531914893617,0.1553532049397236,0.95,31/111,25.83%,MAP2K4;PSMD14;PSMD6;PSMB2;PSMD5;PPP3R1;PSMD1;PSMA5;SOS1;PSMD11;PSMA4;PSMA3;PIK3CB;PSME4;BCL10;PSMD7;ENST00000629691.2;PSMC6;PSMA1;MAPK1;PSMD10;PSMB3;PSME1;PDPK1;PSMC3;SKP1;MAPK8;CUL1;PAK2;PSMA6;PSMD13
gsea,Fc receptor signaling pathway (GO:0038093),0.4106670750607073,1.5346876637606888,0.0425531914893617,0.1553532049397236,0.95,31/112,25.83%,MAP2K4;PSMD14;PSMD6;PSMB2;PSMD5;PPP3R1;PSMD1;PSMA5;SOS1;PSMD11;PSMA4;PSMA3;PIK3CB;PSME4;BCL10;PSMD7;ENST00000629691.2;PSMC6;PSMA1;MAPK1;PSMD10;PSMB3;PSME1;PDPK1;PSMC3;SKP1;MAPK8;CUL1;PAK2;PSMA6;PSMD13
gsea,nuclear membrane organization (GO:0071763),0.5402966613387322,1.5313729584830895,0.02040816326530612,0.15828400661148814,0.96,7/19,26.23%,PLK1;NSFL1C;NEMP1;TARDBP;TOR1B;TOR1AIP1;EMD
gsea,gluconeogenesis (GO:0006094),0.592837830677315,1.5303555480781657,0.09615384615384616,0.15934905428804283,0.96,17/41,25.69%,GOT2;GAPDH;ALDOA;PC;GPI;SLC39A14;PGK1;GOT1;CRY1;PGM1;ENO1;TPI1;ENO2;PGAM1;SLC25A13;MDH1;SLC25A12
gsea,positive regulation of cellular protein localization (GO:1903829),0.3794107064459584,1.5301853288937985,0.041666666666666664,0.15863448453787224,0.96,10/71,9.71%,NDC80;PLK1;NUP62;CDK1;KAT7;GTSE1;TFRC;FERMT2;CENPQ;PARK7
gsea,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.5216629811717117,1.5295007849119822,0.08163265306122448,0.15871623017039807,0.96,24/57,25.83%,PSMD14;PSMD6;PSMB2;PSMD5;PSMD1;PSMA5;PSMD11;PSMA4;PSMA3;PSME4;PSMD7;ENST00000629691.2;PSMC6;PSMA1;PSMD10;PSMB3;USP47;PSME1;PSMC3;AURKA;SKP1;CUL1;PSMA6;PSMD13
gsea,RNA splicing (GO:0008380),0.43054535209733064,1.528387773670466,0.04878048780487805,0.15916021431605085,0.96,35/98,24.66%,USB1;SNRPD1;SRRM1;NCBP1;SNRPA1;SF3B3;SMNDC1;PRPF4B;U2AF1;SNRPF;DHX16;PPP2CA;SCAF11;SRSF7;SF3B1;SNRPD3;WBP4;BCAS2;TARDBP;SNRNP40;SYNCRIP;SRSF4;HNRNPC;PTBP1;LSM1;TXNL4A;DBR1;RP9;WDR83;SMU1;SRPK1;SF3B4;FUS;ZCRB1;SF3B2
gsea,modulation of chemical synaptic transmission (GO:0050804),-0.499986176699252,-1.5264234604409297,0.021739130434782608,1.0,0.96,10/109,19.21%,APP;DLGAP4;DGKZ;CLN3;NTF4;ABR;KCTD13;CDK5;IQSEC2;TPRG1L
gsea,lysosome localization (GO:0032418),-0.4811729139081035,-1.522844158756005,0.075,1.0,0.97,8/37,14.09%,BORCS6;MYH9;KLC2;BLOC1S1;PIK3CD;HPS6;FLCN;RAB34
gsea,positive regulation of mitotic nuclear division (GO:0045840),0.4984413954639291,1.5205987321152366,0.0425531914893617,0.16718881050948925,0.97,9/36,22.07%,NUP62;NUSAP1;ESPL1;CDC27;DLGAP5;RB1;CDC23;PHIP;AURKA
gsea,positive regulation of DNA repair (GO:0045739),0.48003829523891073,1.518441510476518,0.02,0.16843101558192483,0.97,9/48,8.48%,DHX9;PCNA;BRCA1;HMGB1;FOXM1;PARP1;SMCHD1;RNF8;TIMELESS
gsea,RNA biosynthetic process (GO:0032774),0.43780762626199055,1.5170109431424685,0.041666666666666664,0.1703787026863444,0.97,9/32,21.42%,SMARCA5;TTF2;PRMT5;SETX;PRIM2;POLA1;MTERF1;PRIM1;NCOA6
gsea,sphingolipid biosynthetic process (GO:0030148),0.4078889197392575,1.5150215402164815,0.0,0.17153669162293647,0.97,10/74,15.13%,ELOVL6;HACD3;ELOVL5;CERS2;CERS6;ELOVL7;PLPP1;SPTLC1;SMPD1;SAMD8
gsea,membrane protein ectodomain proteolysis (GO:0006509),-0.5071293232112442,-1.5143436763462303,0.06818181818181818,1.0,0.98,6/23,14.28%,APH1A;MYH9;BACE2;SPPL3;RBMX;DAG1
gsea,dicarboxylic acid metabolic process (GO:0043648),0.4500467149565632,1.504275395878684,0.13043478260869565,0.18747938585837925,0.98,11/57,14.61%,ME1;GOT2;DHFR;GCLM;FPGS;FH;MTHFD2;SHMT1;GOT1;ALDH18A1;MTHFD1L
gsea,regulation of cellular ketone metabolic process (GO:0010565),0.44201688178709886,1.5031191614397252,0.10204081632653061,0.1890247032852149,0.98,25/64,30.99%,PSMD14;PSMD6;PSMB2;PSMD5;PSMD1;PSMA5;PSMD11;PSMA4;PSMA3;PSME4;PSMD7;ENST00000629691.2;PSMC6;PSMA1;PSMD10;PSMB3;PSME1;PSMC3;PSMA6;PSMD13;ODC1;AZIN1;PPARA;PSMD12;PDK2
gsea,pyruvate metabolic process (GO:0006090),0.5611404553053635,1.5023954402621245,0.09803921568627451,0.18950065819045786,0.98,19/55,23.82%,GLO1;ME1;GAPDH;ALDOA;PC;HKDC1;LDHA;GPI;PGK1;PDHA1;PGM1;ENO1;TPI1;LDHB;ENST00000630362.2;PKM;ENO2;PGAM1;PDHX
gsea,regulation of microtubule polymerization or depolymerization (GO:0031110),0.5316494897095656,1.5014500132479858,0.0392156862745098,0.1900893619187153,0.98,8/28,26.70%,CAMSAP3;SKA2;SKA3;MAPRE1;CAMSAP2;MAPRE2;MAP2;CLASP1
gsea,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.45091102048231063,1.5011202573044957,0.04081632653061224,0.18968418665199024,0.98,29/75,22.51%,PSMD14;PSMD6;PSMB2;PSMD5;PSMD1;PSMA5;PSMD11;PSMA4;PSMA3;PSME4;PSMD7;ENST00000629691.2;RPS27A;PSMC6;ELOC;ELOB;PSMA1;CUL2;ARNT;PSMD10;PSMB3;NOTCH1;VEGFA;EPAS1;PSME1;HIF1A;PSMC3;RBPJ;NFE2L2
gsea,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.43299172427976756,1.5008753719607635,0.057692307692307696,0.18934037965471148,0.98,34/87,25.88%,CHEK1;PSMD14;PSMD6;PSMB2;PSMD5;PSMD1;PSMA5;PSMD11;PSMA4;PSMA3;PSME4;PSMD7;ENST00000629691.2;RPS27A;PSMC6;ELOC;ELOB;PSMA1;GCN1;CUL2;ARNT;PSMD10;PSMB3;VEGFA;INO80;MUC1;EPAS1;PSME1;HIF1A;PSMC3;NFE2L2;PSMA6;PSMD13;HMOX1
gsea,histone methylation (GO:0016571),0.5289376845255309,1.4992571456764696,0.1276595744680851,0.19113344446714742,0.98,7/26,13.04%,SUV39H2;NSD1;NSD3;PRMT5;EZH2;SUV39H1;PRMT1
gsea,regulation of microtubule-based process (GO:0032886),0.4421488301790437,1.499097257085584,0.06976744186046512,0.19061413020328677,0.98,11/36,26.70%,CAMSAP3;CYLD;MEMO1;DIAPH1;ROCK1;PRKAA1;MARK2;AURKA;GSK3B;PHLDB2;CLASP1
gsea,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3181798403477653,1.4952336685653407,0.020833333333333332,0.1943884213491336,0.98,75/321,22.51%,AURKB;BUB1B;CDK2;ANAPC1;PLK1;ECPAS;UCHL1;NSFL1C;UBE2A;CDK1;HSP90B1;RNF4;UBE2C;CDC26;FBXO5;PSMD14;PSMD6;PSMB2;PSMD5;CCNF;PTTG1;MAD2L1;FBXO45;PSMD1;HUWE1;RAD23B;PSMA5;PSMD11;RFFL;PSMA4;RNF34;PSMA3;PSME4;CDC27;ERLIN1;PSMD7;BUB3;HSPA5;STUB1;ENST00000629691.2;PLAA;RPS27A;SPOP;KIF14;ANAPC2;UBE2G1;PSMC6;EDEM1;PSMA1;UBQLN1;CCNB1;UBE4A;RB1;CUL2;CDC23;PSMD10;UBQLN2;TBL1XR1;PSMB3;DCAF12;CUL5;VCP;UBE2K;FOXRED2;CDC20;FAF1;PSME1;FEM1C;ANAPC10;COP1;PSMC3;AURKA;FEM1B;SKP1;NFE2L2
gsea,positive regulation of DNA recombination (GO:0045911),0.49085736870047425,1.4945109935708702,0.021739130434782608,0.19425848784322602,0.98,8/30,13.25%,SHLD2;PARP1;TFRC;TIMELESS;RAD51AP1;ACTR2;MMS19;PAXIP1
gsea,plasma membrane organization (GO:0007009),-0.3883372409471225,-1.489663358940339,0.018867924528301886,1.0,0.98,8/64,10.04%,SNX33;MYH9;AHNAK2;STX4;ENST00000645179.2;PACSIN2;CLN3;ENST00000639874.2
gsea,regulation of protein export from nucleus (GO:0046825),0.4825077177619843,1.488919570131925,0.04878048780487805,0.20104866011630568,0.98,10/23,28.77%,YWHAE;GTSE1;ANP32B;PARK7;TPR;XPO4;RBM22;GSK3B;EMD;UHMK1
gsea,cell cycle G1/S phase transition (GO:0044843),0.40810702133679666,1.4885032392515007,0.02040816326530612,0.20060977915941247,0.98,20/63,26.21%,CDK2;CDC25A;CDKN3;E2F1;POLE;EIF4E;CDK6;CDC7;PPP6C;RB1;CUL2;CUL5;E2F3;PHF8;GSPT1;BCAT1;CUL1;CUL4B;CCNE1;DBF4
gsea,regulation of lipid metabolic process (GO:0019216),0.3614045749199172,1.4861732265109617,0.0,0.20304299983070934,0.98,21/92,24.59%,ELOVL6;SIN3A;IDI1;HMGCS1;CERS2;HDAC3;CYP51A1;PLPP1;SQLE;FASN;DHCR7;GGPS1;TBL1XR1;SCD;SC5D;ACACA;NCOA6;APOC1;PPARD;MVD;FDPS
gsea,amino acid transmembrane transport (GO:0003333),0.508517991397606,1.4835641586262254,0.061224489795918366,0.20674449619231655,0.98,9/45,25.69%,LRRC8D;SLC7A11;SLC7A5;SFXN1;SLC3A2;SLC7A1;SLC6A6;SLC25A13;SLC25A12
gsea,regulation of protein dephosphorylation (GO:0035304),0.44522510620106276,1.4815265022888462,0.12727272727272726,0.2091884137259533,0.98,12/41,20.21%,HSP90B1;CDCA2;ARPP19;PPP1R7;HTT;TIPRL;PPP2R5A;SMPD1;PTBP1;MFHAS1;YWHAB;PPP6R3
gsea,positive regulation of RNA metabolic process (GO:0051254),0.3993460226700249,1.4812659707798308,0.08,0.20866791879939273,0.98,16/45,28.47%,RIOK1;WDR75;SUPV3L1;MAP2K1;PNPT1;SETX;WDR43;DDX5;BMP4;RBM22;HEATR1;DIMT1;HNRNPLL;UTP15;ZPR1;ZC3H18
gsea,positive regulation of cell division (GO:0051781),0.5729172222902552,1.4796618877535583,0.043478260869565216,0.20929275385781987,0.99,7/44,16.43%,AURKB;CIT;KIF20B;CDC6;RACGAP1;KIF14;RHOA
gsea,positive regulation of cytokinesis (GO:0032467),0.5729172222902552,1.4796618877535583,0.043478260869565216,0.20929275385781987,0.99,7/37,16.43%,AURKB;CIT;KIF20B;CDC6;RACGAP1;KIF14;RHOA
gsea,positive regulation of response to DNA damage stimulus (GO:2001022),0.428280296793886,1.478631660962258,0.0784313725490196,0.2105893012965826,0.99,10/55,13.10%,DHX9;PCNA;BRCA1;EEF1E1;HMGA2;SMCHD1;BCLAF1;RNF8;DDX5;UIMC1
gsea,peptidyl-serine modification (GO:0018209),0.3693342663292224,1.477580301616042,0.06818181818181818,0.21132880045124142,0.99,41/169,25.34%,CDK2;PLK1;PRKDC;TTK;CLSPN;CDK1;PRKCI;PARP1;MAPKAPK5;VRK2;GALNT2;ROCK2;STK4;CSNK1E;PARP2;RPS6KA4;MKNK2;TBK1;GALNT3;CDC7;TOP1;MAPK1;MAST2;ROCK1;MARK2;MAPK12;PDPK1;RPS6KA3;WNK1;AURKA;MAPKAPK3;GSK3B;LMTK2;CAB39;MAPK8;VRK3;MTOR;PAK2;ATR;PKN2;RPS6KB2
gsea,NIK/NF-kappaB signaling (GO:0038061),0.4168935168736472,1.4774861430888748,0.10909090909090909,0.21048348524943644,0.99,24/74,25.83%,PSMD14;PSMD6;PSMB2;PSMD5;PSMD1;COPS8;PSMA5;ZFP91;PSMD11;PSMA4;PSMA3;PSME4;PSMD7;ENST00000629691.2;PSMC6;PSMA1;PSMD10;PSMB3;PSME1;PSMC3;SKP1;CUL1;PSMA6;PSMD13
gsea,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.4977463816433848,-1.4774693992626493,0.13636363636363635,1.0,0.98,9/29,21.26%,PPP1R15A;BBC3;BAX;CEBPB;BAK1;DAB2IP;DDIT3;TRAF2;TNFRSF10B
gsea,cellular response to heat (GO:0034605),0.4107343056914904,1.4757329010031857,0.11320754716981132,0.21219361503315368,0.99,11/36,28.28%,YWHAE;HSP90AA1;ZFAND1;ANO1;TPR;STUB1;HSP90AB1;VCP;HMOX1;DHX36;SUMO1
gsea,acylglycerol metabolic process (GO:0006639),-0.45865302000842995,-1.4724238838105657,0.07317073170731707,1.0,0.98,6/41,19.19%,LYPLA2;DGKZ;PNPLA2;ABHD2;PGS1;DGKQ
gsea,alpha-amino acid metabolic process (GO:1901605),0.49712257274329785,1.4715749002317569,0.09259259259259259,0.2172929705548788,0.99,16/46,35.00%,GOT2;THAP4;GLS;DDAH2;DDAH1;GOT1;ALDH18A1;PYCR2;GPT2;SLC25A13;SLC25A12;PYCR1;MMUT;GLUL;ASNS;GLUD1
gsea,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.6340274750842647,1.4708227831299612,0.08,0.21702589604932906,0.99,10/18,18.87%,CCT8;NAF1;CCT7;CCT2;CCT6A;CCT5;CCT3;CCT4;EXOSC10;DKC1
gsea,organelle fission (GO:0048285),0.4961671502084788,1.4669219839540972,0.0196078431372549,0.22233401130283587,0.99,8/26,23.62%,CORO1C;DNM1L;PEX19;OPA1;MTFR1;DNM2;DNM1;MFF
gsea,negative regulation of supramolecular fiber organization (GO:1902904),0.38136949231494777,1.4665984354658532,0.04878048780487805,0.22172899935236273,0.99,19/72,29.01%,TPX2;CAMSAP3;TWF1;HSPA8;VBP1;PFN2;MAPRE1;KATNB1;CAMSAP2;LDLR;PFN1;PFDN1;MAP2;SSH1;SSH3;CLASP1;LIMA1;PIK3CA;ARFGEF1
gsea,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.46745903880302553,1.4631769477458558,0.11627906976744186,0.22628608007448792,0.99,8/23,14.18%,COPS3;COPS4;PARP1;COPS8;RAD23B;GPS1;DDB2;RPS27A
gsea,transcription by RNA polymerase III (GO:0006383),0.48082033697645393,1.4604513151542617,0.11904761904761904,0.23059584977486214,0.99,13/28,30.10%,GTF3C6;GTF3C2;GTF3C4;GTF3C5;ICE1;SNAPC1;POLR2K;GTF3C3;GTF3A;ICE2;POLR2L;CRCP;ZC3H8
gsea,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.41169358170767395,-1.459593182917639,0.09523809523809523,1.0,0.99,32/71,24.58%,UQCR11;NDUFA1;NDUFA2;NDUFB10;NDUFA13;NDUFA10;COX5B;COX7C;UQCRH;NDUFS7;UQCR10;COX6C;COX4I1;NDUFB4;NDUFS4;NDUFB7;NDUFA11;UQCRB;NDUFA8;SDHC;NDUFB9;UQCRC1;NDUFS3;NDUFC2;UQCRQ;NDUFAF1;NDUFB2;NDUFB1;SDHD;NDUFB8;NDUFB3;NDUFS5
gsea,regulation of cell division (GO:0051302),0.3838282950480092,1.4589210966273096,0.0,0.23160130361415207,0.99,15/76,22.07%,AURKB;KIF20A;PLK1;PRC1;KIF18B;PLK4;MYO19;ORC6;SMYD5;PIK3C3;PIK3R4;AHCTF1;CETN2;RAB11A;AURKA
gsea,cellular response to calcium ion (GO:0071277),0.4231164839086605,1.4586929314468775,0.07317073170731707,0.2310749601619934,0.99,11/69,35.10%,IQGAP1;SLC25A24;CPNE7;SMPD1;LGMN;PRKAA1;ECT2;CLIC4;DMTN;CPNE3;SYT15
gsea,regulation of cellular amino acid metabolic process (GO:0006521),0.47791424960984025,1.456190427678951,0.14583333333333334,0.23406016518520195,0.99,22/54,27.60%,PSMD14;PSMD6;PSMB2;PSMD5;PSMD1;PSMA5;PSMD11;PSMA4;PSMA3;PSME4;PSMD7;ENST00000629691.2;PSMC6;PSMA1;PSMD10;PSMB3;PSME1;PSMC3;PSMA6;PSMD13;ODC1;AZIN1
gsea,negative regulation of protein kinase B signaling (GO:0051898),-0.43094757513291276,-1.455628369241594,0.15,1.0,0.99,11/40,22.60%,CIB1;PHLDA3;NOP53;PPP2R5B;INPP5K;FLCN;ARRB2;DAG1;HYAL2;DDIT3;TSC2
gsea,protein modification by small protein removal (GO:0070646),0.3299167916773901,1.450932627630203,0.0,0.24218536130347057,0.99,55/276,21.56%,USP1;CDC25A;BRCA1;USP10;COPS3;CLSPN;UCHL1;CDK1;COPS4;PSMD14;CYLD;PSMD6;PSMB2;PSMD5;USP12;SENP6;PSMD1;COPS8;RAD23B;PSMA5;GPS1;PSMD11;PSMA4;PSMA3;STAMBP;PSME4;DESI2;USP16;DDB2;TRRAP;STAMBPL1;USP8;PSMD7;UIMC1;ENST00000629691.2;OTUD4;RPS27A;PSMC6;PSMA1;RHOA;USP25;USP34;PSMD10;PSMB3;STAM;INO80;VCP;TNIP1;USP47;CDC20;TAF9B;PSME1;HIF1A;TNIP2;PSMC3
gsea,regulation of protein polymerization (GO:0032271),0.4682529281492035,1.4504091606959948,0.09615384615384616,0.24214415869303518,0.99,8/35,22.65%,CAMSAP3;HSP90AA1;PFN2;CAMSAP2;ARHGAP18;PFN1;FCHSD2;MAP2
gsea,regulation of cellular amine metabolic process (GO:0033238),0.48545156926151845,1.4502836321686727,0.14285714285714285,0.24153397997830353,0.99,22/51,27.60%,PSMD14;PSMD6;PSMB2;PSMD5;PSMD1;PSMA5;PSMD11;PSMA4;PSMA3;PSME4;PSMD7;ENST00000629691.2;PSMC6;PSMA1;PSMD10;PSMB3;PSME1;PSMC3;PSMA6;PSMD13;ODC1;AZIN1
gsea,protein-containing complex subunit organization (GO:0043933),0.36909658471238393,1.4481183856761457,0.044444444444444446,0.2444343371230684,0.99,23/112,20.44%,NDC1;SEH1L;KNTC1;NUP205;CAPZA1;HFE;DNM1L;GEMIN5;AFG3L2;NUP35;NUP133;SNX9;TPR;WASL;FANCA;FANCC;LAMC1;ELOB;ZW10;CD2AP;TFAP4;NAPG;KPNA3
gsea,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.41019740787222947,1.4472826345865797,0.022222222222222223,0.24448784023936726,0.99,10/82,20.38%,ZDHHC3;ROCK2;SLC39A14;GRK6;KLK5;CRY1;METAP2;ROCK1;YWHAB;METAP1
gsea,ubiquitin-dependent protein catabolic process (GO:0006511),0.30704281982760656,1.4470466936860673,0.06818181818181818,0.2438245625088891,0.99,78/354,22.57%,AURKB;BUB1B;DTL;ANAPC1;PLK1;COPS3;UCHL1;NSFL1C;UBE2A;RNF4;UBE2C;CDC26;PSMD14;PSMD6;PSMB2;VPS37A;PSMD5;RNF20;PTTG1;UBA1;MAD2L1;FBXO45;PSMD1;RNF8;HUWE1;RAD23B;NUB1;UBA6;PSMA5;PSMD11;RFFL;PSMA4;RNF34;PSMA3;PSME4;CDC27;VPS4B;PSMD7;BUB3;UBR4;STUB1;ENST00000629691.2;PLAA;NDFIP2;SPOP;KIF14;RNF6;ANAPC2;UBE2G1;PSMC6;ELOC;RC3H2;PSMA1;UBQLN1;UBE4A;RNF14;FBXO11;CDC23;PSMD10;UBQLN2;TBL1XR1;PSMB3;UBAP1;VCP;XBP1;UBE2K;CDC20;FAF1;PSME1;RLIM;FEM1C;ANAPC10;COP1;PSMC3;AURKA;FEM1B;NFE2L2;FBXO7
gsea,RNA processing (GO:0006396),0.3650674503446917,1.445868935490451,0.04081632653061224,0.24454266590460835,0.99,51/179,24.66%,USB1;SNRPD1;SRRM1;LSM3;NCBP1;SNRPA1;SF3B3;RNGTT;THOC1;PRPF4B;U2AF1;HNRNPD;HNRNPL;DDX20;SNRPF;DHX16;PPP2CA;SCAF11;SRSF1;HNRNPA2B1;LSM5;SRSF7;SETX;TENT4A;SF3B1;SNRPD3;WBP4;BCAS2;TARDBP;NUDT21;SNRNP40;SYNCRIP;HNRNPU;SRSF4;CSTF3;HNRNPC;PTBP1;LSM1;RBM6;RP9;DKC1;SMU1;NUFIP1;SRPK1;TENT4B;HNRNPH1;SF3B4;ZCCHC8;FUS;ZCRB1;SF3B2
gsea,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.5078425747181218,1.4445304055525292,0.06976744186046512,0.24545856245090336,0.99,10/26,21.47%,PARP1;STN1;HNRNPU;HNRNPC;EXOSC10;ACD;PIF1;NAT10;GNL3L;TENT4B
gsea,amyloid fibril formation (GO:1990000),-0.4203692212350652,-1.4442148585238042,0.06382978723404255,1.0,0.99,12/63,22.57%,APH1A;GSN;APP;GGA1;MFGE8;UBB;SIAH1;UBC;RIPK1;UBE2L6;B2M;SNCA
gsea,cytoplasmic translational initiation (GO:0002183),0.4516693482914856,1.4438380533120205,0.06521739130434782,0.2457604586011768,0.99,8/19,27.29%,DHX29;EIF2S2;DENR;MCTS1;EIF3M;EIF4H;EIF2S3;EIF4G1
gsea,posttranscriptional regulation of gene expression (GO:0010608),0.3652741809247005,1.4368540901091418,0.06818181818181818,0.2559912480352547,0.99,9/46,12.86%,PUM3;MAPKAPK5;EIF4E;TDRD7;GEMIN5;PUM2;LARP1;NOLC1;NUDT21
gsea,icosanoid metabolic process (GO:0006690),-0.4670587218930692,-1.4364972178568105,0.04,1.0,0.99,9/57,24.37%,GPX4;FAAH2;MAPKAPK2;GGT1;PTGR1;PTGS2;ABCC1;PTGIS;FAAH
gsea,peptidyl-threonine phosphorylation (GO:0018107),0.44552154132698224,1.43496410451804,0.1111111111111111,0.25871311454955187,0.99,17/60,24.41%,CIT;PRKDC;CHEK1;CDK1;MAP2K1;ROCK2;CDC42BPA;TBK1;MAPK1;ROCK1;MARK2;PDPK1;WNK1;GSK3B;LMTK2;MAPK8;NLK
gsea,cellular amide metabolic process (GO:0043603),0.36629243055161737,1.4346212001176435,0.04878048780487805,0.25796212799292023,0.99,18/115,19.85%,DHFR;PDZD11;ACOT9;ACOT7;FPGS;PC;NSMAF;PPP2CA;MTHFD2;AASDHPPT;MIPEP;SHMT1;PLPP1;SMPD1;MTHFD1L;THEM4;THOP1;SLC25A32
gsea,protein homooligomerization (GO:0051260),0.4013985226542266,1.4342259902550651,0.09433962264150944,0.25761550596158067,0.99,24/121,21.10%,POLQ;MLKL;HPRT1;ALDOA;JMJD6;PNPT1;EHD4;GLS;SHMT1;USP16;BCL10;OSBPL2;PRMT1;SIGMAR1;ALS2;PDCD6IP;ELAVL1;SLC1A5;ALDH9A1;MICU1;ATL2;TK1;ACACA;APIP
gsea,peptidyl-threonine modification (GO:0018210),0.44628291839949086,1.4332144467810024,0.075,0.2581655799675349,0.99,19/67,24.41%,CIT;PRKDC;CHEK1;CDK1;GALNT2;MAP2K1;ROCK2;CDC42BPA;TBK1;GALNT3;MAPK1;ROCK1;MARK2;PDPK1;WNK1;GSK3B;LMTK2;MAPK8;NLK
gsea,"mRNA splicing, via spliceosome (GO:0000398)",0.34058969717676296,1.4328726024672322,0.04081632653061224,0.25767225325884546,0.99,98/274,28.58%,DHX9;CPSF3;SNRPD1;WBP11;SRRM1;LSM3;NCBP1;SNRPA1;SF3B3;HSPA8;AQR;SMNDC1;PRPF4B;U2AF1;DDX46;PAPOLA;PHF5A;HNRNPD;RBM14;PRMT5;PRPF38A;CWF19L1;HNRNPL;CPSF2;PPWD1;DDX20;SNRPF;GEMIN5;DHX16;SCAF11;SRSF1;HNRNPA2B1;LSM5;GTF2F2;SRSF7;SF3B1;POLR2B;SNRPD3;CWC22;WBP4;BCAS2;DDX5;CSTF2;U2AF1L5;NUDT21;SNRNP40;HNRNPM;SYNCRIP;SNUPN;BUD13;WDR77;HNRNPU;SRSF4;CDC5L;CSTF3;HNRNPC;FRG1;ELAVL1;PTBP1;SRRM2;PQBP1;CSTF1;POLR2K;RBM6;TXNL4A;DBR1;WDR83;GEMIN4;SMU1;SNW1;RBM22;SRPK1;HNRNPH1;SF3B6;SPEN;CWC27;TRA2A;SF3B4;MTREX;ZCCHC8;FUS;ZCRB1;SF3B2;CPSF7;DDX1;METTL3;SRRT;POLR2L;PRPF19;MFAP1;PABPC1;PPIH;SNRPB2;CPSF1;PPIL1;POLR2C;USP39;PSPC1
gsea,positive regulation of viral genome replication (GO:0045070),0.46738206501738266,1.432386674111979,0.07692307692307693,0.25718250138137827,0.99,14/29,31.03%,TOP2A;HACD3;STAU1;LARP1;CNOT7;SRPK1;PKN2;PABPC1;PPIH;TOP2B;DDB1;PPARA;ADAR;PPIA
gsea,protein polyubiquitination (GO:0000209),0.3104507508258893,1.4290740724220874,0.11363636363636363,0.2617083493882843,1.0,70/314,25.92%,DTL;ANAPC1;RUSC1;BRCA1;UBE2A;RNF4;UBE2C;UBE2V2;CDC26;NPEPPS;PSMD14;PSMD6;BLMH;PSMB2;PSMD5;RNF20;TRIM14;CCNF;UBE2T;PSMD1;RNF8;HUWE1;PSMA5;ZFP91;PSMD11;RFFL;PSMA4;RNF34;PSMA3;UBE2E3;PSME4;CDC27;DDB2;PSMD7;STUB1;ENST00000629691.2;HECTD1;RPS27A;SPOP;RNF6;ANAPC2;UBE2G1;PSMC6;RC3H2;PSMA1;UBE4A;RNF14;FBXO11;CDC23;PSMD10;PSMB3;THOP1;UBE2K;RNF26;PSME1;RLIM;ANAPC10;PSMC3;LNPEP;SKP1;FBXO7;AKTIP;CUL1;UBE4B;UBE2N;ARIH1;PSMA6;TRAF3IP2;PSMD13;PRPF19
gsea,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.3912125157356084,1.428938941482666,0.11538461538461539,0.2608648746983008,1.0,27/89,25.83%,PSMD14;PSMD6;PSMB2;PSMD5;CCNF;PSMD1;PSMA5;PSMD11;PSMA4;PSMA3;PSME4;PSMD7;ENST00000629691.2;KIF14;PSMC6;PSMA1;CUL2;PSMD10;PSMB3;CUL5;PSME1;PSMC3;SKP1;CUL1;CUL4B;PSMA6;PSMD13
gsea,amide biosynthetic process (GO:0043604),0.4747389391572264,1.428758163633673,0.024390243902439025,0.26022258897077494,1.0,13/52,39.72%,CERS2;CERS6;ARG2;SPTLC1;SMPD1;SAMD8;AGK;SPTLC2;CERS5;SGMS1;SPTSSA;SGMS2;CPS1
gsea,antigen receptor-mediated signaling pathway (GO:0050851),0.3481887589978231,1.4250423620211263,0.08,0.2665849330028983,1.0,35/185,27.91%,PSMD14;PSMD6;PSMB2;PSMD5;PSMD1;PSMA5;PSMD11;PSMA4;PSMA3;PIK3CB;PSME4;BCL10;PSMD7;ENST00000629691.2;STOML2;PSMC6;RC3H2;PSMA1;BTN2A1;PSMD10;PSMB3;PSME1;RIPK2;PDPK1;WNK1;PSMC3;SKP1;CUL1;PAK2;UBE2N;PSMA6;PSMD13;EIF2B1;CSK;PIK3CA
gsea,anion transmembrane transport (GO:0098656),0.38750307839529047,1.424860245615858,0.10526315789473684,0.26607217785014037,1.0,7/67,11.23%,SLC25A5;LRRC8D;SLC35B1;SLC7A5;SFXN1;SLC3A2;SLC39A8
gsea,aerobic electron transport chain (GO:0019646),-0.41367246185588313,-1.4246581695639806,0.10256410256410256,1.0,0.99,32/70,24.58%,UQCR11;NDUFA1;NDUFA2;NDUFB10;NDUFA13;NDUFA10;COX5B;COX7C;UQCRH;NDUFS7;UQCR10;COX6C;COX4I1;NDUFB4;NDUFS4;NDUFB7;NDUFA11;UQCRB;NDUFA8;SDHC;NDUFB9;UQCRC1;NDUFS3;NDUFC2;UQCRQ;NDUFAF1;NDUFB2;NDUFB1;SDHD;NDUFB8;NDUFB3;NDUFS5
gsea,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.42010546252290476,1.4240588688979727,0.2,0.2662870588750493,1.0,28/92,25.83%,E2F7;FBXO5;PSMD14;PSMD6;PSMB2;PSMD5;PSMD1;CDK6;PSMA5;PSMD11;PSMA4;PSMA3;PSME4;PSMD7;ENST00000629691.2;PSMC6;PSMA1;RB1;PSMD10;PSMB3;USP47;PSME1;PSMC3;AURKA;SKP1;CUL1;PSMA6;PSMD13
gsea,glycolipid biosynthetic process (GO:0009247),0.42497542282118406,1.4232048239413417,0.09523809523809523,0.2665966134813117,1.0,5/40,13.05%,B3GNT5;DPM2;PIGU;PIGN;PIGH
gsea,intra-Golgi vesicle-mediated transport (GO:0006891),0.47466363394227745,1.4205435597181344,0.1111111111111111,0.27049849326282105,1.0,12/32,36.21%,GOSR1;COPG2;COG2;NAPG;COG1;COPA;COPB1;COG3;NSF;RAB6A;COPG1;COPB2
gsea,"negative regulation of gene expression, epigenetic (GO:0045814)",0.45639868210558093,1.4181234224028152,0.15,0.2737998885776629,1.0,5/30,11.03%,SUZ12;TASOR;EZH2;SMYD5;PHF19
gsea,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3808140189311632,1.4170702398520036,0.07317073170731707,0.27474620963668306,1.0,16/56,22.07%,E2F8;E2F7;PCNA;E2F1;CDK1;CNOT9;GTSE1;CASP2;CDC25C;PRMT1;CNOT7;CCNB1;CNOT11;MUC1;CNOT10;AURKA
gsea,transcription-coupled nucleotide-excision repair (GO:0006283),0.38599077985720653,1.4155977630864476,0.0975609756097561,0.2761601937122408,1.0,22/73,19.61%,PCNA;COPS3;COPS4;RFC3;AQR;RFC5;RFC2;RPA3;ERCC5;COPS8;RPA1;POLD3;GPS1;RPA2;RFC1;POLR2B;GTF2H1;RPS27A;RFC4;POLR2K;POLD1;LIG1
gsea,protein modification by small protein conjugation (GO:0032446),0.30160054119960983,1.4153908996181088,0.047619047619047616,0.275532131753188,1.0,94/409,24.92%,NDC1;NUP188;PLK1;NUP50;PRKDC;SEH1L;NUP62;PCNA;BRCA1;UBE2A;NUP153;UBE2C;UBE2V2;NUP205;ATG3;RFWD3;RNF20;TRIM14;NUP210;CCNF;NUP43;UBA1;POM121C;NUP58;FBXO45;UBE2T;RNF8;LEO1;HUWE1;NUP35;NUB1;CAND1;UBA6;TRAIP;DTX4;RNF34;NUP133;UBE2E3;TPR;CDC27;ZNF598;BCL10;RANBP2;NUP107;NUP85;STUB1;PEX13;NUP37;PIAS1;RPS27A;UFC1;RNF6;BSPRY;UBE2G1;ELOC;DCUN1D5;UFL1;ELOB;UHRF2;NUP214;KLHL2;RNF14;CUL2;FBXO11;CDC23;NUP93;NUP88;EIPR1;CUL5;VCP;CTR9;BRAP;UBE2K;EPAS1;RNF26;HLTF;RLIM;HIF1A;PJA2;DCUN1D2;SKP1;NFE2L2;FBXO7;TRIM24;NUP155;UCHL3;CUL1;RTF1;OTULIN;TRIM52;UFM1;CUL4B;UBE2N;ARIH1
gsea,protein localization to nucleus (GO:0034504),0.393796512161974,1.4151242933944796,0.12,0.27514390400815014,1.0,40/106,28.51%,CSE1L;NUP188;PLK1;NUP50;NUP62;YWHAE;IPO9;NUP153;NXT2;IPO11;IPO8;ARL2BP;INTS13;POM121C;RAN;NUP133;TPR;APPL1;NUP107;IPO7;NUP85;HNRNPU;NUP214;TNPO3;NUP93;NUP88;BMP4;E2F3;SKP1;NUP155;RRS1;TOR1B;TOR1AIP1;IPO4;PHB2;NUP62CL;TNPO1;HEATR3;KPNB1;SIX4
gsea,peptidyl-serine phosphorylation (GO:0018105),0.35030267672283477,1.4146522886796837,0.06382978723404255,0.2750868997286126,1.0,38/156,25.34%,CDK2;PLK1;PRKDC;TTK;CLSPN;CDK1;PRKCI;MAPKAPK5;VRK2;ROCK2;STK4;CSNK1E;RPS6KA4;MKNK2;TBK1;CDC7;TOP1;MAPK1;MAST2;ROCK1;MARK2;MAPK12;PDPK1;RPS6KA3;WNK1;AURKA;MAPKAPK3;GSK3B;LMTK2;CAB39;MAPK8;VRK3;MTOR;PAK2;NLK;ATR;PKN2;RPS6KB2
gsea,wound healing (GO:0042060),-0.3872965641346144,-1.4145781462013913,0.0625,1.0,1.0,13/70,24.33%,MYH9;AHNAK2;TPM1;WNT5A;CFLAR;ERBB2;SRF;CORO1B;MYOF;FZD7;EPPK1;TSKU;PPP3CA
gsea,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.4228085071177962,-1.4141211026069034,0.038461538461538464,1.0,1.0,7/31,18.76%,SH3BP5L;PTPN6;MVP;CADM4;SH3BP5;PRKCZ;HYAL2
gsea,T cell receptor signaling pathway (GO:0050852),0.3531695931491902,1.4120827746011375,0.10416666666666667,0.2791931606262291,1.0,35/158,27.91%,PSMD14;PSMD6;PSMB2;PSMD5;PSMD1;PSMA5;PSMD11;PSMA4;PSMA3;PIK3CB;PSME4;BCL10;PSMD7;ENST00000629691.2;STOML2;PSMC6;RC3H2;PSMA1;BTN2A1;PSMD10;PSMB3;PSME1;RIPK2;PDPK1;WNK1;PSMC3;SKP1;CUL1;PAK2;UBE2N;PSMA6;PSMD13;EIF2B1;CSK;PIK3CA
gsea,organonitrogen compound biosynthetic process (GO:1901566),0.33482858904793866,1.4108848988241276,0.06976744186046512,0.28042786233970934,1.0,21/158,20.68%,ELOVL6;MOCS2;LPIN1;PEMT;MOCOS;HACD3;ELOVL5;SLC44A1;ESD;CERS2;CERS6;ELOVL7;PLPP1;SLC44A2;ARG2;SPTLC1;SAMD8;CHPT1;CEPT1;TNIP1;GOLPH3
gsea,modulation by host of symbiont process (GO:0051851),0.4406255293281745,1.409653262273196,0.0975609756097561,0.2814218631407011,1.0,8/32,19.84%,RRP1B;NUCKS1;CHD1;HMGA2;TARDBP;SAP30BP;TFAP4;SNW1
gsea,regulation of neurotransmitter receptor activity (GO:0099601),-0.5252563767873777,-1.4082082104446336,0.15217391304347827,1.0,1.0,6/58,17.56%,APP;DLGAP4;MINK1;CAPN1;PTK2B;DLG1
gsea,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.33589450425508327,1.4079145120475156,0.06,0.28328873693944895,1.0,90/251,28.58%,DHX9;CPSF3;SNRPD1;WBP11;SRRM1;LSM3;NCBP1;SNRPA1;SF3B3;HSPA8;AQR;SMNDC1;PRPF4B;U2AF1;DDX46;PAPOLA;PHF5A;HNRNPD;RBM14;PRPF38A;CWF19L1;HNRNPL;CPSF2;PPWD1;SNRPF;GEMIN5;DHX16;SRSF1;HNRNPA2B1;LSM5;GTF2F2;SRSF7;SF3B1;POLR2B;SNRPD3;CWC22;WBP4;BCAS2;DDX5;CSTF2;U2AF1L5;NUDT21;SNRNP40;HNRNPM;SYNCRIP;BUD13;HNRNPU;SRSF4;CDC5L;CSTF3;HNRNPC;FRG1;ELAVL1;PTBP1;SRRM2;PQBP1;CSTF1;POLR2K;RBM6;TXNL4A;DBR1;WDR83;SMU1;SNW1;RBM22;HNRNPH1;SF3B6;SPEN;CWC27;TRA2A;SF3B4;MTREX;ZCCHC8;FUS;ZCRB1;SF3B2;CPSF7;METTL3;SRRT;POLR2L;PRPF19;MFAP1;PABPC1;PPIH;SNRPB2;CPSF1;PPIL1;POLR2C;USP39;PSPC1
gsea,lamellipodium organization (GO:0097581),0.5209134668085955,1.40561209554659,0.02127659574468085,0.2866194223367338,1.0,11/29,37.36%,CARMIL1;VCL;SNX1;ITGB1;GOLPH3;ARFIP2;CYFIP1;DMTN;ABLIM1;PARVB;RAC1
gsea,phospholipid dephosphorylation (GO:0046839),0.46559731739043697,1.4045350007879673,0.08163265306122448,0.28767439889168794,1.0,4/39,12.23%,MTMR12;MTMR6;SACM1L;PLPP1
gsea,regulation of mRNA processing (GO:0050684),0.37783106509143666,1.4022393927191035,0.13333333333333333,0.2910595467564006,1.0,7/36,11.40%,DHX9;NCBP1;IWS1;PAPOLA;JMJD6;CWC22;SLTM
gsea,regulation of endocytosis (GO:0030100),-0.429573665585015,-1.401451404630349,0.0425531914893617,1.0,1.0,8/61,7.33%,SNX33;ENST00000639909.2;SNX12;LGALS3;PACSIN2;AP2S1;ARFGAP1;HIP1R
gsea,non-canonical Wnt signaling pathway (GO:0035567),0.3936480612148108,1.40024480928223,0.13333333333333333,0.2933714472056186,1.0,32/124,25.83%,PSMD14;RYK;PSMD6;PSMB2;PSMD5;PPP3R1;PSMD1;TNRC6A;VANGL1;PSMA5;PSMD11;PSMA4;PSMA3;DAAM1;PSME4;PSMD7;ARHGEF19;ENST00000629691.2;PFN1;PSMC6;PSMA1;RHOA;PSMD10;PSMB3;AGO1;SFRP1;PSME1;PSMC3;AP2B1;NLK;PSMA6;PSMD13
gsea,regulation of protein localization (GO:0032880),0.3714825083687488,1.3995473718155749,0.0425531914893617,0.2938014656978388,1.0,15/66,23.39%,HSP90AA1;BORA;TRIM14;PARP1;CSNK1E;TPR;RAB14;FKBP1A;USP8;MMD;UFL1;HSP90AB1;STX6;MAP2;MAPK8
gsea,negative regulation of osteoblast differentiation (GO:0045668),-0.4542453404678492,-1.3992902670307723,0.13333333333333333,1.0,1.0,4/31,7.04%,TRPM4;BAMBI;MEN1;PTCH1
gsea,positive regulation of type I interferon production (GO:0032481),0.35432754323002,1.3985910796813212,0.06666666666666667,0.2942286174001111,1.0,24/77,30.06%,DHX9;PRKDC;GAPDH;OAS3;HSPD1;XRCC5;HSP90AA1;LRRFIP1;TBK1;PTPN11;STAT1;PQBP1;POLR2K;POLR3F;RIPK2;POLR2L;G3BP1;TOMM70;DHX36;POLR3E;SETD2;POLR2E;CHUK;CRCP
gsea,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.5090937787009283,-1.3983072032008295,0.06818181818181818,1.0,1.0,13/49,28.71%,GADD45A;CBR1;RNF41;THBS1;ROMO1;MAPK14;PDGFB;ITGAM;RIPK1;GRB2;GSTP1;TP53;AKR1C1
gsea,regulation of G0 to G1 transition (GO:0070316),0.4087572605870354,1.3980207184912088,0.08695652173913043,0.294517271156324,1.0,9/41,15.36%,BRCA1;E2F1;CHEK1;SUZ12;CBX5;EZH2;RBBP8;CDC7;RAD51
gsea,'de novo' posttranslational protein folding (GO:0051084),0.5389223616051665,1.3978870232039047,0.13636363636363635,0.29390260980246685,1.0,8/31,12.47%,UGGT1;HSPA9;HSPA8;HSPA14;CCT2;HSPA13;PTGES3;HSPA5
gsea,negative regulation of phosphatase activity (GO:0010923),0.4182745122833706,1.3976223572462945,0.06382978723404255,0.29324708419092427,1.0,8/28,26.92%,URI1;TIPRL;FKBP1A;SH2D4A;PPP1R26;SH3RF2;GSK3B;BOD1L1
gsea,protein acetylation (GO:0006473),0.44346845844147165,1.3964178460559353,0.020833333333333332,0.29461068596955486,1.0,3/31,4.05%,DSCC1;NAA15;NAA35
gsea,snRNA transcription by RNA polymerase II (GO:0042795),0.3427393190808078,1.3957596869495494,0.02127659574468085,0.29397507557369706,1.0,27/70,31.62%,NCBP1;INTS13;ELL2;GTF2F2;POLR2B;INTS14;INTS4;INTS7;ICE1;INTS10;SNAPC1;POLR2K;ICE2;NABP2;GTF2E2;TAF11;TAF9;SRRT;POLR2L;RPRD2;CCNT1;POLR2C;GTF2E1;POLR2E;ZC3H8;INTS8;SP1
gsea,snRNA transcription (GO:0009301),0.3427393190808078,1.3957596869495494,0.02127659574468085,0.29397507557369706,1.0,27/71,31.62%,NCBP1;INTS13;ELL2;GTF2F2;POLR2B;INTS14;INTS4;INTS7;ICE1;INTS10;SNAPC1;POLR2K;ICE2;NABP2;GTF2E2;TAF11;TAF9;SRRT;POLR2L;RPRD2;CCNT1;POLR2C;GTF2E1;POLR2E;ZC3H8;INTS8;SP1
gsea,sensory perception of mechanical stimulus (GO:0050954),-0.3683718723981547,-1.3948476923536877,0.1111111111111111,1.0,1.0,10/88,19.14%,SERPINB6;EPS8L2;TIMM10;TIMM8B;NDUFB9;TIMM9;P2RX4;GSDME;WDR1;EML2
gsea,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.4533991192312661,1.3933995805401982,0.09523809523809523,0.29586667436748293,1.0,10/26,25.67%,E2F1;YWHAE;YWHAH;PPP3R1;YWHAZ;YWHAB;BID;MAPK8;YWHAQ;SFN
gsea,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.4533991192312661,1.3933995805401982,0.09523809523809523,0.29586667436748293,1.0,10/26,25.67%,E2F1;YWHAE;YWHAH;PPP3R1;YWHAZ;YWHAB;BID;MAPK8;YWHAQ;SFN
gsea,regulation of nitric-oxide synthase activity (GO:0050999),0.511896735301044,1.3909559703855536,0.02040816326530612,0.2992259954636098,1.0,9/39,20.97%,DHFR;HSP90AA1;PIK3CB;DDAH2;WASL;DDAH1;DNM2;GLA;HIF1A
gsea,positive regulation of interleukin-1 beta production (GO:0032731),-0.41777158710993434,-1.390192523932431,0.08,1.0,1.0,6/56,17.50%,APP;PYCARD;WNT5A;IFI16;LGALS9;IL6
gsea,glycerophospholipid metabolic process (GO:0006650),0.38187742892013216,1.384879746303713,0.06521739130434782,0.3092375186931105,1.0,13/80,26.56%,FAR1;ACP6;DPM2;PNPLA6;PIGN;PGP;PIGH;CPNE7;PIP5K1A;AGK;PAFAH1B1;PIGV;PNPLA3
gsea,positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.4003026485289733,-1.3847724614753165,0.044444444444444446,1.0,1.0,11/147,21.50%,TRPM4;CD24;JPH2;LPAR2;FIS1;SPPL3;CACNB3;P2RX4;BCAP31;P2RX5;TAC4
gsea,monocarboxylic acid metabolic process (GO:0032787),0.36179774665585807,1.3826401416208665,0.061224489795918366,0.3127073069423815,1.0,24/143,23.82%,GLO1;ME1;GOT2;PDZD11;GNPAT;ACOT7;CKB;PC;ACSL3;LDHA;AASDHPPT;AMACR;PDHA1;FASN;MTHFD1L;MSMO1;LDHB;THEM4;ENST00000630362.2;NPC1;UGT1A3;PNPLA8;PPARD;PDHX
gsea,modification-dependent protein catabolic process (GO:0019941),0.31089571271804034,1.3818349205262954,0.12195121951219512,0.3131010597059186,1.0,44/201,21.16%,AURKB;BUB1B;DTL;ANAPC1;PLK1;COPS3;UBE2A;UBE2C;CDC26;PSMD14;RNF20;PTTG1;UBA1;MAD2L1;FBXO45;RNF8;NUB1;UBA6;PSMD11;RFFL;RNF34;CDC27;BUB3;UBR4;STUB1;RPS27A;NDFIP2;RNF6;ANAPC2;UBE2G1;ELOC;RC3H2;UBQLN1;UBE4A;RNF14;FBXO11;CDC23;UBQLN2;XBP1;UBE2K;CDC20;RLIM;FEM1C;ANAPC10
gsea,positive regulation of histone acetylation (GO:0035066),0.47393075879054875,1.3812457807657195,0.058823529411764705,0.31310092032694764,1.0,6/23,19.88%,BRCA1;KAT7;RPS6KA4;GLYR1;PAXIP1;MUC1
gsea,ribosomal small subunit biogenesis (GO:0042274),0.4183793622298711,1.3812290138726968,0.10204081632653061,0.3122771746289183,1.0,16/40,23.60%,RIOK1;RRP36;ENST00000630540.2;DDX52;NPM1;LTV1;METTL17;WDR3;NOM1;ERAL1;RPS27;MRPS11;SRFBP1;UTP4;RPSA;RPS24
gsea,protein methylation (GO:0006479),0.4422173009765862,1.3738449072996868,0.1276595744680851,0.32602047483699936,1.0,18/41,36.24%,NSD1;NSD3;PRMT5;EZH2;SNRPD3;PRMT1;GSPT1;EHMT1;ATPSCKMT;FAM98A;ETF1;NTMT1;PCMT1;FAM98B;PRMT3;RAB6A;ICMT;SNRPB
gsea,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.4105418038991925,-1.3737371625429562,0.061224489795918366,1.0,1.0,10/53,17.48%,TRADD;TRIP6;APP;EGFR;CD27;IFI35;LGALS9;IL23A;SASH1;TCIM
gsea,regulation of phosphoprotein phosphatase activity (GO:0043666),0.4143331409108288,1.3725444943684553,0.13725490196078433,0.3273578011927492,1.0,10/38,26.92%,HSP90B1;HTT;TIPRL;FKBP1A;HSP90AB1;PPP6R3;PPP1R12A;GSK3B;MTOR;BOD1L1
gsea,glycolytic process (GO:0006096),0.669843378023564,1.3715182151794199,0.1509433962264151,0.3285149400915361,1.0,12/29,23.10%,GAPDH;ALDOA;HKDC1;LDHA;GPI;PGK1;PGM1;ENO1;TPI1;PKM;ENO2;PGAM1
gsea,response to retinoic acid (GO:0032526),-0.4335036050653735,-1.3705221877665184,0.19148936170212766,1.0,1.0,16/62,27.97%,NDUFA13;OVCA2;WNT5A;RARG;PTK2B;GATA6;TMEM161A;PTK7;FZD7;WNT5B;AQP3;CTSH;WNT6;PTK6;ASXL1;WNT7B
gsea,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.34349120842060554,-1.3699780836483981,0.06521739130434782,1.0,1.0,5/38,6.57%,DDRGK1;RPL11;UBXN1;NOP53;CCAR2
gsea,melanosome organization (GO:0032438),-0.4757400019725671,-1.3678807383863634,0.15555555555555556,1.0,1.0,4/27,3.48%,BLOC1S4;TRAPPC6A;HPS1;BLOC1S1
gsea,regulation of mRNA catabolic process (GO:0061013),0.36374126032968496,1.3676389810983223,0.16326530612244897,0.334544285593644,1.0,32/122,18.24%,EXOSC8;HSPA8;PSMD14;XPO1;PSMD6;PSMB2;PSMD5;HNRNPD;SERBP1;PCID2;PSMD1;PNPT1;PSMA5;PUM2;PSMD11;PSMA4;PSMA3;PSME4;DIS3;PSMD7;YWHAZ;ENST00000629691.2;RPS27A;ZC3HAV1;ELAVL1;PSMC6;RC3H2;CNOT7;PSMA1;NUP214;PSMD10;PSMB3
gsea,synapse organization (GO:0050808),-0.3969637098763297,-1.3669058846272735,0.09302325581395349,1.0,1.0,19/126,27.97%,REST;DKK1;OBSL1;APP;SPOCK2;AGRN;IGFN1;CACNB3;CDK5;CAST;DVL1;DCTN1;SNCG;SNCA;PPFIBP1;PTPRF;LRFN4;ENST00000631145.1;WNT7B
gsea,nucleic acid metabolic process (GO:0090304),0.3684320938434826,1.3666871945230845,0.10638297872340426,0.33579964648666555,1.0,28/71,30.26%,NCBP1;TOPBP1;KPNA2;FEN1;HNRNPD;HNRNPL;DNA2;RAN;HNRNPA2B1;GTF2F2;POLR2B;MMS19;HNRNPM;HNRNPU;HNRNPC;PTBP1;LSM1;POLR2K;RAD50;HNRNPH1;WTAP;DDX1;METTL3;POLR2L;ATXN2;POLR2C;POLR2E;EXD2
gsea,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.6669399324163042,1.3657732173541535,0.14285714285714285,0.33649420666715674,1.0,9/15,18.87%,CCT8;NAF1;CCT7;CCT2;CCT6A;CCT5;CCT3;CCT4;DKC1
gsea,endosome organization (GO:0007032),0.3770664329140523,1.364655702672075,0.14285714285714285,0.3376084640672846,1.0,13/41,22.96%,PI4K2B;HOOK1;CHMP2B;CORO1C;CLCN3;SNX10;USP8;ALS2;DNAJC13;RNF26;DNM1;AKTIP;WASHC4
gsea,mRNA processing (GO:0006397),0.3193807804779311,1.3645613729116939,0.0625,0.3366868029315455,1.0,100/300,28.58%,DHX9;CPSF3;SNRPD1;WBP11;SRRM1;LSM3;NCBP1;THOC3;SNRPA1;SF3B3;HSPA8;RNGTT;AQR;SMNDC1;THOC1;PRPF4B;U2AF1;DDX46;PAPOLA;PHF5A;HNRNPD;RBM14;PRPF38A;CWF19L1;HNRNPL;CPSF2;PPWD1;SNRPF;GEMIN5;DHX16;SCAF11;SRSF1;HNRNPA2B1;LSM5;GTF2F2;SRSF7;SF3B1;POLR2B;SNRPD3;SARNP;CWC22;WBP4;BCAS2;DDX5;CSTF2;U2AF1L5;GTF2H1;NUDT21;SNRNP40;HNRNPM;SYNCRIP;BUD13;HNRNPU;SRSF4;CDC5L;CSTF3;HNRNPC;FRG1;ELAVL1;PTBP1;SRRM2;PQBP1;CSTF1;POLR2K;RBM6;TXNL4A;DBR1;WDR83;THOC7;SMU1;SNW1;RBM22;HNRNPH1;SF3B6;SPEN;CWC27;TRA2A;SF3B4;MTREX;ZCCHC8;FUS;ZCRB1;SF3B2;CPSF7;METTL3;SRRT;POLR2L;PRPF19;MFAP1;TBRG4;PABPC1;RPRD2;PPIH;SNRPB2;CPSF1;PPIL1;SON;POLR2C;USP39;PSPC1
gsea,organelle fusion (GO:0048284),-0.43870731990983125,-1.3617130220864408,0.07407407407407407,1.0,1.0,6/22,11.37%,STX4;FIS1;BAX;VPS18;SPG7;ENST00000638355.1
gsea,cellular protein-containing complex assembly (GO:0034622),0.3617617134208258,1.361282067175613,0.125,0.3419232763750357,1.0,31/168,19.58%,NDC1;DHX9;CENPF;CENPE;HSPD1;NUP153;HSP90AA1;ANLN;NUP205;HSPA4;VBP1;PSMD11;CCT2;SNX9;TPR;FKBP1A;MKKS;CENPA;PDE4DIP;PTGES3;NUP107;DLGAP5;PSMG2;HSP90AB1;TBCE;FCHO2;NUP93;AHCTF1;EIF4H;PSMG1;PIK3C2A
gsea,fibroblast growth factor receptor signaling pathway (GO:0008543),0.3636715768474603,1.359420069474287,0.1276595744680851,0.3445228149430753,1.0,21/75,29.21%,NCBP1;SHCBP1;GTF2F2;SETX;POLR2B;RAB14;FIBP;GALNT3;HNRNPM;PTPN11;FGFBP1;PTBP1;MAPK1;POLR2K;HNRNPH1;SHOC2;ESRP2;POLR2L;POLR2C;POLR2E;CEP57
gsea,negative regulation of Notch signaling pathway (GO:0045746),-0.4609627780230468,-1.359257709748047,0.16666666666666666,1.0,1.0,8/30,17.48%,MMP14;EGFR;HIF1AN;RITA1;EGFL7;ZBTB7A;ARRB1;TCIM
gsea,mRNA 3'-end processing (GO:0031124),0.35922959578575847,1.3592092397598934,0.045454545454545456,0.3439234312683298,1.0,17/79,14.92%,CPSF3;SRRM1;NCBP1;THOC3;THOC1;U2AF1;PAPOLA;SLBP;CPSF2;LEO1;SRSF1;SRSF7;SARNP;CSTF2;NUDT21;SRSF4;CSTF3
gsea,protein deubiquitination (GO:0016579),0.303233905788978,1.3556958218512822,0.02,0.34971579993614293,1.0,61/267,27.07%,USP1;CDC25A;BRCA1;USP10;CLSPN;UCHL1;CDK1;PSMD14;CYLD;PSMD6;PSMB2;PSMD5;USP12;PSMD1;RAD23B;PSMA5;PSMD11;PSMA4;PSMA3;STAMBP;PSME4;DESI2;USP16;DDB2;TRRAP;STAMBPL1;USP8;PSMD7;UIMC1;ENST00000629691.2;OTUD4;RPS27A;PSMC6;PSMA1;RHOA;USP25;USP34;PSMD10;PSMB3;STAM;INO80;VCP;TNIP1;USP47;CDC20;TAF9B;PSME1;HIF1A;TNIP2;PSMC3;USP24;UCHL3;OTULIN;PSMA6;OTUD6B;PSMD13;USP36;ABRAXAS2;YY1;FOXK2;TNFAIP3
gsea,glucose 6-phosphate metabolic process (GO:0051156),0.5535796045204524,1.3556474048637657,0.1509433962264151,0.3487295815435947,1.0,5/23,14.52%,HKDC1;GPI;PGM2;SHPK;RPE
gsea,microtubule bundle formation (GO:0001578),0.40952787045206224,1.3544736698150355,0.07272727272727272,0.349782756087999,1.0,2/45,0.51%,KIF20A;PLK1
gsea,enzyme linked receptor protein signaling pathway (GO:0007167),-0.36350141406596076,-1.3544173905893144,0.044444444444444446,1.0,1.0,13/140,18.41%,EPHB4;TNK2;EGFR;ERBB2;TRIO;BCAR1;NTF4;YES1;ABI1;PTK2B;RAPGEF1;CSF1;NEDD9
gsea,protein stabilization (GO:0050821),0.33055098069703076,1.3531729145984568,0.08695652173913043,0.3509536425754747,1.0,48/179,28.33%,NAA15;CCT8;GAPDH;BAG2;HSPD1;HSP90AA1;GTSE1;ATP1B3;PFN2;CCT7;STK4;CCT2;CCT6A;PARK7;PEX19;CCT5;PTGES3;CCT3;CCT4;NCLN;PFN1;CTNND1;ATP1B1;HSP90AB1;STK3;GNAQ;FKBPL;MCM8;SUGT1;P3H1;NAPG;TAF9B;TNIP2;RPL23;CREB1;RTN4;SEC16A;NLK;TAF9;HIP1;SEL1L;RAB21;PHB2;USP36;WFS1;FLNA;SUMO1;PRKRA
gsea,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.4943902462590412,1.352639419478376,0.10869565217391304,0.3510862818125388,1.0,5/20,15.11%,HPRT1;ATIC;GART;PPAT;PFAS
gsea,regulation of erythrocyte differentiation (GO:0045646),0.43049005188386186,1.3526177176405678,0.0851063829787234,0.35006671961004304,1.0,10/37,20.97%,PRKDC;HSPA9;CDK6;ABCB10;PRMT1;STAT1;STAT5B;ARNT;ANKRD54;HIF1A
gsea,positive regulation of neuron apoptotic process (GO:0043525),-0.4957573117255268,-1.3463648204829741,0.14583333333333334,1.0,1.0,12/24,39.96%,GRN;BAX;CDK5;ITGAM;DDIT3;CTNNB1;MCL1;SRPK2;FOXO3;PRNP;ATF4;TGFB2
gsea,mRNA metabolic process (GO:0016071),0.35765507403605634,1.3459220392026712,0.0851063829787234,0.36241850672315845,1.0,19/95,15.60%,SSB;CPSF3;LSM3;NCBP1;U2AF1;SLBP;PNPT1;SNRPF;SCAF11;SRSF1;HNRNPA2B1;LSM5;SRSF7;SNRPD3;DDX5;NUDT21;SRSF4;CSTF3;PTBP1
gsea,eye development (GO:0001654),-0.4036415207703352,-1.3436541104580142,0.14,1.0,1.0,7/58,24.31%,RAB3GAP1;PBX2;SH3PXD2B;PBX1;SIPA1L3;SALL2;TSKU
gsea,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.49749797871823387,1.3422129248230417,0.1794871794871795,0.36876931327093043,1.0,7/22,17.65%,NRDC;PTPN3;SH3D19;SNX9;TIMP2;ADAM9;ROCK1
gsea,phosphatidylcholine biosynthetic process (GO:0006656),0.4272941751085199,1.3419573663778028,0.1276595744680851,0.36827649464376155,1.0,7/33,22.28%,LPIN1;PEMT;SLC44A1;SLC44A2;CHPT1;CEPT1;LPCAT3
gsea,cellular response to hypoxia (GO:0071456),0.3738173474090397,1.3414325273960863,0.18,0.36815229205340544,1.0,36/131,21.56%,SUV39H2;NPEPPS;PSMD14;PSMD6;PSMB2;PSMD5;P4HB;FAM162A;PSMD1;PSMA5;PSMD11;PSMA4;PGK1;PSMA3;PSME4;PSMD7;SUV39H1;STUB1;ENST00000629691.2;RPS27A;TBL2;PSMC6;ELOC;ELOB;PSMA1;UBQLN1;CUL2;ARNT;PSMD10;PSMB3;VEGFA;SFRP1;EPAS1;PSME1;HIF1A;PSMC3
gsea,negative regulation of developmental process (GO:0051093),0.40908429249820355,1.341289963481042,0.11363636363636363,0.3672186387173707,1.0,12/77,19.95%,SUZ12;FOXM1;TFRC;ROCK2;HUWE1;CDK6;ANP32B;WDR77;ROCK1;BMP4;NOTCH1;SFRP1
gsea,phospholipid biosynthetic process (GO:0008654),0.44441647954994146,1.3374024162937803,0.14583333333333334,0.37558006445419123,1.0,15/37,32.47%,FAR1;GNPAT;IDI1;CPNE7;PIP5K1A;SAMD8;DHDDS;AGK;MVD;FDPS;FADS1;NUS1;DPAGT1;SGMS1;CPNE3
gsea,fatty-acyl-CoA biosynthetic process (GO:0046949),0.5388850218510743,1.3370572565343417,0.11904761904761904,0.37511319764983847,1.0,9/30,20.75%,HSD17B12;ELOVL6;ELOVL5;TECR;ACSL3;ELOVL7;FASN;SCD;ACACA
gsea,response to ionizing radiation (GO:0010212),0.3511490709297698,1.3368966602025723,0.05660377358490566,0.3741672730878795,1.0,23/72,23.09%,NET1;BRCA1;TOPBP1;RFWD3;MSH2;INIP;RNF8;RAD51AP1;XRCC4;INTS7;NHEJ1;UIMC1;PAXIP1;SMPD1;RAD51;HUS1;TICRR;PRKAA1;INO80;COP1;ECT2;NABP2;RHNO1
gsea,negative regulation of transport (GO:0051051),-0.42690500378311913,-1.3365601497358062,0.10638297872340426,1.0,1.0,5/51,8.44%,SNX33;NR1H3;SNX12;LGALS3;NR1H2
gsea,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.37355723460488705,-1.3334629839582808,0.16279069767441862,1.0,1.0,14/92,20.69%,PTPN6;TNK2;APP;EGFR;CADM4;CD74;RAP2C;PTK2B;PDGFB;PRKCZ;IL23A;IL6;DGKQ;EFNA1
gsea,positive regulation of protein kinase activity (GO:0045860),0.3163347348138917,1.3330993874048727,0.1276595744680851,0.3808331675804694,1.0,24/154,16.57%,TPX2;CENPE;CLSPN;XRCC5;HSP90AA1;BORA;ETAA1;HMGA2;TAOK3;INCENP;IQGAP1;MAP2K1;PPP2CA;STK4;EZH2;SNX9;ALS2;STRADB;RALB;MMD;KIF14;RHOA;HSP90AB1;STK3
gsea,"DNA-templated transcription, termination (GO:0006353)",0.3668135990616634,1.3327860217379701,0.06,0.3803949186355689,1.0,17/70,17.40%,CPSF3;NCBP1;TTF2;PAPOLA;PRMT5;SLBP;CPSF2;SNRPF;SETX;SNRPD3;CSTF2;GTF2H1;NUDT21;CSTF3;CSTF1;POLR2K;MTERF1
gsea,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.41296365022145176,1.3317807927218952,0.1956521739130435,0.3809144039736048,1.0,25/85,22.83%,PSMD14;RYK;PSMD6;PSMB2;PSMD5;PSMD1;VANGL1;PSMA5;PSMD11;PSMA4;PSMA3;DAAM1;PSME4;PSMD7;ARHGEF19;ENST00000629691.2;PFN1;PSMC6;PSMA1;RHOA;PSMD10;PSMB3;PSME1;PSMC3;AP2B1
gsea,RNA stabilization (GO:0043489),0.5176172987690005,1.3317630328735899,0.14,0.3798435491304935,1.0,10/33,27.72%,E2F1;NAF1;LARP1;HNRNPU;ELAVL1;DKC1;NSUN2;FUS;PABPC1;DHX36
gsea,ribosomal small subunit assembly (GO:0000028),0.4485983650169262,1.3312743531910505,0.1702127659574468,0.37960983602633974,1.0,7/17,26.00%,PRKDC;XRCC5;ERAL1;RPS27;MRPS11;RPSA;RPS15
gsea,regulation of vesicle-mediated transport (GO:0060627),-0.37008457732110317,-1.3311074314424474,0.13953488372093023,1.0,1.0,21/96,22.60%,ENST00000639909.2;RAB13;SNX12;MAPK3;STX4;RAB10;PACSIN2;AP2S1;ARFGAP1;HIP1R;ATP9A;SCFD1;BET1L;USP7;MAP2K2;VAMP2;RAB3D;RAB11B;PACSIN3;RAB25;TSC2
gsea,regulation of interleukin-1 beta production (GO:0032651),-0.3954349919093109,-1.3295268120615236,0.09090909090909091,1.0,1.0,13/83,31.70%,APP;PYCARD;WNT5A;IFI16;GIT1;LGALS9;IL6;GSTP1;SIRPA;GSDMD;TRIM16;INAVA;TLR6
gsea,ATP synthesis coupled proton transport (GO:0015986),-0.49799782828241534,-1.3289355337886664,0.14285714285714285,1.0,1.0,6/19,14.29%,ATP5MF;ATP5MC2;ATP5F1E;ATP5ME;ATP5PB;VPS9D1
gsea,nucleocytoplasmic transport (GO:0006913),0.41866842985538183,1.3280186826377456,0.16,0.3847035966971919,1.0,10/40,10.14%,SNRPD1;NCBP1;NXT2;XPO1;NUP205;DDX20;NPM1;SNRPF;GEMIN5;SNRPD3
gsea,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.38441049387451315,-1.326545868972627,0.08163265306122448,1.0,1.0,9/36,25.02%,GAS6;WNT5A;CD74;CSF1;AGPAT2;RIPK1;MAVS;FADD;CPNE1
gsea,protein phosphorylation (GO:0006468),0.27748138493081576,1.3245726869498082,0.11627906976744186,0.39059402652172465,1.0,85/496,25.64%,AURKB;CDK2;CIT;PLK1;BAZ1B;PRKDC;TTK;STK26;CHEK1;CLSPN;CDK1;EIF2AK4;RYK;NEK2;PRPF4B;PLK4;PRKCI;TAOK3;MELK;INCENP;MAPKAPK5;VRK2;GMFB;COPS8;MAP2K1;ROCK2;SLK;CDK6;STK4;GRK6;CSNK1E;STK17A;CDK8;JAK1;MAP4K5;RPS6KA4;MKNK2;CLK3;GTF2H1;CDC42BPA;YWHAZ;TBK1;CRY1;CDC7;NEK7;STRADB;STK24;PRDX4;PIK3R4;MAP3K20;BIRC5;TOP1;STK3;MAPK1;MAST2;ROCK1;BMP4;PRKACB;HASPIN;CDK17;EIF2AK2;PRKAA1;MARK2;MAPK12;SRPK1;CREB1;PDPK1;RPS6KA3;WNK1;AURKA;MAPKAPK3;GSK3B;LMTK2;CAB39;MAPK8;VRK3;MTOR;PAK2;NLK;ATR;PKN2;MAPK6;RPS6KB2;DCLK1;CCNE1
gsea,regulation of cholesterol efflux (GO:0010874),-0.439787967546854,-1.3223503480139658,0.12962962962962962,1.0,1.0,11/33,34.36%,NR1H3;PTCH1;NR1H2;PLTP;ZDHHC8;GPS2;NFKBIA;LRP1;CES1;ABCA2;LAMTOR1
gsea,positive regulation of intracellular transport (GO:0032388),0.393778069233437,1.3209757626331078,0.1,0.39637205506319695,1.0,6/39,19.06%,KIF20B;SPAG5;ZFAND1;TPR;ICE1;EIPR1
gsea,phosphorylation (GO:0016310),0.2820307293527884,1.3207329070101639,0.09090909090909091,0.3956241811344646,1.0,74/400,25.64%,AURKB;CDK2;PLK1;PRKDC;STK26;CHEK1;CDK1;EIF2AK4;RYK;NEK2;PRPF4B;PLK4;PRKCI;TAOK3;MELK;VRK2;GMFB;COPS8;MAP2K1;ROCK2;CDK6;STK4;GRK6;CSNK1E;STK17A;CDK8;PGK1;JAK1;MAP4K5;PIK3CB;RPS6KA4;SHPK;MKNK2;CLK3;PNKP;CDC42BPA;YWHAZ;TBK1;NEK7;STRADB;STK24;PIK3R4;MAP3K20;BIRC5;TOP1;STK3;MAPK1;MAST2;ROCK1;PRKACB;HASPIN;CDK17;EIF2AK2;PRKAA1;MARK2;PI4KA;AGK;SRPK1;CREB1;PDPK1;DGKG;WNK1;AURKA;GSK3B;LMTK2;MAPK8;PANK3;MTOR;PAK2;NLK;PKN2;MAPK6;DCLK1;CCNE1
gsea,organic acid transport (GO:0015849),0.3626161965507357,1.3188525151138972,0.06666666666666667,0.3985076443891018,1.0,13/100,24.11%,LRRC8D;GOT2;ABCC2;SLC7A11;SLC3A2;SLC26A1;SLC1A5;ENST00000630362.2;SLC25A32;SLC7A1;PPARD;SLC23A2;SLC6A6
gsea,regulation of actin cytoskeleton reorganization (GO:2000249),-0.3962594451152395,-1.3160446112171202,0.07692307692307693,1.0,1.0,6/37,15.68%,MDK;PHPT1;PTK2B;BAIAP2L2;CDK5;DAPK3
gsea,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.311278486156283,1.313970117904256,0.10526315789473684,0.40759689027036866,1.0,17/77,21.60%,FANCI;BRCA1;HUWE1;BCL10;FKBP1A;HDAC3;STUB1;CRY1;PAXIP1;PIAS1;NDFIP2;DCUN1D5;UBQLN1;PSMD10;TNIP1;RIPK2;DCUN1D2
gsea,nitrogen compound transport (GO:0071705),0.31964837175769,1.3129510905135737,0.16216216216216217,0.40903379347954477,1.0,9/143,5.44%,NDC1;CENPF;LRRC8D;HSP90B1;CHMP2B;ABCC2;SLC7A11;SLC7A5;SLC44A1
gsea,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.3933762692428435,1.3116117810267522,0.19444444444444445,0.410346527981966,1.0,5/47,18.57%,TTK;HFE;TWSG1;ENG;BMP4
gsea,RNA metabolic process (GO:0016070),0.32442060890415025,1.3108731705826207,0.11764705882352941,0.4107264180201402,1.0,40/133,30.65%,DHX9;NCBP1;RNGTT;THOC1;PAPOLA;HNRNPD;SUPV3L1;HNRNPL;DDX20;PNPT1;HNRNPA2B1;GTF2F2;SETX;POLR2B;SNRNP40;HNRNPM;SYNCRIP;HNRNPU;HNRNPC;PTBP1;LSM1;POLR2K;RBM6;DKC1;AGO1;NUFIP1;HNRNPH1;MTREX;WTAP;METTL3;POLR2L;TBRG4;ATXN2;DHX36;POLR2C;PPP1R8;AGO2;POLR2E;NOL9;ADAR
gsea,aggrephagy (GO:0035973),0.39895742731683015,1.309912190593346,0.1702127659574468,0.4116809072439645,1.0,5/29,16.29%,DYNC1LI1;PARK7;DYNC1I2;RPS27A;UBQLN1
gsea,cellular response to alcohol (GO:0097306),0.40820697263285843,1.3094644739401022,0.13953488372093023,0.4113264118672636,1.0,9/48,21.90%,BRCA1;LARP1;ADCY3;RAD51;RNA5SP498;SFRP1;GOLPH3;AKR1C2;CDH1
gsea,Rho protein signal transduction (GO:0007266),-0.32416575961778105,-1.3086187000272331,0.08,1.0,1.0,8/56,12.44%,CDC42EP5;RTKN;EPS8L2;TAX1BP3;ARHGEF1;RHOB;EPS8L1;CDC42EP2
gsea,activation of protein kinase activity (GO:0032147),0.3128829009993711,1.308005671461318,0.11764705882352941,0.41349733141937756,1.0,22/114,24.42%,TPX2;CLSPN;BORA;TAOK3;COPS8;STK4;ZFP91;PARK7;STRADB;ADCY3;KIF14;STK3;PRKACB;VEGFA;MARK2;PRKAR2A;PDPK1;TXN;ECT2;MTOR;PAK2;EMP2
gsea,positive regulation of interferon-beta production (GO:0032728),0.40357741381121176,1.3075277609252045,0.1875,0.41367350625440813,1.0,7/36,21.24%,DHX9;OAS3;HSP90AA1;TBK1;PTPN11;POLR3F;RIPK2
gsea,connective tissue development (GO:0061448),-0.44619608999432303,-1.3054830528326062,0.14285714285714285,1.0,1.0,5/38,11.32%,DDRGK1;SCX;DYRK1B;SH3PXD2B;PGRMC2
gsea,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.400072065769594,1.305153513349899,0.13043478260869565,0.41818298731285625,1.0,8/32,19.70%,CAMSAP3;PDZD11;PRKCI;MSN;PDCD6IP;RHOA;RAP2A;MARK2
gsea,positive regulation of chemotaxis (GO:0050921),-0.36226847782190813,-1.3042717199710325,0.11627906976744186,1.0,1.0,8/45,17.83%,TMSB4X;STX4;MDK;THBS1;MEGF8;PDGFB;IL6;P2RX4
gsea,metal ion homeostasis (GO:0055065),-0.48099894916877495,-1.3037159317258415,0.11538461538461539,1.0,1.0,4/44,10.26%,SCNN1A;JPH2;COX11;SLC12A7
gsea,negative regulation of DNA recombination (GO:0045910),0.36866798736808376,1.3032806045687557,0.1111111111111111,0.42122660684483804,1.0,14/57,30.03%,POLQ;RMI2;SHLD2;MSH2;SMCHD1;POLR2B;ACD;POLR2K;TERF2IP;POLR2L;POLR2C;POLR2E;UBQLN4;MSH6
gsea,bile acid metabolic process (GO:0008206),0.443426440108252,1.3020495170499276,0.18181818181818182,0.4228543892319253,1.0,6/33,27.78%,AMACR;OSBPL3;OSBPL2;NPC1;OSBP;HSD17B10
gsea,negative regulation of mRNA catabolic process (GO:1902373),0.5001609153974398,1.3014898725743955,0.14893617021276595,0.42273876321748827,1.0,7/29,26.88%,E2F1;LARP1;HNRNPU;ELAVL1;NBAS;FUS;PABPC1
gsea,regulation of mRNA stability (GO:0043488),0.3524635158241338,1.3012966398449244,0.1836734693877551,0.4218717764193502,1.0,35/146,18.24%,E2F1;EXOSC8;HSPA8;PSMD14;XPO1;PSMD6;PSMB2;PSMD5;HNRNPD;SERBP1;PCID2;PSMD1;NPM1;ROCK2;PSMA5;PUM2;PSMD11;PSMA4;PSMA3;PSME4;LARP1;DIS3;PSMD7;YWHAZ;ENST00000629691.2;HNRNPU;RPS27A;ELAVL1;PSMC6;RC3H2;PSMA1;NUP214;ROCK1;PSMD10;PSMB3
gsea,regulation of cellular protein localization (GO:1903827),0.4333439690895535,1.3011020098391657,0.19148936170212766,0.4209720700091179,1.0,11/46,22.65%,HSP90AA1;PARP1;HFE;CSNK1E;GBF1;RALB;CEP72;HSP90AB1;PRKAA1;VCP;MAP2
gsea,regulation of cellular component biogenesis (GO:0044087),0.3752828002237919,1.3008190768462704,0.10909090909090909,0.4204886342952353,1.0,10/39,18.61%,HSPA8;HSP90AA1;ROCK2;MSN;HJURP;RAP1B;NCLN;PTPN11;ROCK1;NOTCH1
gsea,chromatin organization (GO:0006325),0.3044394570108377,1.2960388182525016,0.06521739130434782,0.4291068366945526,1.0,32/142,26.66%,BAZ1B;SMARCA5;NUCKS1;SUV39H2;CHD1;DR1;HMGA2;SUPV3L1;SETD5;NPM1;FOXA1;EZH2;CHRAC1;PHF19;HDAC3;SUV39H1;FAM47E;BPTF;CHD1L;TOP1;RB1;NUDT5;HDAC2;INO80;BAZ1A;SMARCD1;EHMT1;DDX11;HMG20A;HMGN3;LOXL2;HP1BP3
gsea,positive regulation of DNA metabolic process (GO:0051054),0.3673979694842865,1.2956200838944154,0.0625,0.4289013289780301,1.0,9/63,15.36%,DHX9;PCNA;BRCA1;HMGB1;SMCHD1;RNF8;UIMC1;OTUD4;RAD51
gsea,axonal transport (GO:0098930),0.4135919657812643,1.2951121337962777,0.175,0.4286969411945677,1.0,12/36,26.74%,KIF4A;OPA1;AP3B1;AP3M2;BLOC1S6;DST;BLOC1S5;HIF1A;PAFAH1B1;RAB21;AP3S2;KIF1B
gsea,positive regulation of neuron death (GO:1901216),-0.4089559297682273,-1.2941976650908338,0.2,1.0,1.0,13/47,31.70%,REST;DKK1;WNT5A;GRN;BAX;CDK5;ITGAM;DDIT3;SNCA;CLU;CTNNB1;SRPK2;TLR6
gsea,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.43685803015355235,1.2929971652889,0.09090909090909091,0.4321553709693227,1.0,5/32,12.97%,TPX2;CAMSAP3;MAPRE1;KATNB1;CAMSAP2
gsea,regulation of ubiquitin-protein transferase activity (GO:0051438),0.34458467206731963,1.2928436216154933,0.061224489795918366,0.43120553841037773,1.0,12/29,33.40%,PLK1;FBXO5;PARK7;DCUN1D5;DCUN1D2;FEM1B;UBE2N;ARRDC3;TRIB3;UBE2L3;BMI1;ABL1
gsea,regulation of cellular senescence (GO:2000772),0.5071393341056222,1.291341729400227,0.13043478260869565,0.4340131148496335,1.0,7/31,13.06%,EEF1E1;FBXO5;HMGA2;PNPT1;CDK6;ING2;ARG2
gsea,cellular response to UV (GO:0034644),0.3220698883138588,1.290839428386654,0.125,0.43416403082122934,1.0,22/77,28.90%,AURKB;CDC25A;PCNA;CHEK1;EIF2AK4;PARP1;NPM1;DDB2;SMPD1;EIF2S1;ENST00000618924.4;POLD1;INO80;USP47;RHNO1;CUL4B;ATR;METTL3;TIMP1;YY1;DHX36;DDB1
gsea,cellular response to light stimulus (GO:0071482),0.36590337113583,1.290605590543075,0.17391304347826086,0.43325304780693846,1.0,17/70,27.72%,AURKB;CDC25A;PCNA;EIF2AK4;PARP1;NPM1;SMPD1;EIF2S1;ENST00000618924.4;POLD1;INO80;USP47;RHNO1;ATR;METTL3;YY1;DHX36
gsea,phosphatidylinositol metabolic process (GO:0046488),0.3262908234588856,1.2892527183580704,0.14583333333333334,0.43581360710026146,1.0,18/112,19.79%,PIP4K2A;PI4K2B;MTMR12;MTMR6;SACM1L;LPGAT1;PIK3CB;RAB14;FIG4;PIK3C3;PIP5K1A;PIK3R4;PLA2G12A;CDS1;PLBD1;PIK3C2A;PLEKHA2;PI4KA
gsea,regulation of establishment of planar polarity (GO:0090175),0.3956800551488261,1.2885949670211787,0.22448979591836735,0.4362496468743334,1.0,24/88,22.83%,PSMD14;PSMD6;PSMB2;PSMD5;PSMD1;VANGL1;PSMA5;PSMD11;PSMA4;PSMA3;DAAM1;PSME4;PSMD7;ARHGEF19;ENST00000629691.2;PFN1;PSMC6;PSMA1;RHOA;PSMD10;PSMB3;PSME1;PSMC3;AP2B1
gsea,regulation of cell-substrate junction assembly (GO:0090109),0.44732139444750196,1.288556967153609,0.1,0.4351589075108628,1.0,7/21,17.65%,CAMSAP3;CORO1C;ROCK2;SLK;VCL;RHOA;ROCK1
gsea,chaperone cofactor-dependent protein refolding (GO:0051085),0.4838012240589842,1.2871252439136325,0.2391304347826087,0.4370785683601611,1.0,6/26,12.47%,HSPA9;HSPA8;HSPA14;HSPA13;PTGES3;HSPA5
gsea,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.470252267060565,1.2843440933952988,0.17391304347826086,0.4404553178933263,1.0,8/21,16.18%,PARP1;RPA3;ERCC5;RPA1;RPA2;DDB2;GTF2H1;CHD1L
gsea,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.470252267060565,1.2843440933952988,0.17391304347826086,0.4404553178933263,1.0,8/21,16.18%,PARP1;RPA3;ERCC5;RPA1;RPA2;DDB2;GTF2H1;CHD1L
gsea,ribonucleoprotein complex assembly (GO:0022618),0.3456011053822513,1.284316083865858,0.1702127659574468,0.439400906971073,1.0,43/136,26.00%,DHX9;PRKDC;SNRPD1;BRIX1;NCBP1;XRCC5;HSP90AA1;DHX29;EIF2S2;PRMT5;DDX20;SNRPF;GEMIN5;NOP2;NAF1;DENR;SCAF11;SRSF1;SETX;SF3B1;SNRPD3;PTGES3;NUDT21;MCTS1;SNUPN;WDR77;ERAL1;HSP90AB1;RPS27;TXNL4A;EIF4H;MRPS11;GEMIN4;SRPK1;RPL6;EIF2S3;RPSA;RRS1;CPSF7;DDX1;RPL3;PRPF19;RPS15
gsea,fatty acid biosynthetic process (GO:0006633),0.394508644883911,1.2835909895783788,0.16279069767441862,0.43999971628571577,1.0,11/71,20.75%,ELOVL6;HACD3;ELOVL5;ABCD3;ACOT7;TECR;DECR2;ELOVL7;SCD;XBP1;ACACA
gsea,regulation of monooxygenase activity (GO:0032768),0.47705499039063715,1.2829819919289158,0.11764705882352941,0.440774006821626,1.0,5/24,12.22%,HSP90AA1;DDAH2;WASL;DDAH1;DNM2
gsea,response to molecule of bacterial origin (GO:0002237),-0.4045813509100811,-1.2823325142874207,0.17073170731707318,1.0,1.0,14/73,22.57%,CD24;MAPKAPK2;PALM3;GGT1;GGT7;HNRNPA0;SRR;TAB2;LGALS9;IL6;OTUD5;SLPI;PELI1;SNCA
gsea,myeloid leukocyte differentiation (GO:0002573),0.370163586075116,1.2806481168807013,0.14,0.44478670040071366,1.0,11/71,20.92%,CDK2;GLO1;E2F1;PARP1;SNX10;RUNX1;FARP2;BMP4;VEGFA;F2RL1;PIR
gsea,regulation of organelle assembly (GO:1902115),0.3117098175238242,1.2803984761734186,0.09090909090909091,0.44419399122103287,1.0,13/77,19.63%,RNF4;CYLD;ATG3;STIL;SENP6;USP6NL;NPM1;MSN;SGSM3;PDCD6IP;UBQLN2;STAM;TBC1D22B
gsea,autophagosome organization (GO:1905037),-0.32473856569758336,-1.2796945089894665,0.11538461538461539,1.0,1.0,14/56,19.68%,ATG101;RAB43;TP53INP2;ATP2A2;ATG2A;RAB1A;ATG13;VMP1;GABARAPL1;ATG9B;RAB1B;WDR45;ATG14;GABARAP
gsea,negative regulation of mitotic cell cycle (GO:0045930),0.39850985737430134,1.2788022285399465,0.08163265306122448,0.4465818174903623,1.0,5/48,5.76%,BUB1;BUB1B;CHEK1;MAD2L1;PTPN3
gsea,glycolytic process through glucose-6-phosphate (GO:0061620),0.5754433143090492,1.2787509853596302,0.22807017543859648,0.4454925722126546,1.0,13/25,33.51%,GAPDH;ALDOA;GPI;PGK1;ENO1;TPI1;PKM;ENO2;ADPGK;PGAM1;FOXK2;PFKL;HK2
gsea,positive regulation of cell motility (GO:2000147),-0.290745072247818,-1.2757785261929466,0.08888888888888889,1.0,1.0,31/221,16.85%,TRADD;SMIM22;DDRGK1;MMP14;CIB1;TRIP6;SUN2;PIK3CD;STX4;FAM89B;SPOCK2;EGFR;FAM110C;GRN;BCAR1;VSIR;NUMB;ACTG1;MDK;ELP3;THBS1;PHPT1;PDGFC;CCAR1;PTK2B;CLDN4;MYO1C;PDGFB;CSF1;AKT2;MGAT5
gsea,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.48013846451111386,-1.2753562123359692,0.20930232558139536,1.0,1.0,5/17,13.27%,ATP5MF;ATP5MC2;ATP5F1E;ATP5ME;ATP5PB
gsea,negative regulation of viral genome replication (GO:0045071),0.36150467403205316,1.2747925833269593,0.14583333333333334,0.45297767495997066,1.0,10/54,22.90%,FAM111A;OAS3;HMGA2;TASOR;ZC3HAV1;EIF2AK2;TNIP1;APOBEC3B;SRPK1;PLSCR1
gsea,ameboidal-type cell migration (GO:0001667),-0.39500117416106156,-1.2740822076851885,0.08163265306122448,1.0,1.0,8/52,24.81%,SRGAP2;PDXDC1;MEGF8;SGPL1;SEMA7A;SEMA3B;SEMA4C;AMOTL2
gsea,ceramide biosynthetic process (GO:0046513),0.4213515840240347,1.2729960039720811,0.12,0.4556056624172705,1.0,11/42,37.51%,CERS2;CERS6;SPTLC1;SMPD1;SAMD8;AGK;SPTLC2;CERS5;SGMS1;SPTSSA;SGMS2
gsea,peptidyl-threonine dephosphorylation (GO:0035970),0.41697011975356785,1.272738657932619,0.16666666666666666,0.45541367204511307,1.0,7/22,31.75%,PPP2CA;PPP1CA;PPM1G;PPM1A;PPP5C;DUSP7;PPP2CB
gsea,negative regulation of dephosphorylation (GO:0035305),0.4205084666429163,1.272613377218966,0.15384615384615385,0.45476779600334294,1.0,9/20,28.12%,URI1;ARPP19;SH2D4A;PPP1R26;MFHAS1;YWHAB;SH3RF2;ENSA;PPP1R8
gsea,response to unfolded protein (GO:0006986),0.4171642733722144,1.2724510863006346,0.27450980392156865,0.4539158291804572,1.0,11/49,12.47%,HSPD1;HSPA9;HSPA8;HSP90AA1;HSPA14;TM7SF3;HSPA4;ERP44;HSPA4L;HSPA13;HSPA5
gsea,regulation of cell cycle (GO:0051726),0.28873773707543277,1.2723200583869654,0.02040816326530612,0.4532422764178732,1.0,49/296,20.54%,DTL;CENPF;PLK1;KIF20B;CDC25A;BRCA1;CDKN3;MYBL2;CHEK1;PCLAF;CDC26;PRR11;FOXM1;FBXO5;CYLD;HMGA2;RNF20;INTS13;TTLL12;GMNN;IQGAP1;CCPG1;SRA1;MAP2K1;PNPT1;CCNB2;CDK6;TXLNG;TARDBP;GBF1;NEK7;HNRNPU;DLGAP5;MAP3K20;CCNB1;BIRC5;HSP90AB1;UHRF2;RB1;CKS1B;ZNF268;ENST00000618924.4;BMP4;NOTCH1;TFAP4;SFRP1;DHCR24;WDR12;MAPK12
gsea,regulation of viral genome replication (GO:0045069),0.3706629994120307,1.2704425046794516,0.225,0.45659996209598214,1.0,18/67,31.03%,FAM111A;OAS3;HACD3;STAU1;LARP1;ZC3HAV1;CNOT7;EIF2AK2;TNIP1;SRPK1;PLSCR1;PKN2;PABPC1;PPIH;DDB1;PPARA;ADAR;PPIA
gsea,maturation of SSU-rRNA (GO:0030490),0.40965536781112755,1.2702964309600133,0.08695652173913043,0.4557152027580572,1.0,13/35,23.22%,RIOK1;RRP36;NOL10;DDX52;DCAF13;NGDN;BMS1;WDR3;MRPS11;NAT10;SRFBP1;HEATR1;UTP4
gsea,positive regulation of cell adhesion (GO:0045785),-0.36178251175790943,-1.2698004061474535,0.2391304347826087,1.0,1.0,17/80,26.76%,CIB1;STX4;TPM1;FSTL3;ERBB2;MDK;SMAD7;FLCN;AFDN;ZFHX3;PDGFB;TFE3;CITED2;ADGRG1;PPP3CA;RSU1;ADAM8
gsea,negative regulation of DNA biosynthetic process (GO:2000279),0.46157436311450517,1.2677952021475245,0.13636363636363635,0.46088051513663497,1.0,9/32,21.47%,STN1;HNRNPU;HNRNPC;EXOSC10;ACD;PIF1;NAT10;GNL3L;TENT4B
gsea,protein ADP-ribosylation (GO:0006471),0.4007564522109404,1.2674214311662362,0.18181818181818182,0.46036844462475046,1.0,7/29,33.16%,PARP1;PARP2;ZC3HAV1;PARP4;TNKS2;PARP12;PARP14
gsea,regulation of defense response to virus by host (GO:0050691),0.4354578440005758,1.2673642427197005,0.21568627450980393,0.45930901314428224,1.0,9/36,27.17%,DHX9;EIF2AK4;HSP90AA1;SIN3A;STAT1;PQBP1;TRAF3IP2;TNFAIP3;TOMM70
gsea,substantia nigra development (GO:0021762),0.42466668792034423,1.2672831229514971,0.2391304347826087,0.45835777421122004,1.0,11/43,24.63%,YWHAE;CCDC14;YWHAH;CKB;HSPA5;ATP5PF;ZNF148;RHOA;GNB4;SEC16A;YWHAQ
gsea,regulation of transcription by RNA polymerase I (GO:0006356),0.4105380928795784,1.2654513097121685,0.1875,0.4613099987342377,1.0,9/18,27.77%,WDR75;WDR43;LYAR;POLR2K;PHF8;HEATR1;UTP15;POLR2L;FLNA
gsea,negative regulation of protein secretion (GO:0050709),-0.41201227801654494,-1.265204301811724,0.17307692307692307,1.0,1.0,4/39,10.69%,REST;NR1H3;ERP29;RHBDF1
gsea,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.3488594061576341,-1.2651805766119903,0.1956521739130435,1.0,1.0,20/172,19.83%,RAPGEF2;GAS6;SERPINF2;CIB1;MAPK3;APP;EGFR;PYCARD;CD74;PDGFC;ENST00000615721.3;PTK2B;ARRB2;LGALS9;PDGFB;GLIPR2;ARRB1;PRKCZ;ARHGAP8;SEMA7A
gsea,positive regulation of JNK cascade (GO:0046330),-0.41117122449151056,-1.265010618087589,0.2,1.0,1.0,16/73,20.92%,LTBR;GADD45A;SERPINF2;APP;TAOK2;MINK1;PYCARD;CD27;MAP3K11;GADD45B;PTK2B;RIPK1;FZD7;DAB2IP;TRAF2;ZNF622
gsea,mitochondrial calcium ion transmembrane transport (GO:0006851),0.4552325696119467,1.2646828172461848,0.2127659574468085,0.4623029690269976,1.0,6/21,17.50%,MCUR1;MCUB;AFG3L2;MCU;STOML2;MICU1
gsea,regulation of sprouting angiogenesis (GO:1903670),0.3871990443341014,1.264397911587131,0.13636363636363635,0.46162360335195535,1.0,10/33,33.13%,JAK1;PIK3CB;VEGFA;PKM;PDPK1;SYNJ2BP;ITGA5;KLF2;CEMIP2;GLUL
gsea,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.4409558891521537,1.264334354937378,0.1836734693877551,0.4606081947928376,1.0,9/22,25.18%,PSMB2;PSMA5;PSMA4;PSMA3;PSME4;PSMA1;PSMB3;NFE2L2;PSMA6
gsea,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.4790221278677386,-1.2642482640960397,0.14,1.0,1.0,7/42,20.69%,GAS6;UNC119;GPRC5B;DOCK3;PDGFB;NEDD9;EFNA1
gsea,tRNA processing (GO:0008033),0.385655688129447,1.2631053731818997,0.1590909090909091,0.46156164195195737,1.0,16/64,27.34%,SSB;TSEN15;METTL1;CSTF2;RPP40;POP7;DTWD1;CDKAL1;RTCB;NSUN2;TRMT6;POP5;DDX1;TRNT1;RPP30;CPSF1
gsea,organelle assembly (GO:0070925),0.26451453589957413,1.262734238551559,0.12195121951219512,0.4612944691740303,1.0,70/425,23.78%,CENPF;CENPE;NUP62;NSFL1C;LSM3;CHMP2B;HAUS7;DHX29;GORASP2;ANLN;NEK2;VPS37A;PLK4;ATG3;RBM14;HAUS6;HAUS3;VTA1;RAB8A;NPM1;EHD4;GOLGA8A;PATL1;MAPRE1;HAUS2;TMEM138;SNX10;MKKS;CENPA;VPS4B;HDAC3;OFD1;ACTR2;RABL2B;GBF1;IFT74;ACTR3;TMOD3;NEK7;PDCD6IP;PIK3C3;SQLE;VPS25;DLGAP5;EIF2S1;CFAP298;HAUS8;UBQLN1;VPS36;CDS1;TMEM107;UBQLN2;FARP2;CHMP4C;IFT122;NOTCH1;UBAP2L;STAM;INO80;EXOC2;CSDE1;RAB11A;MAPRE2;TCTN3;AMBRA1;GOLGA8B;RAB7A;CEP250;TCTN1;POGZ
gsea,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.364392834138197,-1.2618463483620732,0.11363636363636363,1.0,1.0,16/40,28.22%,BBC3;BMF;FIS1;BAX;BOK;BAD;UBB;SIAH1;GSDME;BCAP31;DDIT3;NCK1;FBH1;NACC2;BCL2L11;TP53
gsea,regulation of nitric oxide biosynthetic process (GO:0045428),0.3469359835011295,1.26164121068417,0.125,0.46271317259629524,1.0,6/40,20.09%,HSP90AA1;ROCK2;DDAH2;DDAH1;HSP90AB1;GLA
gsea,extrinsic apoptotic signaling pathway (GO:0097191),-0.37182883644547243,-1.2602620764791161,0.20833333333333334,1.0,1.0,19/72,25.27%,TRADD;CIB1;DEDD;RNF41;BAX;CD27;BOK;DCC;BCL2L2;BAK1;BAD;RIPK1;GABARAP;DAB2IP;TRAF2;TNFRSF10B;FADD;DEDD2;CASP3
gsea,regulation of intracellular signal transduction (GO:1902531),0.25689276632082586,1.260123236502158,0.08333333333333333,0.4651667144618565,1.0,37/437,9.09%,AURKB;TPX2;CHN1;CDK2;PAK1IP1;NET1;PIP4K2A;BRCA1;ARHGAP5;CHEK1;CDK1;TOPBP1;RMI2;EXO1;RFC3;RFC5;CYLD;TAOK3;RFC2;MAPKAPK5;PRMT5;VRK2;ARHGAP11A;RPA3;ARHGAP29;SUPT16H;DNA2;RPA1;NOP2;SSRP1;STK4;SOS1;RPA2;RFFL;RNF34;RACGAP1;RBBP8
gsea,cell chemotaxis (GO:0060326),-0.41167877472005154,-1.259106053213097,0.0975609756097561,1.0,1.0,8/69,21.06%,RAB13;BCAR1;ARRB2;CORO1B;PDGFB;ARHGEF16;ELMO2;ABCC1
gsea,positive regulation of apoptotic signaling pathway (GO:2001235),-0.3630048393593588,-1.2583182203325904,0.14893617021276595,1.0,1.0,17/59,20.87%,LTBR;BBC3;TNFRSF12A;BMF;FIS1;PYCARD;BAX;BOK;BAD;SIAH1;GSDME;HYAL2;BCAP31;RIPK1;DAB2IP;DDIT3;TRAF2
gsea,cellular respiration (GO:0045333),-0.33181829991706674,-1.2573962666669256,0.1794871794871795,1.0,1.0,12/42,15.21%,BLOC1S1;SURF1;ETFA;UQCRH;ETFB;NDUFS7;UQCR10;NDUFS4;UQCRB;SDHC;SIRT3;UQCRC1
gsea,interleukin-1-mediated signaling pathway (GO:0070498),0.3814010157520262,1.2546719202759615,0.17777777777777778,0.4760900215767699,1.0,28/94,25.83%,PSMD14;PSMD6;PSMB2;PSMD5;PSMD1;PSMA5;PSMD11;PSMA4;PSMA3;PSME4;RPS6KA4;PSMD7;ENST00000629691.2;RPS27A;PSMC6;PSMA1;PSMD10;PSMB3;PSME1;TNIP2;RIPK2;PSMC3;SKP1;IL1RN;CUL1;UBE2N;PSMA6;PSMD13
gsea,positive regulation of nucleocytoplasmic transport (GO:0046824),0.3681581106974966,1.2541150092768485,0.1956521739130435,0.47622453385464264,1.0,15/46,28.46%,DHX9;YWHAE;GTSE1;RAN;ANP32B;TPR;HDAC3;XPO4;RBM22;CDH1;ECT2;GSK3B;EMD;FLNA;ZPR1
gsea,regulation of ion transmembrane transporter activity (GO:0032412),0.3847317332593754,1.253233537050587,0.125,0.47699224132463924,1.0,3/39,5.76%,YWHAE;YWHAH;PTPN3
gsea,canonical glycolysis (GO:0061621),0.5703904493670284,1.252728258773752,0.24561403508771928,0.47556179674557697,1.0,12/24,33.51%,GAPDH;ALDOA;GPI;PGK1;ENO1;TPI1;PKM;ENO2;PGAM1;FOXK2;PFKL;HK2
gsea,glucose catabolic process to pyruvate (GO:0061718),0.5703904493670284,1.252728258773752,0.24561403508771928,0.47556179674557697,1.0,12/24,33.51%,GAPDH;ALDOA;GPI;PGK1;ENO1;TPI1;PKM;ENO2;PGAM1;FOXK2;PFKL;HK2
gsea,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.3597264663921669,1.251833627513687,0.2391304347826087,0.47672292009911693,1.0,16/85,14.23%,KIF4A;KIF2C;KIF11;KIF18A;CENPE;KIF22;KIF2A;RINT1;ERGIC2;PITPNB;HTT;RACGAP1;TMED2;GBF1;COPG2;BNIP1
gsea,negative regulation of DNA binding (GO:0043392),0.41634663553044926,1.2515026396380566,0.23076923076923078,0.476292636898152,1.0,3/31,6.12%,E2F1;HMGA2;SIN3A
gsea,regulation of protein metabolic process (GO:0051246),0.33473181693467025,1.2501801722708483,0.14285714285714285,0.47827028987106535,1.0,16/48,30.31%,ROCK2;FKBP1A;VPS35;LDLR;SPOP;HSP90AB1;PM20D2;FAF1;MAPK8;SSH1;MTPN;ODC1;WFS1;PARL;NEDD4L;KLF2
gsea,regulation of translation (GO:0006417),0.28213468459172497,1.2495359549426235,0.14285714285714285,0.47866027965631025,1.0,45/178,25.62%,DHX9;PRKDC;GAPDH;DHFR;NCBP1;PUM3;TYMS;CNOT9;EIF2AK4;EIF5B;GLE1;HNRNPD;MAPKAPK5;EIF4E;NPM1;GEMIN5;SHMT1;ZNF598;LARP1;NOLC1;MTG2;SYNCRIP;PUS7;ELAVL1;CNOT7;TRAP1;MTIF2;EIF2AK2;EIF4H;NAT10;NCL;GSPT1;CNOT10;METAP1;EIF3E;CSDE1;RPS6KA3;CYFIP1;MTOR;RPS4X;PAIP2;EIF4G3;DDX1;MTPN;METTL3
gsea,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.4160983608999842,1.2486879415777266,0.16,0.4793763705217813,1.0,9/23,30.22%,MED17;ENST00000629691.2;PAXIP1;PSMC6;SUB1;PSMC3;MED13;DHX36;MED24
gsea,regulation of cation channel activity (GO:2001257),-0.3961117466103692,-1.2486260545468997,0.17391304347826086,1.0,1.0,8/89,17.56%,JPH2;APP;MINK1;CAPN1;PTK2B;CACNB3;VAMP2;DLG1
gsea,tight junction assembly (GO:0120192),-0.390328763628628,-1.2481807391337203,0.225,1.0,1.0,15/56,24.42%,RAB13;PATJ;MICALL2;ACTG1;CRB3;MARVELD3;CLDN4;CLDN7;CLDN23;AFDN;GRHL2;DLG1;PARD6B;CLDN12;LSR
gsea,cytosolic transport (GO:0016482),0.2853061365000357,1.24769950733511,0.23255813953488372,0.4803180531367094,1.0,24/116,24.42%,HOOK1;GOSR1;VPS50;SPAG9;RAB14;MYO1D;STX8;ANKFY1;VPS35;VPS26A;GBF1;YKT6;PIK3C3;SNX1;STX6;HEATR5A;GCC2;AP1G1;TMEM87A;ARL1;AKTIP;LMTK2;RAB7A;EMP2
gsea,Golgi organization (GO:0007030),0.3079781640125514,1.247273565823677,0.22727272727272727,0.4801780745353731,1.0,28/130,23.12%,PI4K2B;NSFL1C;CDK1;TMED5;GORASP2;PRMT5;USP6NL;HUWE1;HTT;GOLGA8A;TMED2;LMAN1;GBF1;YWHAZ;BLZF1;COG2;ZW10;ATL2;STX6;LYSMD3;GCC2;COG1;STX17;GOLPH3;TANGO2;ARL1;SEC16A;GOLGA8B
gsea,positive regulation of protein-containing complex assembly (GO:0031334),0.3133335713833526,1.2459301259819133,0.16981132075471697,0.48192740009388363,1.0,27/118,24.50%,HSP90AA1;PARP1;TFRC;RPA3;ERCC5;RPA1;FERMT2;RPA2;PARK7;DDB2;GTF2H1;RAP1B;STUB1;ENST00000629691.2;ICE1;FERMT1;PSMC6;CHD1L;VEGFA;VCP;FAF1;GNL3L;BID;PSMC3;GSK3B;CUL4B;ATR
gsea,regulation of programmed necrotic cell death (GO:0062098),0.4327007168909095,1.245925748050064,0.2727272727272727,0.4807772153681226,1.0,5/20,13.85%,MLKL;HSP90AA1;CYLD;STUB1;PDCD6IP
gsea,regulation of JNK cascade (GO:0046328),-0.36329285609927076,-1.2448234570912784,0.2391304347826087,1.0,1.0,24/105,20.92%,LTBR;GADD45A;SERPINF2;APP;TAOK2;MINK1;EGFR;MEN1;PYCARD;CD27;MAP3K11;MAPK8IP3;MARVELD3;GADD45B;PTK2B;MAP4K4;FKTN;PINK1;RIPK1;FZD7;DAB2IP;DUSP3;TRAF2;ZNF622
gsea,histone H2A ubiquitination (GO:0033522),0.44171374960685916,1.243567863745644,0.2608695652173913,0.48452605559522643,1.0,7/17,29.64%,UBE2A;RNF8;DDB2;SKP1;CUL4B;DDB1;TRIM37
gsea,positive regulation of cholesterol transport (GO:0032376),-0.4406306590124615,-1.243184907843634,0.18604651162790697,1.0,1.0,7/33,23.74%,NR1H3;PTCH1;NR1H2;PLTP;ZDHHC8;GPS2;NFKBIA
gsea,mRNA stabilization (GO:0048255),0.41200711325612654,1.2424884517618857,0.23529411764705882,0.4854119916758683,1.0,8/44,15.48%,DHX9;E2F1;LARP1;TARDBP;SYNCRIP;HNRNPU;HNRNPC;ELAVL1
gsea,regulation of autophagy of mitochondrion (GO:1903146),0.49390915175105543,1.2421218376375964,0.19148936170212766,0.48503582256496436,1.0,6/19,26.12%,DNM1L;HTT;PARK7;FBXO7;USP36;CAMKK2
gsea,response to lipopolysaccharide (GO:0032496),-0.31736017918291715,-1.2420751223442597,0.1111111111111111,1.0,1.0,28/159,23.71%,NR1H3;TICAM1;MAPKAPK2;CACTIN;PALM3;PYCARD;ZFP36;PABPN1;PAF1;WNT5A;GGT1;GGT7;HNRNPA0;SRR;TAB2;MAPK14;GIT1;LGALS9;UPF1;IL6;OTUD5;DAB2IP;SLPI;SELENOS;PELI1;SNCA;CDC73;GSTP1
gsea,histone ubiquitination (GO:0016574),0.4090188739636759,1.2398188582895016,0.1590909090909091,0.4891663185328378,1.0,5/21,7.14%,UBE2A;RNF20;RNF8;LEO1;HUWE1
gsea,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.3222383946618141,-1.238973313555687,0.1320754716981132,1.0,1.0,5/31,6.57%,DDRGK1;RPL11;UBXN1;NOP53;CCAR2
gsea,glycerophospholipid biosynthetic process (GO:0046474),0.2858919675828339,1.237835529242269,0.2608695652173913,0.4922821730660053,1.0,30/177,19.93%,PIP4K2A;PI4K2B;FAR1;LPIN1;PEMT;GNPAT;MTMR12;SLC44A1;ACP6;MTMR6;SACM1L;SELENOI;PTDSS1;PIK3CB;LPCAT4;RAB14;FIG4;SLC44A2;CPNE7;PIK3C3;PIP5K1A;PIK3R4;PLA2G12A;CHPT1;CDS1;CEPT1;PIK3C2A;PLEKHA2;PI4KA;AGK
gsea,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.3597490594409632,-1.2376669709146222,0.23809523809523808,1.0,1.0,37/90,23.34%,RPL37;RPL28;RPS13;RPL37A;RPL10A;RPS18;RPL11;RPL13;RPL39;RPS29;RPL13A;RPS2;RPL29;RPS21;RPL9;RPL27A;RPS12;RPLP2;ZFAND2B;RPLP1;RPL8;RPL31;RPL34;RPL27;RPL23A;RPL10;RPL7;RPL14;RPL35;RPL18A;RPL7A;RPL12;RPS14;RPS8;RPS5;RPS20;RPLP0
gsea,positive regulation of cell projection organization (GO:0031346),-0.3197364747806974,-1.2359714523563219,0.17391304347826086,1.0,1.0,16/117,17.84%,METRN;RAPGEF2;TIAM2;OBSL1;RETREG3;WNT5A;CUL7;DVL2;PLXNB1;MDK;PTK2B;RAPGEF1;DVL1;PTK7;CAPRIN1;GRIP1
gsea,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.41455924915106135,1.2339864794105286,0.1702127659574468,0.4997069201100023,1.0,11/30,23.79%,RRP36;NOL10;DCAF13;NGDN;UTP20;RPP40;BMS1;MRPS11;HEATR1;UTP4;RRS1
gsea,negative regulation of cellular component organization (GO:0051129),0.31953616431133924,1.2325507121585872,0.12244897959183673,0.5018568194754465,1.0,8/80,12.47%,SVIP;XRCC5;HSPA8;AIDA;CARMIL1;WASL;DNM2;HSPA5
gsea,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.30105651955607454,-1.2305145810779232,0.13043478260869565,1.0,1.0,25/143,20.71%,GAS6;SIK1;ENST00000634790.2;TMSB4X;NR0B1;CACTIN;COMMD7;MEN1;PYCARD;PTCH1;GLIS2;CDKN2A;SMAD7;RWDD3;USP7;ARRB2;COMMD1;PARP10;ARRB1;SIGIRR;ANXA4;PEX14;DAB2IP;DDIT3;RBCK1
gsea,cellular macromolecule biosynthetic process (GO:0034645),0.3161837787495846,1.2290302767076715,0.23529411764705882,0.5095750067539946,1.0,83/314,20.25%,MRPS6;CDK2;ORC1;FARSB;MCM6;CDC6;BRCA1;E2F1;NAP1L1;CHEK1;CLSPN;FAM111A;FAM111B;POLE;CDK1;DONSON;MRPL42;MCM2;TOPBP1;PCLAF;TYMS;MRPL11;RMI2;MCM3;KAT7;EXO1;MCM5;RFC3;POLE2;RPS11;RFC5;MCM10;FEN1;RFC2;ENST00000630540.2;RPA3;ORC3;RPL30;DNA2;RPA1;GRWD1;POLD3;EXT2;TIMELESS;RPA2;ORC6;RBBP8;MRPL3;HBS1L;POLR2B;RPL41;DUT;TIPIN;MRPL35;MRPS16;MMS19;CDC7;CDC45;RPS27A;POLA1;IGHMBP2;MCM7;MCM4;HUS1;RFC4;TICRR;RPL35A;TOP1;MRPL10;POLR2K;RPS27;MCM8;RPS3A;POLD1;ORC4;ORC2;PIF1;MRPS11;RAD50;DRG1;TNIP1;MRPL37;GSPT1
gsea,neuron projection morphogenesis (GO:0048812),0.3259693735778657,1.2267268725265708,0.14893617021276595,0.5135363110171921,1.0,17/140,15.06%,KIF20B;EIF2AK4;ALCAM;NCKAP1;RYK;TAOK3;IQGAP1;RAB8A;DOCK7;AFG3L2;WASL;NRCAM;NEFH;DNM2;ALS2;BAIAP2;DOCK10
gsea,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.45409214621447885,1.224577630287895,0.2619047619047619,0.5167811377749632,1.0,8/22,30.22%,MED17;BCLAF1;SETX;PAXIP1;SUB1;MED13;DHX36;MED24
gsea,protein K63-linked ubiquitination (GO:0070534),0.3457929150868621,1.2244464039787881,0.18181818181818182,0.5157692447957624,1.0,9/44,15.42%,RNF4;UBE2V2;UBE2T;RNF8;ZFP91;UBE2E3;STUB1;HECTD1;UBE2G1
gsea,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.3664453405032529,1.2243563223526728,0.24074074074074073,0.5148252083630377,1.0,18/73,21.56%,PSMD14;PSMD6;PSMB2;PSMD5;PSMD1;PSMA5;PSMD11;PSMA4;PSMA3;PSME4;PSMD7;ENST00000629691.2;PSMC6;PSMA1;PSMD10;PSMB3;PSME1;PSMC3
gsea,organic hydroxy compound biosynthetic process (GO:1901617),0.4648538791169659,1.2240701149982225,0.26,0.5142321237671563,1.0,11/50,19.24%,PSAT1;INSIG1;LBR;AMACR;OSBPL3;PARK7;OSBPL2;SQLE;MSMO1;DHCR7;SC5D
gsea,lipid homeostasis (GO:0055088),-0.36579459561739636,-1.221760984994825,0.16,1.0,1.0,10/64,18.72%,NR1H3;ORMDL1;ABHD5;PNPLA2;USF1;IRS2;ZBTB20;ORMDL2;ABHD4;ABHD8
gsea,synapse assembly (GO:0007416),-0.40881578957250914,-1.221358037900376,0.19148936170212766,1.0,1.0,7/69,15.59%,OBSL1;SPOCK2;WNT5A;PLXNB1;IGFN1;CDK5;DVL1
gsea,cytoplasmic translation (GO:0002181),-0.33423868781957317,-1.2197683269424198,0.2608695652173913,1.0,1.0,23/93,11.10%,RPL37;RPL28;RPS13;RPL37A;RPL10A;TMA7;RPS18;RPL11;RPL13;RPL39;RPS29;RPL13A;RPS2;RPL29;RPS21;RPL9;RPL27A;RPS12;RPLP1;RPL8;RPL31;RPL34;RPL27
gsea,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.40263850613524765,1.2192871594405574,0.2549019607843137,0.524581028221786,1.0,3/34,5.93%,NUP62;CNOT9;ADAM17
gsea,regulation of telomere maintenance (GO:0032204),0.3598764312065528,1.215232337173158,0.1956521739130435,0.5336277540580592,1.0,11/26,32.02%,XRCC5;HNRNPD;YLPM1;PIF1;RAD50;TERF2IP;SMG6;DHX36;SMG5;GNL3;NBN
gsea,transcription by RNA polymerase II (GO:0006366),0.26270179478693867,1.2152059579333452,0.0851063829787234,0.5324636037856795,1.0,84/320,31.62%,TRIP13;CPSF3;NCBP1;MED17;TTF2;IWS1;RNGTT;PAPOLA;INTS13;PARP1;ELP4;SLBP;PCID2;CPSF2;ELL2;SUPT16H;LEO1;SNRPF;SSRP1;GTF2F2;SETX;POLR2B;SNRPD3;INTS14;DDX5;DDX21;CSTF2;HDAC3;INTS4;INTS7;GTF2H1;NUDT21;ICE1;CSTF3;INTS10;ELOA;ELOC;ELOB;SNAPC1;CSTF1;POLR2K;TBL1XR1;NOTCH1;E2F3;XBP1;CTR9;SNW1;MBD1;TAF9B;PIR;ICE2;RBPJ;TRIM24;NABP2;PPARD;TEAD4;RTF1;GTF2E2;TAF11;TAF9;CPSF7;NR3C1;SRRT;POLR2L;RPRD2;CPSF1;CCNT1;POLR2C;GTF2E1;SETD2;POLR2E;TCEA1;MED27;NELFCD;EAF1;NOTCH3;PPARA;ZC3H8;MAZ;AFF4;PMF1;INTS8;TAF2;SP1
gsea,positive regulation of organelle assembly (GO:1902117),0.3628386964508109,1.2113419026608192,0.20454545454545456,0.540514201615463,1.0,9/46,16.72%,NUP62;PIP4K2A;SPAG5;PLK4;GPSM2;HTT;PDCD6IP;RALB;RAB3GAP2
gsea,maturation of 5.8S rRNA (GO:0000460),0.39685184801672946,1.210284566076876,0.26666666666666666,0.5415510502923379,1.0,10/17,32.39%,PRKDC;MAK16;RPF1;MPHOSPH6;EXOSC10;WDR12;MTREX;NOL9;NSA2;URB1
gsea,regulation of ubiquitin protein ligase activity (GO:1904666),0.45433995638699787,1.2095890100932,0.29310344827586204,0.542179179326342,1.0,5/21,5.74%,PLK1;BAG2;UBE2C;FBXO5;MAD2L1
gsea,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.33101316487022264,-1.2082934337743099,0.22727272727272727,1.0,1.0,17/52,20.47%,NDUFA13;BBC3;NOC2L;BMF;FIS1;PYCARD;BAX;DAPK2;BOK;BCL2L2;BAD;SIAH1;GSDME;NDUFS3;PINK1;BCAP31;DDIT3
gsea,positive regulation of actin filament polymerization (GO:0030838),-0.33861653829890703,-1.2070575156016188,0.16,1.0,1.0,8/49,13.92%,CDC42EP5;GSN;PYCARD;FCHSD1;VASP;CDC42EP2;PTK2B;BAIAP2L2
gsea,positive regulation of cell death (GO:0010942),-0.3296647232679726,-1.206241309008621,0.23809523809523808,1.0,1.0,9/66,19.57%,MARK4;DKK1;HTATIP2;WNT5A;CELF1;RARG;TRIM13;ITGAM;RIPK1
gsea,protein targeting to ER (GO:0045047),-0.3336735166521454,-1.2048382983566603,0.25,1.0,1.0,25/103,9.83%,RPL37;RPL28;RPS13;RPL37A;RPL10A;RPS18;RPL11;RPL13;RPL39;RPS29;RPL13A;ENST00000645179.2;RPS2;RPL29;RPS21;RPL9;RPL27A;SPCS2;RPS12;RPLP2;ZFAND2B;RPLP1;RPL8;RPL31;RPL34
gsea,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.35516916083125694,-1.2044143949901827,0.16326530612244897,1.0,1.0,5/38,6.57%,DDRGK1;RPL11;UBXN1;NOP53;CCAR2
gsea,sterol biosynthetic process (GO:0016126),0.4795347423646051,1.204311323609713,0.28846153846153844,0.5534391599951508,1.0,15/38,24.59%,INSIG1;HSD17B7;ACAT2;LBR;IDI1;HMGCS1;CYP51A1;SQLE;MSMO1;DHCR7;GGPS1;SC5D;DHCR24;MVD;FDPS
gsea,positive regulation of fat cell differentiation (GO:0045600),-0.37919487713702055,-1.204055207860104,0.2558139534883721,1.0,1.0,11/51,20.24%,TRPM4;ADIRF;CCDC71L;ZFP36;ZFP36L1;SOX13;CEBPB;ZBTB7B;PTGS2;ZNF385A;TFE3
gsea,positive regulation of MAP kinase activity (GO:0043406),-0.3979282586588847,-1.2037365067761148,0.23255813953488372,1.0,1.0,13/69,21.31%,CD24;DKK1;EGFR;ERBB2;DVL2;MAP3K11;PDGFC;PDGFB;SASH1;ARHGEF5;DAB2IP;TRAF2;DVL3
gsea,positive regulation of inflammatory response (GO:0050729),-0.37109086332243113,-1.2035930591805382,0.32,1.0,1.0,20/89,26.76%,TRADD;VAMP8;APP;WNT5A;GRN;IFI35;MDK;GPRC5B;MGST2;ENST00000615721.3;MAPK13;IL23A;IL6;HYAL2;RIPK1;ABCC1;SNCA;NFKBIA;IL18;ADAM8
gsea,sensory perception of sound (GO:0007605),-0.3124069464883437,-1.2029238453645377,0.22727272727272727,1.0,1.0,9/91,19.14%,SERPINB6;EPS8L2;TIMM10;TIMM8B;NDUFB9;TIMM9;GSDME;WDR1;EML2
gsea,cholesterol metabolic process (GO:0008203),0.39263345766644286,1.2028150579692038,0.3018867924528302,0.5559553562677644,1.0,17/77,24.59%,INSIG1;HSD17B7;ACAT2;LBR;IDI1;HMGCS1;CYP51A1;SOAT1;SQLE;MSMO1;DHCR7;GGPS1;DHCR24;SULT2B1;PPARD;MVD;FDPS
gsea,monocarboxylic acid transport (GO:0015718),-0.40374745079096974,-1.2021034988302741,0.15217391304347827,1.0,1.0,6/57,10.74%,SLC16A13;SLC16A5;SLC10A3;SLC27A1;ATP8B1;SLC5A6
gsea,bicellular tight junction assembly (GO:0070830),-0.3868191017858207,-1.2020758905096933,0.23809523809523808,1.0,1.0,11/53,17.56%,RAB13;PATJ;MICALL2;CRB3;MARVELD3;CLDN4;CLDN7;CLDN23;AFDN;GRHL2;DLG1
gsea,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.3978387399216711,1.201889172754175,0.23255813953488372,0.5571638371445151,1.0,11/29,19.59%,PARP1;RPA3;ERCC5;RPA1;RAD23B;RPA2;DDB2;GTF2H1;RPS27A;CHD1L;CETN2
gsea,membrane fusion (GO:0061025),0.4329687645897343,1.201618767244022,0.3191489361702128,0.5567347384297848,1.0,14/36,36.04%,NSFL1C;HUWE1;DNM1L;OPA1;DNM2;RABEP1;NAPG;DNM1;SNAP29;NSF;VAMP3;RABIF;CHP1;VAPA
gsea,vesicle cytoskeletal trafficking (GO:0099518),0.3496740045186708,1.201062855018853,0.25,0.5569835278386011,1.0,6/39,11.37%,KIF5B;MYO19;HTT;ENST00000632578.1;WASL;MYO1D
gsea,regulation of focal adhesion assembly (GO:0051893),0.32890967457192843,1.199144259635922,0.19148936170212766,0.5596836637431316,1.0,16/54,33.40%,CAMSAP3;CORO1C;ROCK2;SLK;FERMT2;VCL;RHOA;ROCK1;VEGFA;SFRP1;PHLDB2;CLASP1;DMTN;PTK2;LIMS1;ABL1
gsea,positive regulation of histone methylation (GO:0031062),0.3890362762819173,1.1976026684047019,0.20833333333333334,0.5623410772553127,1.0,7/26,19.84%,BRCA1;WDR5;PHF19;FAM47E;PAXIP1;CTR9;SNW1
gsea,membrane protein proteolysis (GO:0033619),-0.3555460519994902,-1.1958963154911109,0.26,1.0,1.0,6/39,14.28%,APH1A;MYH9;BACE2;SPPL3;RBMX;DAG1
gsea,negative regulation of hydrolase activity (GO:0051346),0.34919203843653834,1.1958650636223633,0.25,0.5651391659623544,1.0,9/58,22.65%,URI1;RRP1B;SLC39A14;TMED2;SH2D4A;PPP1R26;WNK1;SH3RF2;MAP2
gsea,post-translational protein modification (GO:0043687),0.27325701429608795,1.1953526065363886,0.25,0.5650319761635225,1.0,71/345,25.83%,DSCC1;DTL;COPS3;COPS4;HSP90B1;FUCA2;PSMD14;PSMD6;PSMB2;FN1;PSMD5;P4HB;CCNF;RAB8A;WDR5;PSMD1;COPS8;NUB1;CAND1;PSMA5;DCAF13;GPS1;PSMD11;PSMA4;PSMA3;PSME4;DDB2;CALU;ASB13;DNAJC3;PSMD7;PDIA6;BTBD1;ENST00000629691.2;PSMC6;ELOC;LAMC1;ELOB;PSMA1;KLHL2;CKAP4;CUL2;FBXO11;PSMD10;PSMB3;GOLM1;BMP4;DCAF16;CUL5;EPAS1;PSME1;FEM1C;TGOLN2;HIF1A;RAB11A;COP1;PSMC3;FEM1B;SKP1;LRRC41;FBXO7;UCHL3;CUL1;CUL4B;PRSS23;ASB8;PSMA6;SPP1;STC2;TIMP1;PSMD13
gsea,liver development (GO:0001889),0.35878399296982866,1.194892585181309,0.1951219512195122,0.56538099679191,1.0,2/32,0.78%,E2F8;E2F7
gsea,positive regulation of lamellipodium organization (GO:1902745),0.4699085225911307,1.1939441379363964,0.3333333333333333,0.5668804122635663,1.0,6/32,13.08%,ARPC2;NCKAP1;CORO1C;CARMIL1;ACTR2;ACTR3
gsea,extracellular matrix disassembly (GO:0022617),-0.38432944218894227,-1.1938755729709902,0.25,1.0,1.0,7/66,13.73%,KIF9;GSN;MMP14;MMP15;CAPN1;SH3PXD2B;BMP1
gsea,cellular component disassembly (GO:0022411),-0.38432944218894227,-1.1938755729709902,0.25,1.0,1.0,7/66,13.73%,KIF9;GSN;MMP14;MMP15;CAPN1;SH3PXD2B;BMP1
gsea,regulation of androgen receptor signaling pathway (GO:0060765),0.4006745740041415,1.1933109262667543,0.25,0.5672842682435449,1.0,5/36,19.95%,PARK7;DDX5;RNF6;RNF14;SFRP1
gsea,positive regulation of response to external stimulus (GO:0032103),-0.3546449630398647,-1.1922151494534805,0.2916666666666667,1.0,1.0,25/139,23.74%,TRADD;SERPINF2;APP;STX4;WNT5A;GRN;USF1;IFI35;MDK;ZCCHC3;GPRC5B;THBS1;MGST2;ENST00000615721.3;MAPK13;PDGFB;USP15;IL23A;SASH1;HYAL2;RIPK1;ABCC1;SNCA;POLR3C;NFKBIA
gsea,neurogenesis (GO:0022008),0.38930137293334893,1.1921769521818528,0.2682926829268293,0.5686219141668041,1.0,9/44,28.51%,CIT;RYK;CDK6;WDR62;BTBD1;CDK5RAP2;TRAK2;METTL3;SIX4
gsea,autophagosome assembly (GO:0000045),-0.31062801694868286,-1.1919487278675815,0.125,1.0,1.0,14/58,19.68%,ATG101;RAB43;TP53INP2;ATP2A2;ATG2A;RAB1A;ATG13;VMP1;GABARAPL1;ATG9B;RAB1B;WDR45;ATG14;GABARAP
gsea,NADH dehydrogenase complex assembly (GO:0010257),-0.36001509721484853,-1.1912261868501237,0.2926829268292683,1.0,1.0,22/58,24.62%,NDUFA1;NDUFA2;NDUFB10;NDUFA13;NDUFA10;NDUFS7;NDUFB4;NDUFS4;NDUFB7;NDUFA11;NDUFA8;NDUFB9;DMAC2;NDUFS3;NDUFC2;NDUFAF1;NDUFB2;NDUFB1;NDUFB8;NDUFB3;NDUFS5;ECSIT
gsea,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.36001509721484853,-1.1912261868501237,0.2926829268292683,1.0,1.0,22/58,24.62%,NDUFA1;NDUFA2;NDUFB10;NDUFA13;NDUFA10;NDUFS7;NDUFB4;NDUFS4;NDUFB7;NDUFA11;NDUFA8;NDUFB9;DMAC2;NDUFS3;NDUFC2;NDUFAF1;NDUFB2;NDUFB1;NDUFB8;NDUFB3;NDUFS5;ECSIT
gsea,establishment of protein localization to membrane (GO:0090150),-0.29647421857074213,-1.1899325757146417,0.2033898305084746,1.0,1.0,13/70,15.79%,VPS37C;RAB3GAP1;ZDHHC24;NACA;ZDHHC9;RAB10;TAOK2;EGFR;GORASP1;VPS37B;AFDN;MYO1C;ZDHHC7
gsea,cellular senescence (GO:0090398),0.38401688179225574,1.1885177150167152,0.24074074074074073,0.5766688979208787,1.0,6/27,16.93%,HMGA2;MAPKAPK5;MAP2K1;OPA1;SMC6;SMC5
gsea,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.31588389040791126,-1.1878916020998562,0.14,1.0,1.0,17/79,23.85%,TMSB4X;CACTIN;COMMD7;PYCARD;CDKN2A;RWDD3;USP7;ARRB2;COMMD1;PARP10;ARRB1;ANXA4;DAB2IP;DDIT3;RBCK1;NFKBIA;PTGIS
gsea,regulation of centrosome cycle (GO:0046605),0.3730396402498497,1.1876886607262773,0.13333333333333333,0.5769883776554487,1.0,7/22,22.07%,CHMP2B;NPM1;VPS4B;PDCD6IP;CHMP4C;NAT10;AURKA
gsea,regulation of fatty acid biosynthetic process (GO:0042304),0.4151924161705218,1.1870513755327714,0.2916666666666667,0.5776362365996699,1.0,5/29,10.58%,BRCA1;ENST00000645126.2;ELOVL5;LPGAT1;ERLIN1
gsea,positive regulation of cytoskeleton organization (GO:0051495),0.32277938453031846,1.1868075662547335,0.25,0.5771145741448593,1.0,10/82,14.98%,NUP62;SPAG5;NCKAP1;PLK4;GPSM2;PFN2;SNX9;CARMIL1;BAIAP2;PFN1
gsea,protein ubiquitination (GO:0016567),0.24896951017611624,1.1859303044308862,0.20454545454545456,0.5775503711068811,1.0,103/525,25.92%,DTL;PLK1;PRKDC;RUSC1;PCNA;BRCA1;UBE2A;RNF4;UBE2C;UBE2V2;NPEPPS;PSMD14;PSMD6;BLMH;PSMB2;PSMD5;ATG3;RFWD3;RNF20;TRIM14;CCNF;UBA1;FBXO45;UBE2T;PSMD1;RNF8;LEO1;HUWE1;NUB1;CAND1;UBA6;TRAIP;PSMA5;DTX4;PSMD11;PSMA4;RNF34;PSMA3;UBE2E3;FANCL;PSME4;CDC27;ZNF598;BCL10;DDB2;PSMD7;STUB1;ENST00000629691.2;PEX13;RPS27A;SPOP;RNF6;BSPRY;UBE2G1;PSMC6;ELOC;RC3H2;ELOB;PSMA1;UHRF2;UBE4A;KLHL2;RNF14;CUL2;FBXO11;CDC23;PSMD10;PSMB3;EIPR1;CUL5;THOP1;VCP;CTR9;BRAP;UBE2K;EPAS1;RNF26;HLTF;PSME1;RLIM;HIF1A;PJA2;PSMC3;SH3RF2;LNPEP;SKP1;NFE2L2;FBXO7;TRIM24;AKTIP;UCHL3;CUL1;RTF1;OTULIN;UBE4B;TRIM52;CUL4B;UBE2N;ARIH1;PSMA6;TRIM33;PSMD13;PRPF19
gsea,organophosphate biosynthetic process (GO:0090407),0.3645067064970405,1.1855501223581337,0.21739130434782608,0.5773885850280874,1.0,5/39,15.98%,MOCS2;MOCOS;GNPAT;PIP5K1A;TPI1
gsea,cellular response to fibroblast growth factor stimulus (GO:0044344),0.3088816280150293,1.1851549456981771,0.22448979591836735,0.5770194741079235,1.0,22/92,29.21%,NCBP1;SHCBP1;GTF2F2;SETX;POLR2B;RAB14;FIBP;GALNT3;HNRNPM;PTPN11;FGFBP1;PTBP1;MAPK1;POLR2K;SFRP1;HNRNPH1;SHOC2;ESRP2;POLR2L;POLR2C;POLR2E;CEP57
gsea,cellular response to radiation (GO:0071478),-0.3634437670399067,-1.1849330544227552,0.18,1.0,1.0,9/45,14.19%,GADD45A;EEF1D;ADIRF;SWI5;OPN3;RAD9A;RHOB;IFI16;MAPK14
gsea,regulation of secretion by cell (GO:1903530),-0.348490535013378,-1.184574760752862,0.25,1.0,1.0,6/59,10.69%,VAMP8;RAB13;STX4;RAB10;LLGL2;RHBDF1
gsea,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.4746507512754499,-1.1833696008041878,0.24324324324324326,1.0,1.0,6/20,8.84%,PET117;SURF1;PET100;COX14;COA5;COA3
gsea,positive regulation of cold-induced thermogenesis (GO:0120162),0.36382043255361607,1.1825986302212026,0.32432432432432434,0.5814262678946365,1.0,18/97,29.06%,ENST00000645126.2;ELOVL6;LPIN1;PEMT;FH;FABP5;HADH;HDAC3;GNAS;IL4R;SCD;VEGFA;EPAS1;EHMT1;ADIPOR1;DIO2;CNOT3;KDM3A
gsea,cholesterol biosynthetic process (GO:0006695),0.48301409225334446,1.1825366938903183,0.34615384615384615,0.5803398350442538,1.0,15/35,24.59%,INSIG1;HSD17B7;ACAT2;LBR;IDI1;HMGCS1;CYP51A1;SQLE;MSMO1;DHCR7;GGPS1;SC5D;DHCR24;MVD;FDPS
gsea,protein processing (GO:0016485),-0.33089634072000057,-1.1823261657274244,0.22641509433962265,1.0,1.0,13/106,10.60%,APH1A;TMEM208;MMP14;CPZ;CLN3;PTCH1;XPNPEP3;VSIR;SPCS2;GGT1;RCE1;SPPL3;SPG7
gsea,peptide biosynthetic process (GO:0043043),-0.29620673522605007,-1.1818521798665822,0.2727272727272727,1.0,1.0,38/162,14.68%,RPL37;RPL28;RPS13;RPL37A;RPL10A;RPS18;MRPL51;RPL11;RPL13;RPL39;RPS29;RPL13A;RPS2;RPL29;RPS21;RPL9;MRPS21;HARS2;MRPL28;RPL27A;RPS12;MRPS33;EEF1A1;GGT1;RPLP2;MRPL52;RPLP1;RPL8;RPL31;MRPL36;RPL34;GGT7;RPL27;MRPL34;MRPS7;RPL23A;RPL10;RPL7
gsea,intracellular protein transport (GO:0006886),0.2647648090832769,1.1800580659050213,0.16666666666666666,0.5850155615410635,1.0,76/336,26.49%,CSE1L;NUP188;NUP50;NUP62;CAMSAP3;IPO9;NUP153;NXT2;IPO11;TMED5;SRPRA;XPO1;IPO8;XPO7;YWHAH;POM121C;USP6NL;NPM1;RAN;TBC1D4;NUP133;SNX9;AP1S3;TPR;RAB14;KATNB1;APPL1;TMED2;LMAN1;STX8;RABL2B;VPS35;NUP107;IPO7;VPS26A;NUP85;SGSM3;VPS33A;STRADB;VPS25;SAR1B;AP3B1;SNX1;NUP214;ARL5A;RAB3GAP2;VPS36;TNPO3;ACD;NUP93;NUP88;XPO4;XPO5;STX6;STAM;E2F3;TBC1D22B;NAPG;STX17;ARL5B;VPS45;ARFIP2;ARL1;SEC16A;RAB7A;NUP155;RAB5C;VPS26C;TRAK2;TMED7;RAB21;IPO4;PHB2;ARCN1;NUP62CL;COPA
gsea,protein homotetramerization (GO:0051289),0.3430327989499126,1.1798986001038065,0.2826086956521739,0.5842796003042989,1.0,10/52,21.10%,HPRT1;ALDOA;GLS;SHMT1;USP16;OSBPL2;ALDH9A1;TK1;ACACA;APIP
gsea,gene expression (GO:0010467),0.27230988020191316,1.1790796634283736,0.29411764705882354,0.5848403224478296,1.0,82/356,20.68%,MRPS6;NDC1;NUP188;NUP50;FARSB;SEH1L;NUP62;CPSF3;E2F1;SRRM1;MRPL42;HSPD1;NCBP1;NUP153;THOC3;MRPL11;RNGTT;GLE1;RPS11;THOC1;NUP205;UPF2;U2AF1;NUP210;NUP43;HNRNPD;GALNT2;EIF4E;ENST00000630540.2;SLBP;POM121C;NUP58;HNRNPL;CPSF2;RPL30;DDX20;NUP35;SRSF1;HNRNPA2B1;SRSF7;SETX;MRPL3;HBS1L;NUP133;POLR2B;TPR;SARNP;FYTTD1;RANBP2;RPL41;NUP107;MRPL35;MRPS16;MMS19;NUP85;STUB1;SNRNP40;SYNCRIP;NUP37;HNRNPU;RPS27A;IGHMBP2;SRSF4;RPL35A;NUP214;MRPL10;NUP93;POLR2K;NUP88;RBM6;RPS27;RPS3A;TSPAN5;DKC1;THOC7;MRPS11;DRG1;TNIP1;MRPL37;GSPT1;NUFIP1;GOLPH3
gsea,positive regulation of cell-substrate junction organization (GO:0150117),0.4103532775112245,1.1790672535924371,0.19047619047619047,0.5836092251856283,1.0,6/24,21.58%,FERMT2;IQSEC1;ROCK1;VEGFA;SFRP1;MAPRE2
gsea,protein targeting to membrane (GO:0006612),0.3019705374650298,1.1771992565333638,0.20930232558139536,0.586569230639523,1.0,14/87,15.57%,ZDHHC3;PXMP2;SRPRA;VPS37A;ATG3;PRKCI;ARL6IP1;ABCD3;SEC63;SSR1;PEX19;PEX13;SRP14;ZDHHC6
gsea,positive regulation of viral life cycle (GO:1903902),0.40324470895009834,1.1766026519014798,0.28888888888888886,0.5865956753862261,1.0,3/24,4.54%,CHMP2B;KPNA2;P4HB
gsea,negative regulation of actin filament polymerization (GO:0030837),-0.3914729946029672,-1.1761447472504565,0.2549019607843137,1.0,1.0,4/25,7.33%,GSN;TMSB10;TMSB4X;HIP1R
gsea,positive regulation of viral process (GO:0048524),0.2950726749356675,1.1757790654986866,0.2222222222222222,0.5869426131332662,1.0,23/63,31.03%,DHX9;KPNA2;HACD3;STAU1;GTF2F2;POLR2B;LARP1;CNOT7;POLR2K;SRPK1;RAB7A;PKN2;POLR2L;PABPC1;PPIH;CCNT1;POLR2C;DDB1;POLR2E;NELFCD;PPARA;ADAR;PPIA
gsea,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.29028012167554895,1.1752149916454133,0.24489795918367346,0.5866482258444181,1.0,28/130,22.30%,PSMD14;PSMD6;PSMB2;PSMD5;PSMD1;PSMA5;PSMD11;CSNK1E;PSMA4;PSMA3;PSME4;USP8;PSMD7;ENST00000629691.2;PSMC6;NRARP;PSMA1;USP34;PSMD10;TBL1XR1;PSMB3;VCP;SFRP1;USP47;PSME1;WNK1;PSMC3;PPM1A
gsea,positive regulation of metabolic process (GO:0009893),0.34576775468046,1.1745894690134702,0.2926829268292683,0.5868774851328271,1.0,20/113,29.06%,ENST00000645126.2;ELOVL6;LPIN1;PEMT;FH;FABP5;HADH;HDAC3;FASN;GNAS;IL4R;SCD;VEGFA;EPAS1;ACACA;EHMT1;ADIPOR1;DIO2;CNOT3;KDM3A
gsea,protein N-linked glycosylation via asparagine (GO:0018279),0.34038480514703884,1.1737053693811579,0.22,0.5873374487270119,1.0,7/30,19.99%,UGGT1;DPM2;RPN2;LMAN1;MGAT1;RPN1;OSTC
gsea,secondary alcohol biosynthetic process (GO:1902653),0.47248338795929445,1.1723795913384678,0.34615384615384615,0.5895004705955307,1.0,14/34,24.59%,INSIG1;HSD17B7;ACAT2;LBR;IDI1;HMGCS1;CYP51A1;SQLE;MSMO1;DHCR7;GGPS1;DHCR24;MVD;FDPS
gsea,vesicle organization (GO:0016050),0.3356114683399998,1.170914558624735,0.18421052631578946,0.5922599098470539,1.0,13/46,22.96%,PI4K2B;HOOK1;CHMP2B;SNX10;WASL;USP8;ALS2;DNAJC13;SAR1B;RNF26;DNM1;AKTIP;WASHC4
gsea,negative regulation of programmed cell death (GO:0043069),0.26239218992991437,1.1692147393737642,0.21568627450980393,0.59486379974882,1.0,68/381,24.31%,ANXA5;NAA15;PLK1;GLO1;PRKDC;NUP62;CDK1;HSPD1;HSP90B1;HSPA9;NAA35;HMGA2;STIL;PRKCI;TM7SF3;ARL6IP1;TFRC;MAD2L1;SUPV3L1;PCID2;ERCC5;NPM1;CASP2;SETX;BNIP2;PARK7;OPA1;DDAH2;PA2G4;DNAJC3;HDAC3;HSPA5;YWHAZ;RPS27A;BNIP1;PRELID1;KIF14;BIRC5;ZNF268;PSMD10;RPS3A;NAA38;BMP4;HDAC2;PRKAA1;VEGFA;XBP1;SFRP1;DHCR24;USP47;FXN;GOLPH3;TAF9B;TPT1;BID;APIP;PRDX3;RIPK2;RPS6KA3;TXNDC5;PHIP;SH3RF2;GSK3B;RAB7A;MAPK8;DNAJA1;UFM1;PAK2
gsea,positive regulation of catalytic activity (GO:0043085),-0.3560910014127893,-1.16901219576685,0.16363636363636364,1.0,1.0,8/40,14.19%,APH1A;CIB1;MAPK3;STX4;CHTOP;B3GAT3;SSBP1;MAPK14
gsea,protein lipidation (GO:0006497),0.30260243516273266,1.1689411519477957,0.27450980392156865,0.5941831247614356,1.0,8/61,15.57%,ZDHHC3;ZDHHC13;DPM2;PIGU;PIGN;PIGH;PIK3C3;ZDHHC6
gsea,amino acid transport (GO:0006865),0.47751812575566827,1.1688100052092794,0.29545454545454547,0.5932474194896238,1.0,7/50,27.88%,SLC7A11;SLC7A5;SLC3A2;SLC1A5;SLC7A1;SLC6A6;SLC25A44
gsea,regulation of protein binding (GO:0043393),0.2760399601198167,1.1684613062276379,0.1702127659574468,0.5928017597806544,1.0,29/118,24.83%,AURKB;PLK1;BAG2;IDE;HFE;PPP2CA;STK4;RAN;CSNK1E;PPP1CA;PARK7;FKBP1A;BTBD1;RALB;CRK;STK3;ROCK1;BMP4;STYX;MARK2;GNL3L;RIPK2;AURKA;AKTIP;GSK3B;CTNNBIP1;MAPK8;NES;DDX11
gsea,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.34781727812494373,-1.1670721543646578,0.25,1.0,1.0,19/99,20.92%,LTBR;GADD45A;SERPINF2;APP;STK25;TAOK2;MINK1;PYCARD;CD27;MAP3K11;EMC10;GADD45B;PTK2B;SASH1;RIPK1;FZD7;DAB2IP;TRAF2;ZNF622
gsea,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.3637864160985856,-1.1665847214874747,0.25,1.0,1.0,4/34,12.03%,GADD45A;HDAC5;JUP;THBS1
gsea,positive regulation of cellular protein catabolic process (GO:1903364),0.400201362479978,1.166242549672518,0.23529411764705882,0.5971803828815918,1.0,5/19,24.39%,HSP90AA1;MSN;VPS35;FAF1;CTSC
gsea,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.33944329400739703,1.1654048529159506,0.3333333333333333,0.5981236495378135,1.0,19/78,22.20%,PSMD14;PSMD6;PSMB2;PSMD5;PSMD1;PSMA5;PSMD11;PSMA4;PSMA3;PSME4;PSMD7;ENST00000629691.2;PSMC6;PSMA1;PSMD10;PSMB3;PSME1;PSMC3;LNPEP
gsea,plasma membrane invagination (GO:0099024),0.33928829856740206,1.1646861167521945,0.18604651162790697,0.5988640667518272,1.0,7/30,20.72%,AURKB;SNX9;VAMP7;RHOA;ARHGAP12;GULP1;SPIRE1
gsea,protein insertion into mitochondrial membrane (GO:0051204),-0.4225223611752927,-1.164487093379876,0.3333333333333333,1.0,1.0,10/24,16.72%,NDUFA13;BMF;TIMM10;BAX;TIMM29;TIMM8B;ROMO1;TIMM9;TOMM22;BAD
gsea,ncRNA metabolic process (GO:0034660),0.4274156161006919,1.1640270507279344,0.36363636363636365,0.5993745456810089,1.0,13/37,35.49%,DGCR8;RAN;XPO5;MEPCE;TENT4B;ZCCHC8;NIFK;PRKRA;TUT7;AGO2;DTD1;TUT4;KHSRP
gsea,regulation of cellular protein metabolic process (GO:0032268),0.31673853005577346,1.163267879264672,0.26,0.5998546043385796,1.0,16/49,33.15%,PUM3;MAPKAPK5;EIF4E;GEMIN5;NOLC1;VPS35;PM20D2;METAP1;CYFIP1;SSH1;MTPN;ATXN2;EIF4G1;METTL18;EIF2A;TCOF1
gsea,positive regulation of dephosphorylation (GO:0035306),0.40112836185209855,1.1631929500078013,0.2777777777777778,0.5987230486680551,1.0,5/29,15.60%,CDCA2;PPP1R7;PPP2R5A;SMPD1;PTBP1
gsea,positive regulation of Notch signaling pathway (GO:0045747),0.3735462872444132,1.1619205635281493,0.22727272727272727,0.6003296892948913,1.0,16/45,45.05%,PRKCI;NEPRO;TSPAN5;NOTCH1;SNW1;RBPJ;ROBO1;IL6ST;YAP1;JAG1;EP300;AAK1;MAML2;ZMIZ1;TM2D3;ELF3
gsea,transcription elongation from RNA polymerase II promoter (GO:0006368),0.27672988137215293,1.1597147125381333,0.2978723404255319,0.6054449783040639,1.0,25/67,30.28%,NCBP1;IWS1;ELP4;PCID2;SUPT16H;LEO1;SSRP1;GTF2F2;POLR2B;GTF2H1;ELOA;ELOC;ELOB;POLR2K;CTR9;RTF1;POLR2L;CCNT1;POLR2C;SETD2;POLR2E;TCEA1;NELFCD;EAF1;AFF4
gsea,"transcription, DNA-templated (GO:0006351)",0.2652920773656939,1.1594054074549134,0.18181818181818182,0.6048982460182016,1.0,56/221,30.74%,TRIP13;E2F1;NCBP1;SMARCA5;TTF2;IWS1;RNGTT;GTF3C6;GTF3C2;PARP1;PRMT5;SUPT16H;LEO1;SSRP1;GTF2F2;SETX;POLR2B;GTF3C4;DDX5;DDX21;GTF2H1;MMS19;GTF3C5;ELOA;TFAM;ELOC;ELOB;POLR2K;MTERF1;GTF3C3;XBP1;DRG1;CTR9;MBD1;TAF9B;PIR;GTF3A;NCOA6;TRIM24;RTF1;GTF2E2;TAF11;TAF9;PPP5C;POLR2L;TTF1;CCNT1;POLR2C;GTF2E1;POLR2E;TCEA1;NELFCD;EAF1;CRCP;AFF4;PMF1
gsea,positive regulation of protein ubiquitination (GO:0031398),0.31369051824386124,1.1591376604008803,0.22727272727272727,0.6042977505204029,1.0,29/82,35.79%,PLK1;FANCI;BRCA1;HUWE1;BCL10;FKBP1A;HDAC3;STUB1;CRY1;PAXIP1;NDFIP2;DCUN1D5;UBQLN1;PSMD10;RIPK2;DCUN1D2;UBE2N;ARRDC3;LAPTM5;WFS1;TRIB3;UBE2L3;SPHK1;BMI1;RBX1;BIRC2;BIRC3;XIAP;UBE2D1
gsea,microtubule polymerization (GO:0046785),0.3838788657376505,1.1582735852261772,0.2127659574468085,0.605432562915324,1.0,8/30,26.70%,TPX2;TUBG1;ENST00000632578.1;CKAP5;MAP7D3;RANBP9;TUBGCP3;CLASP1
gsea,spliceosomal snRNP assembly (GO:0000387),0.35211389551311506,1.1581887704591916,0.3111111111111111,0.6043313813600306,1.0,8/38,14.02%,SNRPD1;PRMT5;DDX20;SNRPF;GEMIN5;SNRPD3;SNUPN;WDR77
gsea,regulation of chemotaxis (GO:0050920),-0.43857856248513055,-1.1570711506697209,0.32608695652173914,1.0,1.0,7/32,20.43%,STX4;ZSWIM8;THBS1;PDGFB;ZSWIM4;P2RX4;DUSP3
gsea,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.3768925489497939,-1.1569673573000998,0.23809523809523808,1.0,1.0,5/20,19.36%,FIS1;ATP2A2;BAX;BAK1;BCAP31
gsea,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.29678433709141133,-1.1565270909694227,0.25,1.0,1.0,23/119,21.40%,TRADD;GSN;REST;NDUFA13;BBC3;BEX3;FIS1;PYCARD;PDCD2;CFLAR;HIP1R;BAX;BOK;LGALS9;BAD;SENP1;MYC;HSPE1;BCAP31;RIPK1;TRAF2;TNFRSF10B;EGLN3
gsea,regulation of translational initiation (GO:0006446),0.31706325522067325,1.1563199409184024,0.2222222222222222,0.60774393312685,1.0,19/68,28.97%,NCBP1;EIF2AK4;EIF5B;GLE1;NPM1;TPR;LARP1;DNAJC3;MTIF2;EIF4H;EIF3E;CSDE1;PAIP2;EIF4G3;DDX1;RPS6KB2;EIF4G1;UHMK1;AGO2
gsea,histone lysine demethylation (GO:0070076),-0.4107302805745617,-1.1563013803314137,0.3220338983050847,1.0,1.0,2/26,3.02%,KDM6B;KDM5C
gsea,regulation of myeloid cell differentiation (GO:0045637),0.3115530275159425,1.1558182669634156,0.23076923076923078,0.6075592012753352,1.0,10/68,19.89%,HSPA9;WDR5;SIN3A;LEO1;TNRC6A;CDK6;PRMT1;RUNX1;CTR9;AGO1
gsea,cellular response to chemical stress (GO:0062197),0.2972580391933776,1.1529882880827034,0.2894736842105263,0.6137788584204997,1.0,29/101,32.13%,LRRC8D;GPX8;ZFAND1;PARP1;VRK2;PNPT1;GPX2;SLC25A24;SETX;PRDX1;PARK7;FANCC;EIF2S1;PRKAA1;PYCR2;PRDX3;ERO1A;NFE2L2;CYCS;SRXN1;SLC4A11;PIK3CA;PYCR1;ATG7;PPIA;SOD1;NCF2;SOD2;GSR
gsea,heme biosynthetic process (GO:0006783),0.38198164523956357,1.1520485941876644,0.2978723404255319,0.6144402272087995,1.0,4/22,10.50%,COX15;UROS;ABCB10;PGRMC1
gsea,innate immune response (GO:0045087),-0.2835223698316403,-1.1519351398332396,0.24444444444444444,1.0,1.0,31/302,22.57%,RNF187;TKFC;RELB;TNK2;RPL39;PIK3CD;APP;TRIM56;TRIM17;IFI6;TRIM11;TRIM8;CD74;YES1;WFDC3;TRIM28;POLR3A;PTK2B;ATAD3A;TRIM4;IFITM1;TRIM13;KRT16;LCN2;PPP1R14B;SLPI;B2M;CYBC1;MAVS;SERINC3;SNCA
gsea,regulation of endothelial cell migration (GO:0010594),-0.2873555905026016,-1.1504609878943486,0.23809523809523808,1.0,1.0,15/89,21.27%,AAMP;PIK3CD;SVBP;WNT5A;GRN;BCAR1;RRAS;RHOB;EMC10;THBS1;PTK2B;SASH1;PTPRM;DAB2IP;SH3BP1
gsea,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.3077387528061976,-1.1480447578330695,0.24390243902439024,1.0,1.0,39/113,23.34%,RPL37;RPL28;RPS13;RPL37A;RPL10A;RPS18;RPL11;RPL13;RPL39;RPS29;RPL13A;RPS2;RPL29;RPS21;RPL9;RPL27A;RPS12;RPLP2;RPLP1;RPL8;RPL31;RPL34;RPL27;RPL23A;RPL10;RPL7;PYM1;RPL14;UPF1;RPL35;RPL18A;RPL7A;RPL12;RPS14;RNPS1;RPS8;RPS5;RPS20;RPLP0
gsea,calcium-mediated signaling (GO:0019722),-0.3184817884130392,-1.1473085795065106,0.20408163265306123,1.0,1.0,5/102,6.07%,TRPM4;PPP1R9B;FIS1;ATP2A2;EGFR
gsea,positive regulation of proteolysis (GO:0045862),0.32432054825636736,1.1458634168325066,0.3111111111111111,0.628434016642681,1.0,11/57,20.54%,NRDC;PLK1;BAG2;SH3D19;SNX9;STUB1;ADAM9;ASPH;HDAC2;TNIP1;MAPK12
gsea,endocytic recycling (GO:0032456),0.29329509781040397,1.1452267078468703,0.25,0.6285946401411667,1.0,14/52,24.29%,VPS50;EHD4;RAB14;CCDC93;VPS35;VPS26A;DENND1A;RAB35;ACAP2;STX6;EIPR1;LMTK2;RAB7A;VPS26C
gsea,positive regulation of endothelial cell proliferation (GO:0001938),0.3135975248376877,1.1446333311448695,0.2727272727272727,0.6288921014516428,1.0,13/77,21.33%,HMGB1;AGGF1;ADAM17;GATA2;FGFBP1;NRARP;ARNT;NRAS;BMP4;VEGFA;F3;HIF1A;PDPK1
gsea,"positive regulation of gene expression, epigenetic (GO:0045815)",0.32270227347024777,1.1439143273884513,0.27906976744186046,0.6299567371076819,1.0,14/57,29.11%,ATAD2;BAZ1B;CHEK1;SMARCA5;SF3B1;DDX21;ASF1A;POLR2K;SMARCD1;MYBBP1A;POLR2L;ZMIZ2;CDCA4;POLR2E
gsea,membrane organization (GO:0061024),0.2544136127103967,1.1436102732907427,0.23809523809523808,0.6295108196961835,1.0,46/242,23.95%,CEP55;KIF20A;NSFL1C;FNBP1;ARPC2;CHMP2B;HSPA8;CORO1C;PRKCI;TFRC;TIMM50;HUWE1;DNM1L;NEMP1;SNX9;OPA1;WASL;VPS4B;ACTR2;DNM2;OSBPL2;ACTR3;LDLR;PDCD6IP;RPS27A;SAR1B;VAMP7;RABEP1;NECAP1;FCHO2;ARPC3;NUP93;CHMP4C;NPC1;STAM;PIK3C2A;NAPG;ARPC1A;TGOLN2;DNM1;LEMD3;LPCAT3;AP2B1;NUP155;TOR1B;TOR1AIP1
gsea,skeletal muscle tissue development (GO:0007519),-0.347843638226832,-1.1435291140612727,0.22413793103448276,1.0,1.0,4/37,8.03%,MYL6;MYLPF;CFLAR;LEMD2
gsea,positive regulation of axonogenesis (GO:0050772),-0.35816532181149985,-1.1423293343095553,0.2549019607843137,1.0,1.0,4/43,9.41%,METRN;TIAM2;PLXNB1;DBN1
gsea,regulation of cytosolic calcium ion concentration (GO:0051480),-0.3057823623258194,-1.1422255253602318,0.19642857142857142,1.0,1.0,7/148,10.38%,TRPM4;CD24;LPAR2;FIS1;CLN3;WNT5A;SPPL3
gsea,negative regulation of autophagy (GO:0010507),-0.2976136270768167,-1.1415168323712952,0.29411764705882354,1.0,1.0,13/59,24.51%,GOLGA2;BMF;TAB2;EIF4G2;QSOX1;CTSA;PINK1;WDR6;RRAGA;SNCA;ENST00000639332.2;FOXK1;TAB3
gsea,RNA catabolic process (GO:0006401),0.3224452351418697,1.13796966992967,0.2708333333333333,0.6430058664531694,1.0,7/49,8.88%,NCBP1;FEN1;HNRNPD;SUPV3L1;DNA2;PNPT1;LSM5
gsea,cardiac muscle tissue development (GO:0048738),-0.4014409670150523,-1.137937481817777,0.23529411764705882,1.0,1.0,2/53,0.97%,KDM6B;SIK1
gsea,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.42005450709597203,1.1378259128118793,0.3090909090909091,0.642017323876411,1.0,3/26,6.63%,CDC6;ADAM17;CCND3
gsea,iron-sulfur cluster assembly (GO:0016226),0.38999819577234873,1.136580566843801,0.3409090909090909,0.6437821964128198,1.0,5/24,12.49%,LYRM4;HSPA9;BOLA2;GLRX3;MMS19
gsea,porphyrin-containing compound biosynthetic process (GO:0006779),0.369583090744986,1.1361108999651814,0.2916666666666667,0.643583923987759,1.0,4/24,10.50%,COX15;UROS;ABCB10;PGRMC1
gsea,positive regulation of peptide hormone secretion (GO:0090277),0.36088620808007577,1.1358517087209503,0.20833333333333334,0.6431966439837046,1.0,5/43,15.50%,AIMP1;TM7SF3;HFE;MCU;AACS
gsea,regulation of T cell differentiation (GO:0045580),0.4019784498616157,1.1357063482560326,0.2727272727272727,0.6423779434536562,1.0,11/39,35.64%,CLPTM1;FANCA;PRELID1;TCF7;RUNX1;XBP1;METTL3;SOD1;ABL1;KAT2A;GATA3
gsea,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.35610880451067395,1.1356934019214635,0.29545454545454547,0.6411303903769355,1.0,11/29,30.65%,DGCR8;PUM2;HNRNPA2B1;AGO1;METTL3;SRRT;PRKRA;TUT7;AGO2;ZC3H7A;ADAR
gsea,regulation of embryonic development (GO:0045995),0.38735329265499474,1.1330283227715063,0.30952380952380953,0.64587131235911,1.0,9/36,29.99%,CDK1;RACGAP1;RAB14;NIPBL;EHMT1;PHLDB2;CLASP1;DHX36;TRIP12
gsea,cotranslational protein targeting to membrane (GO:0006613),-0.31502241352695576,-1.1328559122774262,0.3170731707317073,1.0,1.0,37/94,23.34%,RPL37;RPL28;RPS13;RPL37A;RPL10A;RPS18;RPL11;RPL13;RPL39;RPS29;RPL13A;RPS2;RPL29;RPS21;RPL9;RPL27A;RPS12;RPLP2;RPLP1;RPL8;RPL31;RPL34;RPL27;RPL23A;RPL10;RPL7;RPL14;RPL35;SIL1;RPL18A;RPL7A;RPL12;RPS14;RPS8;RPS5;RPS20;RPLP0
gsea,negative regulation of RNA splicing (GO:0033119),0.38730045694224735,1.1322377330064772,0.2641509433962264,0.6464509585842186,1.0,6/19,15.60%,SFSWAP;SRSF7;PTBP3;C1QBP;SRSF4;PTBP1
gsea,sprouting angiogenesis (GO:0002040),0.38148418919610794,1.1307323160660865,0.32727272727272727,0.6491760409640898,1.0,12/52,27.79%,E2F8;E2F7;JMJD6;NAXE;NRARP;ENG;BMP4;VEGFA;EFNB2;OTULIN;LOXL2;ROBO1
gsea,B cell differentiation (GO:0030183),0.3746872960431219,1.1306746271079184,0.22448979591836735,0.6480588974911655,1.0,4/61,5.93%,SLC25A5;DCAF1;MSH2;ADAM17
gsea,mitochondrial respiratory chain complex assembly (GO:0033108),-0.3312908155721072,-1.1305468884873222,0.275,1.0,1.0,36/90,27.75%,NDUFA1;NDUFA2;NDUFB10;NDUFA13;PET117;NDUFA10;SURF1;PET100;COX14;COA5;COA3;NDUFS7;NDUFB4;NDUFS4;NDUFB7;NDUFA11;NDUFA8;UQCC2;NDUFB9;FASTKD3;DMAC2;NDUFS3;COX17;NDUFC2;SDHAF1;NDUFAF1;NDUFB2;NDUFB1;NDUFB8;NDUFB3;NDUFS5;ECSIT;NDUFS6;UQCC1;NDUFB6;SMIM20
gsea,positive regulation of transcription by RNA polymerase I (GO:0045943),0.4009250711030709,1.1296355171914272,0.3404255319148936,0.6497806945335812,1.0,9/23,24.83%,WDR75;WDR43;LYAR;PHF8;NCL;HEATR1;MTOR;UTP15;DDX11
gsea,"DNA-templated transcription, elongation (GO:0006354)",0.2692061528656366,1.1294084669412405,0.29545454545454547,0.6489603211665927,1.0,25/69,30.28%,NCBP1;IWS1;ELP4;PCID2;SUPT16H;LEO1;SSRP1;GTF2F2;POLR2B;GTF2H1;ELOA;ELOC;ELOB;POLR2K;CTR9;RTF1;POLR2L;CCNT1;POLR2C;SETD2;POLR2E;TCEA1;NELFCD;EAF1;AFF4
gsea,GPI anchor metabolic process (GO:0006505),0.3472028926621453,1.129228640058656,0.2391304347826087,0.6480632494989674,1.0,4/28,13.05%,DPM2;PIGU;PIGN;PIGH
gsea,miRNA metabolic process (GO:0010586),0.38058637168163056,1.1283697422842465,0.2682926829268293,0.6485254844240053,1.0,10/20,35.49%,DGCR8;RAN;XPO5;TENT4B;DIS3L2;PRKRA;TUT7;AGO2;TUT4;KHSRP
gsea,positive regulation of binding (GO:0051099),0.2786840448548561,1.1277856886151512,0.1875,0.6487205918681181,1.0,17/90,22.91%,DHX9;NCBP1;HMGB1;GMNN;NME1;IDE;HFE;STK4;RAN;FKBP1A;RALB;STK3;BMP4;RIPK2;AKTIP;TXN;GSK3B
gsea,negative regulation of cellular metabolic process (GO:0031324),0.31919468904979126,1.1273594127405544,0.3023255813953488,0.6486766118609351,1.0,4/39,16.68%,BRCA1;ANKRD13D;RIN3;TRAP1
gsea,positive regulation of macroautophagy (GO:0016239),0.3251113252459282,1.1271001344984897,0.34615384615384615,0.6480513536376603,1.0,8/53,16.72%,SLC25A5;PIP4K2A;HTT;LARP1;TBK1;RALB;SPTLC1;RAB3GAP2
gsea,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.3023714106878271,1.1269841420744775,0.2826086956521739,0.6469800881257755,1.0,9/61,16.30%,CDK1;MED17;BCLAF1;TNRC6A;CDK8;SETX;CCNC;MED6;CCNB1
gsea,positive regulation of cellular catabolic process (GO:0031331),0.25575872545255374,1.1257299537121925,0.24489795918367346,0.6489142742747752,1.0,22/141,20.97%,NRDC;SVIP;HMGB1;HSP90AA1;TRIM14;SUPV3L1;PNPT1;MSN;SH3D19;SNX9;PIK3CB;VPS35;ADAM9;ZC3HAV1;UFL1;CNOT7;ROCK1;ARNT;PRKAA1;PIK3C2A;FAF1;HIF1A
gsea,establishment of epithelial cell polarity (GO:0090162),0.38291513036856584,1.1250247839704126,0.3333333333333333,0.6491330243167938,1.0,6/20,20.68%,CAMSAP3;MSN;FERMT1;RHOA;RAP2A;GOLPH3
gsea,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.34105842883620013,-1.124857915440486,0.36538461538461536,1.0,1.0,17/80,25.02%,TRADD;TMSB4X;TRIP6;APP;EGFR;CD27;IFI35;LGALS9;IL23A;SASH1;TCIM;DLG1;BCL3;HDAC7;NFKBIA;ILK;CPNE1
gsea,regulation of organelle organization (GO:0033043),0.271465236473606,1.1244330753188116,0.21153846153846154,0.6493509313914058,1.0,25/80,32.78%,CAMSAP3;ARL6IP1;USP6NL;MSN;DNM1L;LMAN1;DIAPH1;PDE4DIP;VPS35;CAMSAP2;SAR1B;MAPK1;MARK2;GOLPH3;PDE2A;MFF;PAK2;CLIC4;PISD;TMEM33;SCARB2;PARL;PTK2;TAOK1;CDT1
gsea,positive regulation of cellular biosynthetic process (GO:0031328),0.26577480208387216,1.122808900352037,0.22448979591836735,0.6522378881776854,1.0,28/180,21.07%,DHX9;PRKDC;PCNA;KAT7;HSP90AA1;ARPP19;ELOVL5;SLC25A37;HNRNPD;DNA2;NPM1;STN1;LPGAT1;PARK7;ABCB10;DDAH2;APPL1;DDAH1;PRMT1;LDLR;ELAVL1;HSP90AB1;ARNT;NAT10;FAF1;HIF1A;EIF3E;PTPN2
gsea,positive regulation of endopeptidase activity (GO:0010950),-0.38930431742551747,-1.1225886928178164,0.36363636363636365,1.0,1.0,3/30,7.79%,APH1A;PYCARD;VSIR
gsea,RNA polyadenylation (GO:0043631),0.35515274122734874,1.1218125239323833,0.38636363636363635,0.6525289262079405,1.0,5/26,7.18%,CPSF3;PAPOLA;CPSF2;LEO1;PNPT1
gsea,mRNA polyadenylation (GO:0006378),0.35515274122734874,1.1218125239323833,0.38636363636363635,0.6525289262079405,1.0,5/26,7.18%,CPSF3;PAPOLA;CPSF2;LEO1;PNPT1
gsea,protein K48-linked ubiquitination (GO:0070936),0.28170986598096626,1.1211948948418942,0.375,0.6526085474429314,1.0,10/57,15.42%,UBE2A;RNF4;UBE2C;UBE2T;RNF8;RFFL;RNF34;UBE2E3;RNF6;UBE2G1
gsea,regulation of myotube differentiation (GO:0010830),-0.391225177222309,-1.1211691520436569,0.32558139534883723,1.0,1.0,3/25,5.25%,SIK1;MMP14;HDAC5
gsea,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.31642707373620926,-1.120464982320204,0.2857142857142857,1.0,1.0,11/80,20.88%,BAMBI;SKIL;FSTL3;CADM4;LEMD2;SMAD7;THBS1;EPN2;SMAD4;DAB2IP;HGS
gsea,positive regulation of Wnt signaling pathway (GO:0030177),0.2680679601018615,1.1201645034974994,0.28846153846153844,0.6539087160414576,1.0,30/153,22.30%,PSMD14;PSMD6;PSMB2;PSMD5;PSMD1;PSMA5;PSMD11;CSNK1E;PSMA4;PSMA3;PSME4;USP8;PSMD7;DEPDC1B;ENST00000629691.2;PSMC6;NRARP;PSMA1;USP34;PSMD10;TBL1XR1;PSMB3;VCP;SFRP1;USP47;PSME1;WNK1;PSMC3;SULF2;PPM1A
gsea,phospholipid metabolic process (GO:0006644),0.3921571433676894,1.1195186548849385,0.34782608695652173,0.6541668883568326,1.0,9/76,14.90%,PIP4K2A;GNPAT;ACP6;LPCAT4;PLPP1;PGP;PLAA;SMPD1;PIP5K1A
gsea,protein monoubiquitination (GO:0006513),0.35891845823675544,1.1187983230747167,0.32653061224489793,0.6547346005368584,1.0,7/39,10.42%,DTL;RNF20;UBE2T;LEO1;HUWE1;FANCL;ZNF598
gsea,DNA modification (GO:0006304),0.4071148298900997,1.1186663392664133,0.3541666666666667,0.6536213583421626,1.0,8/26,21.27%,NEIL3;PARP1;SMUG1;PARP2;UNG;MBD4;ACD;TERF2IP
gsea,regulation of interleukin-8 production (GO:0032677),-0.3189750898898538,-1.1175355140510388,0.34,1.0,1.0,15/81,23.91%,TMSB4X;CACTIN;RAB1A;PYCARD;CD74;LGALS9;ARRB1;IL6;ANXA4;BCL3;HYAL2;RIPK1;DDIT3;MAVS;FADD
gsea,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.3373910264418243,1.1174305886442966,0.2857142857142857,0.6559151311705708,1.0,7/22,19.19%,VPS37A;VPS4B;PLAA;VPS25;VPS36;UBAP1;STAM
gsea,arachidonic acid metabolic process (GO:0019369),-0.39824269084192415,-1.116940473634811,0.2641509433962264,1.0,1.0,3/57,3.41%,GPX4;CBR1;FAAH2
gsea,regulation of smoothened signaling pathway (GO:0008589),-0.33331239042385696,-1.116686951737069,0.3170731707317073,1.0,1.0,7/51,15.94%,DLG5;FBXL17;PTCH1;GLIS2;RAB34;MGRN1;MEGF8
gsea,phosphatidylinositol biosynthetic process (GO:0006661),0.2568022768814794,1.1162784154120728,0.3409090909090909,0.6574797906838995,1.0,21/126,21.77%,PIP4K2A;PI4K2B;MTMR12;MTMR6;DPM2;SACM1L;PIGU;PIK3CB;RAB14;FIG4;PIGN;PIGH;PIK3C3;PIP5K1A;PIK3R4;CDS1;PIK3C2A;PLEKHA2;PI4KA;FAM126A;TTC7B
gsea,anterograde axonal transport (GO:0008089),0.3604036241453531,1.11608657469619,0.36363636363636365,0.6566244852143007,1.0,10/37,26.74%,KIF4A;KIF5B;AP3B1;AP3M2;BLOC1S6;BLOC1S5;TRAK2;RAB21;AP3S2;KIF1B
gsea,cellular response to interleukin-1 (GO:0071347),0.3056485472833469,1.1156316093740724,0.3090909090909091,0.6564644957826924,1.0,32/155,25.83%,USP10;PSMD14;PSMD6;PSMB2;PSMD5;PSMD1;PSMA5;PSMD11;PSMA4;PSMA3;PSME4;RPS6KA4;PSMD7;ENST00000629691.2;RPS27A;PSMC6;PSMA1;PSMD10;PSMB3;GBP3;SFRP1;PSME1;HIF1A;TNIP2;RIPK2;PSMC3;SKP1;IL1RN;CUL1;UBE2N;PSMA6;PSMD13
gsea,COPII vesicle coating (GO:0048208),-0.3283055051672785,-1.1144128221846599,0.3191489361702128,1.0,1.0,13/63,16.45%,TRAPPC6A;GOLGA2;CUL3;SEC24C;RAB1A;KLHL12;CD59;TRAPPC2L;GORASP1;SCFD1;CSNK1D;CTSZ;RAB1B
gsea,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.3283055051672785,-1.1144128221846599,0.3191489361702128,1.0,1.0,13/63,16.45%,TRAPPC6A;GOLGA2;CUL3;SEC24C;RAB1A;KLHL12;CD59;TRAPPC2L;GORASP1;SCFD1;CSNK1D;CTSZ;RAB1B
gsea,vesicle coating (GO:0006901),-0.3283055051672785,-1.1144128221846599,0.3191489361702128,1.0,1.0,13/63,16.45%,TRAPPC6A;GOLGA2;CUL3;SEC24C;RAB1A;KLHL12;CD59;TRAPPC2L;GORASP1;SCFD1;CSNK1D;CTSZ;RAB1B
gsea,negative regulation of macromolecule metabolic process (GO:0010605),0.26241014439036325,1.1142846302729037,0.25,0.6585565833136208,1.0,30/194,22.07%,ANXA7;ABCC2;SLC7A5;PC;ANKRD13D;MAP2K1;ROCK2;TNRC6A;PARK7;TARDBP;GATA2;LDLR;NDFIP2;LGMN;ZNF148;RIN3;CNOT7;HSP90AB1;RB1;SUB1;RUNX1;ENG;BMP4;NOTCH1;PRKAA1;VEGFA;AGO1;SFRP1;HIF1A;AURKA
gsea,negative regulation of BMP signaling pathway (GO:0030514),-0.3130443744091951,-1.114028919382852,0.2916666666666667,1.0,1.0,5/52,11.47%,BAMBI;SKIL;FSTL3;LEMD2;SMAD7
gsea,positive regulation of histone modification (GO:0031058),0.3693964630231412,1.1126109039669572,0.36538461538461536,0.6611004856571081,1.0,7/33,13.92%,BRCA1;RPS6KA4;ING2;GLYR1;FAM47E;PAXIP1;SAP30BP
gsea,glucose homeostasis (GO:0042593),0.2681981266648598,1.1123930836217213,0.2926829268292683,0.6603977413927974,1.0,10/86,21.07%,LRRC8D;ENST00000645126.2;NUCKS1;HKDC1;PARK7;CRY1;MCU;PRKAA1;HIF1A;PTPN2
gsea,actomyosin structure organization (GO:0031032),0.31365585408066043,1.1121524232696947,0.2692307692307692,0.6598248316190676,1.0,11/76,17.99%,CIT;MYH14;EPB41L2;ROCK2;EPB41L1;CDC42BPA;TMOD3;RHOA;ITGB1;ROCK1;CSRP2
gsea,erythrocyte differentiation (GO:0030218),0.32924090491861985,1.1120750910096944,0.26,0.6587715732569145,1.0,8/46,21.07%,SLC25A5;HSPA9;ABCB10;LYAR;UFL1;MFHAS1;VEGFA;PTPN2
gsea,positive regulation of RNA splicing (GO:0033120),0.3608052451818727,1.1114289965824675,0.3269230769230769,0.6596485889515462,1.0,11/31,32.50%,NCBP1;SETX;SNW1;NCL;RBM22;TRA2A;SF3B4;HNRNPLL;ZPR1;TRA2B;NUP98
gsea,transport across blood-brain barrier (GO:0150104),0.3441176453673419,1.1103514614171803,0.3333333333333333,0.6609524378171446,1.0,10/86,25.71%,ABCC2;SLC7A5;SLC44A1;TFRC;FABP5;SLC1A5;ENST00000630362.2;SLC7A1;SLC6A6;SLC2A1
gsea,endomembrane system organization (GO:0010256),0.270638917229942,1.1099014180587365,0.34210526315789475,0.6611655835518565,1.0,41/199,23.91%,LNPK;PI4K2B;HOOK1;NSFL1C;CHMP2B;TMED5;GORASP2;USP6NL;HUWE1;DNM1L;HTT;GOLGA8A;SNX10;TMED2;LMAN1;USP8;OSBPL2;GBF1;ALS2;DNAJC13;BNIP1;BLZF1;COG2;ZW10;NUP93;ATL2;LYSMD3;COG1;STX17;RNF26;GOLPH3;DNM1;LEMD3;TANGO2;ARL1;SEC16A;AKTIP;WASHC4;GOLGA8B;NUP155;TOR1B
gsea,stem cell differentiation (GO:0048863),-0.3595196992641692,-1.109807405614499,0.32608695652173914,1.0,1.0,4/40,5.11%,FOXO4;FBXL17;JARID2;NELFB
gsea,negative regulation of endothelial cell migration (GO:0010596),-0.3765387873125528,-1.1097019710315144,0.4318181818181818,1.0,1.0,6/38,20.26%,GADD45A;SVBP;JUP;THBS1;PTPRM;DAB2IP
gsea,histone H4-K16 acetylation (GO:0043984),0.4224989879577043,1.107970062797757,0.425531914893617,0.6647051203168276,1.0,4/19,8.01%,KAT7;MSL3;WDR5;KANSL1
gsea,peptidyl-proline modification (GO:0018208),0.39206844170620314,1.1076446146404992,0.26785714285714285,0.664256399163524,1.0,14/32,42.08%,PPWD1;FKBP1A;CWC27;PPIH;PPIL1;NTMT1;PPIA;PPIG;FKBP4;FKBP10;NKTR;PPIL3;PPIC;OGFOD1
gsea,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.34813044995609826,-1.1067458201265583,0.28205128205128205,1.0,1.0,5/22,13.10%,MEN1;INCA1;CDKN2A;HEXIM2;HEXIM1
gsea,cellular response to ionizing radiation (GO:0071479),0.28893946668443243,1.1062871995444756,0.23529411764705882,0.666471301400753,1.0,14/48,24.50%,NET1;NUCKS1;XRCC5;RAD51AP1;INTS7;RAD51;HUS1;MAP3K20;INO80;ECT2;RHNO1;NIPBL;TMEM109;ATR
gsea,mitochondrial membrane organization (GO:0007006),0.36228160434632733,1.104880990081444,0.36538461538461536,0.6680012459773775,1.0,10/32,24.65%,SLC25A5;HSPA9;TIMM50;OPA1;MICOS13;APOO;CHCHD3;GHITM;IMMT;MTX2
gsea,ribonucleoprotein complex biogenesis (GO:0022613),0.35410440291367434,1.1045698775751795,0.36,0.6676240020596595,1.0,29/60,34.59%,RIOK1;PAK1IP1;RRP36;XPO1;ENST00000630540.2;NPM1;NAF1;LTV1;MRTO4;METTL17;SDAD1;NOM1;RPL35A;NOP16;WDR12;GTF3A;URB2;RPS24;RRS1;CUL4B;RPS15;NVL;HEATR3;EBNA1BP2;RPF2;GLUL;RPL26L1;SHQ1;RPL26
gsea,regulation of small GTPase mediated signal transduction (GO:0051056),0.2471425240726664,1.1040519418921815,0.2765957446808511,0.6674479398485964,1.0,13/141,13.19%,CHN1;NET1;NUP62;ARHGAP5;FOXM1;ARHGAP11A;ARHGAP29;SOS1;RACGAP1;ARHGEF19;RHOF;DEPDC1B;ARHGAP18
gsea,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.3869854028489058,-1.1030113308102034,0.43636363636363634,1.0,1.0,7/24,23.11%,SH3BP5L;MVP;ZGPAT;SH3BP5;HYAL2;GPRC5A;CHMP6
gsea,cellular macromolecule catabolic process (GO:0044265),0.3305399861882209,1.1024992980955837,0.3137254901960784,0.670338780269683,1.0,5/53,7.18%,NCBP1;HNRNPD;SUPV3L1;IDE;PNPT1
gsea,lymphocyte differentiation (GO:0030098),0.2901768410803122,1.101900439782683,0.32608695652173914,0.6705067656732856,1.0,5/84,5.93%,SLC25A5;DCAF1;KAT7;MSH2;ADAM17
gsea,lytic vacuole organization (GO:0080171),-0.38925527919022695,-1.1018243389343603,0.3392857142857143,1.0,1.0,5/33,9.03%,HPS1;ACP2;CLN3;GRN;VPS18
gsea,regulation of mitochondrial fission (GO:0090140),0.3725436534018803,1.1016532851592657,0.23255813953488372,0.669804809985041,1.0,8/25,23.62%,MYO19;DNM1L;VPS35;MCU;SPIRE1;INF2;AURKA;MFF
gsea,regulation of intracellular protein transport (GO:0033157),0.37771747100541186,1.1016287333873747,0.475,0.6687087282982416,1.0,6/32,19.72%,KIF20B;ZFAND1;TPR;ICE1;BMP4;GCC2
gsea,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.30952812364055093,1.1013522134552138,0.3191489361702128,0.6682848181907282,1.0,16/93,27.70%,CNOT9;HSP90AA1;TFRC;DOCK7;PFN2;STK4;PARK7;TBK1;HSP90AB1;VEGFA;RIPK2;TERF2IP;TXN;RAF1;EIF4G1;RPTOR
gsea,regulation of synapse organization (GO:0050807),-0.3985955166856113,-1.1005999483350424,0.37777777777777777,1.0,1.0,4/26,6.79%,GRIPAP1;ABHD17A;CLN3;WNT5A
gsea,cellular response to peptide hormone stimulus (GO:0071375),0.28575763740095395,1.10057705038197,0.2553191489361702,0.6688752578553726,1.0,15/106,21.33%,PRKDC;LPIN1;INSIG1;PRKCI;PARP1;RAB8A;SLC39A14;TBC1D4;GOT1;ADCY3;PRKACB;XBP1;PKM;PRKAR2A;PDPK1
gsea,negative regulation of protein metabolic process (GO:0051248),0.33458146897969676,1.0997620180755354,0.3137254901960784,0.6697347957832805,1.0,8/52,17.65%,SF3B3;MAD2L1;VBP1;CYP51A1;LDLR;HSP90AB1;PFDN1;ROCK1
gsea,protein targeting to lysosome (GO:0006622),0.4152223080768183,1.0989254633158374,0.32558139534883723,0.6704435448638569,1.0,9/20,31.27%,HSPA8;GCC2;RAB7A;M6PR;LAPTM5;GNPTAB;SCARB2;NCOA4;NEDD4
gsea,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.3473463206659556,1.0983757535552943,0.2777777777777778,0.6703880981420132,1.0,9/24,24.99%,HSPA5;GCN1;NOTCH1;VEGFA;MUC1;HIF1A;RBPJ;NFE2L2;MBTPS2
gsea,regulation of cholesterol biosynthetic process (GO:0045540),0.4445556555851578,1.0969243349527582,0.3673469387755102,0.6726381703667796,1.0,7/17,31.20%,RAN;ERLIN1;PRKAA1;LPCAT3;MBTPS2;KPNB1;SOD1
gsea,stress-activated MAPK cascade (GO:0051403),-0.2648475490887631,-1.0967583238360408,0.20408163265306123,1.0,1.0,14/62,17.65%,MAPK3;TAOK2;MINK1;ZFP36;TAB1;MAP3K11;ZFP36L1;TAB2;MAPK13;MAPK14;LGALS9;MAPK11;UBB;UBC
gsea,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.34349739336293816,-1.096557082922171,0.30952380952380953,1.0,1.0,7/43,25.57%,TICAM1;CUEDC2;PYCARD;MAPK14;IL6;ADCY7;SIRPA
gsea,regulation of peptide hormone secretion (GO:0090276),0.3399017985787639,1.0964114342300062,0.3076923076923077,0.6726034564879706,1.0,12/74,43.16%,HFE;HADH;EIPR1;ENSA;RAP1A;SLC2A1;ITPR3;KCNS3;SLC8B1;PRKCA;PPP3CB;PASK
gsea,multivesicular body assembly (GO:0036258),0.3175306574359847,1.0952966118193856,0.3333333333333333,0.6745482328128577,1.0,10/30,21.12%,CHMP2B;VPS37A;VTA1;VPS4B;PDCD6IP;VPS25;VPS36;CHMP4C;STAM;RAB11A
gsea,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.3323187919539138,-1.0950933251924666,0.3269230769230769,1.0,1.0,4/25,4.86%,UBXN6;MVB12A;CHMP1B;ENST00000645179.2
gsea,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.3190404727706253,1.0949906609166589,0.3673469387755102,0.6740467567519146,1.0,12/54,18.58%,CDC6;CDC25A;CDKN3;CCNF;CCND3;CCNB2;PKMYT1;CDC25C;GTF2H1;CCNB1;HSP90AB1;BCCIP
gsea,cellular protein metabolic process (GO:0044267),-0.22989810809286582,-1.0948424718660243,0.27906976744186046,1.0,1.0,81/417,19.80%,UBL5;APH1A;RPL37;RPL28;GAS6;TMEM208;RPS13;RPL37A;CDC34;RPL10A;RPS18;MRPL51;MELTF;RPL11;RPL13;RPL39;MSRB2;RPS29;APP;RPL13A;RPS2;RPL29;RPS21;RPL9;MEN1;MRPS21;HARS2;MMP15;MRPL28;IGFBP6;FSTL3;RPL27A;CCDC59;PNPLA2;SPCS2;RPS12;MRPS33;EEF1A1;RPLP2;MRPL52;RPLP1;MFGE8;RPL8;RPL31;MRPL36;RPL34;YES1;PRKCSH;SPPL3;SPG7;PROC;RPL27;NUCB1;MRPL34;MRPS7;GATA6;RPL23A;RPL10;RPL7;APLP2;ST3GAL1;QSOX1;UBE2I;RNF5;MCRS1;CSF1;AKT2;RPL14;IL6;RPL35;MAGEA2;NEDD8;B4GALT7;BAP1;RPL18A;DHPS;RPL7A;KTN1;RIPK1;MSLN;RPL12
gsea,regulation of neuron apoptotic process (GO:0043523),-0.269564097840436,-1.0945841342471017,0.3181818181818182,1.0,1.0,16/98,22.06%,EGLN2;FOXQ1;CLN3;GRN;AKT1S1;BAX;NTF4;MDK;PTK2B;CDK5;PINK1;DDIT3;RASA1;EGLN3;PRKCG;CLCF1
gsea,plasma membrane bounded cell projection organization (GO:0120036),-0.2836002927459928,-1.0936610067114292,0.28846153846153844,1.0,1.0,12/128,6.96%,BLOC1S4;RAPGEF2;MAP4;MARK4;NCDN;RAB13;BLOC1S1;GPRIN2;PPP1R9B;APP;TPM1;MICALL2
gsea,positive regulation of autophagy (GO:0010508),0.3031720907275431,1.093093161070197,0.3333333333333333,0.6766881193699912,1.0,18/90,26.12%,SVIP;HMGB1;EIF2AK4;TRIM14;HTT;PARK7;PIK3CB;LARP1;TBK1;UFL1;ROCK1;PRKAA1;PIK3C2A;FBXO7;GSK3B;SCOC;PHB2;CAMKK2
gsea,response to glucose (GO:0009749),-0.3287345063418603,-1.0930121757039324,0.3877551020408163,1.0,1.0,7/49,21.18%,SOX4;GAS6;IRS2;THBS1;ZBTB20;VAMP2;SELENOS
gsea,neurotransmitter transport (GO:0006836),0.4020890944961493,1.092098051594267,0.34146341463414637,0.6782992090911637,1.0,3/73,9.03%,PDZD11;HSPA8;GLS
gsea,regulation of cell migration (GO:0030334),-0.23520192350840857,-1.0917696257250438,0.2857142857142857,1.0,1.0,50/408,17.45%,TRADD;SMIM22;DDRGK1;TMSB10;TMSB4X;SRGAP2;MMP14;CIB1;DLG5;TRIP6;SUN2;LMNA;PIK3CD;RNF41;STX4;FAM89B;MINK1;TPM1;EGFR;FAM110C;CLN3;GRN;BCAR1;VSIR;NUMB;CD74;PLXNB1;ACTG1;MDK;ELP3;RHOB;SMAD7;THBS1;PDGFC;CCAR1;RAP2C;PTK2B;FLCN;CLDN4;DAG1;AFDN;MYO1C;IFITM1;PDGFB;LDB1;CSF1;AKT2;MGAT5;KRT16;SASH1
gsea,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.34213820626688135,-1.090031501119546,0.35294117647058826,1.0,1.0,6/35,12.93%,DDRGK1;PAGR1;EGFR;PAF1;FAM83D;TFDP1
gsea,RNA modification (GO:0009451),0.33657644808791715,1.0900231948052952,0.3018867924528302,0.6820153818657719,1.0,12/58,21.13%,SSB;JMJD6;METTL1;NOP2;PUS7;DTWD1;CDKAL1;NSUN4;NSUN2;MEPCE;NAT10;TRMT6
gsea,triglyceride metabolic process (GO:0006641),0.3508035816254439,1.0897574073057426,0.3,0.6816010651043601,1.0,8/55,31.15%,LPIN1;FABP5;LPGAT1;APOC1;SEL1L;PNPLA3;LIPG;GPAT3
gsea,proteasomal protein catabolic process (GO:0010498),0.24007342455930933,1.089522741130136,0.2708333333333333,0.680946458299713,1.0,46/205,25.92%,UCHL1;NSFL1C;UBE2A;RNF4;PSMD14;PSMD6;PSMB2;PSMD5;FBXO45;PSMD1;HUWE1;RAD23B;PSMA5;PSMD11;RFFL;PSMA4;RNF34;PSMA3;PSME4;PSMD7;STUB1;ENST00000629691.2;PLAA;SPOP;KIF14;UBE2G1;PSMC6;PSMA1;PSMD10;TBL1XR1;PSMB3;VCP;UBE2K;FAF1;PSME1;FEM1C;COP1;PSMC3;FEM1B;NFE2L2;UBE4B;CUL4B;PSMA6;SEL1L;PSMD13;PRPF19
gsea,protein maturation (GO:0051604),0.2886636642049464,1.0890386208353868,0.3170731707317073,0.6808733724888314,1.0,12/97,12.79%,NAA15;HSPD1;BOLA2;NAA35;GALNT2;ADAM17;AFG3L2;CASP2;GCSH;GLRX3;MMS19;STUB1
gsea,regulation of DNA binding (GO:0051101),0.3517603128303779,1.0888587637263396,0.36538461538461536,0.6801019177944366,1.0,13/47,32.78%,E2F1;HMGB1;HMGA2;NME1;HJURP;TFAP4;TXN;MAPK8;SUMO1;SUMO3;MDFI;HES1;CDT1
gsea,peptidyl-asparagine modification (GO:0018196),0.30950870176204187,1.0888297573261254,0.29411764705882354,0.6789484203876847,1.0,6/31,15.10%,UGGT1;DPM2;RPN2;LMAN1;MGAT1;RPN1
gsea,negative regulation of intracellular signal transduction (GO:1902532),-0.2590706083600776,-1.0880949885880873,0.35294117647058826,1.0,1.0,34/198,20.47%,TMSB4X;NDUFA13;CDC34;CIB1;DLG5;PHLDA3;NOP53;TMEM127;NOC2L;PPP2R5B;CACTIN;PYCARD;PIK3IP1;AKT1S1;IFI35;DUSP1;AJUBA;INPP5K;THBS1;BCL2L2;FLCN;ARRB2;MAPK14;DAG1;WWC1;MGRN1;HYAL2;NDUFS3;PINK1;RIPK1;HDAC7;DAB2IP;DUSP3;DDIT3
gsea,negative regulation of binding (GO:0051100),0.3039290804473356,1.0864488485548427,0.34,0.6832002587335987,1.0,24/88,31.02%,AURKB;E2F1;BAG2;HMGA2;CSNK1E;PPP1CA;PARK7;PEX19;RALB;ROCK1;STYX;TFAP4;GNL3L;AURKA;GSK3B;CTNNBIP1;MAPK8;NES;DDX11;SUMO1;BTAF1;SUMO3;GTPBP4;MDFI
gsea,positive regulation of protein transport (GO:0051222),0.30461447670751884,1.0853077812546938,0.35555555555555557,0.684920972221647,1.0,9/69,20.68%,KIF20B;ZFAND1;ACSL3;DNM1L;TPR;ICE1;ADAM9;CD2AP;GOLPH3
gsea,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.3618126916115121,1.0849009125681994,0.3902439024390244,0.6847697797970099,1.0,10/25,37.38%,PLK1;MAPK1;UBE2K;RIPK2;CAB39;RPTOR;SPHK1;TNKS1BP1;CALM1;CALM2
gsea,regulation of ERK1 and ERK2 cascade (GO:0070372),-0.28716628579652403,-1.0843104441837046,0.34782608695652173,1.0,1.0,30/238,20.43%,RAPGEF2;GAS6;SERPINF2;PTPN6;CIB1;MAPK3;APP;EGFR;PYCARD;ERBB2;RRAS;CD74;FAM83D;PDGFC;ENST00000615721.3;PTK2B;FLCN;ARRB2;LGALS9;PDGFB;GLIPR2;ARRB1;PRKCZ;DLG1;SMAD4;ARHGAP8;ARHGEF5;SEMA7A;DAB2IP;DUSP3
gsea,cell junction organization (GO:0034330),-0.29940381392424564,-1.0823652154026542,0.24489795918367346,1.0,1.0,20/72,31.24%,APP;AGRN;ACTG1;FBLIM1;MARVELD3;VASP;VMP1;DVL1;GRHL2;TJP2;SH3BP1;SNCG;SNCA;PPFIBP1;ILK;WNT7B;CLDN3;PIN1;PSEN1;TJP1
gsea,cortical cytoskeleton organization (GO:0030865),0.31366976919107453,1.0818140999040031,0.3018867924528302,0.6906844564120288,1.0,7/41,17.65%,FHOD1;NCKAP1;ROCK2;RND3;RHOF;RHOA;ROCK1
gsea,regulation of apoptotic process (GO:0042981),0.22215513317977287,1.0809767396084113,0.3,0.6916202233023391,1.0,111/742,22.09%,ANXA5;NAA15;PLK1;GLO1;NET1;PRKDC;TOP2A;NUP62;E2F1;STK26;CDK1;RBM25;HSPD1;RRP1B;EEF1E1;HSP90B1;HSPA9;HMGB1;HSP90AA1;PHLDA1;NAA35;HMGA2;STIL;PRKCI;MELK;FAM162A;ANP32E;ARL6IP1;NME1;TFRC;MAD2L1;SRA1;SUPV3L1;PCID2;ERCC5;BCLAF1;DDX20;NPM1;DNM1L;SLK;HTT;CASP2;MLLT11;STK4;SOS1;FOXA1;ANO6;STK17A;SETX;BNIP2;ANP32B;PARK7;OPA1;C1QBP;BCL10;DDAH2;PA2G4;DNAJC3;HDAC3;TARDBP;DNM2;HSPA5;ARHGEF19;YWHAZ;SIGMAR1;LANCL1;STAT1;RPS27A;BNIP1;SPTLC1;PRELID1;SMPD1;KIF14;CALHM2;MAP3K20;BIRC5;STK3;FBXO11;ZNF268;ITGB1;PSMD10;ITGA6;RPS3A;NAA38;BMP4;HDAC2;PRKAA1;VEGFA;VCP;XBP1;TFAP4;SFRP1;DHCR24;IFT57;USP47;FAF1;FXN;GOLPH3;TAF9B;TPT1;BID;APIP;PRDX3;RIPK2;RPS6KA3;RTN4;TXNDC5;PHIP;TCTN3;SH3RF2;MTCH2
gsea,"regulation of gene expression, epigenetic (GO:0040029)",0.2971238686076342,1.0807860193128838,0.30952380952380953,0.6908156254947639,1.0,9/82,11.03%,BAZ1B;SMARCA5;SUZ12;TASOR;EZH2;SMYD5;SF3B1;DDX21;PHF19
gsea,regulation of transport (GO:0051049),-0.39882989455354456,-1.0802043268333101,0.36538461538461536,1.0,1.0,12/37,29.36%,POFUT2;ACTG1;SCFD1;WWC1;CDK5;VAMP2;PINK1;RAB25;SNCA;ARL6IP5;CLDN3;ICA1
gsea,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.3016834275524456,1.0801966378957046,0.3584905660377358,0.6907027096879249,1.0,17/82,19.65%,PLK1;CDC6;CDC25A;CDKN3;CCNF;ADAM17;CCND3;CCNB2;PKMYT1;CDC25C;GTF2H1;IPO7;CCNB1;CCNYL1;PSMD10;BCCIP;TFAP4
gsea,snRNA 3'-end processing (GO:0034472),0.367627596639219,1.0801699225195556,0.35714285714285715,0.6895468206215225,1.0,4/30,12.05%,USB1;EXOSC8;INTS14;INTS7
gsea,sphingolipid metabolic process (GO:0006665),0.2678428542155105,1.0796688363684732,0.3829787234042553,0.6894365041824868,1.0,18/116,21.38%,ELOVL6;HACD3;ELOVL5;TECR;NSMAF;PPP2CA;CERS2;CERS6;ELOVL7;PLPP1;SPTLC1;SMPD1;SAMD8;TEX2;AGK;GLA;ESYT1;HEXB
gsea,neuron projection development (GO:0031175),-0.26679062280610805,-1.0795508541511276,0.3333333333333333,1.0,1.0,19/171,9.97%,BLOC1S4;RAPGEF2;SRGAP2;MAP4;NCDN;RAB13;BLOC1S1;GPRIN2;PPP1R9B;APP;SVBP;TAOK2;MINK1;MICALL2;TRIO;PLXNB1;NTF4;DBN1;ATXN10
gsea,protein import into peroxisome membrane (GO:0045046),0.3708475956781381,1.0794161676659435,0.3877551020408163,0.6887358072108422,1.0,4/22,13.58%,PXMP2;ABCD3;PEX19;PEX13
gsea,regulation of necroptotic process (GO:0060544),0.3938935290899366,1.0793176289334905,0.4186046511627907,0.687848822287121,1.0,5/23,13.85%,MLKL;HSP90AA1;CYLD;STUB1;PDCD6IP
gsea,release of cytochrome c from mitochondria (GO:0001836),-0.3598859974646044,-1.0786224630304484,0.34146341463414637,1.0,1.0,7/18,16.72%,BBC3;FIS1;IFI6;BAX;BOK;BAK1;BAD
gsea,negative regulation of protein kinase activity (GO:0006469),-0.27449157651902123,-1.078463562528314,0.3269230769230769,1.0,1.0,22/90,27.06%,GADD45A;SH3BP5L;TESK1;MVP;PYCARD;TARBP2;AKT1S1;TAB1;PRKRIP1;INPP5K;SH3BP5;DVL1;HYAL2;DAB2IP;DUSP3;SNCA;TSC2;ENST00000639332.2;GSTP1;PTPRB;CAMK2N1;PTK6
gsea,protein tetramerization (GO:0051262),0.3294664425983923,1.0782102778977622,0.38636363636363635,0.6888959061840486,1.0,15/71,27.78%,FARSB;HPRT1;ALDOA;GLS;SHMT1;USP16;OSBPL2;NUDT21;ALDH9A1;TK1;ACACA;APIP;CPSF7;CRYZ;HSD17B10
gsea,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.2811251900972047,1.076966361739428,0.3333333333333333,0.690268486680659,1.0,12/92,19.84%,TTK;FOXD1;ADAM17;HFE;ING2;TWSG1;HSP90AB1;NUP93;ENG;BMP4;NOTCH1;SNW1
gsea,B cell activation (GO:0042113),0.3536529890133925,1.0769489396517777,0.3076923076923077,0.6891253037477144,1.0,5/85,5.93%,SLC25A5;DCAF1;HSPD1;MSH2;ADAM17
gsea,negative regulation of cytokine production (GO:0001818),-0.29268277050834857,-1.0766510451139446,0.3409090909090909,1.0,1.0,29/182,24.36%,GAS6;TMSB4X;PTPN6;CUEDC2;CACTIN;PYCARD;ZFP36;INHA;VSIR;HOMER3;THBS1;LGALS9;ARRB1;SIGIRR;IL23A;IL6;ANXA4;TNFRSF21;BCL3;OTUD5;ATP2B1;HDAC7;DDIT3;SELENOS;UBE2L6;MAVS;SLC2A10;ASB1;ADCY7
gsea,positive regulation of interleukin-1 production (GO:0032732),-0.30349482211789686,-1.0759514919626816,0.3695652173913043,1.0,1.0,6/62,17.50%,APP;PYCARD;WNT5A;IFI16;LGALS9;IL6
gsea,glycogen metabolic process (GO:0005977),0.43053131171853365,1.075829157644808,0.3695652173913043,0.690492764522196,1.0,9/28,37.40%,PGM2;PGM1;AGL;GSK3B;PHKA2;GYG1;GYS1;CALM1;UGP2
gsea,positive regulation of T cell differentiation (GO:0045582),-0.35953363311103353,-1.075630179540969,0.3877551020408163,1.0,1.0,5/43,9.81%,SOX4;ZBTB1;SOX12;VSIR;MDK
gsea,regulation of axon extension (GO:0030516),0.3825220750207105,1.07506311563937,0.4186046511627907,0.6912474659599142,1.0,10/38,26.37%,SIN3A;NRCAM;DNM2;RNF6;RTN4;GOLGA4;MAP2;GSK3B;DIP2B;SHTN1
gsea,negative regulation of cold-induced thermogenesis (GO:0120163),0.29896695324574485,1.0745754570509487,0.32653061224489793,0.6910890526093879,1.0,8/47,22.41%,NRDC;ADAM17;DOCK7;ID1;RB1;NOTCH1;LNPEP;RBPJ
gsea,positive regulation of defense response to virus by host (GO:0002230),0.4492412611734522,1.0739406657493578,0.4791666666666667,0.6913040911617452,1.0,9/28,34.08%,EIF2AK4;HSP90AA1;SIN3A;STAT1;PQBP1;TRAF3IP2;TOMM70;ZDHHC11;CGAS
gsea,muscle contraction (GO:0006936),-0.30847731621865654,-1.0734376285338163,0.3023255813953488,1.0,1.0,15/129,25.95%,MYL6;TNNT1;MYLPF;TPM1;PABPN1;CALD1;SMTN;GAMT;PXN;TNNC1;MYOF;MYL5;MYL12B;MYL9;ITGB5
gsea,tRNA modification (GO:0006400),0.3079387662919942,1.0729574458542186,0.3409090909090909,0.6930540162898293,1.0,10/65,21.13%,SSB;DUS2;METTL1;THADA;PUS7;DTWD1;CDKAL1;THUMPD3;NSUN2;TRMT6
gsea,MAPK cascade (GO:0000165),0.2448754592469616,1.0712913968558004,0.28846153846153844,0.6956341514692025,1.0,53/303,26.12%,YWHAE;CDK1;PSMD14;PSMD6;PSMB2;PPP1CC;PSMD5;TAOK3;PTPN3;ABHD17B;PSMD1;MAP2K1;PSMA5;SOS1;PSMD11;SYNGAP1;PSMA4;SETX;PSMA3;JAK1;PIK3CB;PSME4;PSMD7;KITLG;ENST00000629691.2;RPS27A;PSMC6;MAP3K20;PSMA1;MAPK1;PSMD10;NRAS;PSMB3;WDR83;BRAP;YWHAB;MAPK12;PSME1;TNIP2;PSMC3;SPTAN1;SHOC2;SKP1;RANBP9;KRAS;RASGRP1;MAPK8;RASAL2;CUL1;PPP5C;PSMA6;PSMD13;CAMKK2
gsea,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.3018514322599805,1.0708434410783836,0.38636363636363635,0.695631658591245,1.0,8/42,21.77%,PIP4K2A;PI4K2B;PIK3CB;PIK3C3;PIK3C2A;PI4KA;FAM126A;TTC7B
gsea,cellular response to hormone stimulus (GO:0032870),0.28349545875897997,1.069768032484163,0.3684210526315789,0.6970875162767254,1.0,11/76,30.48%,URI1;SRA1;STAT5B;ATP1A1;XBP1;SFRP1;AKR1C2;TRIM24;NR3C1;NCOA4;UBE2L3
gsea,long-chain fatty acid transport (GO:0015909),0.4074254561415378,1.068955575704846,0.375,0.6982611226399505,1.0,3/32,6.83%,ABCD3;ACSL3;FABP5
gsea,neuron development (GO:0048666),-0.26739079269743454,-1.0680278974345612,0.42592592592592593,1.0,1.0,13/143,10.14%,BLOC1S4;RAPGEF2;MAP4;NCDN;RAB13;BLOC1S1;GPRIN2;PPP1R9B;APP;MICALL2;PBX2;ATXN10;SRF
gsea,O-glycan processing (GO:0016266),0.403616988515385,1.0677211084586191,0.4358974358974359,0.7004227528626509,1.0,13/61,32.38%,B3GNT5;GALNT2;GALNT7;B3GNT2;GALNT3;XXYLT1;MUC1;GALNT14;POFUT1;GALNT12;GALNT6;GALNT10;C1GALT1C1
gsea,nucleobase-containing small molecule interconversion (GO:0015949),0.416143546197003,1.0671631144568061,0.34615384615384615,0.7006655129301573,1.0,7/27,21.32%,RRM1;TYMS;NME1;DUT;CMPK1;AK2;DTYMK
gsea,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.3018764071665501,-1.0666495742399396,0.36,1.0,1.0,11/78,13.10%,PKIG;GADD45A;TESK1;MEN1;PYCARD;INCA1;DUSP1;CDKN2A;INPP5K;HEXIM2;HEXIM1
gsea,regulation of RNA metabolic process (GO:0051252),0.2873170494416606,1.0660220353072807,0.3877551020408163,0.7018961036896938,1.0,17/65,27.85%,OAS3;RRP1B;ZNF326;HNRNPL;PTBP3;CLK3;PTBP1;RC3H2;PQBP1;HNRNPH1;CLK1;ESRP2;HNRNPLL;FUS;USP36;MBNL2;SON
gsea,calcium ion transport (GO:0006816),-0.2881755846445087,-1.0655688927887195,0.29310344827586204,1.0,1.0,10/115,18.51%,TRPM4;GAS6;ORAI1;ATP2A2;ORAI3;SLC24A1;CACNB3;ORAI2;P2RX4;CATSPER1
gsea,water-soluble vitamin metabolic process (GO:0006767),0.33829069128373623,1.0651783384270304,0.391304347826087,0.702801200552891,1.0,7/76,9.80%,DHFR;PDZD11;FPGS;PC;MTHFD2;AASDHPPT;SHMT1
gsea,establishment of endothelial barrier (GO:0061028),-0.3282165558941936,-1.0650610470239439,0.43137254901960786,1.0,1.0,15/29,34.25%,RAPGEF2;RAB1A;RAP2C;RAPGEF1;AFDN;RAB1B;TJP2;MYADM;ICAM1;CLDN3;TJP1;F11R;RAP2B;EZR;RDX
gsea,regulation of cell growth (GO:0001558),-0.2393422866668512,-1.064806223911154,0.30612244897959184,1.0,1.0,31/217,18.94%,EGLN2;NDUFA13;MMP14;DNAJB2;CIB1;MELTF;LAMTOR2;PPP1R9B;TAOK2;EGFR;CCAR2;ERBB2;BCAR1;OGFR;JADE1;CDKN2A;LTBP4;EI24;DNPH1;MUC12;FLCN;EIF4G2;EXOSC4;ATAD3A;SMARCA4;BTG1;SMAD4;BAP1;HYAL2;SERTAD3;NDUFS3
gsea,regulation of protein autophosphorylation (GO:0031952),-0.3392092301484987,-1.064199125686785,0.3508771929824561,1.0,1.0,7/37,16.18%,TESK1;MVP;PPP2R5B;TAOK2;PDGFC;RAP2C;PDGFB
gsea,phosphatidylcholine metabolic process (GO:0046470),0.3229002048311282,1.0637539506255704,0.4166666666666667,0.7049864600462463,1.0,12/77,23.71%,LPIN1;PEMT;SLC44A1;LPCAT4;SLC44A2;PLA2G12A;CHPT1;CEPT1;PLBD1;LPCAT3;MBOAT2;PNPLA8
gsea,zymogen activation (GO:0031638),-0.3550520108491216,-1.0629998092462154,0.3409090909090909,1.0,1.0,10/45,24.19%,MMP14;VSIR;GGT1;IFI16;C1R;BAK1;BAD;C1RL;FADD;CTSH
gsea,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.23756496584197878,1.0625159974377327,0.20930232558139536,0.7065924752729672,1.0,72/468,26.67%,DSCC1;E2F1;MYBL2;PUM3;NUCKS1;KAT7;FBXO5;MSL3;NSD2;NSD1;NSD3;HMGA2;SPIN4;RNF20;GMNN;HNRNPD;MAPKAPK5;PRMT5;EIF4E;ORC3;GEMIN5;NUP35;PPP2CA;EZH2;IRF2;RPS6KA4;NOLC1;PHF19;ING2;TRRAP;SLC39A8;SMC3;NUP107;DNM2;ZNF488;RNF6;MYCBP;ASCC1;PQBP1;RB1;RNF14;ZNF268;RNA5SP498;DMTF1;TCF7;ENG;NOTCH1;ZNF506;PHF12;CTR9;METAP1;ATF7;CRABP2;HIF1A;TERF2IP;TGFBRAP1;RPL6;UTP4;POFUT1;CYFIP1;FUS;NLK;NR3C1;HMG20A;MYBBP1A;FADS1;MTPN;SRRT;ASCC2;GPBP1;HP1BP3;ATXN2
gsea,regulation of mRNA polyadenylation (GO:1900363),0.32588566643330547,1.0624587752943477,0.32558139534883723,0.7054982677157068,1.0,6/18,27.61%,NCBP1;RNF20;NUDT21;CTR9;CPSF7;CCNT1
gsea,positive regulation of response to wounding (GO:1903036),-0.3325673883373444,-1.061930419939508,0.3076923076923077,1.0,1.0,4/28,13.43%,GRN;ACTG1;MDK;CLDN4
gsea,positive regulation of MAPK cascade (GO:0043410),-0.2688323135170848,-1.0609623036766807,0.35555555555555557,1.0,1.0,32/274,20.92%,RAPGEF2;GAS6;SERPINF2;CD24;CIB1;MAPK3;APP;STK25;TAOK2;EGFR;PYCARD;ERBB2;MYDGF;GDF15;CD74;PDGFC;ENST00000615721.3;PTK2B;ARRB2;WWC1;LGALS9;PDGFB;GLIPR2;ARRB1;PRKCZ;IL6;GSDME;ARHGAP8;SEMA7A;DAB2IP;JCAD;ZNF622
gsea,positive regulation of neurogenesis (GO:0050769),-0.3178296799640506,-1.0594364472389999,0.3584905660377358,1.0,1.0,6/72,9.31%,METRN;TIAM2;OBSL1;CUL7;NUMB;PLXNB1
gsea,negative regulation of fibroblast proliferation (GO:0048147),-0.3537443044398177,-1.0586420507170624,0.391304347826087,1.0,1.0,8/18,28.22%,FTH1;PARP10;MYC;B4GALT7;DAB2IP;CDC73;GSTP1;TP53
gsea,multivesicular body organization (GO:0036257),0.30357815743205024,1.0582171900135464,0.3953488372093023,0.7143254291320039,1.0,10/31,21.12%,CHMP2B;VPS37A;VTA1;VPS4B;PDCD6IP;VPS25;VPS36;CHMP4C;STAM;RAB11A
gsea,response to organonitrogen compound (GO:0010243),0.3025546701929762,1.0579605453740988,0.4,0.7135633676500812,1.0,2/40,2.72%,DHFR;KAT7
gsea,regulation of protein-containing complex assembly (GO:0043254),0.2595717643524454,1.0573432073099243,0.3220338983050847,0.7134628232195285,1.0,21/116,21.04%,SVIP;HSPA8;HSP90AA1;AIDA;TFRC;PARK7;HJURP;HSPA5;NCLN;PTPN11;RALB;ICE1;SAR1B;RB1;FARP2;EIF2AK2;VEGFA;VCP;FAF1;GNL3L;BID
gsea,regulation of viral release from host cell (GO:1902186),-0.35202953469095827,-1.057296743598708,0.3541666666666667,1.0,1.0,5/22,15.88%,TRIM11;TRIM8;TRIM28;VPS37B;TRIM13
gsea,cellular response to organic cyclic compound (GO:0071407),0.2617757478726561,1.0563557741368041,0.3673469387755102,0.71438345339606,1.0,22/150,25.50%,BRCA1;URI1;HSP90B1;INSIG1;ROCK2;MSN;LARP1;P2RY6;DIAPH1;RAP1B;ADCY3;RAD51;RNA5SP498;ATP1A1;SFRP1;GOLPH3;CDH1;PDE2A;SSH1;NR3C1;RAP1A;SPP1
gsea,regulation of neuron differentiation (GO:0045664),0.3194363869928758,1.0562242318090378,0.3953488372093023,0.7134892138832939,1.0,9/79,18.52%,EIF2AK4;YWHAH;SIN3A;NRCAM;MMD;NEPRO;RHOA;ROCK1;CDK5RAP2
gsea,protein O-linked glycosylation (GO:0006493),0.33511440048465624,1.0558979003402833,0.4634146341463415,0.7132084140453772,1.0,16/102,23.97%,B3GNT5;PLOD2;GALNT2;GALNT7;DPM2;TMTC3;B3GNT2;GALNT3;PGM3;XXYLT1;MUC1;GALNT14;B3GLCT;POMGNT2;POFUT1;SDF2L1
gsea,fatty-acyl-CoA metabolic process (GO:0035337),0.4152958392939421,1.0557507504070804,0.39622641509433965,0.7123868065338309,1.0,10/22,40.94%,FAR1;ACSL3;FASN;SCD;ACACA;SCD5;CBR4;ACLY;ACSL4;HSD17B8
gsea,negative regulation of gene expression (GO:0010629),0.24060843150899022,1.0554573851377522,0.40816326530612246,0.7121087616744328,1.0,46/322,20.28%,GAPDH;DHFR;ANXA7;SUZ12;TYMS;CNOT9;ABCC2;SLC7A5;HELLS;TASOR;PC;MAP2K1;ROCK2;PNPT1;TNRC6A;EZH2;LSM5;PTBP3;SMYD5;PARK7;SHMT1;RPS6KA4;LARP1;PHF19;TARDBP;GATA2;SYNCRIP;PUS7;NDFIP2;LGMN;TWSG1;ZNF148;PTBP1;CNOT7;RB1;RUNX1;ENG;BMP4;NOTCH1;EIF2AK2;PRKAA1;VEGFA;AGO1;SFRP1;NCL;CNOT10
gsea,negative regulation of cell population proliferation (GO:0008285),-0.24091206758598147,-1.0552141300940154,0.30952380952380953,1.0,1.0,56/379,22.60%,TMEM115;SOX4;RAPGEF2;REST;ATRAID;PTPN6;DNAJB2;CIB1;DLG5;CDKN2B;FOXO4;LMNA;ING4;RNF41;TMEM127;APP;FTH1;MEN1;WNT5A;IGFBP6;RBM5;INCA1;CELF1;RARG;PLXNB1;VHL;IFI35;COL18A1;CDKN2A;ABI1;MARVELD3;MNT;TFDP1;PTK2B;FLCN;GATA6;KDF1;IFITM1;IRF6;PARP10;MYC;BTG1;IL6;B4GALT7;BAP1;GSDME;FKTN;WDR6;EPPK1;DAB2IP;HGS;B2M;FUZ;ADGRG1;DNAJA3;TSC2
gsea,positive regulation of cellular metabolic process (GO:0031325),-0.2803877496869087,-1.0545618006441935,0.35555555555555557,1.0,1.0,17/105,19.57%,GADD45A;NR1H3;CD63;CBR1;RNF41;RAB1A;NR1H2;THBS1;ROMO1;ARRB2;MAPK14;PDGFB;CSF1;RAB1B;ARRB1;SCRIB;RIPK1
gsea,positive regulation of DNA binding (GO:0043388),0.46708903298376614,1.053524257693599,0.4489795918367347,0.7152288097083745,1.0,8/34,36.11%,HMGB1;NME1;PARK7;RB1;TXN;HES1;GATA3;PPARG
gsea,positive regulation of cell population proliferation (GO:0008284),0.24234472725025122,1.0533701795497161,0.375,0.7147448462870398,1.0,73/474,26.75%,SLC25A5;CDK2;DHX9;KIF20B;TTK;E2F1;NAP1L1;PRC1;UBE2A;FOXM1;FBXO5;CDCA7L;FN1;HMGA2;PRKCI;NME1;ADAM17;CCPG1;NPM1;NOP2;CDK6;EZH2;SSR1;STAMBP;DBF4B;OSMR;TIPIN;KITLG;PRMT1;MCTS1;CDC7;CAPNS1;STAT1;WDR77;HNRNPU;LGMN;KIF14;LAMC1;UFL1;CNOT7;BIRC5;IL13RA1;ZNF268;BMP4;NOTCH1;HDAC2;VEGFA;S1PR3;XBP1;SFRP1;FXN;PRDX3;RPL23;PHIP;AKR1C2;RBPJ;KRAS;PTN;EFNB2;CRKL;NES;SAAL1;RPS4X;EMP2;MVD;CEACAM6;CNOT6;SLC35F6;TIMP1;HMOX1;FAM98A;TBRG4;RPS15A
gsea,positive regulation of transport (GO:0051050),-0.24794706049983362,-1.0527511293447682,0.375,1.0,1.0,9/91,11.21%,GAS6;NR1H3;PYCARD;HIP1R;BAX;ZNF205;BOK;LMAN2;INPP5K
gsea,retinoid metabolic process (GO:0001523),-0.3616456651444928,-1.0524445143620258,0.44642857142857145,1.0,1.0,8/92,19.72%,RETSAT;DHRS3;RDH10;AGRN;AKR1B1;ALDH1A3;SDC4;SCPEP1
gsea,regulation of proteasomal protein catabolic process (GO:0061136),0.30123125600333006,1.051854211428335,0.36538461538461536,0.7175363393297284,1.0,11/54,21.56%,TMF1;BAG2;PSMD14;XPO1;RAD23B;TMTC3;PSMC6;UFL1;HSP90AB1;PSME1;PSMC3
gsea,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.3191605316813472,1.0513878283523677,0.4666666666666667,0.71758745654013,1.0,8/30,21.07%,OAS3;ABCE1;TTLL12;PTPN11;CNOT7;HSP90AB1;UBE2K;PTPN2
gsea,negative regulation of apoptotic process (GO:0043066),0.2338340348024111,1.050522274708244,0.3125,0.71842065833691,1.0,68/485,22.00%,ANXA5;NAA15;PLK1;GLO1;PRKDC;NUP62;YWHAE;CDK1;HSPD1;HSP90B1;HSPA9;NAA35;HMGA2;STIL;PRKCI;MSH2;ARL6IP1;TFRC;MAD2L1;SUPV3L1;PCID2;ERCC5;NPM1;CASP2;SETX;BNIP2;PARK7;OPA1;DDAH2;PA2G4;DNAJC3;HDAC3;HSPA5;YWHAZ;RPS27A;BNIP1;PRELID1;LGMN;KIF14;BIRC5;MAPK1;RB1;ZNF268;ITGB1;PSMD10;RPS3A;NAA38;BMP4;NOTCH1;HDAC2;PRKAA1;VEGFA;XBP1;SFRP1;DHCR24;USP47;FXN;GOLPH3;TAF9B;TPT1;BID;APIP;PRDX3;RIPK2;RPS6KA3;TXNDC5;PHIP;SH3RF2
gsea,regulation of cell differentiation (GO:0045595),-0.26350072437994365,-1.0492585613519594,0.3333333333333333,1.0,1.0,22/156,17.32%,REST;MCRIP1;SIK1;SERPINF2;CD24;LGALS3;SPOCK2;PDCD2;NTF4;VHL;MDK;SRF;ZFP36L1;SMAD7;LTBP4;CEBPB;DAG1;UQCC2;ZFHX3;CSF1;CEBPD;DDX17
gsea,cellular response to retinoic acid (GO:0071300),-0.3187585818854088,-1.0489579599375007,0.4375,1.0,1.0,9/43,27.97%,NDUFA13;WNT5A;PTK2B;PTK7;FZD7;WNT5B;WNT6;PTK6;WNT7B
gsea,regulation of cytoskeleton organization (GO:0051493),0.24982009735948474,1.0488289917700084,0.40425531914893614,0.721125456511505,1.0,23/112,26.70%,CAMSAP3;CYLD;IQGAP1;ROCK2;IQGAP3;DIAPH1;RND3;ARHGEF19;RHOF;ARHGAP18;BAIAP2;CRK;RHOA;MAPK1;ROCK1;PRKAA1;MARK2;GSK3B;MTOR;PAK2;PHLDB2;CLIC4;CLASP1
gsea,positive regulation of defense response (GO:0031349),-0.3193096528812512,-1.04785889983905,0.38,1.0,1.0,20/98,27.93%,TRADD;APP;WNT5A;GRN;IFI35;MDK;GPRC5B;MGST2;ENST00000615721.3;MAPK13;IL23A;HYAL2;RIPK1;ABCC1;SNCA;POLR3C;NFKBIA;IL18;ADAM8;POLR3B
gsea,regulation of lamellipodium assembly (GO:0010591),0.4524241463239254,1.0446340254749145,0.45454545454545453,0.7305490282133572,1.0,14/34,40.38%,ARPC2;TWF1;NCKAP1;ACTR2;ACTR3;CYFIP1;PIK3CA;DMTN;EPHA2;OCLN;RAC1;AKIRIN1;CAPZB;TWF2
gsea,positive regulation of fibroblast proliferation (GO:0048146),0.3807750323893152,1.0442376417027448,0.4576271186440678,0.7305785487608091,1.0,4/28,7.67%,DHX9;E2F1;FN1;CDK6
gsea,negative regulation of cell growth (GO:0030308),-0.2595018893293009,-1.0440161592321324,0.3404255319148936,1.0,1.0,15/126,18.94%,NDUFA13;DNAJB2;PPP1R9B;CCAR2;JADE1;CDKN2A;EI24;DCC;FLCN;SMARCA4;BTG1;SMAD4;HYAL2;SERTAD3;NDUFS3
gsea,regulation of MAPK cascade (GO:0043408),-0.25790668756220797,-1.0418009490018894,0.32653061224489793,1.0,1.0,27/166,20.92%,PTPN6;CD24;MAPK3;RNF41;TAOK2;MINK1;EGFR;ERBB2;MYDGF;GDF15;RRAS;CD74;DUSP1;FAM83D;MAP2K2;DAG1;WWC1;PDGFB;IL6;LBH;MAP4K4;GSDME;ARHGEF5;DAB2IP;JCAD;DUSP3;ZNF622
gsea,regulation of osteoblast differentiation (GO:0045667),-0.28584703674220296,-1.041209850325759,0.3488372093023256,1.0,1.0,6/83,7.04%,REST;TRPM4;ATRAID;BAMBI;MEN1;PTCH1
gsea,protein polymerization (GO:0051258),-0.28363828041404043,-1.0410237838760503,0.40476190476190477,1.0,1.0,5/59,6.96%,GSN;GPX4;MSRB2;ENST00000645179.2;MICALL2
gsea,negative regulation of phosphorylation (GO:0042326),-0.2585469057223782,-1.0409254756487263,0.425531914893617,1.0,1.0,11/86,11.21%,CIB1;CDKN2B;TESK1;CACTIN;MEN1;INHA;CADM4;PRKRIP1;IRS2;CDKN2A;INPP5K
gsea,platelet aggregation (GO:0070527),0.3226351902965421,1.0387345202220701,0.5098039215686274,0.743020137377629,1.0,7/36,20.38%,FN1;PIK3CB;FIBP;UBASH3B;VCL;GNAS;METAP1
gsea,lipid biosynthetic process (GO:0008610),0.3415555963175645,1.038425503890334,0.38,0.742275536255703,1.0,26/80,40.94%,GNPAT;ABCD3;PDSS1;PDSS2;CYP51A1;PIP5K1A;GGPS1;SCD;PRKAA1;XBP1;ACACA;MVD;FADS1;AGPS;LIPG;SCD5;ACSL5;CBR4;ACLY;HMGCR;LPCAT1;ACSL1;DOLPP1;DHRS11;ACSS2;HSD17B8
gsea,cytokine-mediated signaling pathway (GO:0019221),0.22997298683361017,1.0381336379446753,0.39215686274509803,0.7419096009542865,1.0,78/621,25.88%,PLP2;ENST00000645126.2;OAS3;LMNB1;HSP90B1;HSPA9;SNRPA1;HSPA8;HSP90AA1;PSMD14;BOLA2;PSMD6;PSMB2;FN1;PSMD5;P4HB;ADAM17;PSMD1;CAPZA1;MSN;PSMA5;SOS1;PSMD11;PSMA4;HNRNPA2B1;PSMA3;IRF2;JAK1;PIK3CB;PSME4;OSMR;RPS6KA4;APPL1;PSMD7;RAP1B;YWHAZ;ENST00000629691.2;PTPN11;STAT1;RPS27A;CRK;PSMC6;PSMA1;BIRC5;STAT5B;IL13RA1;ITGB1;PSMD10;PSMB3;IL4R;VEGFA;MTAP;F3;CTR9;MUC1;PTAFR;ACKR3;PSME1;HIF1A;TNIP2;RIPK2;PSMC3;IL10RB;IFNAR1;SKP1;IL1RN;CRKL;CUL1;PAK2;UBE2N;LAMA5;CANX;PSMA6;SDC1;TRAF3IP2;TIMP1;PSMD13;HMOX1
gsea,regulation of multicellular organismal development (GO:2000026),0.3650455684418643,1.035929094355274,0.44680851063829785,0.7464722823119251,1.0,11/28,36.28%,CDK1;RACGAP1;RAB14;PTN;NIPBL;EHMT1;DHX36;TRIP12;KAT2A;GATA3;MYSM1
gsea,ceramide metabolic process (GO:0006672),0.30649091494154396,1.0356827235989743,0.3829787234042553,0.7457036462882894,1.0,8/55,15.13%,NSMAF;PPP2CA;CERS2;CERS6;PLPP1;SPTLC1;SMPD1;SAMD8
gsea,GPI anchor biosynthetic process (GO:0006506),0.28815208453002417,1.0350406986684402,0.3829787234042553,0.7459506286145295,1.0,4/32,13.05%,DPM2;PIGU;PIGN;PIGH
gsea,regulation of neuron death (GO:1901214),-0.2719533299728815,-1.0339806397223659,0.38,1.0,1.0,16/86,22.57%,REST;EGLN2;DKK1;ENST00000645179.2;WNT5A;AKT1S1;DCC;CDK5;CTSZ;CSF1;UBB;ITGAM;TRAF2;EGLN3;SNCG;SNCA
gsea,negative regulation of protein binding (GO:0032091),0.28968967270913737,1.0337682632443326,0.4489795918367347,0.7479779221702508,1.0,17/74,24.83%,AURKB;BAG2;HFE;CSNK1E;PPP1CA;PARK7;RALB;ROCK1;STYX;GNL3L;AURKA;MAP2;GSK3B;CTNNBIP1;MAPK8;NES;DDX11
gsea,negative regulation of cytoskeleton organization (GO:0051494),0.31274379001699115,1.0326866241783097,0.37777777777777777,0.7492742093565145,1.0,9/30,29.01%,TWF1;PFN2;PFN1;SSH1;SSH3;CLASP1;LIMA1;PIK3CA;ARFGEF1
gsea,steroid biosynthetic process (GO:0006694),0.3909570923609068,1.0324103502643533,0.375,0.7488347851023578,1.0,10/65,19.24%,INSIG1;LBR;AMACR;OSBPL3;CYP51A1;OSBPL2;SQLE;MSMO1;DHCR7;SC5D
gsea,regulated exocytosis (GO:0045055),-0.2651806692067844,-1.031833852667106,0.36538461538461536,1.0,1.0,21/180,20.13%,GAS6;TMSB4X;MYH9;SERPINF2;CD63;APP;RAB10;CYB5R1;MAGED2;PSAP;TEX264;THBS1;LGALS3BP;APLP2;CDK5;QSOX1;PDGFB;VAMP2;WDR1;LAMP2;RAB11B
gsea,sodium ion transmembrane transport (GO:0035725),-0.3576772594387315,-1.0317747744726882,0.46296296296296297,1.0,1.0,3/87,5.33%,TRPM4;SCNN1A;SLC9A3
gsea,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.3775485808781913,1.0317163468232162,0.45098039215686275,0.7491845598655965,1.0,11/22,34.02%,EXOSC8;UTP20;RPP40;EXOSC10;WDR12;ERI3;RRS1;NOL9;URB1;EXOSC9;EXOSC2
gsea,regulation of protein ubiquitination (GO:0031396),0.22898941261096156,1.0313612327402404,0.41304347826086957,0.7487248423613801,1.0,25/109,27.54%,FANCI;BRCA1;BAG2;HSP90AA1;HUWE1;PARK7;BCL10;FKBP1A;HDAC3;STUB1;CRY1;PAXIP1;NDFIP2;UFL1;UBQLN1;HSP90AB1;PSMD10;GNL3L;RIPK2;SH3RF2;DNAJA1;UBE2N;TNFAIP3;LAPTM5;WFS1
gsea,regulation of protein serine/threonine kinase activity (GO:0071900),0.2950938696751197,1.0299341345197142,0.40816326530612246,0.7512549531372121,1.0,20/111,16.90%,CDC6;CDC25A;CDKN3;ETAA1;HMGA2;CCNF;INCENP;CCND3;MAP2K1;CCNB2;HTT;PKMYT1;PPP2CA;EZH2;CDC25C;GTF2H1;RALB;CCNB1;RHOA;RB1
gsea,apical junction assembly (GO:0043297),-0.31223197735615527,-1.0283983664597085,0.3333333333333333,1.0,1.0,12/60,18.90%,RAB13;PATJ;MICALL2;CRB3;MARVELD3;CLDN4;CLDN7;CLDN23;AFDN;GRHL2;DLG1;WDR1
gsea,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.2830707935553589,-1.0266474672254327,0.44680851063829785,1.0,1.0,23/134,33.32%,GAS6;TNK2;UNC119;CD74;GPRC5B;PTK2B;PDGFB;CTF1;IL23A;IL6;NEDD9;DGKQ;EFNA1;CLCF1;IL18;PTK6;TP53;ERBB3;PTPN1;ARHGEF2;PTPRJ;CD40;NRP1
gsea,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.2997828374428367,-1.026155681595483,0.42592592592592593,1.0,1.0,16/67,23.37%,MVB12A;MVP;ARAP1;IFI6;RNF126;EGFR;HIP1R;SHKBP1;RHBDF1;SH3KBP1;DAB2IP;DUSP3;HGS;PTPN12;BCAR3;GRB2
gsea,sensory perception of light stimulus (GO:0050953),-0.30300195548774633,-1.0259767759521836,0.42105263157894735,1.0,1.0,5/95,13.13%,UNC119;DHRS3;RDH10;COL18A1;SLC24A1
gsea,positive regulation of insulin secretion (GO:0032024),-0.36537399772361984,-1.0255471302372052,0.4883720930232558,1.0,1.0,4/38,9.49%,SOX4;TRPM4;STX4;IRS2
gsea,regulation of type I interferon production (GO:0032479),0.2528220904018295,1.025527502903581,0.39215686274509803,0.7606370087229246,1.0,21/89,30.06%,DHX9;PRKDC;GAPDH;XRCC5;CYLD;DTX4;LRRFIP1;TBK1;POLA1;PQBP1;POLR2K;POLR3F;RNF26;TAX1BP1;POLR2L;G3BP1;TNFAIP3;DHX36;POLR3E;POLR2E;CRCP
gsea,response to hydrogen peroxide (GO:0042542),0.28206449248992643,1.025516680094516,0.43137254901960786,0.7594436767485852,1.0,12/49,27.07%,NET1;STK26;SETX;PARK7;ADAM9;STK24;FXN;PRDX3;NFE2L2;ECT2;HMOX1;TNFAIP3
gsea,negative regulation of stress-activated MAPK cascade (GO:0032873),0.3010602185987547,1.0253565367526403,0.5,0.7586014863189534,1.0,4/37,4.78%,FOXM1;CYLD;AIDA;TAOK3
gsea,positive regulation of ATPase activity (GO:0032781),0.3285265127216532,1.0247385249843015,0.42857142857142855,0.7591491059517278,1.0,11/42,23.99%,DHX9;DNAJC9;MSH2;ATP1B3;PFN2;HNRNPU;PFN1;ATP1B1;PLSCR1;TOR1AIP1;DNAJB11
gsea,lipid transport (GO:0006869),0.3152268771285278,1.0243677141387697,0.40425531914893614,0.7589808836111827,1.0,9/109,14.43%,GOT2;ABCC2;ABCD3;PITPNB;FABP5;PEX19;OSBPL2;LDLR;PRELID1
gsea,cellular response to amyloid-beta (GO:1904646),-0.33985512441099025,-1.0239224587708433,0.46808510638297873,1.0,1.0,8/35,31.70%,APP;CDK5;ABCC1;ICAM1;LRP1;IGF1R;PSEN1;TLR6
gsea,response to amyloid-beta (GO:1904645),-0.33985512441099025,-1.0239224587708433,0.46808510638297873,1.0,1.0,8/44,31.70%,APP;CDK5;ABCC1;ICAM1;LRP1;IGF1R;PSEN1;TLR6
gsea,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.23875652262294625,-1.0227660288172005,0.3333333333333333,1.0,1.0,29/171,11.15%,RPL37;EXOSC5;RPL28;RPS13;RPL37A;RPL10A;RPS18;ENST00000643983.1;RPL11;SAMD4B;RPL13;RPL39;RPS29;RPL13A;RPS2;RPL29;RPS21;RPL9;ZFP36;RPL27A;RPS12;RPLP2;RPLP1;RPL8;RPL31;RPL34;CNOT8;RPL27;ZFP36L1
gsea,second-messenger-mediated signaling (GO:0019932),0.3118027848263051,1.022702173802202,0.40816326530612246,0.7612761730521213,1.0,9/89,27.69%,PPP2CA;DDAH2;DDAH1;NUDT4;MCU;ACKR3;PDPK1;CAMKK2;INPP5A
gsea,negative regulation of neuron death (GO:1901215),-0.25401957725261687,-1.0220741193298064,0.4423076923076923,1.0,1.0,16/98,22.57%,REST;ENST00000645179.2;FOXQ1;CLN3;GRN;NTF4;MDK;PTK2B;CDK5;CSF1;PINK1;RASA1;TRAF2;PRKCG;CLCF1;SNCA
gsea,positive regulation of protein polymerization (GO:0032273),0.2735691432036975,1.02149275408647,0.42857142857142855,0.7625935001249594,1.0,11/69,20.30%,HSP90AA1;NCKAP1;PFN2;MAPRE1;SNX9;CARMIL1;BAIAP2;PFN1;CDK5RAP2;DRG1;FCHSD2
gsea,cellular modified amino acid biosynthetic process (GO:0042398),0.4031831250066038,1.0205238884872592,0.3953488372093023,0.7634974611897468,1.0,5/20,9.38%,GCLM;PLOD2;CHAC2;FPGS;PTDSS1
gsea,vascular transport (GO:0010232),0.3136831914462309,1.020221000953025,0.4473684210526316,0.7630869030095073,1.0,12/84,33.78%,ABCC2;SLC7A5;SLC44A1;TFRC;SLC1A5;ENST00000630362.2;SLC7A1;SLC6A6;SLC2A1;SLCO3A1;ABCC4;SLC27A4
gsea,TOR signaling (GO:0031929),0.29048799811740983,1.018617884938496,0.43902439024390244,0.7655759223411435,1.0,10/26,37.75%,TIPRL;LARP1;MTOR;RPS6KB2;RPTOR;SYAP1;RICTOR;RPS6KB1;GATA3;SMG1
gsea,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.28232286099377446,1.0181957336925573,0.42,0.7655706481264968,1.0,9/33,16.71%,EXOSC8;LSM3;PATL1;LSM5;HBS1L;DIS3;TTC37;CNOT7;LSM1
gsea,hexose metabolic process (GO:0019318),0.3649781855738954,1.0173812437810514,0.4772727272727273,0.7658008042091455,1.0,14/41,44.48%,FUCA2;ALDOA;PGM1;SORD;ADPGK;PPARD;CHST15;FBP1;FUCA1;GALM;SLC35A2;GALK2;HK1;DCXR
gsea,regulation of protein kinase B signaling (GO:0051896),-0.24639150694844345,-1.0173252136850102,0.4318181818181818,1.0,1.0,24/207,19.12%,GAS6;CIB1;PHLDA3;PIK3CD;RNF41;NOP53;PPP2R5B;EGFR;FAM110C;ERBB2;MYDGF;GDF15;RRAS;IRS2;INPP5K;THBS1;FLCN;ARRB2;DAG1;PDGFB;AKT2;P2RX4;HYAL2;PINK1
gsea,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.3148438454571289,-1.016054017358987,0.40384615384615385,1.0,1.0,11/106,12.25%,PTPN6;PIK3CD;MAPK3;NOP53;PPP2R5B;EGFR;MYDGF;PIK3IP1;PLXNB1;IRS2;PDGFC
gsea,homotypic cell-cell adhesion (GO:0034109),0.28686106872647543,1.0151595323235036,0.5,0.7698977822418407,1.0,8/44,20.38%,FN1;PIK3CB;FIBP;UBASH3B;VCL;GNAS;DSC2;METAP1
gsea,positive regulation of protein dephosphorylation (GO:0035307),0.3253446950855908,1.015053988758363,0.44,0.7690537265915705,1.0,6/34,16.49%,CDCA2;PPP1R7;PPP2R5A;SMPD1;PTBP1;HSP90AB1
gsea,cellular glucose homeostasis (GO:0001678),0.3241110427479193,1.0142278041704629,0.44,0.7699376752089085,1.0,7/43,20.97%,LRRC8D;NUCKS1;HKDC1;SLC39A14;PRKAA1;XBP1;HIF1A
gsea,metal ion transport (GO:0030001),0.3198889261142034,1.0131744606244921,0.5,0.7710102688853768,1.0,10/88,27.53%,SLC3A2;NIPA2;SLC39A8;MMGT1;NDFIP2;TPT1;TRPM7;SLC30A9;SLC30A5;ATP2C1
gsea,regulation of protein localization to plasma membrane (GO:1903076),-0.27937976560839034,-1.0130903315617268,0.44,1.0,1.0,13/80,18.12%,MMP14;VAMP8;CIB1;STX4;LGALS3;EGFR;CLN3;NUMB;CDK5;ZDHHC7;ARHGEF16;DLG1;ZDHHC5
gsea,organelle disassembly (GO:1903008),-0.2995913701554732,-1.0130038124517855,0.4406779661016949,1.0,1.0,6/34,7.29%,KIF9;DDRGK1;UBA5;GOLGA2;ATG2A;TEX264
gsea,sterol metabolic process (GO:0016125),0.32147194757163644,1.0126875574240641,0.4230769230769231,0.7706992857779585,1.0,11/70,23.76%,INSIG1;LBR;CYP51A1;SOAT1;FDX2;SQLE;MSMO1;DHCR7;SC5D;SULT2B1;PPARD
gsea,respiratory chain complex IV assembly (GO:0008535),-0.38163498005894186,-1.0125792840781835,0.5135135135135135,1.0,1.0,6/23,8.84%,PET117;SURF1;PET100;COX14;COA5;COA3
gsea,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.2857964012215449,-1.0122602973366421,0.4423076923076923,1.0,1.0,15/62,24.51%,TRADD;RELB;TICAM1;TAB1;NKIRAS2;TAB2;UBB;UBC;BCL3;RIPK1;DAB2IP;RBCK1;TRAF2;NFKBIA;TAB3
gsea,cellular response to lipopolysaccharide (GO:0071222),-0.2674184847847783,-1.0116428914415947,0.4186046511627907,1.0,1.0,18/120,25.57%,NR1H3;TICAM1;CACTIN;PYCARD;ZFP36;PABPN1;PAF1;WNT5A;MAPK14;GIT1;UPF1;IL6;DAB2IP;SELENOS;CDC73;GSTP1;IL18;SIRPA
gsea,positive regulation of biosynthetic process (GO:0009891),-0.31533026070908404,-1.0115752469891783,0.5813953488372093,1.0,1.0,3/44,5.58%,LARP6;SERPINF2;SCX
gsea,Ras protein signal transduction (GO:0007265),0.23357325921374036,1.0109467773631988,0.4166666666666667,0.7735694566957431,1.0,30/142,26.37%,CDK2;ARHGAP5;NCKAP1;HACD3;MAPKAPK5;ARHGAP29;GPSM2;ROCK2;SOS1;PARK7;USP8;RAP1B;SGSM3;RALB;RHOA;RB1;ROCK1;RAP2A;NRAS;FARP2;BRAP;SHOC2;KRAS;RASGRP1;CRKL;CYFIP1;CTNNAL1;RAP1A;G3BP1;SHTN1
gsea,epithelial to mesenchymal transition (GO:0001837),0.28753383038821706,1.0108529492695073,0.4583333333333333,0.7724722350895789,1.0,10/47,22.91%,HMGA2;TASOR;ROCK2;DDX5;ROCK1;ENG;NOTCH1;HIF1A;RBPJ;GSK3B
gsea,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.24221037260361444,-1.0107754539612368,0.4716981132075472,1.0,1.0,16/100,18.73%,CDKN2B;BAMBI;FAM89B;MEN1;SKIL;SMAD7;LTBP4;THBS1;FLCN;ZBTB7A;GIPC1;UBB;UBC;BCL9L;SMAD4;BCL9
gsea,regulation of cellular component organization (GO:0051128),0.251077396104607,1.010319411391303,0.4716981132075472,0.7728156276956661,1.0,22/139,17.65%,MKI67;NET1;CAMSAP3;URI1;HSPA8;HSP90AA1;TMEM97;TFRC;SETD5;ROCK2;SSRP1;PARK7;HJURP;RAP1B;CAMSAP2;NCLN;PTPN11;HNRNPU;KIF14;DCUN1D5;CHPT1;ROCK1
gsea,regulation of Rho protein signal transduction (GO:0035023),-0.2703120416720343,-1.0101700998376255,0.47058823529411764,1.0,1.0,12/73,24.07%,CUL3;EPS8L2;EPS8L1;FLCN;TNFAIP1;KCTD13;ARHGEF18;ARRB1;HEG1;MYO9B;ADGRG1;ARHGAP35
gsea,peptidyl-lysine trimethylation (GO:0018023),0.38862617078957273,1.00964620207072,0.5,0.7733267765142796,1.0,7/30,28.95%,SUV39H2;SETD5;SMYD5;SUV39H1;CTR9;ATPSCKMT;SETD2
gsea,protein deacylation (GO:0035601),-0.30048152412051293,-1.0093685950673503,0.47058823529411764,1.0,1.0,3/23,5.25%,LYPLA2;ABHD17A;HDAC5
gsea,negative regulation of signal transduction (GO:0009968),-0.2318523799150248,-1.008775999107572,0.44680851063829785,1.0,1.0,57/267,31.18%,MMP14;DKK1;NR0B1;TAX1BP3;CACTIN;PALM3;EGFR;FSTL3;PTCH1;ERBB2;CADM4;GDF15;GLIS2;HIF1AN;INPP5K;THBS1;DCC;EPN2;RITA1;MGRN1;NXN;EGFL7;ZBTB7A;MEGF8;ARRB1;SIGIRR;PRKCZ;TCIM;SIAH1;ENST00000613180.2;DAB2IP;HGS;PTPN12;GRB10;GPR108;SNCA;TSC2;NCK1;TMEM25;GPS2;SLC2A10;TSKU;CSNK2A2;MTMR2;IRS1;SNAI2;NTN1;PTK6;ASXL1;NOG;ULK3;TLE1;LRP1;PDCD6;ERBB3;PTPN1;PTPRJ
gsea,chloride transport (GO:0006821),0.36523756803845037,1.0085405869453186,0.4634146341463415,0.7754797995429621,1.0,4/76,12.60%,CLCN3;ANO6;ANO1;SLC26A1
gsea,negative regulation of oxidative stress-induced cell death (GO:1903202),0.327464745970391,1.0082732962821348,0.4583333333333333,0.7750175305290243,1.0,8/28,31.90%,PDE8A;PARK7;NFE2L2;FBXO7;TXN;PYCR1;PPIA;SOD2
gsea,chemical homeostasis (GO:0048878),-0.33352993964663036,-1.0079573975723863,0.49019607843137253,1.0,1.0,10/65,22.88%,NR1H3;ABHD5;PNPLA2;USF1;IRS2;ZBTB20;ABHD4;ABHD8;SLC4A2;USF2
gsea,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.28378126267676723,-1.0073025327819596,0.46296296296296297,1.0,1.0,7/64,7.01%,LTBR;TRADD;STX4;LGALS3;TNFRSF12A;PYCARD;CFLAR
gsea,regulation of microtubule polymerization (GO:0031113),0.32890088934650186,1.0069600731811081,0.4444444444444444,0.7765731612767003,1.0,12/40,37.81%,CAMSAP3;MAPRE1;CAMSAP2;CDK5RAP2;DRG1;MAP2;CLASP1;ABL1;OCLN;TBCD;RAC1;RPS3
gsea,positive regulation of Ras protein signal transduction (GO:0046579),0.32013644835191457,1.0064093815874267,0.43478260869565216,0.7767817541201741,1.0,10/63,23.69%,NET1;LRRC59;PIK3CB;ALS2;NOTCH1;F2RL1;MAPRE2;SHOC2;RASGRP1;CRKL
gsea,regulation of epithelial cell migration (GO:0010632),0.30927164179112404,1.0062173433084045,0.44680851063829785,0.7759008097165992,1.0,11/51,26.70%,CORO1C;PFN2;DOCK5;PFN1;HIF1A;RAB11A;RTN4;PTN;EMP2;ADIPOR1;CLASP1
gsea,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.3040702425830448,1.0061930736986975,0.40816326530612246,0.7747716741845603,1.0,2/32,2.85%,BRCA1;CNOT9
gsea,skeletal system development (GO:0001501),-0.29320537426159565,-1.005424333893065,0.4489795918367347,1.0,1.0,7/158,10.20%,SOX4;DDRGK1;MMP14;RPL13;WNT5A;INHA;SH3PXD2B
gsea,protein peptidyl-prolyl isomerization (GO:0000413),0.37356060236485034,1.0052739999668028,0.46,0.7755248478884774,1.0,10/27,38.44%,PPWD1;FKBP1A;CWC27;PPIH;PPIL1;PPIA;PPIG;FKBP4;NKTR;PPIL3
gsea,positive regulation of endothelial cell migration (GO:0010595),-0.260928968422854,-1.0049922178354325,0.45454545454545453,1.0,1.0,15/86,17.83%,AAMP;TMSB4X;PIK3CD;WNT5A;GRN;BCAR1;RRAS;RHOB;EMC10;THBS1;PTK2B;MAPK14;PDGFB;SASH1;P2RX4
gsea,regulation of p38MAPK cascade (GO:1900744),-0.36158991539221064,-1.004765729585812,0.46,1.0,1.0,9/37,20.26%,GADD45A;MINK1;DUSP1;EMC10;GADD45B;LGALS9;SASH1;DLG1;DAB2IP
gsea,regulation of viral entry into host cell (GO:0046596),-0.3456812582287562,-1.0038699715157788,0.3953488372093023,1.0,1.0,5/39,15.91%,GSN;TRIM11;CD74;IFITM1;LGALS9
gsea,negative regulation of peptidase activity (GO:0010466),-0.318017062927194,-1.0038224785426695,0.42857142857142855,1.0,1.0,4/63,5.74%,SERPINF2;SERPINB6;UBXN1;SPOCK2
gsea,inflammatory response (GO:0006954),-0.3006196763534916,-1.0032237925900926,0.4339622641509434,1.0,1.0,25/230,32.32%,TUSC2;PRDX5;RELB;PIK3CD;MAPKAPK2;HDAC5;NFATC3;HNRNPA0;THBS1;CEBPB;LGALS9;KRT16;IL6;ADM;TAC4;TPST1;ABCF1;IL18;ADAM8;NFX1;HDAC4;MGLL;TLR6;F11R;CD40
gsea,vacuolar acidification (GO:0007035),-0.31782245013202737,-1.0030223746645204,0.5098039215686274,1.0,1.0,3/21,8.16%,CLN3;GRN;TMEM199
gsea,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.33478587792699555,1.0021767563701218,0.46511627906976744,0.7816534907983554,1.0,8/26,37.81%,MAPRE1;KATNB1;CDK5RAP2;DRG1;CLASP1;OCLN;RAC1;RPS3
gsea,cellular response to molecule of bacterial origin (GO:0071219),-0.27634602480853676,-1.0020964233601906,0.5,1.0,1.0,16/115,23.71%,NR1H3;TICAM1;CACTIN;PYCARD;ZFP36;PABPN1;PAF1;WNT5A;MAPK14;GIT1;UPF1;IL6;DAB2IP;SELENOS;CDC73;GSTP1
gsea,receptor-mediated endocytosis (GO:0006898),0.2606105211721056,1.001989602607641,0.4666666666666667,0.7809369830663824,1.0,27/143,31.69%,HSP90B1;HSP90AA1;RABEPK;SCGB3A2;TFRC;SNX9;DNM2;LDLR;DNAJC13;SNX1;FCHO2;ITGB1;GPR107;FCHSD2;AP1G1;ACKR3;DNM1;AP2B1;HSPH1;CANX;M6PR;SCARB2;IGF2R;EPS15;CD9;NEDD4;LMBR1L
gsea,cellular amino acid catabolic process (GO:0009063),0.3200690999877873,1.0012408556797345,0.45098039215686275,0.7817604162224401,1.0,20/90,35.00%,GOT2;BLMH;GCSH;GLS;SHMT1;DDAH1;GOT1;QDPR;BCAT1;DLD;ACAT1;MCCC2;HSD17B10;SLC25A44;CARNMT1;OGDH;IVD;GLUL;FAH;GLUD1
gsea,regulation of cell cycle G1/S phase transition (GO:1902806),-0.2875728758036597,-1.0006784791796108,0.46808510638297873,1.0,1.0,6/36,13.62%,DDRGK1;PTPN6;PAGR1;PAF1;FAM83D;SUSD2
gsea,proton transmembrane transport (GO:1902600),0.4313367042709191,0.9987071594278429,0.4666666666666667,0.7864821075759642,1.0,6/37,21.97%,COX15;NNT;ATP6V0E2;ATP1A1;ATP6V0E1;ATP5PO
gsea,positive regulation of ERBB signaling pathway (GO:1901186),0.32640307782840483,0.9985422025159315,0.4339622641509434,0.7856579361339243,1.0,2/25,2.85%,NUP62;CNOT9
gsea,response to insulin (GO:0032868),0.27558579268021544,0.9967716225525484,0.4489795918367347,0.7884562678537541,1.0,8/84,9.07%,PRKDC;LPIN1;INSIG1;PRKCI;PARP1;RAB8A;SLC39A14;TBC1D4
gsea,organelle organization (GO:0006996),0.21602408625553415,0.996636892801687,0.4883720930232558,0.7876109476860995,1.0,66/420,23.17%,KIF4A;CEP55;MNS1;CDCA8;LNPK;PI4K2B;NSFL1C;CHMP2B;TMED5;GORASP2;PRKCI;PARP1;ABCD3;HPS3;PITPNB;DIAPH3;MICAL3;USP6NL;HUWE1;DNM1L;HTT;ZMYM3;GOLGA8A;SH3D19;PARK7;PEX19;OPA1;GABPA;RAB14;TMED2;WASL;LMAN1;DIAPH1;VPS4B;MTFR1;GBF1;PALLD;PDCD6IP;BNIP1;BLZF1;SAR1B;STOML2;TFAM;COG2;MAST2;ZW10;MTERF1;ZMYM4;DPYSL2;CHMP4C;ATL2;LYSMD3;DST;COG1;STX17;GOLPH3;GABPB1;PRDX3;PHIP;TANGO2;ARL1;SEC16A;RANBP9;CYCS;GOLGA8B;RAB7A
gsea,protein destabilization (GO:0031648),0.29996640534050795,0.9964350643558775,0.4642857142857143,0.7867681890947107,1.0,3/34,7.62%,PLK1;ISOC2;HTT
gsea,positive regulation of protein catabolic process (GO:0045732),0.25267531926889836,0.9964169255004063,0.45098039215686275,0.7855779195196809,1.0,21/85,31.37%,DTL;NRDC;HSP90AA1;IDE;HUWE1;MSN;SH3D19;SNX9;VPS35;ADAM9;VCP;FAF1;GSK3B;RAB7A;TNFAIP3;DDB1;ATG7;NEDD4L;SMURF2;NEDD4;NSF
gsea,ribosome assembly (GO:0042255),0.30620353783566034,0.9962993978199821,0.5,0.784658535209566,1.0,20/50,32.56%,BRIX1;DHX29;NPM1;NOP2;C1QBP;ERAL1;EFL1;RPS27;MTERF3;MRPS11;RPL6;RPSA;RRS1;SBDS;RPL3;RPS15;MDN1;MPV17L2;EIF2A;RPF2
gsea,inner mitochondrial membrane organization (GO:0007007),-0.30495664019899993,-0.9945995169701173,0.4634146341463415,1.0,1.0,13/49,15.65%,NDUFA13;ATP5MF;ATP5MC2;MTX1;ATP5F1E;TIMM10;ATP5ME;TIMM29;SPG7;TIMM8B;ATP5PB;ROMO1;TIMM9
gsea,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.257089588813346,0.9942811807569832,0.44680851063829785,0.7887306420242235,1.0,29/165,26.69%,PSMD14;CYLD;PSMD6;PSMB2;PSMD5;ENST00000634826.1;PSMD1;STK4;PSMA5;PSMD11;PSMA4;PSMA3;PSME4;PSMD7;ENST00000629691.2;CTNND1;PSMC6;PSMA1;STK3;PSMD10;PSMB3;SFRP1;PSME1;PSMC3;GSK3B;PSMA6;PSMD13;EMD;SDHAF2
gsea,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.2932668473631808,0.9928144923809278,0.4523809523809524,0.7905151183977309,1.0,11/34,25.67%,E2F1;YWHAE;YWHAH;PPP3R1;YWHAZ;YWHAB;BID;GSK3B;MAPK8;YWHAQ;SFN
gsea,regulation of peptidyl-serine phosphorylation (GO:0033135),0.24611306293761329,0.9927318460637353,0.48,0.7894696495723283,1.0,17/98,27.70%,CNOT9;HSP90AA1;NSD1;TFRC;DOCK7;PFN2;STK4;PARK7;TBK1;HSP90AB1;VEGFA;RIPK2;TERF2IP;TXN;RAF1;EIF4G1;RPTOR
gsea,regulation of tumor necrosis factor production (GO:0032680),-0.32645832921132045,-0.9918376306596441,0.4489795918367347,1.0,1.0,19/124,23.91%,GAS6;PTPN6;APP;MAPKAPK2;CACTIN;PYCARD;ZFP36;WNT5A;VSIR;THBS1;ENST00000615721.3;LGALS9;IL23A;IL6;RIPK1;SELENOS;MAVS;GSTP1;FADD
gsea,negative regulation of mitochondrion organization (GO:0010823),0.36731715657975894,0.9915641288976164,0.48,0.7910024108201115,1.0,8/34,20.95%,SLC25A5;TFRC;HUWE1;OPA1;PRELID1;PSMD10;FXN;GHITM
gsea,mitochondrial translation (GO:0032543),0.2686117856996106,0.9911029430892224,0.47058823529411764,0.7911021150700746,1.0,27/105,24.05%,MRPS6;MRPL1;MRPL42;MRPL11;MRPL50;MRPS30;GFM1;GATC;MRPL3;MRPS10;MRPL35;MRPS16;MRPS35;IARS2;LARS2;ERAL1;MRPL47;MRPL10;MTIF2;MRPS11;MRPL37;MRPL16;MRPS9;EARS2;MRPL58;MTIF3;MRPS18A
gsea,platelet degranulation (GO:0002576),-0.26362684441092543,-0.9907344626619466,0.42857142857142855,1.0,1.0,14/125,16.18%,GAS6;TMSB4X;SERPINF2;CD63;APP;CYB5R1;MAGED2;PSAP;TEX264;THBS1;LGALS3BP;APLP2;QSOX1;PDGFB
gsea,response to calcium ion (GO:0051592),0.2844134274888618,0.9905708473213726,0.475,0.791201520804319,1.0,21/107,37.54%,IQGAP1;SLC25A24;CPNE7;ADAM9;SMPD1;LGMN;PRKAA1;ECT2;SLC25A13;SLC25A12;AHCYL1;CLIC4;DMTN;NEDD4;CPNE3;ITPR3;SYT15;ALG2;CALM1;CALM2;SEC31A
gsea,actin filament organization (GO:0007015),-0.23571029938782856,-0.9895405385370762,0.45,1.0,1.0,27/152,22.15%,MARCKSL1;GSN;ELMO3;PPP1R9B;TPM1;MARCKS;HIP1R;BCAR1;ENST00000640412.1;DSTN;DBN1;RND1;ABI1;RHOB;INPPL1;CDC42EP2;BAIAP2L2;MYO1C;CORO1B;DLG1;NEDD9;ELMO2;VILL;SVIL;SH3BP1;SPIRE2;BIN3
gsea,cell-substrate junction assembly (GO:0007044),0.37706698683300055,0.9892193627157253,0.5384615384615384,0.7935589887027277,1.0,8/34,19.82%,FN1;FERMT2;PIP5K1A;LAMC1;ITGA6;ENST00000618924.4;DST;ITGB4
gsea,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.33490266908347094,-0.9883868525964886,0.5306122448979592,1.0,1.0,8/30,25.04%,TRADD;DEDD;BAX;GABARAP;DAB2IP;TNFRSF10B;FADD;DEDD2
gsea,regulation of glucose metabolic process (GO:0010906),-0.3389150845570362,-0.9881775163529116,0.46296296296296297,1.0,1.0,10/34,31.63%,IRS2;USP7;AKT2;DGKQ;SELENOS;FOXK1;IRS1;SIRT7;SLC45A3;PMAIP1
gsea,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.33883970966237703,-0.9862399287402772,0.4074074074074074,1.0,1.0,7/31,19.12%,UBL5;TOMM7;ARIH2;MICALL2;ATG13;BAP1;PINK1
gsea,regulation of protein secretion (GO:0050708),0.270988112501773,0.9854301313405003,0.45454545454545453,0.8010491683013922,1.0,25/125,41.39%,DNM1L;HADH;DNAJC1;CYP51A1;ADAM9;CD2AP;P3H1;EIPR1;GOLPH3;ENSA;SERGEF;RAP1A;SLC2A1;RHBDF2;PPIA;EXOC1;ARFIP1;ITPR3;GOLPH3L;KCNS3;TMED10;HMGCR;SLC8B1;PRKCA;PPP3CB
gsea,protein localization to plasma membrane (GO:0072659),-0.2500047319023264,-0.9852641721524557,0.5,1.0,1.0,19/136,15.15%,RAPGEF2;GAS6;TSPAN17;RAB13;TTC7A;RAB10;RAB40C;PTCH1;SLC9A3R2;JUP;GORASP1;CRB3;INPP5K;PLEKHF1;PDZK1;CACNB3;RAB34;MAP7;AFDN
gsea,actin filament polymerization (GO:0030041),-0.34942837032007684,-0.9851742827295542,0.5576923076923077,1.0,1.0,3/29,6.96%,GSN;MSRB2;MICALL2
gsea,negative regulation of apoptotic signaling pathway (GO:2001234),0.2599212461967041,0.9844475741546308,0.4074074074074074,0.8021069823565232,1.0,13/78,21.82%,SLC25A5;URI1;HTT;PARK7;OPA1;PRELID1;RB1;PSMD10;ITGA6;BMP4;FXN;GHITM;PHIP
gsea,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.27193109374890445,-0.9840441652171703,0.5365853658536586,1.0,1.0,18/81,23.91%,TRADD;BBC3;BEX3;PYCARD;PDCD2;CFLAR;HIP1R;BAX;BOK;BAD;SENP1;HSPE1;RIPK1;TRAF2;TNFRSF10B;EGLN3;SNCA;FADD
gsea,proteolysis (GO:0006508),-0.2503428561516367,-0.9839032540067945,0.5,1.0,1.0,24/287,11.03%,CASP6;APH1A;MMP14;CPZ;DPP7;CTSF;BACE2;RNF123;SVBP;PRSS22;CLN3;PRSS16;MMP15;ATG4B;CUL7;PTCH1;CAPN1;XPNPEP3;GGT1;VHL;PSMB5;SPPL3;SPG7;PROC
gsea,chromatin remodeling (GO:0006338),0.241986164770654,0.9835576039619619,0.4444444444444444,0.802898336390324,1.0,17/103,19.49%,BAZ1B;SMARCA5;SUV39H2;DR1;HMGA2;NPM1;FOXA1;CHRAC1;BPTF;HNRNPC;MBD2;CHD1L;TOP1;RB1;NUDT5;HDAC2;INO80
gsea,diterpenoid metabolic process (GO:0016101),-0.3676263324688014,-0.9833205862386195,0.5535714285714286,1.0,1.0,6/64,22.26%,DHRS3;RDH10;AGRN;AKR1B1;SDC4;ALDH3A2
gsea,COPII-coated vesicle budding (GO:0090114),-0.29817047687891374,-0.9812504273987026,0.5,1.0,1.0,13/70,16.45%,TRAPPC6A;GOLGA2;CUL3;SEC24C;RAB1A;KLHL12;CD59;TRAPPC2L;GORASP1;SCFD1;CSNK1D;CTSZ;RAB1B
gsea,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.3002645409303719,-0.9810602666672925,0.4827586206896552,1.0,1.0,8/24,23.83%,CDKN2B;MEN1;THBS1;FLCN;GIPC1;SMAD4;CITED2;SLC2A10
gsea,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.3002645409303719,-0.9810602666672925,0.4827586206896552,1.0,1.0,8/24,23.83%,CDKN2B;MEN1;THBS1;FLCN;GIPC1;SMAD4;CITED2;SLC2A10
gsea,import into cell (GO:0098657),0.337277554820719,0.9795808652964463,0.5476190476190477,0.8106648446637275,1.0,3/41,7.99%,LRRC8D;SLC7A5;SLC39A14
gsea,glycosphingolipid metabolic process (GO:0006687),-0.3437446030879701,-0.9787661817656782,0.5319148936170213,1.0,1.0,9/47,24.45%,PSAP;ST6GALNAC6;SUMF1;ESYT2;CTSA;GLB1;ARSA;ASAH1;HEXA
gsea,ion transport (GO:0006811),0.25512745855540864,0.9781467794610267,0.46808510638297873,0.8129759465927721,1.0,6/116,13.59%,PLP2;ANO6;ANO1;ATP11B;SLC26A1;SLC20A1
gsea,gland development (GO:0048732),-0.266564600740729,-0.977602133820607,0.5333333333333333,1.0,1.0,12/71,30.18%,GFER;NR0B1;ZBTB1;MDK;PRKCSH;CITED2;FADD;ARHGAP35;LSR;GLI2;WNT10A;PAX8
gsea,lysosome organization (GO:0007040),-0.3399879933533598,-0.9765494995027967,0.5,1.0,1.0,5/38,9.03%,HPS1;ACP2;CLN3;GRN;VPS18
gsea,protein targeting (GO:0006605),-0.24709793664395116,-0.9762685569076929,0.5098039215686274,1.0,1.0,27/125,19.94%,VPS37C;ZDHHC24;NACA;RPL11;ZDHHC9;TOMM7;FIS1;TAOK2;TIMM10;SPCS2;ZFAND2B;HOMER3;TIMM8B;VPS37B;PEX6;SLC25A6;MYO1C;TIMM9;TOMM22;ZDHHC7;GIPC1;TRAK1;CDC37;TSPO;BCAP31;GABARAP;LAMP2
gsea,negative regulation of translation (GO:0017148),0.24991277656732452,0.9750201031272817,0.5106382978723404,0.8193938057434088,1.0,17/90,20.99%,GAPDH;DHFR;TYMS;CNOT9;EIF2AK4;ROCK2;SHMT1;TPR;LARP1;SYNCRIP;PUS7;CNOT7;ROCK1;EIF2AK2;NCL;CNOT10;EIF3E
gsea,"retrograde transport, endosome to Golgi (GO:0042147)",0.21667759910531545,0.9743224596678881,0.4772727272727273,0.8199938257804439,1.0,16/88,23.17%,GOSR1;VPS50;SPAG9;LMAN1;ANKFY1;VPS35;VPS26A;GBF1;YKT6;SNX1;STX6;HEATR5A;GCC2;TMEM87A;ARL1;RAB7A
gsea,spliceosomal complex assembly (GO:0000245),0.29010649032742536,0.9741244827267613,0.5319148936170213,0.8192249224060292,1.0,6/46,9.48%,SNRPD1;NCBP1;SCAF11;SRSF1;SETX;SF3B1
gsea,protein palmitoylation (GO:0018345),0.28357508344757426,0.9731618418462085,0.5172413793103449,0.8200442521243535,1.0,2/31,2.79%,ZDHHC3;ZDHHC13
gsea,cellular response to hydrogen peroxide (GO:0070301),0.2830097538709624,0.97297165862011,0.5306122448979592,0.8193978149312693,1.0,7/35,22.86%,NET1;SETX;PARK7;SIGMAR1;FXN;NFE2L2;ECT2
gsea,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.26247368621958894,0.9716891808452429,0.4528301886792453,0.8208950402419126,1.0,18/116,18.24%,PSMD14;PSMD6;PSMB2;PSMD5;ADAM17;PSMD1;PSMA5;PSMD11;PSMA4;PSMA3;PSME4;PSMD7;ENST00000629691.2;STAT1;PSMC6;PSMA1;PSMD10;PSMB3
gsea,regulation of ossification (GO:0030278),0.35089357089917517,0.971595497948097,0.5,0.8199094720780491,1.0,8/36,23.46%,TXLNG;PTPN11;CHSY1;BMP4;NOTCH1;SFRP1;RBPJ;PTN
gsea,nucleobase-containing compound catabolic process (GO:0034655),0.344125272308275,0.9715752536123948,0.5227272727272727,0.8187671320579336,1.0,4/41,7.18%,NCBP1;HNRNPD;SUPV3L1;PNPT1
gsea,sensory organ development (GO:0007423),-0.28533522562922753,-0.9701591226984764,0.46,1.0,1.0,9/56,30.18%,PBX2;NTF4;SH3PXD2B;PBX1;SIPA1L3;SALL2;WNT10A;FOXC1;PAX8
gsea,regulation of cellular localization (GO:0060341),0.3576403696067532,0.9701350081338008,0.5609756097560976,0.8211156315951629,1.0,5/49,8.51%,SPAG5;HSP90AA1;GOSR1;PARP1;CSNK1E
gsea,regulation of inflammatory response (GO:0050727),-0.22707773482972685,-0.9680344488197707,0.5,1.0,1.0,28/206,23.85%,TRADD;TMSB4X;NR1H3;APP;WNT5A;GRN;CELF1;GGT1;IFI35;MDK;GPRC5B;PROC;MGST2;ENST00000615721.3;MAPK13;IL23A;PTGS2;IL6;VAMP2;HYAL2;RIPK1;SEMA7A;ABCC1;SELENOS;SNCA;GPS2;NFKBIA;PTGIS
gsea,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.29099587749616285,0.9677712032602043,0.54,0.825188512379973,1.0,3/25,8.05%,TMF1;PSMD14;NUB1
gsea,negative regulation of transferase activity (GO:0051348),-0.2904544014217372,-0.9661248158663817,0.4339622641509434,1.0,1.0,6/29,12.20%,MEN1;ZFP36;IRS2;INPP5K;SMAD7;PHPT1
gsea,actin cytoskeleton reorganization (GO:0031532),-0.23920016989682472,-0.9660672089927739,0.4782608695652174,1.0,1.0,5/63,7.72%,GSN;MYH9;MINK1;MICALL2;BCAR1
gsea,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.25733360877566114,0.9641623158455204,0.52,0.8322499250613996,1.0,7/50,14.77%,PRKDC;P4HB;FERMT2;C1QBP;CARMIL1;DOCK5;CRK
gsea,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.2352475641638417,-0.963963266217552,0.5333333333333333,1.0,1.0,12/108,18.13%,DKK1;BAMBI;FAM89B;SKIL;FSTL3;LEMD2;SMAD7;ZBTB7A;UBB;UBC;BCL9L;SMAD4
gsea,negative regulation of protein polymerization (GO:0032272),0.3389743137497203,0.9638902877479494,0.5957446808510638,0.8317113399734657,1.0,8/27,29.01%,TWF1;PFN2;MAPRE1;PFN1;MAP2;SSH1;SSH3;ARFGEF1
gsea,cellular response to oxidative stress (GO:0034599),0.25365559972909857,0.962841918407127,0.4489795918367347,0.8330763235575459,1.0,35/125,32.13%,GPX8;ZFAND1;PARP1;VRK2;PNPT1;GPX2;SLC25A24;SETX;PRDX1;PARK7;FANCC;EIF2S1;MAPK1;ARNT;ENST00000618924.4;PRKAA1;PYCR2;HIF1A;PRDX3;ERO1A;NFE2L2;CYCS;MAPK8;SRXN1;HMOX1;CAMKK2;SLC4A11;PYCR1;CHUK;PDK2;PPIA;SOD1;NCF2;SOD2;GSR
gsea,cellular zinc ion homeostasis (GO:0006882),0.3681420768335707,0.9613962186973105,0.49056603773584906,0.8338979243846292,1.0,7/28,32.12%,SLC39A14;SLC39A8;MT1A;SLC30A9;SLC30A5;SLC39A10;MT1E
gsea,zinc ion homeostasis (GO:0055069),0.3681420768335707,0.9613962186973105,0.49056603773584906,0.8338979243846292,1.0,7/30,32.12%,SLC39A14;SLC39A8;MT1A;SLC30A9;SLC30A5;SLC39A10;MT1E
gsea,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.24342593009361038,0.9612913412041649,0.5,0.8330839039952728,1.0,18/79,22.91%,PLK1;BAG2;NUB1;CSNK1E;STUB1;PIAS1;HECTD1;ELOB;UBQLN1;RNF14;PSMD10;UBQLN2;VCP;CDC20;COP1;SH3RF2;NFE2L2;GSK3B
gsea,response to lipid (GO:0033993),-0.2595794245392038,-0.960489816062722,0.5238095238095238,1.0,1.0,19/114,24.19%,OVCA2;MAPKAPK2;PALM3;GGT1;RARG;GGT7;HNRNPA0;SRR;TAB2;GATA6;TMEM161A;LGALS9;OTUD5;SLPI;PELI1;SNCA;PAQR7;AQP3;CTSH
gsea,positive regulation of production of molecular mediator of immune response (GO:0002702),0.2906522079415636,0.9601430009995945,0.5217391304347826,0.8342223237312937,1.0,9/38,33.55%,SLC7A5;GPI;F2RL1;XBP1;PHB2;LAPTM5;EPHB2;DNAJB9;VAMP3
gsea,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.28195155022687596,-0.9598223240879509,0.5238095238095238,1.0,1.0,12/136,24.36%,MYH9;GGT1;YES1;LHB;MAPK14;VIPR1;ADCY6;IL6;ADM;SELENOS;P2RY11;ADCY7
gsea,central nervous system development (GO:0007417),-0.21239870497995808,-0.9588534249595859,0.4807692307692308,1.0,1.0,33/268,28.11%,MARCKSL1;SOX4;GSN;RAB3GAP1;JARID2;MARCKS;SOX12;PTCH1;PBX2;GLIS2;NDUFS4;ELP3;PDGFC;CDK5;ZFHX3;MAL;GRHL2;PBX1;RNF103;ITGAM;CTNS;ADGRG1;ALDH3A2;ALDH5A1;GSTP1;LSR;DHX30;THOC6;MAP1S;AMIGO2;C3;JRKL;ROGDI
gsea,defense response to bacterium (GO:0042742),-0.26579989885107624,-0.958339287736832,0.5416666666666666,1.0,1.0,13/176,26.13%,RPL39;RAB1A;PYCARD;WFDC3;CEBPB;ROMO1;IL23A;IL6;LCN2;SLPI;MAVS;DROSHA;GBP2
gsea,glycosaminoglycan biosynthetic process (GO:0006024),-0.26895645792191325,-0.9578718871433157,0.5416666666666666,1.0,1.0,16/97,25.76%,DSE;NDST2;NDST1;AGRN;CHPF;B3GAT3;CHPF2;ST3GAL1;SDC4;B4GALT7;B3GALT6;B4GALT3;EXT1;HEXA;HS6ST1;CHST12
gsea,regulation of endopeptidase activity (GO:0052548),-0.2727621405269255,-0.9575510008549989,0.5660377358490566,1.0,1.0,5/71,7.79%,APH1A;SERPINF2;SERPINB6;SPOCK2;VSIR
gsea,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.2601381631990659,0.9575219722827902,0.52,0.8393109933381263,1.0,9/35,16.71%,EXOSC8;LSM3;PATL1;LSM5;HBS1L;DIS3;TTC37;CNOT7;LSM1
gsea,regulation of glucose import (GO:0046324),0.32059959473279925,0.9571455699618501,0.5,0.8389444281093796,1.0,4/37,13.36%,ARPP19;PRKCI;APPL1;PTPN11
gsea,axon development (GO:0061564),0.3102131788184321,0.9563272253995406,0.6086956521739131,0.839128074016768,1.0,9/79,13.80%,DHFR;RYK;RAB8A;DOCK7;AFG3L2;NRCAM;NEFH;CAMSAP2;BAIAP2
gsea,stress-activated protein kinase signaling cascade (GO:0031098),0.2676981325114516,0.9563018509989788,0.5106382978723404,0.837920695493003,1.0,8/27,23.86%,KAT7;RPS27A;MAP3K20;MAPK1;TNIP2;SKP1;MAPK8;CUL1
gsea,apoptotic process (GO:0006915),0.20517979285976234,0.9551359814286012,0.5,0.839396001119797,1.0,19/231,9.36%,CIT;GAPDH;CHEK1;HSPD1;MCM2;NCKAP1;THOC1;MELK;FAM162A;PARP1;MRPS30;BCLAF1;CASP2;NDUFS1;TRAIP;PPP2CA;STK4;ESPL1;BNIP2
gsea,cellular response to insulin stimulus (GO:0032869),0.22614178544089883,0.9543449118388344,0.5609756097560976,0.8400468867920946,1.0,23/129,22.91%,PRKDC;LPIN1;INSIG1;PRKCI;PARP1;RAB8A;IDE;SLC39A14;SOS1;TBC1D4;APPL1;GOT1;BAIAP2;ATP6V1C1;ATP6V0E2;XBP1;PIK3C2A;PKM;PTPN2;PDPK1;ATP6V0E1;PHIP;GSK3B
gsea,response to endoplasmic reticulum stress (GO:0034976),-0.23721837211985683,-0.9519535631826592,0.5185185185185185,1.0,1.0,24/110,23.16%,OS9;DDRGK1;UBXN6;USP19;UBA5;PPP1R15A;BBC3;ATP2A2;BAX;ATF6B;TMEM259;THBS1;CEBPB;BAK1;RNF5;BCAP31;ATF3;DAB2IP;DDIT3;TRAF2;SELENOS;TNFRSF10B;RASGRF1;NCK1
gsea,protein autoubiquitination (GO:0051865),0.25170718452149404,0.9498101483624886,0.6,0.8493150295421287,1.0,7/65,12.79%,BRCA1;UBE2A;RNF4;UBE2T;RNF8;DDB2;STUB1
gsea,regulation of cilium assembly (GO:1902017),-0.25740221129111135,-0.9494521489078263,0.574468085106383,1.0,1.0,15/64,24.78%,MARK4;TESK1;TBC1D22A;TBC1D16;TBC1D2;TBC1D1;IFT140;TBC1D17;IFT20;LIMK2;TBC1D9B;FUZ;EVI5L;ARHGAP35;CROCC
gsea,endothelial cell migration (GO:0043542),-0.2901476190757332,-0.9493588882973281,0.5208333333333334,1.0,1.0,6/39,16.35%,MYH9;S100P;RAB13;CORO1B;PXN;GIPC1
gsea,positive regulation of cell-substrate adhesion (GO:0010811),0.2565139949561823,0.9480910455233342,0.5625,0.8521112966157532,1.0,13/70,24.42%,FN1;P4HB;CDK6;FERMT2;C1QBP;CARMIL1;DOCK5;CRK;PLEKHA2;SFRP1;GSK3B;CRKL;EMP2
gsea,positive regulation of proteasomal protein catabolic process (GO:1901800),0.2324277308198366,0.9480275649365241,0.5581395348837209,0.8511273294969266,1.0,32/86,38.85%,PLK1;BAG2;TMTC3;NUB1;CSNK1E;STUB1;PIAS1;HECTD1;PSMC6;ELOB;RNF14;PSMD10;VCP;COP1;PSMC3;SH3RF2;GSK3B;ARIH1;SUMO1;RNFT1;TRIB3;FBXO22;CSNK1A1;RBX1;ZER1;FMR1;RNF185;TRIB2;RACK1;ANKIB1;RNF19B;TRIB1
gsea,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.24807949496286355,-0.9479763477002418,0.5,1.0,1.0,10/55,17.88%,SOX4;RPL11;UBXN1;SVBP;SMAD7;ARRB2;NXN;ARRB1;U2AF2;MAGEA2
gsea,positive regulation of supramolecular fiber organization (GO:1902905),0.2442622424086869,0.9477115735499356,0.5185185185185185,0.8506510070951971,1.0,14/91,20.30%,NCKAP1;PFN2;MAPRE1;SNX9;CARMIL1;KATNB1;BAIAP2;PFN1;RB1;COLGALT1;CDK5RAP2;F2RL1;DRG1;FCHSD2
gsea,organic substance transport (GO:0071702),0.2542930223873783,0.9475421874722548,0.5111111111111111,0.8496913126495113,1.0,5/136,5.32%,NDC1;CENPF;HSP90B1;CHMP2B;ABCD3
gsea,branching morphogenesis of an epithelial tube (GO:0048754),0.3029587546533602,0.9474088818894872,0.5,0.8487343484867433,1.0,4/44,19.01%,NRARP;ENG;BMP4;VEGFA
gsea,negative regulation of JNK cascade (GO:0046329),0.30142930573023113,0.9467688897619719,0.5555555555555556,0.8486694706826423,1.0,7/33,24.07%,CYLD;AIDA;TAOK3;HDAC3;F2RL1;SH3RF2;DNAJA1
gsea,regulation of protein import into nucleus (GO:0042306),0.3154095127143021,0.9445449854613249,0.4528301886792453,0.852369574933808,1.0,10/36,28.46%,RAN;TPR;HDAC3;BMP4;RBM22;CDH1;ECT2;UFM1;FLNA;ZPR1
gsea,positive regulation of response to stimulus (GO:0048584),0.31658556750695316,0.9438099819310534,0.5102040816326531,0.8528009939308525,1.0,4/46,6.81%,DHX9;EEF1E1;HMGA2;BCLAF1
gsea,mitochondrial gene expression (GO:0140053),0.2996581215473902,0.9420503754116322,0.5,0.8558109659623921,1.0,11/42,26.18%,MRPS6;GATC;MRPS16;IARS2;LARS2;MRPL47;TFAM;MRPS11;MRPL16;MRPS18A;MRPS18B
gsea,receptor internalization (GO:0031623),0.267665234932829,0.9414314020646286,0.5476190476190477,0.8557749091742707,1.0,13/49,39.01%,TFRC;DNM2;SNX1;ITGB1;ACKR3;DNM1;RAB5A;CD9;NEDD4;AP2M1;GRK2;RAB31;CAV1
gsea,negative regulation of growth (GO:0045926),-0.2420939706173532,-0.9407946170476738,0.5952380952380952,1.0,1.0,15/126,18.94%,NDUFA13;DNAJB2;ING4;PPP1R9B;CCAR2;JADE1;CDKN2A;EI24;FLCN;SMARCA4;BTG1;SMAD4;HYAL2;SERTAD3;NDUFS3
gsea,cell morphogenesis involved in neuron differentiation (GO:0048667),0.2885073767727667,0.9396700083081726,0.5531914893617021,0.8589257777967623,1.0,11/76,22.97%,RYK;RAB8A;DOCK7;AFG3L2;NRCAM;NEFH;BAIAP2;RB1;FARP1;MAP2;LMTK2
gsea,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.27369146112297615,0.9394059813207358,0.5384615384615384,0.8586745578834173,1.0,5/51,7.76%,PRKDC;BRCA1;E2F1;MSH2;CASP2
gsea,cytoplasmic microtubule organization (GO:0031122),0.27348411794545957,0.9378828112499645,0.5227272727272727,0.8611424544475694,1.0,11/54,28.50%,CAMSAP3;HOOK1;SLK;VPS4B;CAMSAP2;RHOA;DST;RAB11A;TUBGCP3;CLASP1;KPNB1
gsea,cellular component assembly (GO:0022607),0.21549821567260327,0.9367043852633108,0.6363636363636364,0.8630107965601657,1.0,31/261,20.44%,RAD21;TRIP13;KNTC1;NCKAP1;GORASP2;CHAF1B;ARL6IP1;CHAF1A;CAPZA1;HFE;DNM1L;GEMIN5;AFG3L2;FERMT2;SNX9;WASL;NEFH;YWHAZ;FANCA;BAIAP2;PLS3;FANCC;LAMC1;ELOB;RHOA;ACD;ZW10;CD2AP;TFAP4;NAPG;KPNA3
gsea,regulation of cellular component movement (GO:0051270),0.2520323832965623,0.9367003088353613,0.5,0.8618004027360983,1.0,9/50,19.01%,MEMO1;ADAM17;ROCK2;CDK6;DIAPH1;ARHGAP18;RHOA;ROCK1;VEGFA
gsea,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.3196532484043585,-0.9355240968085947,0.6545454545454545,1.0,1.0,7/77,16.18%,PTPN6;PIK3CD;MYDGF;PLXNB1;IRS2;PDGFC;PDGFB
gsea,histone lysine methylation (GO:0034968),0.351044561730908,0.9354495531439474,0.574468085106383,0.8636054000155389,1.0,5/34,13.25%,SUV39H2;WDR5;EZH2;SUV39H1;PAXIP1
gsea,cellular response to nutrient levels (GO:0031669),0.25680833028503763,0.9347423420196666,0.6,0.8638253077903181,1.0,16/66,30.99%,STK26;HSPA8;RALB;STK24;KLF10;PRKAA1;XBP1;SFRP1;MTOR;FADS1;EIF4G1;VPS41;RPTOR;ATG7;PPARA;PDK2
gsea,positive regulation of protein localization to plasma membrane (GO:1903078),-0.25507714777185103,-0.9344873303419445,0.49019607843137253,1.0,1.0,5/52,6.34%,CIB1;STX4;LGALS3;EGFR;CLN3
gsea,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.21425509264055906,0.9331666567217731,0.6341463414634146,0.8662117465177565,1.0,22/102,24.92%,PLK1;BAG2;XPO1;HFE;RAD23B;NUB1;CSNK1E;PARK7;STUB1;PIAS1;HECTD1;UFL1;ELOB;HSP90AB1;RNF14;PSMD10;VCP;COP1;SH3RF2;GSK3B;TAF9;ARIH1
gsea,transition metal ion homeostasis (GO:0055076),0.33363646858610285,0.933143806676428,0.5,0.8650605914715106,1.0,3/29,7.99%,HFE;CYBRD1;SLC39A14
gsea,primary neural tube formation (GO:0014020),0.2828894622983259,0.9324594658990396,0.6304347826086957,0.8653154678685635,1.0,5/30,18.26%,STIL;BCL10;LMO4;MTHFD1L;IFT122
gsea,glycoprotein biosynthetic process (GO:0009101),0.28508302376824324,0.931552178238515,0.5777777777777777,0.8664025872834313,1.0,8/83,20.68%,B3GNT5;B3GNT2;ALG3;MGAT1;CHST11;NPC1;TNIP1;GOLPH3
gsea,regulation of epithelial cell proliferation (GO:0050678),-0.25262205908272506,-0.9308384063919829,0.5813953488372093,1.0,1.0,15/93,24.18%,CDKN2B;EGFR;ZFP36;ERBB2;GRN;ZBED9;ZFP36L1;MARVELD3;BAD;MYC;EPPK1;DAB2IP;B2M;CDC73;NME2
gsea,glutathione metabolic process (GO:0006749),-0.2714517848174846,-0.9301489450512991,0.5686274509803921,1.0,1.0,12/43,29.53%,GSTZ1;ETHE1;GGT1;GGT7;MGST2;CTNS;GSTP1;GSS;GSTK1;G6PD;HAGH;GPX1
gsea,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.26210858732993464,-0.9295434946394293,0.5769230769230769,1.0,1.0,7/52,9.41%,SRGAP2;TAOK2;MINK1;TRIO;PLXNB1;NTF4;DBN1
gsea,positive regulation of developmental process (GO:0051094),-0.2224356935081304,-0.9289904852204275,0.5416666666666666,1.0,1.0,25/177,19.12%,REST;TRPM4;SERPINF2;DLG5;LMNA;FIS1;SCX;TP53BP1;WNT5A;DVL2;VHL;MDK;SRF;ENST00000638355.1;NR2C2;KMT5C;CEBPB;BMP1;DAG1;DVL1;CORO1B;PDGFB;GRIP1;RBM19;PINK1
gsea,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.2525482892334689,0.9286702803562825,0.5625,0.8717779935367593,1.0,10/64,19.89%,CDK1;MED17;TNRC6A;CDK8;PAXIP1;CCNC;MED6;CCNB1;SUB1;AGO1
gsea,regulation of GTPase activity (GO:0043087),0.2086237128531735,0.9285851107164834,0.6078431372549019,0.8707198958235205,1.0,25/189,23.31%,CHN1;NET1;RRP1B;ZC3H15;ARHGAP11A;USP6NL;FERMT2;EZH2;SNX9;TMED2;SGSM3;ALS2;CRK;DOCK10;RAB3GAP2;ARHGAP12;ITGB1;ITGA6;F2RL1;SFRP1;WNK1;MAPRE2;ECT2;GSK3B;RASGRP1
gsea,regulation of cell-cell adhesion (GO:0022407),-0.31462573449716913,-0.9279109992576593,0.5454545454545454,1.0,1.0,8/43,29.10%,MINK1;FSTL3;SMAD7;AFDN;CITED2;SPINT2;ADAM8;FLOT2
gsea,negative regulation of Wnt signaling pathway (GO:0030178),0.22926011178961095,0.9276730522605756,0.56,0.8717761606968566,1.0,32/191,26.69%,PSMD14;CYLD;PSMD6;PSMB2;PSMD5;ENST00000634826.1;PSMD1;STK4;PSMA5;PSMD11;PSMA4;PSMA3;PSME4;PSMD7;ENST00000629691.2;CTNND1;PSMC6;PSMA1;STK3;PSMD10;PSMB3;SFRP1;PSME1;PSMC3;HMGXB4;GSK3B;CTNNBIP1;NLK;PSMA6;PSMD13;EMD;SDHAF2
gsea,phosphatidic acid metabolic process (GO:0046473),-0.3339694772347391,-0.9269600990003997,0.5714285714285714,1.0,1.0,9/50,19.19%,PLD2;DGKZ;ABHD5;SLC27A1;GPAT4;AGPAT2;ABHD4;ABHD8;DGKQ
gsea,phosphatidic acid biosynthetic process (GO:0006654),-0.3339694772347391,-0.9269600990003997,0.5714285714285714,1.0,1.0,9/48,19.19%,PLD2;DGKZ;ABHD5;SLC27A1;GPAT4;AGPAT2;ABHD4;ABHD8;DGKQ
gsea,negative regulation of response to stimulus (GO:0048585),0.2582915492134673,0.926819872965943,0.6666666666666666,0.8723400278631471,1.0,5/61,12.58%,FBXO5;HMGA2;CDK6;DDAH1;UBASH3B
gsea,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.2682701362077506,0.9265748239575595,0.6382978723404256,0.8716427380528856,1.0,6/36,14.77%,P4HB;FERMT2;C1QBP;CARMIL1;DOCK5;CRK
gsea,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.26096239325349274,-0.9262864684518909,0.6046511627906976,1.0,1.0,11/137,24.36%,MYH9;GGT1;YES1;LHB;MAPK14;VIPR1;ADCY6;IL6;ADM;P2RY11;ADCY7
gsea,positive regulation of lamellipodium assembly (GO:0010592),0.4269395032907427,0.9254137723073097,0.5555555555555556,0.8734255475908033,1.0,4/24,13.08%,ARPC2;NCKAP1;ACTR2;ACTR3
gsea,negative regulation of immune response (GO:0050777),-0.2524337427255352,-0.9253062504197367,0.6341463414634146,1.0,1.0,12/178,17.50%,MYH9;LGALS3;CACTIN;GGT1;TRAFD1;YES1;IFI16;LHB;MAPK14;VIPR1;ADCY6;IL6
gsea,regulation of interferon-beta production (GO:0032648),0.2603916924291908,0.9252179561755068,0.6111111111111112,0.8726349424857217,1.0,3/49,2.95%,DHX9;OAS3;HSP90AA1
gsea,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.314806013665814,-0.9249396929167213,0.56,1.0,1.0,3/37,5.05%,DDRGK1;UBA5;NR0B1
gsea,negative regulation of protein-containing complex assembly (GO:0031333),0.29638186241219433,0.9243730016632863,0.4888888888888889,0.8733068604171631,1.0,6/52,14.97%,SVIP;HMGB1;AIDA;PARK7;HSPA5;KIF14
gsea,negative regulation of cell projection organization (GO:0031345),-0.2793356102152873,-0.9240539497374509,0.574468085106383,1.0,1.0,5/49,17.38%,RAPGEF2;CIB1;GORASP1;DCC;ADCY6
gsea,signal transduction by p53 class mediator (GO:0072331),0.2753754921919734,0.9231216683563351,0.675,0.8747995869292915,1.0,4/33,13.25%,E2F7;USP10;DDX5;PAXIP1
gsea,regulation of RNA splicing (GO:0043484),0.2241283509794755,0.9229395628361278,0.6046511627906976,0.8740476926082285,1.0,22/76,29.39%,RRP1B;ZNF326;JMJD6;HNRNPL;SETX;PTBP3;CWC22;CLK3;PTBP1;PQBP1;RBM22;SRPK1;HNRNPH1;QKI;CLK1;ESRP2;HNRNPLL;FUS;MBNL2;SON;ZPR1;RPS26
gsea,cellular response to decreased oxygen levels (GO:0036294),0.2668685257754113,0.9224995229691765,0.5306122448979592,0.873913158767432,1.0,16/69,26.66%,SUV39H2;NPEPPS;P4HB;FAM162A;PGK1;SUV39H1;STUB1;TBL2;UBQLN1;VEGFA;SFRP1;EPAS1;HIF1A;MTOR;HMOX1;HP1BP3
gsea,regulation of epidermal cell differentiation (GO:0045604),0.31102601051301104,0.9217709940393819,0.58,0.8745424114819372,1.0,7/25,27.16%,ROCK2;ROCK1;RUNX1;BMP4;SULT2B1;SFN;ERRFI1
gsea,development of primary male sexual characteristics (GO:0046546),-0.2934882332682375,-0.9215184095529116,0.625,1.0,1.0,5/43,13.48%,NR0B1;WNT5A;LHB;MEA1;GATA6
gsea,positive regulation of actin filament bundle assembly (GO:0032233),0.30771169368978535,0.9213381050238456,0.5576923076923077,0.8743331912718267,1.0,8/51,19.95%,FHOD1;ROCK2;PFN2;FERMT2;CARMIL1;PFN1;RHOA;SFRP1
gsea,positive regulation of glucose transmembrane transport (GO:0010828),0.3989815508195842,0.9211826921875056,0.6428571428571429,0.8736231746567864,1.0,4/32,13.36%,ARPP19;PRKCI;APPL1;PTPN11
gsea,negative regulation of cellular process (GO:0048523),-0.21404983048048304,-0.9211512764011978,0.6,1.0,1.0,65/566,19.26%,TMEM115;SOX4;RAPGEF2;REST;SRGAP2;NR1H3;ZBED6;MYH9;NDUFA13;PTPN6;DNAJB2;VAMP8;CIB1;DLG5;CDKN2B;FOXO4;LMNA;ING4;RNF41;PPP1R9B;TMEM127;APP;FTH1;MEN1;CCAR2;IGFBP6;INHA;RBM5;INCA1;CELF1;NR1H2;JADE1;RARG;PLXNB1;VHL;IFI35;MDK;COL18A1;TXNIP;RND1;DUSP1;CDKN2A;ABI1;RHOB;MNT;EI24;PTK2B;FLCN;SUSD2;APOBEC3D;IFITM1;IRF6;SMARCA4;MYC;BTG1;IL6;TNFRSF21;SMAD4;BAP1;GSDME;HYAL2;SERTAD3;FKTN;NDUFS3;WDR6
gsea,regulation of protein localization to cell periphery (GO:1904375),-0.29397064758656183,-0.9204082345128056,0.625,1.0,1.0,6/20,19.77%,MMP14;VAMP8;CLN3;CDK5;ZDHHC7;MISP
gsea,positive regulation of synaptic transmission (GO:0050806),-0.2636401499432081,-0.9200919869765075,0.6491228070175439,1.0,1.0,7/73,17.53%,APP;STX4;SLC24A1;PTK2B;KCTD13;PRKCZ;VAMP2
gsea,response to metal ion (GO:0010038),0.28259619157657245,0.9184755695501752,0.5,0.8786080575222173,1.0,22/71,37.54%,HFE;PPP2CA;PPP1CA;ADAM9;MT1A;FXN;HIF1A;PLSCR1;SLC25A13;PPP5C;SLC25A12;AHCYL1;LOXL2;SLC30A5;NEDD4L;NEDD4;PPP2CB;ITPR3;ALG2;CALM1;CALM2;SEC31A
gsea,positive regulation of secretion by cell (GO:1903532),0.27560658329798715,0.9168913295399252,0.5714285714285714,0.8807089884861128,1.0,13/72,37.15%,DNM1L;ADAM9;CD2AP;GOLPH3;CLASP1;RAB27A;RAB5A;PPIA;EXOC1;GOLPH3L;GRK2;TMED10;NMB
gsea,organophosphate ester transport (GO:0015748),0.3857082406330365,0.9159681747260623,0.6326530612244898,0.8821569390023821,1.0,4/25,14.43%,PITPNB;OSBPL2;LDLR;PRELID1
gsea,negative regulation of protein modification process (GO:0031400),0.23164873801313604,0.9154825692374525,0.5306122448979592,0.881883401282327,1.0,15/81,24.03%,PRKDC;ARPP19;CORO1C;PARK7;TARDBP;PNKP;CDYL;MFHAS1;PRKAA1;P3H1;YWHAB;TERF2IP;GSK3B;CRKL;ENSA
gsea,tube closure (GO:0060606),0.2706549765126568,0.9152874141150902,0.7272727272727273,0.8810573043371325,1.0,5/31,18.26%,STIL;BCL10;LMO4;MTHFD1L;IFT122
gsea,regulation of megakaryocyte differentiation (GO:0045652),0.2869786237226439,0.9152275473705768,0.5106382978723404,0.8799571672053259,1.0,7/54,19.89%,WDR5;SIN3A;TNRC6A;PITHD1;PRMT1;RUNX1;AGO1
gsea,heart development (GO:0007507),-0.22445084979727045,-0.9148391314135638,0.6122448979591837,1.0,1.0,12/164,17.70%,EPHB4;SOX4;KDM6B;CRIP1;DVL2;SRF;SH3PXD2B;TAB2;MEGF8;PDGFB;HEG1;MICAL2
gsea,protein localization to Golgi apparatus (GO:0034067),0.30522744347803565,0.9140146378882033,0.6136363636363636,0.8816006354781715,1.0,12/28,36.97%,GBF1;ARL5A;GCC2;GOLPH3;ARL5B;ARL1;SYS1;VPS13A;RAB6A;OPTN;RIPOR1;TMED10
gsea,myeloid cell differentiation (GO:0030099),0.2678917217249764,0.9134623480751463,0.574468085106383,0.8817334360789072,1.0,8/52,21.42%,SLC25A5;HSPA9;UFL1;RUNX1;MFHAS1;PTPN2;PRDX3;NCOA6
gsea,dephosphorylation (GO:0016311),0.22047651878566638,0.913272540090147,0.6511627906976745,0.8810037142238965,1.0,16/153,14.28%,PPP1CC;PTPN3;ACP6;TIMM50;MTMR6;PPP2CA;PPP1CA;PPP2R1B;PLPP1;PNKP;PPP4R2;PGP;CTDSP1;PPP6C;PPP2R5A;PPM1G
gsea,visual perception (GO:0007601),-0.2802274063431028,-0.9131171299355197,0.5849056603773585,1.0,1.0,5/93,13.13%,UNC119;DHRS3;RDH10;COL18A1;SLC24A1
gsea,circulatory system development (GO:0072359),-0.2506266539505815,-0.9127440363817664,0.6382978723404256,1.0,1.0,11/126,17.70%,SOX4;KDM6B;CRIP1;DVL2;SRF;SH3PXD2B;TAB2;NXN;PDGFB;HEG1;MICAL2
gsea,macroautophagy (GO:0016236),0.2202797984124841,0.9124245220824564,0.7021276595744681,0.8819430071566051,1.0,24/120,20.06%,PIP4K2A;CHMP2B;VPS37A;ATG3;VTA1;TOMM5;FUNDC1;VPS4B;VPS33A;PIK3C3;PLAA;VPS25;SNX14;VAMP7;PIK3R4;UBQLN1;VPS16;VPS36;CHMP4C;PRKAA1;STAM;MTERF3;VCP;STX17
gsea,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.3338612126199812,0.9122050862205449,0.5581395348837209,0.8812332598518884,1.0,12/21,34.91%,CNOT9;PAN3;CNOT7;CNOT11;CNOT10;CNOT6;CNOT3;TUT7;CNOT1;TNKS1BP1;CNOT2;TUT4
gsea,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.24652877377283264,0.9120028074877097,0.6976744186046512,0.8803609873921805,1.0,14/56,20.28%,EXOSC8;LSM3;CNOT9;PATL1;LSM5;HBS1L;PAN3;DIS3;TTC37;RC3H2;CNOT7;LSM1;CNOT11;CNOT10
gsea,BMP signaling pathway (GO:0030509),-0.2558205188660513,-0.9119884425031293,0.6122448979591837,1.0,1.0,7/65,18.13%,MAPK3;SCX;GDF15;SMAD7;MEGF8;USP15;SMAD4
gsea,phosphate-containing compound metabolic process (GO:0006796),0.196662406753343,0.9108656740622578,0.6976744186046512,0.88140683797201,1.0,29/212,24.31%,PPA1;PIP4K2A;ALDOA;ACP6;HKDC1;GPI;GFPT1;PPP1CA;PGK1;PIK3CB;LPCAT4;SHPK;PLPP1;PNKP;NUDT4;PGP;SLC20A1;PLAA;TOP1;NUDT5;IMPA2;PLBD1;PI4KA;AGK;GPD2;PPM1A;PANK3;MTOR;PAK2
gsea,carboxylic acid transport (GO:0046942),-0.3001761123031435,-0.9104745131823543,0.5517241379310345,1.0,1.0,5/57,9.77%,SLC16A13;SLC16A5;PSAP;CLN3;LLGL2
gsea,actin polymerization or depolymerization (GO:0008154),-0.29013719143417843,-0.910381943444864,0.6829268292682927,1.0,1.0,12/50,21.90%,GSN;MSRB2;MICALL2;ENST00000640412.1;DSTN;ABI1;MICAL1;MICAL2;WDR1;VILL;SVIL;SPIRE2
gsea,cellular response to oxygen-containing compound (GO:1901701),-0.20185194282158192,-0.9102100651033144,0.6875,1.0,1.0,32/323,17.83%,RAPGEF2;NR1H3;NDUFA13;PRDX5;TICAM1;LAMTOR2;MAPK3;P2RY2;CACTIN;TPM1;EGFR;PYCARD;ZFP36;PABPN1;PAF1;WNT5A;ZFP36L1;INPP5K;RRAGB;PTK2B;ROMO1;RAPGEF1;MAPK14;GIT1;PDGFB;PTK7;PXN;UPF1;AGAP3;ADCY6;IL6;P2RX4
gsea,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.23289952071090178,-0.9101815095102082,0.6226415094339622,1.0,1.0,8/74,9.30%,TRADD;GAS6;PTPN6;CD24;PALM3;PYCARD;CFLAR;CD74
gsea,organic anion transport (GO:0015711),0.24526137248821356,0.9088669500225601,0.6153846153846154,0.8850737328089843,1.0,4/99,11.23%,LRRC8D;SLC35B1;SLC25A24;SLC39A8
gsea,regulation of reactive oxygen species metabolic process (GO:2000377),-0.28062063433251444,-0.9088034014223714,0.6363636363636364,1.0,1.0,15/57,30.15%,GADD45A;CBR1;RNF41;THBS1;ROMO1;MAPK14;PDGFB;PINK1;RIPK1;SNCA;GRB2;TP53;AKR1C1;RAC2;EIF6
gsea,protein modification process (GO:0036211),0.23764485272804747,0.9087180130232259,0.5306122448979592,0.884127037318897,1.0,13/78,21.46%,PRKDC;SEPHS1;PLOD2;ATG3;PARP1;RPN2;PPP4R2;PIGH;RPN1;FBXO11;USP25;PARP4;ERO1A
gsea,negative regulation of inflammatory response (GO:0050728),-0.219234013114079,-0.9079663667804363,0.6326530612244898,1.0,1.0,21/212,25.57%,NR1H3;MYH9;GRN;GGT1;MDK;YES1;PROC;LHB;MAPK14;GIT1;VIPR1;ADCY6;IL6;ADM;SELENOS;GPS2;GSTP1;PTGIS;P2RY11;ADCY7;SIRPA
gsea,positive regulation of macromolecule biosynthetic process (GO:0010557),0.23534585407815128,0.9065675677919597,0.6666666666666666,0.8876169565562736,1.0,21/129,25.62%,DHX9;PRKDC;PCNA;KAT7;SLC25A37;HNRNPD;DNA2;NPM1;STN1;ABCB10;PRMT1;ELAVL1;XBP1;NAT10;FAF1;EIF3E;HSPH1;MTOR;RPS4X;MTPN;METTL3
gsea,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.31950437007908083,0.9064377193746211,0.5652173913043478,0.8866512463654481,1.0,8/17,24.15%,SRPRA;SPCS3;SRP14;SEC61G;EDEM1;RAB3GAP2;SRPRB;MAN1A1
gsea,generation of neurons (GO:0048699),0.23181203432741426,0.9062406148849925,0.5681818181818182,0.8858512247970721,1.0,14/202,21.28%,CIT;ITM2C;RYK;ACSL3;MAP2K1;DOCK7;CDK6;RACGAP1;NRCAM;PEX13;RUNX1;MARK2;TUBB2A;PAFAH1B1
gsea,negative regulation of neurogenesis (GO:0050768),-0.32997186497261244,-0.9061747273898091,0.5625,1.0,1.0,6/35,21.91%,RAPGEF2;REST;GORASP1;IL6;B2M;DYNLT1
gsea,anterograde trans-synaptic signaling (GO:0098916),-0.23990173523990815,-0.9058119452567919,0.5471698113207547,1.0,1.0,13/244,22.57%,UNC119;MINK1;SLC12A7;CACNB3;CDK5;GIPC1;DLG1;GABRP;CNP;GABARAP;APBA3;SNCG;SNCA
gsea,renal system development (GO:0072001),0.2819598200342501,0.9054364546058088,0.6458333333333334,0.8870624298808653,1.0,7/57,28.96%,CENPF;STAT1;BMP4;VEGFA;SULF2;WFS1;SIX2
gsea,negative regulation of cell-cell adhesion (GO:0022408),0.35629497982791014,0.9053075446635904,0.6382978723404256,0.886155531423914,1.0,14/41,39.68%,PODXL;NOTCH1;VEGFA;WNK1;CDH1;IL1RN;PPARA;EPCAM;GTPBP4;PTK2;MAD2L2;JAG1;MAP2K5;MAPK7
gsea,protein autophosphorylation (GO:0046777),-0.222085251691892,-0.905152940879338,0.5660377358490566,1.0,1.0,15/159,9.66%,EPHB4;STK10;SIK1;MAPK3;HTATIP2;STK25;PIM3;MAPKAPK2;STK16;TAOK2;MINK1;EGFR;ERBB2;MAP3K11;DAPK2
gsea,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.299747150924297,0.9037589024399212,0.5531914893617021,0.8884462389618073,1.0,7/22,19.59%,PARP1;RAD23B;DDB2;GTF2H1;RPS27A;CHD1L;CETN2
gsea,regulation of cellular metabolic process (GO:0031323),0.2822071038022085,0.9034362000636881,0.5333333333333333,0.888062724052723,1.0,14/47,30.99%,FOXM1;RNF34;STK17A;VPS35;STUB1;FASN;COQ7;PM20D2;ACACA;MKLN1;SSH1;PPARA;PARL;PDK2
gsea,intraciliary transport involved in cilium assembly (GO:0035735),-0.31802847008260626,-0.9027295733000552,0.509090909090909,1.0,1.0,6/40,21.35%,IFT43;IFT52;IFT27;IFT22;IFT140;IFT20
gsea,regulation of protein targeting to mitochondrion (GO:1903214),-0.28759745443601975,-0.9024865472599737,0.5294117647058824,1.0,1.0,8/39,21.29%,UBL5;TOMM7;ARIH2;MICALL2;ATG13;BAP1;PINK1;ENST00000647074.2
gsea,cellular response to metal ion (GO:0071248),0.23277791847181084,0.9023618193654255,0.52,0.8892645953804438,1.0,18/131,32.47%,IQGAP1;HFE;SLC25A24;CPNE7;SMPD1;LGMN;MT1A;MAPK1;PRKAA1;CDH1;ECT2;MAPK8;CLIC4;SUMO1;CHUK;DMTN;MT1E;CPNE3
gsea,regulation of bone mineralization (GO:0030500),-0.2786961012339027,-0.9020147978162295,0.6170212765957447,1.0,1.0,2/57,1.77%,TRPM4;ATRAID
gsea,positive regulation of mRNA processing (GO:0050685),0.31697965217918883,0.9015770111636092,0.5769230769230769,0.8901396434415708,1.0,9/23,32.50%,NCBP1;LEO1;SNW1;NCL;TRA2A;SF3B4;DHX36;TRA2B;NUP98
gsea,positive regulation of cell migration (GO:0030335),-0.19859425995625782,-0.9014254718207843,0.6792452830188679,1.0,1.0,31/269,16.85%,TRADD;RAPGEF2;SMIM22;DDRGK1;MMP14;CIB1;TRIP6;SUN2;PIK3CD;STX4;FAM89B;EGFR;FAM110C;GRN;BCAR1;VSIR;NUMB;ACTG1;MDK;ELP3;THBS1;PDGFC;CCAR1;PTK2B;CLDN4;MYO1C;PDGFB;CSF1;AKT2;GLIPR2;MGAT5
gsea,cognition (GO:0050890),0.2748910441400668,0.901418203381589,0.6458333333333334,0.8893064943907801,1.0,5/48,23.93%,CHMP2B;SETD5;RP9;NIPBL;CYFIP1
gsea,internal peptidyl-lysine acetylation (GO:0018393),0.27500119890488284,0.9011842897678712,0.5454545454545454,0.8886010721484303,1.0,3/28,11.18%,KAT7;MSL3;TRRAP
gsea,chordate embryonic development (GO:0043009),0.268788761756932,0.8996534603071618,0.6808510638297872,0.890709292158653,1.0,3/58,7.95%,BRCA1;STIL;ZNF358
gsea,regulation of T cell proliferation (GO:0042129),-0.3045585793128616,-0.8992874962848346,0.6229508196721312,1.0,1.0,9/76,24.93%,DLG5;LGALS3;CEBPB;IL23A;SDC4;IL6;TNFRSF21;NCK1;VTCN1
gsea,positive regulation of cellular process (GO:0048522),0.1943551911697768,0.8985109575128244,0.6346153846153846,0.8922396217494455,1.0,92/625,27.72%,SLC25A5;CDK2;KIF20B;TTK;CDC6;SPAG5;NAP1L1;PRC1;CHEK1;UBE2A;NCBP1;FOXM1;FBXO5;CDCA7L;FN1;HMGA2;P4HB;ADAM17;CCPG1;SUPV3L1;BCLAF1;NPM1;NOP2;EZH2;SSR1;STAMBP;DBF4B;C1QBP;OSMR;LYAR;PA2G4;SMC6;TIPIN;KITLG;PRMT1;MCTS1;CDC7;GATA2;CAPNS1;WDR77;FASN;LGMN;KIF14;UFL1;CNOT7;BIRC5;HSP90AB1;SMC5;IL13RA1;ZNF268;PSMD10;BMP4;NOTCH1;HDAC2;PRKAA1;VEGFA;S1PR3;INO80;XBP1;SFRP1;USP47;FAF1;FXN;ACACA;TAF9B;PRDX3;RPL23;RIPK2;RPS6KA3;PHIP;AKR1C2;KRAS;MAPK8;PTN;EFNB2;CRKL;SLC6A6;RPS4X;EMP2;MVD;CEACAM6;CNOT6;MTPN;SLC35F6;TIMP1;FAM98A;TBRG4;RPS15A;EIF4G1;RAB27A;RPTOR;DHX36
gsea,negative regulation of metabolic process (GO:0009892),0.2548514911464453,0.8978323935000084,0.6511627906976745,0.8927834995522648,1.0,9/56,22.43%,NRDC;ADAM17;DOCK7;ID1;RB1;NOTCH1;LNPEP;RBPJ;APOC1
gsea,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.26674045003409735,-0.8958832451685834,0.7142857142857143,1.0,1.0,8/118,24.36%,RAPGEF2;LPAR2;GPR78;ADCY6;ADM;S1PR2;ADGRG1;ADCY7
gsea,phosphatidylserine metabolic process (GO:0006658),0.32509207718863203,0.8958003655539348,0.6122448979591837,0.8959839697136337,1.0,6/34,23.06%,PTDSS1;LPCAT4;PLA2G12A;LPCAT3;PLSCR1;MBOAT2
gsea,regulation of insulin receptor signaling pathway (GO:0046626),0.2877866526797267,0.8954265941427638,0.631578947368421,0.8956485536027028,1.0,2/45,2.35%,PIP4K2A;NUCKS1
gsea,positive regulation of catabolic process (GO:0009896),-0.25734485140525637,-0.8945045072231936,0.6666666666666666,1.0,1.0,6/67,7.79%,EGLN2;NDUFA13;RNF41;OAZ2;WNT5A;VSIR
gsea,cilium organization (GO:0044782),0.22048390918049665,0.8940789777454916,0.5952380952380952,0.8978227440474703,1.0,23/228,23.94%,MNS1;PLK4;RAB8A;EHD4;TMEM138;SNX10;MKKS;OFD1;ACTR2;RABL2B;GBF1;IFT74;ACTR3;CFAP298;TMEM107;IFT122;NOTCH1;EXOC2;RAB11A;TCTN3;CEP250;TCTN1;CEP78
gsea,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.2676030759365103,-0.8935699110964892,0.6122448979591837,1.0,1.0,13/50,31.22%,FLCN;DLG1;SMAD4;DAB2IP;DUSP3;PSCA;GSTP1;SIRPA;CAMK2N1;FBLN1;TIMP3;PTPN1;PIN1
gsea,male gonad development (GO:0008584),-0.2658832263025015,-0.892739069262167,0.6206896551724138,1.0,1.0,5/43,13.48%,NR0B1;WNT5A;LHB;MEA1;GATA6
gsea,regulation of actin filament-based process (GO:0032970),0.23834235510529056,0.8923276423940429,0.5625,0.9004354872843675,1.0,11/73,17.65%,IQGAP1;ROCK2;IQGAP3;RND3;ARHGEF19;RHOF;ARHGAP18;BAIAP2;CRK;RHOA;ROCK1
gsea,photoperiodism (GO:0009648),-0.27200674003436986,-0.8914212906716152,0.7291666666666666,1.0,1.0,3/28,10.01%,SIK1;FBXL17;FBXL12
gsea,entrainment of circadian clock by photoperiod (GO:0043153),-0.27200674003436986,-0.8914212906716152,0.7291666666666666,1.0,1.0,3/27,10.01%,SIK1;FBXL17;FBXL12
gsea,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.2719936420672161,0.8908167270390828,0.6888888888888889,0.9002503088474322,1.0,12/74,17.31%,ARPC2;HSP90AA1;NCKAP1;PIK3CB;WASL;ACTR2;ACTR3;BAIAP2;CRK;HSP90AB1;MAPK1;ARPC3
gsea,Fc-gamma receptor signaling pathway (GO:0038094),0.2719936420672161,0.8908167270390828,0.6888888888888889,0.9002503088474322,1.0,12/72,17.31%,ARPC2;HSP90AA1;NCKAP1;PIK3CB;WASL;ACTR2;ACTR3;BAIAP2;CRK;HSP90AB1;MAPK1;ARPC3
gsea,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.2719936420672161,0.8908167270390828,0.6888888888888889,0.9002503088474322,1.0,12/71,17.31%,ARPC2;HSP90AA1;NCKAP1;PIK3CB;WASL;ACTR2;ACTR3;BAIAP2;CRK;HSP90AB1;MAPK1;ARPC3
gsea,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.2604939556123853,0.8903357444710188,0.6170212765957447,0.9000887344058471,1.0,10/71,20.82%,E2F7;E2F1;ADAM17;CCND3;CDK6;APPL1;KIF14;RB1;INO80;PSME1
gsea,fatty acid oxidation (GO:0019395),0.27460003571440733,0.890053035388634,0.5531914893617021,0.899539192269815,1.0,16/59,33.38%,ENST00000645126.2;ACAT2;ABCD3;HADHA;HADH;PEX13;PPARD;ADIPOR1;ACAT1;HSD17B10;SLC25A17;ECI2;ACADM;ECHDC1;PEX2;CYP24A1
gsea,positive regulation of apoptotic process (GO:0043065),-0.1920609882097608,-0.8895402768737724,0.7291666666666666,1.0,1.0,53/310,21.26%,APH1A;GADD45A;SOX4;TRADD;REST;SIK1;TIAM2;PHLDA3;ING4;TNFRSF12A;BMF;PYCARD;CCAR2;PDCD2;GRN;TRIO;HIP1R;RBM5;BAX;RARG;MAP3K11;DAPK2;ARHGEF1;BOK;RHOB;ABR;GADD45B;CCAR1;FLCN;FANK1;CDK5;BAK1;ARHGEF18;DAPK3;MCF2L;ARHGEF16;ADAMTSL4;BAD;UBB;BTG1;IL6;SIAH1;UBC;ARHGEF17;SCRIB;RIPK1;ARHGEF5;ARHGEF12;DAB2IP;DDIT3;RNPS1;ZNF622;TNFRSF10B
gsea,T cell activation (GO:0042110),0.2333834455114313,0.8892994484512297,0.7317073170731707,0.8998902588337577,1.0,8/92,23.31%,HSPD1;EIF2AK4;MSN;FKBP1A;NHEJ1;F2RL1;PTPN2;RASGRP1
gsea,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.2546689052464942,0.8890864331831548,0.5686274509803921,0.8990430547086891,1.0,5/58,18.57%,TTK;HFE;TWSG1;ENG;BMP4
gsea,apoptotic mitochondrial changes (GO:0008637),0.2566159547477908,0.8885725911703214,0.6153846153846154,0.8989542171185909,1.0,11/33,25.67%,HSPD1;ATG3;TIMM50;DNM1L;NDUFS1;VPS35;THEM4;BID;MFF;GGCT;SFN
gsea,T cell differentiation (GO:0030217),-0.29754686489053206,-0.8884536919875876,0.6792452830188679,1.0,1.0,4/41,11.43%,SOX4;PIK3CD;ZFP36L1;SOX13
gsea,positive regulation of neuron differentiation (GO:0045666),0.292743726859243,0.8883128951521478,0.6304347826086957,0.898215784098921,1.0,5/43,22.86%,SIN3A;NRCAM;MMD;RHOA;ECT2
gsea,protein-containing complex assembly (GO:0065003),0.21131288390979197,0.8877683953707544,0.6170212765957447,0.8981984023296159,1.0,47/267,24.39%,DHX9;KNTC1;PDZD11;FN1;CAPZA1;LEO1;HFE;DNM1L;GEMIN5;AFG3L2;CAND1;FERMT2;ANO6;WDCP;SNX9;OPA1;TMED2;WASL;LMAN1;TRRAP;PDE4DIP;FANCA;PPP6C;MCU;FANCC;SAR1B;STOML2;LAMC1;ELOB;ZW10;ZNHIT6;TCF7;CD2AP;FARP2;TFAP4;NAPG;PPP6R3;KPNA3;TFG;SKP1;SEC16A;RANBP9;GSK3B;CAPZA2;SEC23A;CUL1;CTSC
gsea,supramolecular fiber organization (GO:0097435),0.20022337459347953,0.8875314263144385,0.5925925925925926,0.8973577370372432,1.0,37/351,19.82%,KIF2C;KIF18A;CAMSAP3;HOOK1;PLOD2;KIF18B;KIF2A;CORO1C;P4HB;LTBP3;ALDOA;MYO19;SLK;FAT1;CARMIL1;CKAP5;KATNB1;FKBP1A;MYO1D;VPS4B;RND3;RHOF;CAMSAP2;TMOD3;RPS27A;KIF14;P4HA1;RHOA;HSP90AB1;ARHGAP12;COLGALT1;ITGA6;CD2AP;TSPAN5;P3H1;DST;ITGB4
gsea,protein acylation (GO:0043543),0.24114970318538148,0.886197773830311,0.6964285714285714,0.8989335575226501,1.0,2/39,2.79%,ZDHHC3;ZDHHC13
gsea,endoplasmic reticulum organization (GO:0007029),0.25531699962536103,0.8859731963215303,0.6363636363636364,0.8984959777366697,1.0,25/73,39.45%,LNPK;DNM1L;LMAN1;BNIP1;SEC61G;ATL2;RTN4;LPCAT3;SEC16A;TOR1B;REEP5;HMOX1;EMD;SHTN1;TRAM1;TMEM33;SGTA;CAV2;SEC61B;VAPA;REEP3;SEC31A;SEC61A1;SERP1;VAPB
gsea,positive regulation of immunoglobulin production (GO:0002639),0.28704545276939014,0.8858718176267444,0.66,0.8975360125352775,1.0,11/35,33.77%,SHLD2;TFRC;GPI;PAXIP1;XBP1;PHB2;EPHB2;DNAJB9;VAMP3;KMT5B;RIF1
gsea,positive regulation of protein import into nucleus (GO:0042307),0.3117410143307556,0.8854909722531275,0.5576923076923077,0.8971536264534181,1.0,8/28,28.46%,RAN;TPR;HDAC3;RBM22;CDH1;ECT2;FLNA;ZPR1
gsea,positive regulation of cell-cell adhesion (GO:0022409),-0.2839932212829613,-0.8853877732677481,0.6727272727272727,1.0,1.0,8/47,26.42%,SERPINF2;FSTL3;MDK;SMAD7;AFDN;CITED2;PTPRU;PLPP3
gsea,positive regulation of nucleic acid-templated transcription (GO:1903508),0.20105538216288998,0.8850263985937592,0.75,0.8973466037144182,1.0,55/511,22.30%,NAA15;ATAD2;NUP62;DNAJC2;BRCA1;E2F1;MED17;RNF4;FOXM1;NSD1;NSD3;HMGA2;YWHAH;RNF20;PHF5A;HNRNPD;ILF2;JMJD6;PCID2;MAP2K1;NPM1;MLLT11;EHF;USP16;BCL10;ING2;ETS2;GTF2H1;DNM2;PITHD1;MMS19;NUP85;STAT1;ELF4;RNF6;TFAM;MAP3K2;RNF14;RNA5SP498;BRD4;TBL1XR1;RUNX1;CDK5RAP2;BMP4;NOTCH1;HDAC2;TFAP4;SFRP1;PHF8;HIF1A;CREB1;NCOA6;PHIP;CDH1;PPM1A
gsea,sulfur compound transport (GO:0072348),0.3036195588683834,0.8843878632552893,0.5818181818181818,0.8975390880577657,1.0,3/28,12.60%,LRRC8D;RACGAP1;SLC26A1
gsea,endoplasmic reticulum mannose trimming (GO:1904380),-0.31686209177162417,-0.8840122470258797,0.6140350877192983,1.0,1.0,6/19,17.81%,OS9;TRIM13;RNF5;UBB;UBC;RNF103
gsea,epithelial cell differentiation (GO:0030855),0.22614227002101558,0.8834264409375546,0.6909090909090909,0.8984776136270444,1.0,8/101,9.83%,E2F8;E2F7;PCNA;CDK1;ANXA7;TDRD7;PGK1;EHF
gsea,positive regulation of programmed cell death (GO:0043068),-0.1936810290662455,-0.8830463249742794,0.76,1.0,1.0,50/286,21.26%,APH1A;GADD45A;SOX4;TRADD;REST;TIAM2;MARK4;PHLDA3;ING4;HTATIP2;TNFRSF12A;BMF;PYCARD;CCAR2;PDCD2;TRIO;HIP1R;RBM5;BAX;RARG;MAP3K11;DAPK2;ARHGEF1;BOK;RHOB;ABR;GADD45B;CCAR1;FLCN;FANK1;BAK1;ARHGEF18;DAPK3;MCF2L;ARHGEF16;ADAMTSL4;BAD;UBB;IL6;SIAH1;UBC;ARHGEF17;SCRIB;RIPK1;ARHGEF5;ARHGEF12;DAB2IP;RNPS1;ZNF622;TNFRSF10B
gsea,regulation of actin cytoskeleton organization (GO:0032956),0.2221897599353414,0.8829795590632582,0.7659574468085106,0.8982346893101879,1.0,12/91,17.65%,TWF1;IQGAP1;ROCK2;IQGAP3;RND3;ARHGEF19;RHOF;ARHGAP18;BAIAP2;CRK;RHOA;ROCK1
gsea,translation (GO:0006412),-0.21253671641940475,-0.8825324016659297,0.6,1.0,1.0,40/214,14.68%,RPL37;RPL28;RPS13;RPL37A;RPL10A;TMA7;RPS18;MRPL51;RPL11;RPL13;RPL39;EEF1D;RPS29;RPL13A;RPS2;RPL29;RPS21;RPL9;MRPS21;HARS2;MRPL28;RPL27A;RPS12;MRPS33;EEF1A1;RPLP2;MRPL52;RPLP1;RPL8;RPL31;MRPL36;RPL34;RPL27;MRPL34;EEF2;MRPS7;RPL23A;TRMT112;RPL10;RPL7
gsea,response to reactive oxygen species (GO:0000302),-0.25436569573437284,-0.8817741650866775,0.5833333333333334,1.0,1.0,6/59,6.07%,PRDX5;MAPK3;STK25;CAT;TPM1;EGFR
gsea,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.25568456876263496,0.8816868645702838,0.6382978723404256,0.9000184767040776,1.0,6/56,7.14%,E2F1;YWHAE;NPEPPS;YWHAH;PPP3R1;HUWE1
gsea,ATP-dependent chromatin remodeling (GO:0043044),0.24816207147827235,0.8815402247291833,0.6923076923076923,0.8992726558112999,1.0,8/42,19.49%,SMARCA5;ANP32E;RNF8;ACTR6;HNRNPC;MBD2;HDAC2;INO80
gsea,intrinsic apoptotic signaling pathway (GO:0097193),-0.2241315861221096,-0.8811031027723193,0.5957446808510638,1.0,1.0,20/102,21.26%,CRIP1;CD24;PPP1R15A;BBC3;CUL3;IFI6;PYCARD;BAX;BOK;IFI16;BCL2L2;CEBPB;HINT1;BAK1;BAD;DAB2IP;DDIT3;TRAF2;ZNF622;TNFRSF10B
gsea,positive regulation of protein secretion (GO:0050714),0.24516345741726078,0.8802258991073945,0.7272727272727273,0.90058422525275,1.0,8/72,20.68%,TM7SF3;DNM1L;MCU;ADAM9;AACS;CD2AP;F2RL1;GOLPH3
gsea,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.262914426832826,-0.8799332955478308,0.5849056603773585,1.0,1.0,11/54,20.78%,REST;RBM15B;RBM5;CELF1;KHDRBS1;PUF60;RBMX;ZBTB7A;DDX17;FXR2;RNPS1
gsea,regulation of cell morphogenesis (GO:0022604),0.3049709923313883,0.8789312112601837,0.7209302325581395,0.9022029915652682,1.0,5/32,21.82%,ZMYM3;FERMT2;SH3D19;ZMYM4;PHIP
gsea,negative regulation of protein phosphorylation (GO:0001933),-0.22361937141743327,-0.8775320184107488,0.6739130434782609,1.0,1.0,30/152,26.49%,PTPN6;DKK1;CIB1;TESK1;MVP;CACTIN;MEN1;TARBP2;CADM4;AKT1S1;TAB1;PRKRIP1;INPP5K;SMAD7;DVL1;PRKCZ;ATG14;DGKQ;DAB2IP;SNCA;TSC2;CALM3;FKBP8;ENST00000639332.2;NCK1;GSTP1;SIRPA;MYADM;PLPP3;CAMK2N1
gsea,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.28695112127238365,-0.8773764950422536,0.6590909090909091,1.0,1.0,5/18,15.14%,HIP1R;BAX;ZNF205;BOK;BAK1
gsea,positive regulation of cell differentiation (GO:0045597),-0.20730160586939575,-0.8772125263424712,0.6274509803921569,1.0,1.0,27/258,18.55%,RAPGEF2;REST;TRPM4;SERPINF2;ATRAID;ADIRF;BAMBI;CCDC71L;ZFP36;RRAS;VHL;MDK;HIF1AN;SRF;GPRC5B;ZFP36L1;CEBPB;MAPK14;IFITM1;CSF1;MAPK11;GLIPR2;BTG1;IL6;BCL9L;SMAD4;ZNF385A
gsea,ribosome biogenesis (GO:0042254),0.25077444676657107,0.8764298170087151,0.6346153846153846,0.9067294212300429,1.0,58/192,24.73%,RIOK1;NOP58;PAK1IP1;RRP36;EXOSC8;TEX10;RRP1B;DHX29;XPO1;ABCE1;ENST00000630540.2;WDR75;DDX52;RPL30;NPM1;NAF1;DCAF13;RAN;UTP20;WDR43;LYAR;RPL41;NOLC1;DIS3;LTV1;MRTO4;BMS1;METTL17;WDR3;NOL6;SDAD1;NOM1;RPF1;RPL35A;MPHOSPH6;EXOSC10;RCL1;RPS27;DDX27;NOP16;DKC1;ESF1;WDR12;GTF3A;HEATR1;RPL23;RPL6;URB2;FCF1;UTP4;RPS24;UTP18;RRS1;MTREX;UTP15;CUL4B;SBDS;POP5
gsea,fatty acid derivative biosynthetic process (GO:1901570),0.31809173500869636,0.8749010228211294,0.6851851851851852,0.9089041757010313,1.0,9/40,35.65%,FAR1;FASN;AACS;SCD;ACACA;ACAT1;SCD5;CBR4;ACLY
gsea,peptide metabolic process (GO:0006518),-0.24375280845316627,-0.8731400692037025,0.6226415094339622,1.0,1.0,7/83,10.38%,GSTZ1;ETHE1;CPZ;BACE2;SPCS2;GGT1;SPPL3
gsea,negative regulation of blood vessel morphogenesis (GO:2000181),0.27947015414014875,0.871800186753554,0.5833333333333334,0.9143043780696309,1.0,8/78,24.72%,ROCK2;PGK1;NAXE;STAT1;ROCK1;AGO1;FOXJ2;SYNJ2BP
gsea,negative regulation of Ras protein signal transduction (GO:0046580),-0.26224103612164074,-0.8715526996710661,0.7045454545454546,1.0,1.0,7/35,24.07%,CUL3;FLCN;TNFAIP1;KCTD13;HEG1;DAB2IP;ARHGAP35
gsea,regulation of viral transcription (GO:0046782),-0.22987148275215094,-0.8709364824784294,0.6666666666666666,1.0,1.0,10/41,15.88%,NELFB;ZFP36;TARBP2;POLR2F;TRIM11;GTF2F1;HEXIM1;POLR2A;POLR2G;TRIM13
gsea,positive regulation of gene silencing by miRNA (GO:2000637),0.262377420987819,0.8709286531379977,0.62,0.9150394686477372,1.0,4/27,10.91%,DHX9;MAP2K1;PUM2;DDX5
gsea,negative regulation of developmental growth (GO:0048640),-0.31087365963632624,-0.8706025455433376,0.6481481481481481,1.0,1.0,4/32,14.60%,PTCH1;GDF15;DCC;WWC1
gsea,positive regulation of cytokine production (GO:0001819),0.2005636314631513,0.8704812037820324,0.7358490566037735,0.9147784391215997,1.0,28/335,19.54%,DHX9;PRKDC;BRCA1;GAPDH;HSPD1;XRCC5;HMGB1;SLC7A5;PNP;ADAM17;ROCK2;CD58;PARK7;BCL10;APPL1;LRRFIP1;TBK1;PTPN11;STOML2;PQBP1;POLR2K;ARNT;POLR3F;RUNX1;EIF2AK2;F2RL1;F3;XBP1
gsea,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.22145893737065658,0.8695385410149465,0.6585365853658537,0.9155966890981011,1.0,23/79,33.46%,PLK1;BAG2;NUB1;CSNK1E;STUB1;PIAS1;HECTD1;ELOB;RNF14;PSMD10;VCP;COP1;SH3RF2;GSK3B;ARIH1;LAPTM5;SUMO1;TRIB3;FBXO22;PTK2;CSNK1A1;RBX1;ZER1
gsea,regulation of peptidase activity (GO:0052547),-0.3086629735137112,-0.8694420353369183,0.6122448979591837,1.0,1.0,4/23,11.70%,NDUFA13;SVBP;PRSS22;CSTB
gsea,positive regulation of B cell activation (GO:0050871),-0.29401130615739907,-0.8684770151054478,0.675,1.0,1.0,8/53,17.50%,MMP14;TP53BP1;CD27;CD74;IRS2;KMT5C;SH3KBP1;IL6
gsea,cellular response to tumor necrosis factor (GO:0071356),0.22358444817252066,0.8680860537042769,0.7169811320754716,0.9175414494062,1.0,26/194,22.51%,DHX9;BRCA1;PSMD14;PSMD6;PSMB2;PSMD5;ADAM17;PSMD1;CD58;PSMA5;PSMD11;PSMA4;PSMA3;PSME4;PSMD7;ENST00000629691.2;STAT1;PSMC6;PSMA1;PSMD10;PSMB3;GBP3;SFRP1;PSME1;PSMC3;NFE2L2
gsea,protein localization to cell periphery (GO:1990778),-0.22401620405596337,-0.8678285127018419,0.7962962962962963,1.0,1.0,17/140,14.59%,RAPGEF2;GAS6;TSPAN17;RAB13;TTC7A;RAB10;RAB40C;PTCH1;SLC9A3R2;JUP;CRB3;INPP5K;PLEKHF1;PDZK1;CACNB3;RAB34;MAP7
gsea,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.2782641910178412,0.8667714687315649,0.6511627906976745,0.919310549176682,1.0,12/36,43.29%,PPP3R1;TNRC6A;AGO1;NLK;AGO2;MAP3K7;TNRC6B;CALM1;GNB1;PPP3CB;PLCB3;AGO4
gsea,plasma membrane bounded cell projection assembly (GO:0120031),0.20933964841431116,0.8665084691507396,0.7567567567567568,0.9186702299215647,1.0,36/278,25.16%,STK26;PLK4;RAB8A;EHD4;ANO6;TMEM138;SNX10;CARMIL1;MKKS;OFD1;ACTR2;RABL2B;RAP1B;GBF1;IFT74;ACTR3;VCL;PIP5K1A;CFAP298;TMEM107;ITGB1;EMP3;RAP2A;CD2AP;IFT122;NOTCH1;EXOC2;GOLPH3;RAB11A;ARFIP2;TCTN3;CEP250;TCTN1;CYFIP1;EMP2;RAP1A
gsea,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.1976320566042843,0.8663975545130389,0.8367346938775511,0.9176226666259415,1.0,47/171,38.10%,NUP62;GAPDH;ZDHHC13;TRIM14;TFRC;BCL10;FKBP1A;DDX21;SLC44A2;TBK1;SLC20A1;NDFIP2;RHOA;BRD4;F2RL1;TNIP2;RIPK2;TERF2IP;TFG;PPM1A;ECT2;TRIM52;UBE2N;PPP5C;DDX1;TRAF3IP2;HMOX1;NEK6;ATP2C1;DHX36;FLNA;MTDH;CHUK;ANKRD17;TNFSF10;MIER1;MAP3K7;IRAK1;BIRC2;BIRC3;WLS;VAPA;TRIM32;MAP3K14;NDFIP1;GOLT1B;CC2D1A
gsea,protein N-linked glycosylation (GO:0006487),0.23169104759340817,0.8662965098407202,0.6274509803921569,0.9166798061844555,1.0,24/67,36.56%,UGGT1;DPM2;GFPT1;RPN2;LMAN1;SLC39A8;ALG3;MGAT1;PGM3;RPN1;ALG11;OSTC;STT3A;DPAGT1;MOGS;TMEM165;ALG13;ALG8;MCFD2;B4GALT1;ALG2;FUT8;MPDU1;UBE2J1
gsea,positive regulation of growth (GO:0045927),0.23596795784180905,0.8638885787022426,0.6326530612244898,0.9205482482141858,1.0,15/76,28.46%,NCBP1;ADAM17;SUPV3L1;PSMD10;INO80;SFRP1;USP47;FXN;TAF9B;RPS6KA3;MTPN;EIF4G1;WFS1;RPTOR;ZPR1
gsea,positive regulation of protein binding (GO:0032092),-0.22679633843193175,-0.8630049177963952,0.6181818181818182,1.0,1.0,7/58,10.38%,RAPGEF2;RPL11;BAMBI;APP;MEN1;HIP1R;SPPL3
gsea,regulation of protein modification process (GO:0031399),0.2498312803800607,0.8621483413883226,0.7073170731707317,0.9233378348454064,1.0,4/51,8.15%,PUM3;CORO1C;FN1;PPP2CA
gsea,IRE1-mediated unfolded protein response (GO:0036498),0.24280756740190856,0.8621149138001668,0.6888888888888889,0.9222557762355686,1.0,15/53,27.82%,SRPRA;GFPT1;SSR1;DNAJC3;PDIA6;HSPA5;EDEM1;XBP1;KDELR3;SRPRB;PDIA5;DNAJB11;DDX11;WFS1;YIF1A
gsea,positive regulation of T cell proliferation (GO:0042102),0.27647823754455725,0.860605695543869,0.6190476190476191,0.9243083380022362,1.0,3/66,5.90%,HMGB1;TFRC;PNP
gsea,regulation of exocytosis (GO:0017157),-0.27165585110937923,-0.8605998975481552,0.6666666666666666,1.0,1.0,10/52,29.21%,RAB13;STX4;RAB10;VAMP2;RAB3D;SNCA;CHMP6;ATP6AP1;UNC13D;RAB15
gsea,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.24097017400089765,0.860056923982271,0.7045454545454546,0.9242084443559712,1.0,8/44,31.27%,TMF1;DDX5;PLPP1;RNF14;NR3C1;KDM3A;NCOA4;NEDD4
gsea,epithelium development (GO:0060429),0.21943015947960723,0.8595211968252502,0.7446808510638298,0.9240919112487959,1.0,11/122,14.62%,PCNA;CDK1;ANXA7;STIL;ZNF358;TIMELESS;PGK1;EHF;CNN3;STAT1;VCL
gsea,regulation of Ras protein signal transduction (GO:0046578),0.22752096920227005,0.859469861074598,0.7254901960784313,0.9230311479931371,1.0,14/86,23.69%,NUP62;FOXM1;SYNGAP1;LRRC59;STAMBP;SGSM3;DENND1A;RALGPS1;KIF14;NOTCH1;DENND4B;SHOC2;RASGRP1;CRKL
gsea,histone H4 acetylation (GO:0043967),0.25851110051700416,0.8583160199639364,0.6956521739130435,0.9242976943055964,1.0,5/48,11.18%,KAT7;MSL3;WDR5;KANSL1;TRRAP
gsea,positive regulation of stress fiber assembly (GO:0051496),0.2924399258270878,0.8582994728232285,0.6730769230769231,0.9231720002369693,1.0,5/44,10.32%,FHOD1;ROCK2;PFN2;FERMT2;CARMIL1
gsea,purine ribonucleotide metabolic process (GO:0009150),0.2332205830039828,0.8578704519977649,0.660377358490566,0.9226876354449128,1.0,13/77,32.63%,HPRT1;ACOT9;ACOT7;RAN;OPA1;THEM4;EFL1;SULT2B1;ACAT1;GTPBP1;ACBD6;EPHA2;SULT1A4
gsea,mRNA splice site selection (GO:0006376),0.2606933295342142,0.8575336086729519,0.6938775510204082,0.922355514135793,1.0,3/30,9.24%,SFSWAP;SRSF1;SETX
gsea,regulation of anatomical structure morphogenesis (GO:0022603),0.22217914405898181,0.8569658286488605,0.6382978723404256,0.9222588865971517,1.0,22/123,31.76%,CHN1;MYO19;ZMYM3;FERMT2;SH3D19;ZMYM4;RAP2A;MARK2;SFRP1;INF2;PHIP;GSK3B;PAK2;EMP2;PHLDB2;HMOX1;CLASP1;TNFAIP3;BCL6;NEDD4L;NEDD4;EPHA2
gsea,positive regulation of transcription by RNA polymerase II (GO:0045944),0.1990260209040619,0.8560424103847781,0.7391304347826086,0.9228321741464989,1.0,107/908,21.82%,DHX9;ATAD2;E2F8;E2F7;PRKDC;BRCA1;E2F1;TMF1;FHOD1;MYBL2;MED17;SMARCA5;RRP1B;LPIN1;RNF4;KAT7;HMGB1;CKAP2;FOXM1;ZBED4;NKRF;DR1;HMGA2;PPP3R1;PARP1;RBM14;CTBP2;ZBTB18;JMJD6;SIN3A;PRDM4;BCLAF1;SUPT16H;NPM1;LEO1;ELK3;FOXA1;CDK8;SETX;SS18;PARK7;IRF2;EHF;GABPA;FOXJ3;USP16;RPS6KA4;WASL;GLYR1;HDAC3;ACTR2;MED21;AKIRIN2;TBK1;ACTR3;CEBPZ;PAXIP1;GATA2;BPTF;STAT1;CCNC;TOX2;HNRNPU;RPS27A;ELF4;CDC5L;DLGAP5;MED6;GCN1;STAT5B;SUB1;ZNF268;RNA5SP498;ARNT;BRD4;TBL1XR1;ITGA6;RUNX1;ENG;KLF10;BMP4;NOTCH1;HDAC2;VEGFA;F2RL1;MEPCE;E2F3;INO80;XBP1;TNIP1;SNW1;MUC1;AGO1;EPAS1;PPP1R12A;NUFIP1;FOXJ2;HIF1A;GABPB1;TNIP2;RIPK2;CREB1;RPS6KA3;NCOA6;PSMC3;GAL;PHIP
gsea,regulation of protein localization to cell surface (GO:2000008),-0.29338733295936537,-0.8555096349300613,0.6610169491525424,1.0,1.0,3/33,5.26%,SNX33;STX4;TAX1BP3
gsea,7-methylguanosine RNA capping (GO:0009452),0.22849413500609417,0.854101098028932,0.75,0.9249431780259505,1.0,5/32,12.17%,NCBP1;RNGTT;GTF2F2;POLR2B;GTF2H1
gsea,7-methylguanosine mRNA capping (GO:0006370),0.22849413500609417,0.854101098028932,0.75,0.9249431780259505,1.0,5/32,12.17%,NCBP1;RNGTT;GTF2F2;POLR2B;GTF2H1
gsea,positive regulation of leukocyte chemotaxis (GO:0002690),0.27781695653543037,0.8539641261791745,0.6545454545454545,0.9239931534458339,1.0,8/54,19.12%,HMGB1;ADAM17;ANO6;C1QBP;LGMN;MAPK1;VEGFA;F2RL1
gsea,global genome nucleotide-excision repair (GO:0070911),0.2785055422593984,0.8535699612718227,0.6304347826086957,0.923695193208228,1.0,7/26,19.59%,PARP1;RAD23B;DDB2;GTF2H1;RPS27A;CHD1L;CETN2
gsea,maintenance of protein localization in organelle (GO:0072595),0.2917370077091621,0.8530731178246139,0.6666666666666666,0.923780672279379,1.0,4/19,22.35%,ARL2BP;HSPA5;HNRNPU;SKP1
gsea,secondary alcohol metabolic process (GO:1902652),0.2673551311040118,0.8525150894311482,0.76,0.9240321354405446,1.0,11/49,37.37%,IDH3A;SOAT1;SQLE;UGT1A3;SULT2B1;PPARD;IDH1;EBP;CLN6;FDX1;SCAP
gsea,positive regulation of cell-matrix adhesion (GO:0001954),0.2586497459109995,0.852079016651756,0.7948717948717948,0.9239676039806561,1.0,10/44,24.93%,CDK6;FERMT2;RIN2;ROCK1;VEGFA;PLEKHA2;SFRP1;GSK3B;EMP2;CEACAM6
gsea,negative regulation of cell cycle (GO:0045786),0.24129561738785496,0.8516038371284402,0.7021276595744681,0.9236048113670086,1.0,10/80,19.65%,PLK1;GMNN;MAD2L1;PTPN3;CDK6;IPO7;RB1;ENST00000618924.4;BMP4;TFAP4
gsea,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.25746633054310897,-0.8511499149409706,0.7142857142857143,1.0,1.0,7/25,19.60%,BBC3;BMF;PYCARD;BAX;BAD;PINK1;BIK
gsea,ncRNA catabolic process (GO:0034661),0.25823012928148203,0.8504296873166844,0.7,0.9251802610176435,1.0,9/30,26.44%,EXOSC8;DIS3L;DIS3;EXOSC10;TENT4B;MTREX;ZCCHC8;SLFN13;DIS3L2
gsea,regulation of cholesterol metabolic process (GO:0090181),0.3040717506302276,0.8500250872940301,0.7045454545454546,0.9247341840349292,1.0,5/21,29.65%,RAN;LPCAT3;MBTPS2;KPNB1;ARV1
gsea,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.27351856884207393,-0.8494160836574388,0.6909090909090909,1.0,1.0,12/62,25.78%,REST;NDUFA13;FIS1;PYCARD;IFI16;BAK1;BAD;MYC;BCAP31;FADD;CTSD;ARL6IP5
gsea,negative regulation of macroautophagy (GO:0016242),-0.2794009243554576,-0.8484666585582892,0.62,1.0,1.0,6/26,23.07%,ENST00000645179.2;SCFD1;QSOX1;PINK1;TSC2;ENST00000639332.2
gsea,protein deacetylation (GO:0006476),0.23627110045826127,0.847473942792339,0.7021276595744681,0.9285509467280232,1.0,11/45,34.11%,MSL3;RBM14;SIN3A;HDAC3;TBL1XR1;HDAC2;RCOR1;FLNA;MORF4L2;HDAC10;MIER1
gsea,positive regulation of hydrolase activity (GO:0051345),-0.19512809287634356,-0.8469670420228277,0.8571428571428571,1.0,1.0,12/149,9.31%,RAPGEF2;SRGAP2;RAB3GAP1;NDUFA13;RGS10;ARAP1;PRSS22;PSAP;AGRN;ERBB2;MTCL1;PLXNB1
gsea,negative regulation of epithelial cell migration (GO:0010633),-0.2838178507040064,-0.8460892328433192,0.6792452830188679,1.0,1.0,6/35,20.26%,SVBP;MARVELD3;THBS1;PTPRM;EPPK1;DAB2IP
gsea,negative regulation of ERBB signaling pathway (GO:1901185),-0.27426659044008805,-0.8451894779824555,0.6491228070175439,1.0,1.0,10/40,23.37%,MVP;RNF126;EGFR;ERBB2;SH3KBP1;DAB2IP;DUSP3;HGS;PTPN12;GRB2
gsea,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.24702157044931244,-0.8446152503997431,0.7169811320754716,1.0,1.0,7/89,6.41%,REST;GAS6;NDUFA13;BEX3;FIS1;IFI6;PYCARD
gsea,inorganic anion transmembrane transport (GO:0098661),0.24136465027473897,0.8435135478058764,0.8490566037735849,0.9360870985657814,1.0,4/65,13.59%,CLCN3;ANO6;ANO1;SLC20A1
gsea,receptor metabolic process (GO:0043112),0.22650378882072775,0.8434854658488881,0.6829268292682927,0.9350691702981532,1.0,18/58,39.01%,TFRC;DNM2;LGMN;PIK3R4;SNX1;ITGB1;ACKR3;DNM1;LMTK2;ARFGEF2;CD9;NEDD4;NSG1;AP2M1;GRK2;BECN1;RAB31;CAV1
gsea,protein localization to organelle (GO:0033365),-0.21325111470829022,-0.8434411051170039,0.7115384615384616,1.0,1.0,12/142,6.78%,TSPAN10;DDRGK1;TIA1;PPP1R15A;RPL11;TSPAN17;LMNA;OBSL1;TOLLIP;APP;PACSIN2;PAF1
gsea,neutrophil mediated immunity (GO:0002446),0.20067714121521574,0.843346519972129,0.6530612244897959,0.9342676644764248,1.0,97/488,29.45%,CCT8;DYNC1LI1;SVIP;TUBB;FUCA2;XRCC5;HMGB1;HSPA8;HSP90AA1;PSMD14;DSN1;PSMD6;ALDOA;GGH;IQGAP1;ILF2;PNP;ADAM17;PSMD1;FABP5;ERP44;GPI;HUWE1;CD58;CAND1;PSMA5;PGM2;PSMD11;ANO6;ANPEP;CCT2;RAB14;PGRMC1;PA2G4;TUBB4B;DNAJC3;DIAPH1;PSMD7;ACTR2;SLC44A2;RAP1B;ATP11B;UBR4;TIMP2;RHOF;NAPRT;PGM1;SRP14;DNAJC13;VCL;PRDX4;ADGRE5;VAMP7;RHOA;HSP90AB1;MAPK1;CKAP4;ROCK1;AGL;NRAS;VCP;COMMD9;MLEC;GLA;PTAFR;PKM;CRISPLD2;HEXB;PSMC3;TXNDC5;SPTAN1;CAB39;PGAM1;RAB7A;RAB5C;CYFIP1;CTSC;YPEL5;CEACAM6;RAP1A;ATP6V0A1;PSMD13;QPCT;PDAP1;ATP11A;RAB27A;MGST1;TMEM63A;SLC15A4;COPB1;KPNB1;GLIPR1;IDH1;IGF2R;ATG7;RAB5B;ANXA2
gsea,regulation of cell-matrix adhesion (GO:0001952),0.2348917649108089,0.842978169917138,0.5957446808510638,0.9341256402043351,1.0,13/65,24.42%,CAMSAP3;CORO1C;ROCK2;SLK;CDK6;PIK3CB;VCL;RHOA;ROCK1;PLEKHA2;SFRP1;GSK3B;EMP2
gsea,cellular response to cytokine stimulus (GO:0071345),0.2100008382350653,0.8427628948429323,0.78,0.9333436250153252,1.0,53/482,23.69%,PLP2;DHX9;BRCA1;GAPDH;USP10;HSP90B1;HSPA8;HSP90AA1;PTPN20;FN1;PNPT1;CD58;SOS1;SHMT1;JAK1;PIK3CB;TPR;OSMR;SHPK;YWHAZ;TBK1;PTPN11;SYNCRIP;STAT1;HNRNPU;RPS27A;CRK;BIRC5;RHOA;STAT5B;IL13RA1;ITGB1;TCF7;IL4R;GBP3;VEGFA;F3;XBP1;UBE2K;MUC1;SFRP1;PTAFR;HIF1A;PTPN2;WNK1;IL10RB;IFNAR1;IL1RN;NFE2L2;GSK3B;PDE2A;MAPK8;CRKL
gsea,negative regulation of DNA recombination at telomere (GO:0048239),0.280976754794343,0.8416848849135432,0.7083333333333334,0.9335705839331605,1.0,7/22,29.11%,POLR2B;ACD;POLR2K;TERF2IP;POLR2L;POLR2C;POLR2E
gsea,regulation of DNA recombination at telomere (GO:0072695),0.280976754794343,0.8416848849135432,0.7083333333333334,0.9335705839331605,1.0,7/22,29.11%,POLR2B;ACD;POLR2K;TERF2IP;POLR2L;POLR2C;POLR2E
gsea,glycosaminoglycan metabolic process (GO:0030203),-0.2779074220042623,-0.8407131432496507,0.74,1.0,1.0,14/54,28.51%,NDST2;NDST1;AGRN;B3GAT3;GLB1;SDC4;B4GALT7;HYAL2;B3GALT6;EXT1;HEXA;HS6ST1;HS3ST1;HGSNAT
gsea,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.2451233081766249,-0.8406044339216305,0.6538461538461539,1.0,1.0,3/25,8.44%,NR1H3;UBXN1;NR1H2
gsea,positive regulation of intracellular protein transport (GO:0090316),0.20351709257915154,0.8400593980844732,0.7446808510638298,0.9356059080002864,1.0,31/148,26.23%,KIF20B;E2F1;YWHAE;NPEPPS;GTSE1;ZFAND1;YWHAH;PPP3R1;HUWE1;RAN;ANP32B;TPR;HDAC3;YWHAZ;ICE1;SAR1B;XPO4;YWHAB;TMEM30B;RBM22;BID;CDH1;SEC16A;ECT2;GSK3B;MAPK8;MFF;YWHAQ;SFN;USP36;EMD
gsea,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.19583566957842097,0.8399063647854346,0.7692307692307693,0.9347441711174325,1.0,15/133,18.57%,HFE;FERMT2;ID1;FKBP1A;APPL1;DDX5;STUB1;RPS27A;ADAM9;TWSG1;RHOA;ITGB1;ENST00000618924.4;ENG;BMP4
gsea,cardiac ventricle morphogenesis (GO:0003208),-0.2845701485420612,-0.8385389073067263,0.6739130434782609,1.0,1.0,4/44,16.56%,SOX4;TPM1;SMAD7;TNNC1
gsea,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.18750141002042472,0.8385199363576715,0.8,0.9363651977565256,1.0,38/224,27.77%,NUP62;GAPDH;USP10;ZDHHC13;TRIM14;TFRC;BCL10;FKBP1A;DDX21;SLC44A2;TBK1;SLC20A1;STAT1;NDFIP2;UFL1;RHOA;BRD4;F2RL1;TNIP1;TNIP2;RIPK2;TERF2IP;PDPK1;TFG;PPM1A;TRIM59;ECT2;TRIM52;UBE2N;PPP5C;DDX1;TRAF3IP2;HMOX1;TNFAIP3;NEK6;ATP2C1;DHX36;FLNA
gsea,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.2920151079943393,-0.8379757621448596,0.6923076923076923,1.0,1.0,5/21,19.51%,PHLDA3;PYCARD;IFI16;BCL3;DYRK2
gsea,small GTPase mediated signal transduction (GO:0007264),-0.22005465540648747,-0.8365924763456181,0.7735849056603774,1.0,1.0,15/106,16.25%,RAPGEF2;TIAM2;PLD2;RGL2;TNK2;RAB42;RRAS;RRAD;CDKN2A;ABR;NUCB1;TRIM28;MAPK14;ARHGEF18;MAPK11
gsea,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.2643187885668185,0.8364018221340253,0.7142857142857143,0.9392864080718305,1.0,6/27,17.88%,SUPT16H;RNF8;LEO1;WDR43;HNRNPU;BRD4
gsea,branched-chain amino acid catabolic process (GO:0009083),0.27740925473795,0.8361531524509495,0.6511627906976745,0.9375623762355367,1.0,9/20,40.83%,BCAT1;DLD;ACAT1;MCCC2;HSD17B10;SLC25A44;IVD;BCKDK;AUH
gsea,branched-chain amino acid metabolic process (GO:0009081),0.27740925473795,0.8361531524509495,0.6511627906976745,0.9375623762355367,1.0,9/20,40.83%,BCAT1;DLD;ACAT1;MCCC2;HSD17B10;SLC25A44;IVD;BCKDK;AUH
gsea,regulation of JUN kinase activity (GO:0043506),-0.31817379328794704,-0.8343921039310783,0.6862745098039216,1.0,1.0,9/35,23.71%,DKK1;DVL2;MAP3K11;SASH1;ARHGEF5;DAB2IP;TRAF2;DVL3;GSTP1
gsea,beta-catenin-TCF complex assembly (GO:1904837),-0.29167039645848375,-0.8338661283342329,0.5918367346938775,1.0,1.0,10/29,29.22%,MEN1;PYGO2;SMARCA4;MYC;BCL9L;BCL9;CDC73;KMT2D;CTNNB1;TLE1
gsea,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.2798556714969903,0.8335704246912419,0.7254901960784313,0.9415274609204042,1.0,4/28,24.50%,EEF1E1;DDX5;PSMD10;ATR
gsea,positive regulation of phosphate metabolic process (GO:0045937),-0.2509408974272541,-0.8334559962952177,0.7169811320754716,1.0,1.0,6/30,24.29%,APP;EGFR;THBS1;FZD7;SNCA;ILK
gsea,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.23948109786365296,0.8327824975907119,0.7555555555555555,0.9419464547866626,1.0,7/51,14.77%,CORO1C;P4HB;FERMT2;C1QBP;CARMIL1;DOCK5;CRK
gsea,cellular protein localization (GO:0034613),-0.19058531644083124,-0.8321601049262106,0.7272727272727273,1.0,1.0,43/329,18.23%,SNX8;ARMCX3;CD63;RAB43;LAMTOR2;ABHD17A;UNC93B1;STX4;TMED9;EGFR;RAB20;GGA1;RAB1A;SNX15;WNT5A;UNC50;TBC1D3L;CD74;ERP29;ENST00000646762.2;STX16;SH3PXD2B;SCFD1;KIF13A;HPS6;TBC1D22A;ATG13;RRAGB;IFT27;ATG9B;IFT22;TMED3;TBC1D16;TBC1D2;CTSA;CORO1B;TBC1D1;RAB1B;ARL4C;TMEM250;WDR45;SIL1;VPS26B
gsea,autophagosome maturation (GO:0097352),-0.2708043859992521,-0.8316780515736141,0.6545454545454545,1.0,1.0,8/34,19.94%,VAMP8;ATP2A2;CLN3;VMP1;GABARAPL1;ATG14;GABARAP;LAMP2
gsea,cholesterol transport (GO:0030301),0.27498816364398426,0.8316280124582595,0.7291666666666666,0.9433366791046518,1.0,8/51,29.93%,SOAT1;OSBPL2;LDLR;NPC1;APOC1;OSBP;LIMA1;LIPG
gsea,positive regulation of interleukin-6 production (GO:0032755),0.31447110720183047,0.8315700349596923,0.7142857142857143,0.9422959172554572,1.0,7/76,19.54%,DHX9;HSPD1;HMGB1;BCL10;PTPN11;F2RL1;XBP1
gsea,cellular nitrogen compound biosynthetic process (GO:0044271),0.26355324816462533,0.8313702739385013,0.7058823529411765,0.9414677765819424,1.0,3/31,14.25%,DDAH2;ARG2;SPTLC1
gsea,post-Golgi vesicle-mediated transport (GO:0006892),-0.2199473430175554,-0.8312203542246069,0.711864406779661,1.0,1.0,9/89,6.88%,BLOC1S4;VAMP8;BLOC1S1;APP;STX4;RAB10;FTH1;SNAP23;SCAMP2
gsea,metallo-sulfur cluster assembly (GO:0031163),0.2933884566159266,0.8305544888338005,0.6304347826086957,0.9421270451820918,1.0,5/22,23.37%,LYRM4;HSPA9;MMS19;FXN;CIAO2A
gsea,purine nucleotide metabolic process (GO:0006163),0.3218012922122254,0.8302865859287936,0.6041666666666666,0.9415107180863541,1.0,4/24,12.62%,HPRT1;GART;PNP;PPAT
gsea,muscle organ development (GO:0007517),-0.30244496627009904,-0.8296594302440281,0.7209302325581395,1.0,1.0,8/58,27.76%,TCF12;SRI;SMTN;CTF1;FKTN;FHL3;SPEG;TAGLN
gsea,regulation of stem cell population maintenance (GO:2000036),0.28956703151470925,0.8292919812726351,0.6326530612244898,0.9425066417987054,1.0,10/19,34.68%,HMGA2;WDR43;ELAVL1;PTN;LOXL2;CNOT3;CNOT1;KAT2A;ZC3H13;CNOT2
gsea,positive regulation of GTPase activity (GO:0043547),-0.1872328708869369,-0.8287100099677843,0.8367346938775511,1.0,1.0,32/214,23.02%,RAPGEF2;TIAM2;SRGAP2;RAB3GAP1;RGS10;ARAP1;TAX1BP3;GMIP;AGRN;ERBB2;TBC1D3L;PLXNB1;ABR;TBC1D22A;FLCN;RAPGEF1;AFDN;TBC1D16;TBC1D2;TBC1D1;ARHGEF16;SCRIB;MAP4K4;ARHGEF5;TBC1D17;SIPA1L3;SH3BP1;DVL3;TBC1D9B;BCAR3;EVI5L;RASGRF1
gsea,regulation of cell motility (GO:2000145),0.19678282012091255,0.8285449158084798,0.8125,0.9426314115419167,1.0,14/133,17.65%,CAMSAP3;KIF2A;MEMO1;ROCK2;SLK;CDK6;DIAPH1;LMO4;ARHGAP18;CRK;KIF14;DOCK10;RHOA;ROCK1
gsea,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.20695851829428347,-0.8284814133385826,0.7551020408163265,1.0,1.0,44/246,28.57%,TRADD;DDRGK1;CIB1;TICAM1;APP;HDAC5;TP53BP1;PYCARD;WNT5A;CFLAR;TRIM8;TAB1;DVL2;JUP;SRF;TFDP1;TAB2;FANK1;ZBTB7A;TRIM13;LGALS9;SMARCA4;PRKCZ;UBB;IL6;UBC;RIPK1;ARHGEF5;DDIT3;RBCK1;TRAF2;NFKB2;MAVS;NFKBIA;TAB3;FZD2;IL18;RNF25;PLPP3;ADAM8;CLU;TRIM41;CTNNB1;HDAC4
gsea,protein dephosphorylation (GO:0006470),0.2056169418757499,0.828255833667366,0.7291666666666666,0.9421452310308529,1.0,15/139,14.28%,PPP1CC;PTPN3;TIMM50;MTMR6;PPP2CA;PPP1CA;PPP2R1B;UBASH3B;PPP4R2;PGP;CTDSP1;PTPN11;PPP6C;PPP2R5A;PPM1G
gsea,regulation of stress-activated MAPK cascade (GO:0032872),-0.22337826406502936,-0.8280142842190051,0.6808510638297872,1.0,1.0,13/49,25.78%,MAPK3;STK25;TAOK2;EGFR;MAPK8IP3;MAP2K2;LGALS9;MYC;MAP4K4;DAB2IP;GSTP1;SEMA4C;ARL6IP5
gsea,protein localization to lysosome (GO:0061462),0.2901423771638674,0.8279045493762827,0.7083333333333334,0.941804655585945,1.0,8/28,31.27%,GCC2;RTN4;RAB7A;M6PR;LAPTM5;SCARB2;NCOA4;NEDD4
gsea,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.25106051923575273,0.827281555711509,0.6481481481481481,0.942138227665089,1.0,9/34,28.30%,BRCA1;RFFL;RNF34;PARK7;FAIM;GSK3B;HMOX1;TNFAIP3;TNFRSF10A
gsea,proteolysis involved in cellular protein catabolic process (GO:0051603),0.21536741950968108,0.8269447408874536,0.7058823529411765,0.9416223169655984,1.0,17/74,28.90%,RSPRY1;IDE;VPS4B;STUB1;PDCD6IP;RPS27A;LGMN;CHMP4C;VCP;CLPX;CTSC;CUL4B;PSMA6;PRPF19;TNFAIP3;DDI2;DDB1
gsea,positive regulation of kinase activity (GO:0033674),-0.21350769557219978,-0.8257955767904495,0.8148148148148148,1.0,1.0,14/114,21.10%,EPHB4;RAPGEF2;GAS6;EGFR;ERBB2;CD74;PRKAG1;TAB2;PTK2B;JTB;CSF1;TIGAR;ZNF622;ENST00000639837.1
gsea,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.2713059866142593,0.8256225733634305,0.6938775510204082,0.943026940879235,1.0,13/55,28.18%,YWHAE;ARL6IP1;RFFL;RNF34;PARK7;VEGFA;DHCR24;USP47;RPS6KA3;PAK2;SFN;RAF1;BCL2L12
gsea,regulation of cellular biosynthetic process (GO:0031326),0.3114271165180723,0.8255490491123664,0.7083333333333334,0.9420479063738502,1.0,1/32,1.24%,ENST00000645126.2
gsea,positive regulation of chemokine production (GO:0032722),0.2830430774452798,0.8255030710627365,0.6956521739130435,0.9410392536778887,1.0,6/53,20.97%,OAS3;HMGB1;ADAM17;EIF2AK2;F2RL1;HIF1A
gsea,monocarboxylic acid biosynthetic process (GO:0072330),0.28295173191836887,0.8253963570900811,0.7291666666666666,0.9402082829796351,1.0,10/63,29.93%,ABCD3;AMACR;OSBPL3;PARK7;OSBPL2;XBP1;ACACA;OSBP;HSD17B10;LIPG
gsea,positive regulation of neuron projection development (GO:0010976),-0.23863230731475266,-0.8253339529022246,0.7391304347826086,1.0,1.0,9/88,16.78%,RAPGEF2;RETREG3;WNT5A;DBN1;MDK;PTK2B;RAPGEF1;PTK7;CAPRIN1
gsea,regulation of mitochondrion organization (GO:0010821),-0.23250132789082728,-0.82378337466798,0.7169811320754716,1.0,1.0,8/48,14.69%,FIS1;RHOT1;ENST00000639874.2;ENST00000638355.1;STAT2;FLCN;PRMT6;RHOT2
gsea,negative regulation of angiogenesis (GO:0016525),0.2539088748387348,0.8234692369348241,0.6739130434782609,0.9424517241517659,1.0,8/87,20.67%,ROCK2;PGK1;PIK3CB;NAXE;STAT1;ROCK1;AGO1;FOXJ2
gsea,neutrophil degranulation (GO:0043312),0.19956261177651102,0.8218839600507267,0.6808510638297872,0.9441333912235819,1.0,96/481,29.45%,CCT8;DYNC1LI1;SVIP;TUBB;FUCA2;XRCC5;HMGB1;HSPA8;HSP90AA1;PSMD14;DSN1;PSMD6;ALDOA;GGH;IQGAP1;ILF2;PNP;PSMD1;FABP5;ERP44;GPI;HUWE1;CD58;CAND1;PSMA5;PGM2;PSMD11;ANO6;ANPEP;CCT2;RAB14;PGRMC1;PA2G4;TUBB4B;DNAJC3;DIAPH1;PSMD7;ACTR2;SLC44A2;RAP1B;ATP11B;UBR4;TIMP2;RHOF;NAPRT;PGM1;SRP14;DNAJC13;VCL;PRDX4;ADGRE5;VAMP7;RHOA;HSP90AB1;MAPK1;CKAP4;ROCK1;AGL;NRAS;VCP;COMMD9;MLEC;GLA;PTAFR;PKM;CRISPLD2;HEXB;PSMC3;TXNDC5;SPTAN1;CAB39;PGAM1;RAB7A;RAB5C;CYFIP1;CTSC;YPEL5;CEACAM6;RAP1A;ATP6V0A1;PSMD13;QPCT;PDAP1;ATP11A;RAB27A;MGST1;TMEM63A;SLC15A4;COPB1;KPNB1;GLIPR1;IDH1;IGF2R;ATG7;RAB5B;ANXA2
gsea,mitochondrion organization (GO:0007005),0.2036419565311994,0.8217292968454123,0.7115384615384616,0.9433811308386088,1.0,48/175,33.51%,HSPD1;ATPAF1;PARP1;MYH14;TOMM5;SUPV3L1;TIMM50;PNPT1;DNM1L;AFG3L2;NDUFS1;PARK7;OPA1;GABPA;MTFR1;DNM2;MGME1;STOML2;TFAM;MTERF1;CHCHD3;GABPB1;BID;PRDX3;DNM1;FBXO7;CYCS;TOMM34;COX7A2L;MFF;AIFM1;MTX2;TRAK2;PHB2;PISD;SLC25A36;TOMM70;HSD17B10;SLIRP;RAB38;TIMM13;DNAJC19;MIGA2;YME1L1;CHCHD4;ALAS1;PITRM1;HK2
gsea,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.20510642539048451,-0.8213179434592363,0.7555555555555555,1.0,1.0,8/68,18.10%,BAMBI;FAM89B;SKIL;SMAD7;ZBTB7A;UBB;UBC;BCL9L
gsea,negative regulation of multicellular organismal process (GO:0051241),-0.20685547168186305,-0.8203217681779964,0.8148148148148148,1.0,1.0,25/214,20.69%,TNNT1;GAS6;NR1H3;DKK1;EGFR;PTCH1;GRN;PGAM5;GDF15;IP6K1;NR1H2;MDK;SRF;PROC;SMAD7;MARVELD3;FLCN;WWC1;GRHL2;ATP2B1;TFE3;DAB2IP;ADM;DDIT3;EFNA1
gsea,response to interleukin-1 (GO:0070555),-0.271121383201664,-0.8200271035732554,0.6666666666666666,1.0,1.0,14/86,26.13%,APP;CACTIN;PYCARD;RBMX;MAPK13;LGALS9;MAPK11;UPF1;HYAL2;DAB2IP;SNCA;PTGIS;SIRPA;GBP2
gsea,brain development (GO:0007420),0.19063903908208985,0.8191111652090933,0.8095238095238095,0.9473104629859996,1.0,14/150,24.28%,CENPF;B3GNT5;MKKS;PTPN11;BPTF;UFC1;CDK5RAP2;PHF8;PAFAH1B1;NCOA6;PHGDH;NIPBL;NES;UFM1
gsea,regulation of canonical Wnt signaling pathway (GO:0060828),0.18560240027417785,0.8187449082094941,0.813953488372093,0.946841472588411,1.0,42/253,26.69%,PSMD14;CYLD;PSMD6;PSMB2;PSMD5;ENST00000634826.1;PSMD1;STK4;PSMA5;PSMD11;CSNK1E;PSMA4;PPP1CA;PSMA3;PSME4;USP8;PSMD7;ENST00000629691.2;CTNND1;PSMC6;NRARP;PSMA1;STK3;GNAQ;USP34;PSMD10;TBL1XR1;PSMB3;VCP;SFRP1;USP47;PSME1;WNK1;PSMC3;PPM1A;GSK3B;OTULIN;PSMA6;PSMD13;EMD;TNKS2;SDHAF2
gsea,neutrophil activation involved in immune response (GO:0002283),0.19894523616306575,0.8187081033733064,0.6808510638297872,0.9457879750369819,1.0,96/485,29.45%,CCT8;DYNC1LI1;SVIP;TUBB;FUCA2;XRCC5;HMGB1;HSPA8;HSP90AA1;PSMD14;DSN1;PSMD6;ALDOA;GGH;IQGAP1;ILF2;PNP;PSMD1;FABP5;ERP44;GPI;HUWE1;CD58;CAND1;PSMA5;PGM2;PSMD11;ANO6;ANPEP;CCT2;RAB14;PGRMC1;PA2G4;TUBB4B;DNAJC3;DIAPH1;PSMD7;ACTR2;SLC44A2;RAP1B;ATP11B;UBR4;TIMP2;RHOF;NAPRT;PGM1;SRP14;DNAJC13;VCL;PRDX4;ADGRE5;VAMP7;RHOA;HSP90AB1;MAPK1;CKAP4;ROCK1;AGL;NRAS;VCP;COMMD9;MLEC;GLA;PTAFR;PKM;CRISPLD2;HEXB;PSMC3;TXNDC5;SPTAN1;CAB39;PGAM1;RAB7A;RAB5C;CYFIP1;CTSC;YPEL5;CEACAM6;RAP1A;ATP6V0A1;PSMD13;QPCT;PDAP1;ATP11A;RAB27A;MGST1;TMEM63A;SLC15A4;COPB1;KPNB1;GLIPR1;IDH1;IGF2R;ATG7;RAB5B;ANXA2
gsea,regulation of Notch signaling pathway (GO:0008593),-0.21141328989759794,-0.8182319244183682,0.8367346938775511,1.0,1.0,11/83,17.48%,MMP14;MFNG;EGFR;LLGL2;HIF1AN;EPN2;RITA1;EGFL7;ZBTB7A;ARRB1;TCIM
gsea,cellular response to reactive oxygen species (GO:0034614),-0.2154533425983467,-0.8180531588996813,0.8409090909090909,1.0,1.0,12/63,19.57%,PRDX5;MAPK3;TPM1;EGFR;RHOB;ROMO1;MAPK13;OSER1;PXN;AGAP3;IL6;RIPK1
gsea,extracellular matrix organization (GO:0030198),-0.22233440263998897,-0.8178738234161964,0.76,1.0,1.0,22/300,16.54%,KIF9;GSN;GAS6;SERPINF2;MMP14;APP;SCX;SPOCK2;MMP15;AGRN;CAPN1;THSD4;COL18A1;SH3PXD2B;COL4A5;THBS1;BMP1;DAG1;QSOX1;PDGFB;COL6A1;ADAMTSL4
gsea,nervous system development (GO:0007399),-0.18312936190669107,-0.8178332732999739,0.8333333333333334,1.0,1.0,33/447,18.86%,MARCKSL1;GSN;MARK4;OBSL1;FBXL17;BTBD6;JARID2;UNC119;SPOCK2;LRCH4;MARCKS;ACTL6A;GLIS2;NTF4;MDK;ATXN10;IGFN1;ELP3;SPG7;PDGFC;NR2C2;NUMBL;CDK5;RITA1;MAL;DVL1;LDB1;GRHL2;SIAH1;TRAK1;RNF103;UNC119B;FKTN
gsea,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.21474891827824555,0.8174582290252281,0.7674418604651163,0.9468236580231976,1.0,20/90,24.82%,RBM25;NCBP1;SFSWAP;JMJD6;HNRNPL;SRSF7;C1QBP;CWC22;DDX5;HNRNPU;SRSF4;PTBP1;SMU1;SNW1;NCL;SRPK1;QKI;TRA2A;SF3B4;WTAP
gsea,pattern recognition receptor signaling pathway (GO:0002221),0.22243280471051,0.8174578924112383,0.7636363636363637,0.9457252547076254,1.0,7/61,22.40%,HSP90B1;HMGB1;BCL10;RPS27A;LGMN;RPS6KA3;MAPKAPK3
gsea,activation of GTPase activity (GO:0090630),-0.19951695916696655,-0.8173535732527459,0.8444444444444444,1.0,1.0,17/105,23.02%,TIAM2;TAX1BP3;GMIP;TBC1D3L;ABR;TBC1D22A;TBC1D16;TBC1D2;TBC1D1;ARHGEF16;SCRIB;ARHGEF5;TBC1D17;SIPA1L3;TBC1D9B;EVI5L;RASGRF1
gsea,positive regulation of cellular component biogenesis (GO:0044089),0.20208727776868443,0.8169332542587802,0.8085106382978723,0.9455126261344307,1.0,16/92,23.17%,TFRC;PFN2;PARK7;TPR;VPS4B;PDCD6IP;ICE1;PFN1;VEGFA;STAM;VCP;FAF1;GNL3L;BID;GSK3B;RAB7A
gsea,positive regulation of cell cycle (GO:0045787),0.22738678306127844,0.8169225869806656,0.7346938775510204,0.9444340365124999,1.0,10/66,17.86%,CHEK1;EIF4E;ADAM17;CCPG1;CCND3;FOXA1;LGMN;CCNB1;CCNYL1;PSMD10
gsea,positive regulation of protein kinase B signaling (GO:0051897),0.19687063035031924,0.8160053960775646,0.8,0.9448842825894458,1.0,24/161,30.25%,HSP90AA1;FERMT2;STRN;PARK7;PIK3CB;C1QBP;KITLG;PTPN11;HSP90AB1;THEM4;ITGB1;ENG;MFHAS1;F3;PDPK1;RTN4;AKR1C2;TXN;HIP1;PIK3CA;RICTOR;TRIB3;MTDH;MAZ
gsea,regulation of endothelial cell proliferation (GO:0001936),0.22406789535028995,0.81569522781616,0.7307692307692307,0.9443747327632432,1.0,10/92,20.97%,AIMP1;AGGF1;STAT1;NRARP;ARNT;NRAS;BMP4;VEGFA;F3;HIF1A
gsea,regulation of cell-substrate adhesion (GO:0010810),0.25376383047242945,0.8151932770858424,0.7446808510638298,0.9441960412394257,1.0,10/43,37.36%,CORO1C;PIK3CB;RHOA;NOTCH1;EMP2;DMTN;PTK2;LIMS1;TBCD;RAC1
gsea,protein localization to membrane (GO:0072657),-0.19272400913524432,-0.812884429206782,0.8727272727272727,1.0,1.0,22/195,14.59%,RAPGEF2;GAS6;TSPAN17;RAB13;ABHD17A;TTC7A;RAB10;AGRN;RAB40C;PTCH1;SLC9A3R2;JUP;ENST00000646762.2;SH3PXD2B;CRB3;HPS6;INPP5K;PLEKHF1;PDZK1;CACNB3;RAB34;MAP7
gsea,negative regulation of response to DNA damage stimulus (GO:2001021),0.23756089562127009,0.8124234641432121,0.7872340425531915,0.948016441355687,1.0,5/31,20.84%,FBXO5;THOC1;PSMD10;ACKR3;TPT1
gsea,vesicle transport along microtubule (GO:0047496),-0.275014612220867,-0.8122234957989724,0.7192982456140351,1.0,1.0,5/23,17.64%,RAB1A;CLN3;KIF13A;BICDL2;TRAK1
gsea,protein catabolic process (GO:0030163),0.19754087658814942,0.8121789680886441,0.7959183673469388,0.9473954049255803,1.0,13/64,28.90%,HSPA8;HSP90AA1;IDE;UBE2G1;VCP;CLPX;TRIM24;UCHL3;MTOR;CUL4B;PRPF19;DDI2;DDB1
gsea,positive regulation of epithelial cell proliferation (GO:0050679),-0.21768264114579966,-0.8120555111380967,0.7916666666666666,1.0,1.0,13/123,17.05%,PIK3CD;EGFR;WNT5A;ERBB2;MYDGF;GRN;MDK;ZBED9;EMC10;EGFL7;PDGFB;BAD;MYC
gsea,mitochondrial translational elongation (GO:0070125),0.2304056523435523,0.8112688611385857,0.7692307692307693,0.9478083694112955,1.0,21/89,24.05%,MRPS6;MRPL1;MRPL42;MRPL11;MRPL50;MRPS30;GFM1;MRPL3;MRPS10;MRPL35;MRPS16;MRPS35;ERAL1;MRPL47;MRPL10;MRPS11;MRPL37;MRPL16;MRPS9;MRPL58;MRPS18A
gsea,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.2563949973592644,-0.8102834612174793,0.7333333333333333,1.0,1.0,3/32,7.08%,GTF2H5;MAPK3;POLR2F
gsea,regulation of early endosome to late endosome transport (GO:2000641),0.26671232053669397,0.8094106431329916,0.7272727272727273,0.9497674672573847,1.0,4/18,16.62%,MAP2K1;MSN;DNAJC13;MAPK1
gsea,positive regulation of exocytosis (GO:0045921),0.24722620912203175,0.8089336517287578,0.7735849056603774,0.9497397076727748,1.0,8/37,29.77%,VPS4B;PDCD6IP;STAM;RAB7A;SDC1;CLASP1;RAB27A;RAB5A
gsea,cellular response to BMP stimulus (GO:0071773),-0.23552452933345222,-0.8087973053609117,0.6938775510204082,1.0,1.0,7/71,18.13%,MAPK3;SCX;GDF15;SMAD7;MEGF8;USP15;SMAD4
gsea,positive regulation of intracellular signal transduction (GO:1902533),-0.17062474008719283,-0.8086801798074903,0.8653846153846154,1.0,1.0,68/546,20.92%,LTBR;RPL37;TRADD;RAPGEF2;GAS6;PTPN6;DLG5;TRIP6;TICAM1;LAMTOR2;PIK3CD;EEF1D;BBC3;APP;BMF;FIS1;EGFR;FAM110C;WNT5A;CFLAR;ERBB2;MYDGF;GDF15;BAX;TRIM8;CD27;CD74;PLXNB1;IRS2;IFI35;ZCCHC3;BOK;GPRC5B;THBS1;TMEM101;PDGFC;RRAGB;TAB2;HEXIM1;FLCN;WWC1;TRIM13;LGALS9;PDGFB;AKT2;BAD;USP15;IL23A;SASH1;TCIM;IL6;SIAH1;P2RX4;RNF13;GSDME;PINK1;BCAP31;SLC35B2;RIPK1;IQCJ-SCHIP1;P2RX5;DAB2IP;JCAD;DDIT3;RRAGA;RBCK1;TRAF2;ZNF622
gsea,anterior/posterior pattern specification (GO:0009952),-0.29004789781797713,-0.8083049963874229,0.75,1.0,1.0,17/63,71.06%,HES4;DDIT3;HOXB6;HOXC9;LRP5;HOXA3;SMAD2;ATP6AP2;BHLHE41;SKI;BHLHE40;BMPR2;HOXB7;WLS;HOXB5;HES1;SIX2
gsea,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.24889332527186256,-0.8080655846785162,0.75,1.0,1.0,7/36,19.51%,PHLDA3;PYCARD;BOK;IFI16;HINT1;BCL3;DYRK2
gsea,fat cell differentiation (GO:0045444),0.24239567447212357,0.8070178575785868,0.7547169811320755,0.9522222087500037,1.0,4/58,15.85%,HMGA2;CTBP2;MKKS;OSBPL11
gsea,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.24138013687973184,0.806691868514319,0.75,0.9516777803046667,1.0,12/31,33.41%,PLK1;UBE2C;DCUN1D5;CDC20;DCUN1D2;SKP1;UBE2N;ARRDC3;TRIB3;UBE2L3;BMI1;UBE2S
gsea,regulation of exosomal secretion (GO:1903541),0.2672891327671069,0.8063919890677413,0.75,0.9511501519161032,1.0,5/19,25.27%,VPS4B;PDCD6IP;STAM;RAB7A;SDC1
gsea,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.24769568570404935,0.8061871887864308,0.7142857142857143,0.9503440461150068,1.0,14/106,19.01%,ETAA1;HMGA2;INCENP;ADAM17;CCND3;MAP2K1;PPP2CA;FERMT2;EZH2;RALB;RHOA;CCNYL1;PSMD10;VEGFA
gsea,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.26443175954952314,0.8060079894541656,0.627906976744186,0.9496018593364283,1.0,5/23,21.07%,JAK1;PIAS1;STAT1;HSP90AB1;PTPN2
gsea,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.17930373414986864,-0.8058181003136698,0.8703703703703703,1.0,1.0,43/404,16.51%,EPHB4;APH1A;RAPGEF2;AAMP;TIA1;TNK2;FOXO4;MAPK3;MVP;ATP6V0B;ANKS1A;ARPC5;MAPKAPK2;BRK1;GIGYF1;EGFR;AP2S1;POLR2F;ERBB2;ATP6V1G1;BCAR1;GDF15;EFNA4;ESRP1;GTF2F1;NTF4;ACTG1;IRS2;YES1;ABI1;PDGFC;PTK2B;RAPGEF1;MAPK14;GIT1;POLR2A;POLR2G;PDGFB;CSF1;MAPK11;PXN;SOGA1;AKT2
gsea,cristae formation (GO:0042407),-0.2925530804820367,-0.8052371927079003,0.627906976744186,1.0,1.0,6/28,13.27%,ATP5MF;ATP5MC2;ATP5F1E;ATP5ME;SPG7;ATP5PB
gsea,negative regulation of type I interferon production (GO:0032480),-0.23982353437335985,-0.804750295852392,0.66,1.0,1.0,9/43,27.61%,RELB;CACTIN;PYCARD;OTUD5;UBE2L6;MAVS;SIRPA;UBA7;PCBP2
gsea,regulation of cellular catabolic process (GO:0031329),0.23048844338563307,0.8036963790047189,0.7777777777777778,0.952395932613504,1.0,4/65,5.60%,PIP4K2A;USP10;WDR41;RAB8A
gsea,ribosomal large subunit biogenesis (GO:0042273),0.23032675644742445,0.803592255592425,0.75,0.9514208272857355,1.0,23/57,33.31%,PAK1IP1;MRPL1;BRIX1;NPM1;NOP2;MRTO4;MAK16;SDAD1;RPF1;RPL35A;NOP16;WDR12;GTF3A;RPL6;RRS1;RPL3;NVL;HEATR3;MDN1;NSA2;EBNA1BP2;RPF2;RPL26L1
gsea,regulation of neuron projection development (GO:0010975),0.19281145319034124,0.8027998870682584,0.8301886792452831,0.951561581152602,1.0,16/165,25.16%,CHN1;ITM2C;TWF1;PRKCI;SETX;CAMSAP2;ITGA6;HDAC2;P3H1;MARK2;FBXO7;GSK3B;PTN;EFNB2;PAK2;RAP1A
gsea,regulation of TOR signaling (GO:0032006),-0.21588377143413115,-0.8023975072216761,0.7777777777777778,1.0,1.0,13/71,23.07%,GAS6;LAMTOR2;TMEM127;FBXO9;AKT1S1;FAM83D;RRAGB;FLCN;DGKQ;RRAGA;TELO2;TSC2;ENST00000639332.2
gsea,negative regulation of endopeptidase activity (GO:0010951),-0.2621000630678317,-0.8023866956872517,0.8478260869565217,1.0,1.0,4/63,11.69%,SERPINF2;SERPINB6;SPOCK2;IFI16
gsea,regulation of cell population proliferation (GO:0042127),0.17667836196878117,0.8017010918165408,0.8627450980392157,0.9522582049769921,1.0,74/764,19.65%,SLC25A5;CDK2;KIF20B;E2F7;PRKDC;TTK;NUP62;CDC6;CDKN3;NAP1L1;PRC1;UBE2A;SHCBP1;EEF1E1;XRCC5;FOXM1;FBXO5;CDCA7L;FN1;CTBP2;NME1;TFRC;ADAM17;CCPG1;COPS8;CDCA7;MAP2K1;NPM1;NOP2;CDK6;TIMELESS;EZH2;STRN;SSR1;UTP20;STAMBP;DBF4B;OSMR;THAP12;DDAH1;TIPIN;PLPP1;KITLG;PRMT1;MCTS1;CDC7;CAPNS1;FGFBP1;PIAS1;STAT1;WDR77;SQLE;LGMN;KIF14;UFL1;CNOT7;BIRC5;RHOA;STAT5B;IL13RA1;ZNF268;RUNX1;ENST00000618924.4;ENG;KLF10;BMP4;NOTCH1;EIF2AK2;HDAC2;VEGFA;P3H1;S1PR3;XBP1;TFAP4
gsea,positive regulation of protein phosphorylation (GO:0001934),0.18113723727193465,0.8014278188735485,0.8478260869565217,0.9516878094633586,1.0,43/371,23.69%,PLK1;TTK;CENPE;XRCC5;CNOT9;HSP90AA1;IQGAP1;TFRC;ADAM17;CCND3;DOCK7;ROCK2;HFE;PDE8A;PFN2;STK4;SNX9;PARK7;RPS6KA4;HDAC3;TBK1;PTPN11;ALS2;RALB;MMD;TWSG1;HSP90AB1;MAPK1;RAP2A;ENG;BMP4;VEGFA;RAD50;UBE2K;RIPK2;TERF2IP;AKTIP;TXN;CAB39;KRAS;RASGRP1;CDK2AP1;CRKL
gsea,translational termination (GO:0006415),0.23269750676062007,0.8006597526025762,0.7843137254901961,0.9520127593321042,1.0,22/96,24.05%,MRPS6;MRPL1;MRPL42;MRPL11;ABCE1;MRPL50;MRPS30;MRPL3;MRPS10;MRPL35;MRPS16;MRPS35;ERAL1;MRPL47;MRPL10;MRPS11;MRPL37;GSPT1;MRPL16;MRPS9;MRPL58;MRPS18A
gsea,gene silencing by miRNA (GO:0035195),0.2368725048326377,0.7996685900780284,0.7777777777777778,0.9529374678195526,1.0,12/32,33.06%,TNRC6A;RAN;PUM2;CNOT7;XPO5;AGO1;CNOT6;PRKRA;AGO2;ZC3H7A;ADAR;CNOT1
gsea,acyl-CoA metabolic process (GO:0006637),0.32894879664257004,0.7994482558035539,0.78,0.9522144395328505,1.0,7/37,30.07%,ACOT9;ACOT7;HMGCS1;THEM4;ACACA;OGDH;ACBD6
gsea,cellular response to interferon-gamma (GO:0071346),0.2381583355877302,0.7988652238496214,0.7254901960784313,0.9520768191270261,1.0,9/121,20.10%,GAPDH;OAS3;CD58;IRF2;JAK1;SYNCRIP;STAT1;GBP3;PTAFR
gsea,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.2473110647985002,0.7988185820657535,0.7916666666666666,0.9510494874012451,1.0,4/42,8.05%,XPO1;HFE;RAD23B;NUB1
gsea,positive regulation of tumor necrosis factor production (GO:0032760),0.27708633907358116,0.7987517164781751,0.8085106382978723,0.9500857811648756,1.0,3/77,2.90%,DHX9;OAS3;HMGB1
gsea,regulation of defense response (GO:0031347),-0.22560088940174022,-0.7983765202545907,0.7222222222222222,1.0,1.0,6/83,8.60%,TMSB4X;TKFC;WNT5A;GRN;CELF1;GGT1
gsea,defense response to symbiont (GO:0140546),0.22115454424712594,0.7979077931596822,0.72,0.9506246894454277,1.0,20/124,29.15%,MLKL;OAS3;ABCE1;NDUFAF4;IRF2;STAT1;CNOT7;PQBP1;AGBL5;EIF2AK2;F2RL1;APOBEC3B;NCBP3;PLSCR1;TRIM52;SLFN13;G3BP1;FLNA;SETD2;ATG7
gsea,positive regulation of protein localization to membrane (GO:1905477),-0.20915638526137162,-0.796993595676424,0.84,1.0,1.0,18/101,18.97%,CIB1;BBC3;STX4;LGALS3;FIS1;EGFR;ERBB2;MTCL1;ENST00000638355.1;PDZK1;TFDP1;MYO1C;ARHGEF16;AKT2;BAD;DLG1;ZDHHC5;ITGAM
gsea,regulation of fat cell differentiation (GO:0045598),-0.25048850659979555,-0.7969649666819597,0.7755102040816326,1.0,1.0,12/80,20.48%,TRPM4;ADIRF;CCDC71L;ZFP36;WNT5A;TRIO;ZFP36L1;ZADH2;CEBPB;IL6;ZNF385A;ZFP36L2
gsea,negative regulation of protein transport (GO:0051224),-0.2822450354228054,-0.7965583336088394,0.7636363636363637,1.0,1.0,3/26,10.69%,SNX12;ERP29;RHBDF1
gsea,canonical Wnt signaling pathway (GO:0060070),-0.23335487255883047,-0.7962606167603655,0.7346938775510204,1.0,1.0,17/68,29.93%,WNT5A;DVL2;RARG;FRAT2;DVL1;BCL9L;BCL9;FZD7;DVL3;WNT5B;FZD2;WNT6;PLPP3;WNT7B;CTNNB1;WNT10A;LRP5
gsea,neural tube closure (GO:0001843),0.22706440683334522,0.7953215855099013,0.8333333333333334,0.9541904947542417,1.0,5/34,18.26%,STIL;BCL10;LMO4;MTHFD1L;IFT122
gsea,negative regulation of cell death (GO:0060548),0.21420621898299624,0.7945252359550002,0.8148148148148148,0.9545860997068157,1.0,8/94,12.19%,NUP62;DUS2;TM7SF3;PDE8A;FERMT2;PARK7;VPS4B;VPS35
gsea,toll-like receptor signaling pathway (GO:0002224),0.22342073941756868,0.7944623762130923,0.7872340425531915,0.953622750211074,1.0,13/91,22.40%,HSPD1;HSP90B1;HMGB1;BCL10;PIK3C3;RPS27A;LGMN;PIK3R4;TNIP1;TNIP2;RIPK2;RPS6KA3;MAPKAPK3
gsea,response to tumor necrosis factor (GO:0034612),-0.2520792285737043,-0.7932176550636778,0.7647058823529411,1.0,1.0,16/110,20.48%,TRADD;CIB1;CACTIN;PYCARD;ZFP36;GGT1;GGT7;ZFP36L1;INPP5K;YBX3;TNFRSF21;GSDME;HYAL2;RIPK1;DAB2IP;ZFP36L2
gsea,aminoglycan biosynthetic process (GO:0006023),-0.2595700220509474,-0.7930658593356005,0.7674418604651163,1.0,1.0,15/49,33.56%,NDST2;NDST1;AGRN;B3GAT3;SDC4;B4GALT7;B3GALT6;EXT1;HEXA;HS6ST1;HS3ST1;B3GNT7;B3GNT9;B3GNT3;SLC35D2
gsea,regulation of actin polymerization or depolymerization (GO:0008064),-0.29244621866521064,-0.7926942639710147,0.723404255319149,1.0,1.0,7/29,24.07%,BRK1;FCHSD1;DBN1;WDR1;RASA1;SH3BP1;ARHGAP35
gsea,regulation of actin filament polymerization (GO:0030833),-0.2178527969966528,-0.7922328023511173,0.7413793103448276,1.0,1.0,9/73,13.92%,CDC42EP5;PYCARD;FCHSD1;HIP1R;DBN1;VASP;CDC42EP2;PTK2B;BAIAP2L2
gsea,phagosome maturation (GO:0090382),-0.2554798408908262,-0.7922258516310435,0.8035714285714286,1.0,1.0,4/37,7.42%,RAB43;ATP6V0B;RAB20;ATP6V1G1
gsea,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.2624080784399689,-0.7922018442983306,0.7884615384615384,1.0,1.0,9/29,25.04%,LTBR;TNFRSF12A;PYCARD;THBS1;HYAL2;RIPK1;TRAF2;FADD;DEDD2
gsea,peroxisomal membrane transport (GO:0015919),0.2771325590968413,0.7919588620448735,0.75,0.9565330509580489,1.0,4/27,13.58%,PXMP2;ABCD3;PEX19;PEX13
gsea,positive regulation of ion transport (GO:0043270),-0.27481183907808854,-0.7914163710380574,0.7090909090909091,1.0,1.0,6/50,20.54%,VAMP8;ORAI1;DLG1;P2RX4;ATP2B1;PRSS8
gsea,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.2656530933164482,-0.7910696326000085,0.7457627118644068,1.0,1.0,11/44,23.37%,MVP;RNF126;EGFR;ZGPAT;SH3KBP1;GPRC5A;DAB2IP;DUSP3;HGS;CHMP6;GRB2
gsea,fatty acid metabolic process (GO:0006631),0.24123330675947594,0.7900004419003066,0.7755102040816326,0.9586908136199797,1.0,26/124,36.11%,ENST00000645126.2;LPIN1;GNPAT;ABCD3;ACOT7;ACSL3;FASN;MSMO1;THEM4;XBP1;ACACA;PNPLA8;PPARD;PNPLA3;ADIPOR1;ACADM;NUDT19;PPARA;LIPG;PON2;PEX2;SLC27A4;ACSL5;CBR4;ACLY;PPARG
gsea,inorganic cation import across plasma membrane (GO:0098659),-0.28785021550020606,-0.7897712120274467,0.7037037037037037,1.0,1.0,5/77,13.13%,TRPM4;SLC9A3;SLC12A7;ENST00000642871.1;SLC24A1
gsea,regulation of endothelial cell apoptotic process (GO:2000351),0.27052750124281744,0.7889817795200924,0.76,0.9594294070590478,1.0,7/44,27.07%,PRKCI;ANO6;GATA2;TNIP2;PDPK1;NFE2L2;TNFAIP3
gsea,negative regulation of cell motility (GO:2000146),-0.2162687606066123,-0.7886564140937277,0.7142857142857143,1.0,1.0,30/114,32.82%,SRGAP2;DLG5;RNF41;TPM1;CD74;RHOB;SMAD7;RAP2C;FLCN;DAG1;AFDN;IFITM1;KRT16;EPPK1;DUSP3;CITED2;FUZ;SPINT2;PTPRU;CLDN3;NOG;TACSTD2;FBLN1;NAV3;LIMCH1;PTPRJ;PIN1;SERPINE1;DUSP22;RAP2B
gsea,cellular response to organonitrogen compound (GO:0071417),0.21524068061266313,0.7883705955206998,0.8604651162790697,0.9595435182535599,1.0,15/103,25.16%,BRCA1;HSP90B1;LARP1;P2RY6;DIAPH1;RAP1B;RNA5SP498;XBP1;SFRP1;GOLPH3;CDH1;PDE2A;MTOR;SSH1;RAP1A
gsea,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.2614124158365416,-0.7882892394245702,0.7678571428571429,1.0,1.0,4/32,9.03%,DDRGK1;UBA5;PAGR1;VPS18
gsea,positive regulation of multicellular organismal process (GO:0051240),0.17682070919667656,0.7879623504421507,0.8913043478260869,0.9590504099008631,1.0,30/345,20.24%,ENST00000645126.2;GAPDH;ELOVL6;LPIN1;PEMT;FBXO5;SHLD2;FOXD1;TFRC;FH;FABP5;FERMT2;EZH2;C1QBP;HADH;HDAC3;PAXIP1;PTPN11;VAMP7;ENO1;GNAS;ROCK1;IL4R;BMP4;SCD;EIF2AK2;VEGFA;F2RL1;XBP1;EPAS1
gsea,membrane assembly (GO:0071709),0.2503896709949148,0.7875871026295862,0.875,0.9587251293180507,1.0,1/36,1.74%,NSFL1C
gsea,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.24567150143933908,-0.7870750775392535,0.7551020408163265,1.0,1.0,5/27,17.65%,AAMP;TAB1;TAB2;UBB;UBC
gsea,regulation of kinase activity (GO:0043549),-0.22374816909868928,-0.7858969722045647,0.7924528301886793,1.0,1.0,6/94,9.49%,EPHB4;EGFR;ERBB2;EEF1A1;CD74;IRS2
gsea,cell-matrix adhesion (GO:0007160),0.2342981928108686,0.7847986491495393,0.6938775510204082,0.9627458586249743,1.0,13/100,26.41%,FN1;FERMT2;ADAM9;FERMT1;VCL;PIP5K1A;ITGB1;ENST00000618924.4;ITGA3;ITGB4;EMP2;MKLN1;SGCE
gsea,autophagy of mitochondrion (GO:0000422),-0.23614223647485463,-0.7840925589074498,0.8181818181818182,1.0,1.0,10/40,19.68%,FIS1;ATG2A;FUNDC2;ATG13;GABARAPL1;ATG9B;WDR45;ATG14;PINK1;GABARAP
gsea,cytoskeleton organization (GO:0007010),-0.1947839900182516,-0.7837299095560629,0.8367346938775511,1.0,1.0,17/120,18.41%,PLD2;OBSL1;SPRYD3;TPM1;PACSIN2;MDK;RND1;STRIP1;AJUBA;RHOB;CNN2;MICAL1;RANBP10;SH3KBP1;KRT16;MICAL2;NEDD9
gsea,regulation of smooth muscle cell proliferation (GO:0048660),0.2617226698552101,0.783174180603269,0.8421052631578947,0.9642925147287835,1.0,2/49,2.73%,PRKDC;XRCC5
gsea,regulation of macromolecule metabolic process (GO:0060255),-0.2142395758344691,-0.7822185805598705,0.8571428571428571,1.0,1.0,12/200,7.26%,KDM6B;REST;CRIP1;RNF187;ATRAID;DKK1;APP;TRIM17;CACTIN;HMG20B;ATXN7L3B;TRIM11
gsea,regulation of phagocytosis (GO:0050764),-0.28168058690528497,-0.7817511550962735,0.803921568627451,1.0,1.0,3/58,11.20%,GAS6;PYCARD;LMAN2
gsea,response to interferon-gamma (GO:0034341),0.2501648663343469,0.7811145427813354,0.8148148148148148,0.9669838515646255,1.0,5/80,13.95%,GAPDH;CD58;NUB1;SYNCRIP;STAT1
gsea,regulation of interleukin-12 production (GO:0032655),0.2924234683457381,0.779971900407389,0.7543859649122807,0.9679338692828268,1.0,5/51,21.24%,HSPD1;HMGB1;C1QBP;MAST2;RIPK2
gsea,negative regulation of cell differentiation (GO:0045596),-0.20334524245893223,-0.7789190113964661,0.82,1.0,1.0,13/191,8.44%,REST;TRPM4;NR1H3;ZBED6;BAMBI;NELFB;EGFR;MEN1;PAF1;WNT5A;PTCH1;TRIO;NR1H2
gsea,negative regulation of MAP kinase activity (GO:0043407),0.2712422759493726,0.7786718249385761,0.7209302325581395,0.9688516362579395,1.0,5/48,18.57%,UCHL1;AIDA;PIK3CB;SMPD1;BMP4
gsea,insulin receptor signaling pathway (GO:0008286),0.193625716887947,0.7784405548636614,0.8125,0.9682466532271005,1.0,21/73,35.58%,IDE;SLC39A14;SOS1;APPL1;BAIAP2;ATP6V1C1;ATP6V0E2;PIK3C2A;PTPN2;ATP6V0E1;PHIP;GSK3B;ATP6V0A1;PIK3CA;C2CD5;NAMPT;PDK2;ATP6V1E1;ATP6V1D;CAV2;ATP6V1A
gsea,regulation of protein phosphorylation (GO:0001932),0.1796374015176731,0.7783693433247428,0.92,0.9672670073746049,1.0,34/266,24.20%,PRKDC;TWF1;HSP90AA1;NSD1;CORO1C;FN1;TFRC;ADAM17;CCND3;NPM1;ROCK2;PDE8A;PPP2CA;STK4;PARK7;HDAC3;TARDBP;RALB;PPP2R5A;BRD4;RAP2A;ANKRD54;ENG;BMP4;VEGFA;TERF2IP;PHIP;AKTIP;ECT2;KRAS;RASGRP1;CDK2AP1;CRKL;PPIL4
gsea,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.22322698155403592,0.7781627432332312,0.7636363636363637,0.9665148749696829,1.0,6/31,27.46%,BAG2;TMTC3;PSMC6;PSMC3;CTSC;LAPTM5
gsea,transferrin transport (GO:0033572),0.260286037258449,0.7781597445521596,0.76,0.9654642645152359,1.0,8/36,25.72%,TFRC;HFE;DNM2;ATP6V1C1;ATP6V0E2;ATP6V0E1;LMTK2;ATP6V0A1
gsea,nuclear envelope organization (GO:0006998),0.2672770362351431,0.7772720782471572,0.8235294117647058,0.9658250564207383,1.0,7/21,26.23%,NEMP1;NUP93;LEMD3;NUP155;TOR1B;TOR1AIP1;EMD
gsea,positive regulation of protein import (GO:1904591),0.26591745457416205,0.7767819472986989,0.8113207547169812,0.9655861021268253,1.0,8/30,28.46%,RAN;TPR;HDAC3;RBM22;CDH1;ECT2;FLNA;ZPR1
gsea,maintenance of protein location in nucleus (GO:0051457),0.24777675573331698,0.7753854731673319,0.8113207547169812,0.9666788775764077,1.0,3/20,14.17%,ARL2BP;PARK7;HNRNPU
gsea,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.17761115149140602,0.7751130840149056,0.9545454545454546,0.9661257509871238,1.0,61/547,20.28%,CENPF;DEPDC1;CDC6;BRCA1;GAPDH;DHFR;E2F1;TYMS;SUV39H2;KAT7;XRCC5;CNOT9;HSPA8;PDS5A;FOXM1;NKRF;HMGA2;FOXD1;GMNN;NKAP;CTBP2;ZBTB18;SIN3A;BCLAF1;CBX5;TIMELESS;ELK3;EZH2;ID1;SHMT1;PA2G4;LARP1;HDAC3;SUV39H1;CRY1;UIMC1;SYNCRIP;PUS7;ZNF148;ENO1;MBD2;CNOT7;BIRC5;RB1;RNA5SP498;ENST00000618924.4;KLF10;BMP4;NOTCH1;EIF2AK2;HDAC2;MTERF3;YEATS2;PHF12;TFAP4;SNW1;MBD1;SFRP1;USP47;NCL;CNOT10
gsea,negative regulation of viral process (GO:0048525),0.21561910506232906,0.7749912635950298,0.8461538461538461,0.965305195431856,1.0,9/70,22.90%,FAM111A;OAS3;TRIM14;STAT1;ZC3HAV1;EIF2AK2;TNIP1;SRPK1;PLSCR1
gsea,mitochondrial translational termination (GO:0070126),0.22351029142399467,0.7735591598157839,0.8269230769230769,0.9667524847995334,1.0,20/89,24.05%,MRPS6;MRPL1;MRPL42;MRPL11;MRPL50;MRPS30;MRPL3;MRPS10;MRPL35;MRPS16;MRPS35;ERAL1;MRPL47;MRPL10;MRPS11;MRPL37;MRPL16;MRPS9;MRPL58;MRPS18A
gsea,negative regulation of neuron apoptotic process (GO:0043524),-0.2105119899127878,-0.772081507176031,0.8260869565217391,1.0,1.0,10/71,22.06%,FOXQ1;CLN3;GRN;NTF4;MDK;PTK2B;PINK1;RASA1;PRKCG;CLCF1
gsea,inorganic cation transmembrane transport (GO:0098662),-0.22177356519240513,-0.7718645736878453,0.7692307692307693,1.0,1.0,9/274,10.27%,TRPM4;GAS6;SCNN1A;ATP5MF;ORAI1;SLC9A3;ATP2A2;CCDC51;ENST00000642871.1
gsea,mesenchymal cell differentiation (GO:0048762),-0.22750229187362314,-0.7715781394330253,0.7659574468085106,1.0,1.0,6/51,12.17%,DLG5;FBXL17;WNT5A;CUL7;FAM83D;TRIM28
gsea,negative regulation of TOR signaling (GO:0032007),-0.24897061492372285,-0.7708943854859368,0.7407407407407407,1.0,1.0,3/38,13.41%,TMEM127;AKT1S1;FLCN
gsea,transforming growth factor beta receptor signaling pathway (GO:0007179),0.19971638643427858,0.7708505311774013,0.8478260869565217,0.9702665807520893,1.0,11/89,18.34%,FERMT2;ID1;FKBP1A;APPL1;RPS27A;ADAM9;TWSG1;RHOA;ITGB1;ENST00000618924.4;ENG
gsea,odontogenesis (GO:0042476),0.2244811069718101,0.7698938340871183,0.8,0.970842498375866,1.0,17/39,77.59%,BMP4;HDAC2;TUFT1;OSR2;ZNF22;HDAC1;TGFB2;BCOR;INHBA;FOXC1;WNT10A;ROGDI;LAMB1;GLI2;WNT6;AQP3;ANKRD11
gsea,JNK cascade (GO:0007254),0.2121205809628462,0.769644063643045,0.7843137254901961,0.9700798142681726,1.0,8/41,24.68%,MAP2K4;GPS1;RPS27A;ADORA2B;RIPK2;MAPK8;CRKL;UBE2N
gsea,regulation of cell junction assembly (GO:1901888),0.2139274958246634,0.7696152722778444,0.8679245283018868,0.9690813027707654,1.0,5/27,18.20%,SETD5;ROCK2;RAP1B;ROCK1;RUNX1
gsea,positive regulation of endocytosis (GO:0045807),0.23400620829037685,0.7693246033708975,0.7954545454545454,0.9685297769014496,1.0,11/48,35.60%,HFE;ANO6;ANKFY1;SMPD1;F2RL1;HIP1;RAB21;NEDD4L;TOR1A;CBL;APPL2
gsea,protein targeting to peroxisome (GO:0006625),0.2700972664829449,0.7693239254010403,0.7872340425531915,0.967475881605583,1.0,4/29,13.58%,PXMP2;ABCD3;PEX19;PEX13
gsea,regulation of T cell receptor signaling pathway (GO:0050856),-0.23839506904569596,-0.7685052044574152,0.8421052631578947,1.0,1.0,3/35,12.20%,LGALS3;DGKZ;PHPT1
gsea,extracellular structure organization (GO:0043062),-0.2240503929744487,-0.7682156215429856,0.8043478260869565,1.0,1.0,16/216,20.06%,MMP14;APP;SPOCK2;MMP15;AGRN;THSD4;COL18A1;COL4A5;THBS1;DAG1;PDGFB;COL6A1;ADAMTSL4;ITGAM;GFOD2;ITGAE
gsea,external encapsulating structure organization (GO:0045229),-0.2240503929744487,-0.7682156215429856,0.8043478260869565,1.0,1.0,16/217,20.06%,MMP14;APP;SPOCK2;MMP15;AGRN;THSD4;COL18A1;COL4A5;THBS1;DAG1;PDGFB;COL6A1;ADAMTSL4;ITGAM;GFOD2;ITGAE
gsea,regulation of cellular component size (GO:0032535),0.2452420773368139,0.7670782143441851,0.8367346938775511,0.9698862546821269,1.0,12/31,41.43%,MSN;PPP1CA;RIN3;MTOR;MTPN;HP1BP3;RPTOR;AP2M1;RAC1;RAB22A;RAP1GAP2;SLC9A3R1
gsea,response to peptide hormone (GO:0043434),0.23398260680086153,0.7667600041764404,0.7659574468085106,0.9693947661600882,1.0,7/52,21.29%,ROCK2;CRY1;STAT1;STAT5B;ROCK1;XBP1;CREB1
gsea,positive regulation of microtubule polymerization (GO:0031116),0.24217750014468087,0.766454501085555,0.8125,0.9687862423178245,1.0,4/28,19.57%,MAPRE1;CKAP5;CDK5RAP2;DRG1
gsea,cellular metal ion homeostasis (GO:0006875),0.23331469766458093,0.7664166837100609,0.7857142857142857,0.9677956231724593,1.0,20/104,43.90%,ATP1B3;STOML2;ATP1B1;ATP1A1;TPT1;STC2;ATP2C1;TMEM165;NEDD4L;CHERP;CAV1;VAPB;ATP13A1;SLC8B1;LETM1;DMPK;SLC9A1;ATP2B4;SLC30A1;TESMIN
gsea,protein glycosylation (GO:0006486),0.23707561670542815,0.7662588114619716,0.8292682926829268,0.966954455505617,1.0,24/130,30.17%,B3GNT5;PLOD2;GALNT2;GALNT7;GFPT1;RPN2;B3GNT2;SLC39A8;ALG3;MGAT1;PGM3;RPN1;ALG11;NPC1;POMGNT2;POFUT1;NUS1;STT3A;DPAGT1;MOGS;GALNT6;COG3;TMEM165;GALNT10
gsea,regulation of nucleic acid-templated transcription (GO:1903506),0.1745750215387054,0.76604067879582,0.9583333333333334,0.9662769694128118,1.0,58/430,27.05%,E2F1;MYBL2;KAT7;MSL3;NSD2;NSD1;NSD3;HMGA2;SPIN4;RNF20;HNRNPD;PRMT5;NUP35;PPP2CA;EZH2;IRF2;RPS6KA4;PHF19;ING2;TRRAP;SLC39A8;NUP107;DNM2;ZNF488;RNF6;MYCBP;ASCC1;PQBP1;RB1;RNF14;ZNF268;RNA5SP498;DMTF1;TCF7;ENG;NOTCH1;ZNF506;PHF12;CTR9;ATF7;CRABP2;HIF1A;TERF2IP;TGFBRAP1;RPL6;UTP4;POFUT1;FUS;NLK;NR3C1;HMG20A;MYBBP1A;FADS1;SRRT;ASCC2;GPBP1;HP1BP3;FOXK2
gsea,regulation of innate immune response (GO:0045088),0.21201150704582708,0.7645450276555921,0.7777777777777778,0.9673795149607672,1.0,18/64,35.60%,DHX9;ABCE1;LYAR;APPL1;AKIRIN2;PTPN11;HSP90AB1;POLR3F;PLSCR1;TNFAIP3;SLC15A4;ERAP1;NMI;RIOK3;BIRC2;BIRC3;XIAP;APPL2
gsea,translational elongation (GO:0006414),0.20401548910320888,0.7632022458069909,0.7719298245614035,0.9685824631607282,1.0,15/104,14.73%,MRPS6;MRPL1;MRPL42;MRPL11;MRPL50;MRPS30;GFM1;MRPL3;ZNF598;MRPS10;MRPL35;MRPS16;MRPS35;ERAL1;MRPL47
gsea,positive regulation of epithelial cell migration (GO:0010634),-0.1971109969300507,-0.7629078576044278,0.9166666666666666,1.0,1.0,13/94,18.58%,AAMP;PIK3CD;WNT5A;GRN;BCAR1;RRAS;RHOB;EMC10;THBS1;PTK2B;GLIPR2;SASH1;MAP4K4
gsea,positive regulation of mitochondrion organization (GO:0010822),-0.21029460146600717,-0.7626941838661314,0.8913043478260869,1.0,1.0,13/58,19.60%,BBC3;BMF;FIS1;PYCARD;HIP1R;BAX;ZNF205;BOK;ENST00000638355.1;BAK1;BAD;PINK1;BIK
gsea,negative regulation of signaling receptor activity (GO:2000272),0.25500653306682736,0.7618168814602131,0.7608695652173914,0.9696801481646711,1.0,9/26,41.03%,HFE;VPS25;ERRFI1;PPARA;EPHB2;CBL;PPARG;CBLC;ZFYVE28
gsea,regulation of programmed cell death (GO:0043067),-0.17799965603492815,-0.7617734787321147,0.8695652173913043,1.0,1.0,30/194,22.78%,CASP6;TMEM219;PTPN6;MARK4;HS1BP3;HTATIP2;RTKN;NOP53;RSL1D1;BCAR1;AKT1S1;BAX;RARG;DAPK2;ENST00000639874.2;FANK1;STEAP3;CDK5;ZBTB7A;DAPK3;BCL3;PINK1;TP53I3;RIPK1;TIGAR;TRAF2;TNFRSF10B;APEX1;DNAJA3;ASAH1
gsea,positive regulation of innate immune response (GO:0045089),0.2598729701050542,0.7610071405165381,0.75,0.9699842919625046,1.0,8/36,31.95%,DHX9;AKIRIN2;POLR3F;UBE2K;PLSCR1;SLC15A4;NMI;RIOK3
gsea,selective autophagy (GO:0061912),0.18470322043371534,0.7598111050958257,0.825,0.9706975810403644,1.0,12/59,25.87%,DYNC1LI1;PARK7;DYNC1I2;RPS27A;UFC1;UFL1;UBQLN1;AMBRA1;RAB7A;UFM1;UBE2N;PHB2
gsea,RNA methylation (GO:0001510),0.2006176451987366,0.7591957857899938,0.9333333333333333,0.9705906194477668,1.0,17/60,34.49%,METTL1;NOP2;THADA;THUMPD3;NSUN4;NSUN2;MEPCE;TRMT6;DIMT1;WTAP;METTL3;FTSJ1;METTL2B;VIRMA;TARBP1;MRM2;ZC3H13
gsea,regulation of receptor internalization (GO:0002090),-0.22945286677851393,-0.7560639824617033,0.8070175438596491,1.0,1.0,7/36,25.15%,CD63;DKK1;ARRB2;ARRB1;ANKRD13B;ANKRD13A;MTMR2
gsea,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.23524056841177776,0.75585758608373,0.851063829787234,0.9741203541287823,1.0,8/68,33.16%,ARL2BP;PPP2CA;CNOT7;VEGFA;PTPN2;IL6ST;HES1;PARP14
gsea,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.20757824725330987,-0.7552581850118472,0.8723404255319149,1.0,1.0,10/165,24.36%,LPAR2;PSAP;GPR78;VIPR1;ADCY6;ADM;S1PR2;ADGRG1;GNA11;ADCY7
gsea,cellular response to organic substance (GO:0071310),0.18883713470286945,0.7549795388062361,0.9024390243902439,0.9745205553417816,1.0,22/123,40.38%,URI1;PTPN20;PARK7;TBK1;PTPN11;RHOA;STAT5B;SFRP1;PTPN2;MAPK8;EMD;SPHK1;CPNE3;RPS6KB1;PTPN18;KHSRP;BMPR2;RACK1;CYP1B1;MAP2K5;MAPK7;TWF2
gsea,cellular response to interleukin-6 (GO:0071354),0.3075412006302989,0.7548299483608093,0.782608695652174,0.9736957666227822,1.0,4/28,19.67%,JAK1;PTPN11;STAT1;CTR9
gsea,response to steroid hormone (GO:0048545),-0.2557999245438595,-0.7542402641643706,0.8035714285714286,1.0,1.0,6/34,23.13%,NR1H3;ABHD2;THBS1;CATSPER1;WBP2;PAQR7
gsea,cellular divalent inorganic cation homeostasis (GO:0072503),0.2133276138771958,0.7540550727862928,0.8305084745762712,0.9741392381710109,1.0,22/111,43.07%,SLC39A14;SLC39A8;MT1A;STOML2;ATP1B1;TPT1;SLC30A9;STC2;SLC30A5;ATP2C1;SLC39A10;TMEM165;MT1E;CHERP;CAV1;VAPB;ATP13A1;SLC8B1;DMPK;ATP2B4;SLC39A6;SLC30A1
gsea,phagosome acidification (GO:0090383),-0.26090116487307613,-0.7534147447675408,0.8448275862068966,1.0,1.0,3/28,7.42%,ATP6V0B;RAB20;ATP6V1G1
gsea,histone deacetylation (GO:0016575),0.21145809687039013,0.7523090967354231,0.8571428571428571,0.9757451119412675,1.0,6/47,18.86%,MSL3;RBM14;SIN3A;HDAC3;TBL1XR1;HDAC2
gsea,positive regulation of protein localization to cell periphery (GO:1904377),-0.2105822441214887,-0.7520715627432599,0.7959183673469388,1.0,1.0,4/52,6.07%,CIB1;STX4;LGALS3;EGFR
gsea,glycolipid metabolic process (GO:0006664),-0.25110386597793827,-0.7520223504985819,0.7777777777777778,1.0,1.0,9/52,24.45%,PSAP;ST6GALNAC6;SUMF1;ESYT2;CTSA;GLB1;ARSA;ASAH1;HEXA
gsea,regulation of interleukin-6 production (GO:0032675),-0.28054446077724343,-0.7517236861504089,0.8125,1.0,1.0,14/110,22.20%,GAS6;PTPN6;APP;MAPKAPK2;PYCARD;WNT5A;CD74;MAPK13;LGALS9;ARRB1;IL6;HYAL2;SELENOS;MAVS
gsea,regulation of axonogenesis (GO:0050770),-0.2427894357315129,-0.7515693609371117,0.8269230769230769,1.0,1.0,2/51,1.24%,METRN;TIAM2
gsea,mRNA catabolic process (GO:0006402),0.22583460967637742,0.750963473599948,0.8444444444444444,0.9763742923665597,1.0,17/44,36.51%,SUPV3L1;PNPT1;LSM5;DDX5;MRTO4;EXOSC10;AGO1;CNOT10;NBAS;METTL3;DIS3L2;TUT7;EXOSC9;PDE12;TUT4;RIDA;METTL16
gsea,cartilage development (GO:0051216),0.2529677714967489,0.7508441391861166,0.8367346938775511,0.9754639794056976,1.0,5/52,22.24%,HMGA2;SLC39A14;RUNX1;BMP4;SULF2
gsea,purine nucleoside bisphosphate metabolic process (GO:0034032),0.2917290800343123,0.7506407553555375,0.8518518518518519,0.9737794839231682,1.0,2/31,5.41%,ACOT9;ACOT7
gsea,ribonucleoside bisphosphate metabolic process (GO:0033875),0.2917290800343123,0.7506407553555375,0.8518518518518519,0.9737794839231682,1.0,2/31,5.41%,ACOT9;ACOT7
gsea,regulation of release of cytochrome c from mitochondria (GO:0090199),0.22029925088592356,0.7503371806467755,0.8181818181818182,0.9732509103456997,1.0,10/41,23.62%,FAM162A;DNM1L;MLLT11;OPA1;PRELID1;PSMD10;FXN;GHITM;BID;MFF
gsea,regulation of protein catabolic process (GO:0042176),-0.18899593064654008,-0.7500850714794692,0.9183673469387755,1.0,1.0,8/102,8.47%,EGLN2;NDUFA13;SNX12;RNF41;OAZ2;EGFR;WNT5A;EEF1A1
gsea,protein-containing complex disassembly (GO:0032984),0.21666204913118375,0.7483564807250256,0.8695652173913043,0.9752520776225635,1.0,11/56,22.91%,HSPA8;PPP1CA;VPS33A;SNX14;VAMP7;UBQLN1;VPS16;VCP;STX17;RPL23;GSK3B
gsea,negative regulation of protein catabolic process (GO:0042177),0.2202718051337044,0.7478123545420003,0.8367346938775511,0.9749973080921763,1.0,5/42,12.87%,SF3B3;MAD2L1;PTPN3;CYP51A1;TIMP2
gsea,regulation of cardiac conduction (GO:1903779),0.3109935549308041,0.7466836129133874,0.75,0.9756370337861745,1.0,5/55,25.73%,ATP1B3;ATP1B1;ASPH;ATP1A1;AHCYL1
gsea,regulation of epithelial to mesenchymal transition (GO:0010717),-0.20192983291111416,-0.7465039080611973,0.875,1.0,1.0,11/76,20.69%,MCRIP1;BAMBI;MDK;SMAD7;DAG1;GLIPR2;IL6;BCL9L;SMAD4;DAB2IP;EFNA1
gsea,regulation of synapse assembly (GO:0051963),-0.26271912649830703,-0.7454727476244883,0.8260869565217391,1.0,1.0,7/47,26.31%,DLG5;APP;SNCA;CLSTN3;PDLIM5;LRFN4;SRPX2
gsea,carboxylic acid transmembrane transport (GO:1905039),0.24646286588461902,0.7453204627008192,0.8,0.9767075069216596,1.0,2/41,4.06%,SLC7A11;SLC7A5
gsea,rRNA modification (GO:0000154),0.2676370873513494,0.7441820291033939,0.8148148148148148,0.9773296841558229,1.0,5/21,23.49%,GAR1;NSUN4;DKC1;NAT10;DIMT1
gsea,positive regulation of ossification (GO:0045778),-0.2411864386209088,-0.7431045183013159,0.8260869565217391,1.0,1.0,2/40,6.79%,ATRAID;WNT5A
gsea,negative regulation of catalytic activity (GO:0043086),-0.25385977371017193,-0.7430059713335627,0.8863636363636364,1.0,1.0,5/27,21.29%,CLN3;CCAR2;PHPT1;APBA3;ENST00000647074.2
gsea,defense response to virus (GO:0051607),0.20528302951259303,0.7427079609799967,0.76,0.9787123142550471,1.0,21/133,29.15%,MLKL;OAS3;ABCE1;NDUFAF4;IRF2;STAT1;CNOT7;PQBP1;AGBL5;EIF2AK2;F2RL1;APOBEC3B;NCBP3;PLSCR1;TRIM52;SLFN13;PHB2;G3BP1;FLNA;SETD2;ATG7
gsea,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.25561726162482756,0.7414031039724066,0.8478260869565217,0.9794746420863227,1.0,3/81,2.90%,DHX9;OAS3;HMGB1
gsea,positive regulation of cell growth (GO:0030307),0.1954634992150811,0.7410901638496521,0.8125,0.9789158377869193,1.0,22/102,34.02%,NCBP1;ADAM17;SUPV3L1;PLAA;PSMD10;INO80;SFRP1;USP47;FXN;TAF9B;RPS6KA3;GOLGA4;MTPN;SHTN1;EIF4G1;RPTOR;NEDD4L;SPHK1;ITSN2;MAP3K13;EXOSC9;EXOSC2
gsea,response to peptide (GO:1901652),0.26376290678838643,0.7410007038423561,0.8,0.9780000206337661,1.0,3/39,16.54%,KAT7;STAT1;STAT5B
gsea,rRNA catabolic process (GO:0016075),0.28193905099696337,0.7408109218611048,0.7358490566037735,0.977186317028259,1.0,4/18,16.86%,EXOSC8;DIS3L;DIS3;EXOSC10
gsea,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.22312957582754897,0.7407616780007278,0.82,0.9762027532271361,1.0,8/60,27.79%,DSG2;EMB;PALLD;ITGB1;CDH1;CEACAM6;NECTIN3;ROBO1
gsea,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.23108695961180564,-0.7404831989506641,0.75,1.0,1.0,3/34,11.15%,PIK3CD;ERBB2;ZFP36L1
gsea,ephrin receptor signaling pathway (GO:0048013),0.21885438875396301,0.7403396649664709,0.8222222222222222,0.975749704914681,1.0,15/82,23.61%,CHN1;ARPC2;ROCK2;WASL;ACTR2;ACTR3;PTPN11;CRK;RHOA;ARPC3;ROCK1;ARPC1A;DNM1;AP2B1;EFNB2
gsea,cellular response to lipid (GO:0071396),0.1718795115242221,0.7399784748645378,0.9565217391304348,0.9751834664076069,1.0,20/219,21.29%,URI1;HMGB1;INSIG1;ROCK2;MSN;SETX;BCL10;SHPK;ADCY3;PLAA;ADAM9;RHOA;RNA5SP498;ATP1A1;XBP1;CTR9;SNW1;SFRP1;TNIP2;CREB1
gsea,cellular iron ion homeostasis (GO:0006879),0.2388101676439319,0.7397213742474559,0.9130434782608695,0.974589908624555,1.0,12/58,25.88%,BOLA2;TFRC;HFE;CYBRD1;SLC39A14;CAND1;GLRX3;ACO1;FXN;SKP1;CUL1;HMOX1
gsea,cellular response to growth factor stimulus (GO:0071363),-0.18280806774786656,-0.7387024286324805,0.8541666666666666,1.0,1.0,21/158,20.48%,RAPGEF2;CIB1;MAPKAPK2;EGFR;ZFP36;WNT5A;ERBB2;BCAR1;EEF1A1;ZFP36L1;INPP5K;SMAD7;RAPGEF1;MAPK14;CORO1B;PDGFB;SMAD4;HYAL2;DAB2IP;DUSP3;ZFP36L2
gsea,artery morphogenesis (GO:0048844),0.2697917223926669,0.7385707393096381,0.8,0.975421357530007,1.0,4/30,19.01%,ENG;BMP4;NOTCH1;VEGFA
gsea,hippo signaling (GO:0035329),0.2612587714832696,0.7385381344252865,0.8181818181818182,0.9744732223224858,1.0,6/26,23.92%,YWHAE;STK4;MOB1A;STK3;YWHAB;TEAD4
gsea,phospholipid transport (GO:0015914),0.2620884602725755,0.7384487214633676,0.8269230769230769,0.9735270665204081,1.0,11/59,33.97%,PITPNB;OSBPL2;ATP11B;LDLR;PRELID1;TMEM30B;APOC1;ATP11A;SCARB2;TMEM30A;PRELID3B
gsea,regulation of anoikis (GO:2000209),0.24827579103039,0.7378639602522776,0.8837209302325582,0.9731931876749739,1.0,7/21,31.53%,ITGB1;NOTCH1;CEACAM6;MYBBP1A;PIK3CA;ITGA5;PTK2
gsea,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.20227592904434646,-0.737837611434081,0.8775510204081632,1.0,1.0,22/155,21.53%,TRADD;DDRGK1;CIB1;TICAM1;APP;PYCARD;WNT5A;CFLAR;TRIM8;TAB1;TAB2;ZBTB7A;TRIM13;LGALS9;PRKCZ;UBB;IL6;UBC;RIPK1;RBCK1;TRAF2;NFKB2
gsea,gonad development (GO:0008406),-0.23370592582393324,-0.7371194199975843,0.8363636363636363,1.0,1.0,5/51,13.48%,NR0B1;WNT5A;LHB;MEA1;GATA6
gsea,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.22306040253231618,-0.7357797327961161,0.84,1.0,1.0,6/83,6.73%,CDC42EP5;MARK4;EPS8L2;ARAP1;BRK1;AGRN
gsea,positive regulation of gene expression (GO:0010628),0.16554934388565617,0.7355807004158967,0.9,0.9756531345968505,1.0,54/482,24.38%,BAZ1B;PRKDC;BRCA1;GAPDH;E2F1;SMARCA5;FN1;HMGA2;FOXD1;HNRNPD;TFRC;MAP2K1;NPM1;ROCK2;HFE;MSN;TNRC6A;SETX;TENT4A;SF3B1;PARK7;GABPA;PIK3CB;DDX5;DDX21;VPS35;GATA2;ELAVL1;MAPK1;POLR2K;ROCK1;BMP4;NOTCH1;EIF2AK2;PRKAA1;VEGFA;F3;AGO1;NAT10;RBM22;HIF1A;EIF3E;RPL23;TENT4B;RBPJ;NFE2L2;PLSCR1;GSK3B;PDE2A;KRAS;MAPK8;HNRNPLL;MTOR;RPS4X
gsea,regulation of fibroblast proliferation (GO:0048145),0.23098774515923107,0.7355428505871946,0.8035714285714286,0.9747087046585939,1.0,4/46,7.67%,DHX9;E2F1;FN1;CDK6
gsea,"negative regulation of transcription, DNA-templated (GO:0045892)",-0.16509240402418038,-0.7352689685271899,0.9615384615384616,1.0,1.0,86/948,15.41%,PBXIP1;PATZ1;GADD45A;REST;CBX6;GAS6;MAFK;ENST00000634790.2;NR1H3;ZBED6;NDUFA13;DKK1;ENST00000639670.2;PRDX5;IRF2BP1;VPS72;RBM15B;KDM5C;ING4;NOP53;JARID2;MAF1;NOC2L;ZNF263;NR0B1;HDAC5;MXD4;ZBTB1;COMMD7;PIAS4;MEN1;CCAR2;MBTD1;ZFP36;PAF1;WNT5A;SKIL;PTCH1;ZNF282;CHD3;ZNF219;GLIS2;NR1H2;KHDRBS1;ZBED2;ZHX2;RARG;TSC22D4;ZNF205;VHL;ZNF274;ATP8B1;PURA;ERF;CDKN2A;INPP5K;ZGPAT;SOX13;SMAD7;IFI16;MNT;FHL2;TRIM28;HEXIM2;NR2C2;HMBOX1;SIN3B;IRX3;NACC1;DNMT3A;HEXIM1;FLCN;GATA6;CBX4;CEBPB;PRMT6;CBX8;ZNF75A;WWC1;ZBTB7B;RPL10;CDK5;RITA1;ZBTB7A;ZFHX3;UBE2I
gsea,positive regulation of cellular amide metabolic process (GO:0034250),-0.1857269205161342,-0.7352330792197462,0.9230769230769231,1.0,1.0,13/81,20.69%,SOX4;LARP6;EIF3C;ERBB2;NSUN5;EEF2;THBS1;PYM1;SIRT3;IL6;BCL3;FXR2;EFNA1
gsea,protein transmembrane import into intracellular organelle (GO:0044743),0.2543457421561219,0.7352188395976972,0.8,0.9740492151731492,1.0,11/32,32.83%,HSPD1;GRPEL1;TIMM50;GRPEL2;AIFM1;TIMM21;TOMM70;DNAJC19;PEX2;CHCHD4;PEX26
gsea,keratinocyte differentiation (GO:0030216),-0.2613764392087285,-0.735136117764567,0.7358490566037735,1.0,1.0,6/41,25.27%,OPN3;WNT5A;TXNIP;KRT16;ASAH1;CASP3
gsea,negative regulation of cellular amide metabolic process (GO:0034249),0.19920510743867917,0.7351296191146548,0.8958333333333334,0.9732356196215781,1.0,14/86,21.71%,GAPDH;DHFR;TYMS;CNOT9;SHMT1;LARP1;SYNCRIP;PUS7;CNOT7;ROCK1;EIF2AK2;NCL;CNOT10;RTN4
gsea,ERBB signaling pathway (GO:0038127),0.20753004751536655,0.7341584208458143,0.8775510204081632,0.9735109131111467,1.0,11/66,21.33%,HSP90AA1;IQGAP1;ADAM17;SOS1;STUB1;PTPN11;FAM83A;MAPK1;CUL5;PIK3C2A;PDPK1
gsea,bone development (GO:0060348),0.2437622374367745,0.7339589773873619,0.8125,0.972755981045908,1.0,6/40,24.99%,PLS3;GNAS;P3H1;SULF2;SBDS;MBTPS2
gsea,steroid metabolic process (GO:0008202),0.22193516557707582,0.7338992198102059,0.8775510204081632,0.9718053483234439,1.0,11/104,22.39%,HSD17B7;AMACR;CYP51A1;FDX2;LGMN;MSMO1;NPC1;DHCR24;AKR1C2;UGT1A3;SULT2B1
gsea,regulation of intracellular transport (GO:0032386),0.23421614912638336,0.7338357722679918,0.8113207547169812,0.9708989088210465,1.0,7/39,25.68%,SPAG5;RINT1;NEFH;NUP214;MAP2;ATPSCKMT;REEP5
gsea,regulation of autophagosome assembly (GO:2000785),-0.22726129017488278,-0.7334181219902914,0.82,1.0,1.0,8/35,23.07%,RAB3GAP1;ENST00000645179.2;SCFD1;RAB1B;ENST00000613180.2;PINK1;IFT20;ENST00000639332.2
gsea,mRNA modification (GO:0016556),0.238642151986932,0.7334136007995466,0.7959183673469388,0.9705849104095944,1.0,9/22,36.51%,PUS7;DKC1;NSUN2;TRMT6;WTAP;METTL3;VIRMA;ZC3H13;METTL16
gsea,Wnt signaling pathway (GO:0016055),-0.1818795610652272,-0.7324942137003547,0.9056603773584906,1.0,1.0,22/92,29.93%,CD24;WNT5A;KLHL12;DVL2;RARG;CSNK1G2;NXN;DVL1;UBB;UBC;BCL9L;BCL9;FZD7;DVL3;WNT5B;FZD2;WNT6;PLPP3;WNT7B;CTNNB1;WNT10A;LRP5
gsea,negative regulation of neuron projection development (GO:0010977),0.23014310970264007,0.7324065839072964,0.8431372549019608,0.9708896121833084,1.0,5/58,23.61%,ITM2C;RHOA;HDAC2;RTN4;EFNB2
gsea,regulation of hydrolase activity (GO:0051336),0.18317923455876364,0.7318753273893248,0.9555555555555556,0.9706043350904475,1.0,16/73,39.01%,CHN1;CRK;RAB3GAP2;ARHGAP12;PAFAH1B1;FGD6;SCARB2;RALBP1;SOD1;PTK2;PLXNA1;RABGAP1;PLXNB2;FGD1;PLXND1;CAV1
gsea,cellular response to mechanical stimulus (GO:0071260),-0.2253279941602511,-0.7314182579151254,0.7872340425531915,1.0,1.0,3/49,3.63%,LTBR;GADD45A;MAPK3
gsea,response to cadmium ion (GO:0046686),-0.24827983205008874,-0.7312936047234133,0.8780487804878049,1.0,1.0,2/29,6.07%,MAPK3;EGFR
gsea,cellular response to cadmium ion (GO:0071276),-0.24827983205008874,-0.7312936047234133,0.8780487804878049,1.0,1.0,2/27,6.07%,MAPK3;EGFR
gsea,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.19993133280286876,0.7308949224167116,0.9111111111111111,0.9708943715490073,1.0,4/70,6.80%,TWF1;CYLD;ATG3;USP6NL
gsea,calcium ion transmembrane transport (GO:0070588),-0.2154238000051846,-0.7303021373239414,0.8461538461538461,1.0,1.0,8/87,13.79%,TRPM4;GAS6;ORAI1;ATP2A2;SPG7;SLC24A1;CACNB3;PMPCB
gsea,negative regulation of organelle assembly (GO:1902116),-0.22422076866787122,-0.7300734170751575,0.9047619047619048,1.0,1.0,8/35,23.07%,TESK1;ENST00000645179.2;SCFD1;SMAD4;PINK1;LIMK2;EVI5L;ENST00000639332.2
gsea,fatty acid beta-oxidation (GO:0006635),0.24790059201704173,0.7293813564285689,0.9215686274509803,0.9718419656084367,1.0,6/52,10.26%,ACAT2;ABCD3;DECR2;HADHA;AMACR;HADH
gsea,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.2126370449259698,-0.7291166310974361,0.8301886792452831,1.0,1.0,8/55,17.50%,GAS6;NR1H3;CACTIN;PALM3;NR1H2;STAT2;SIGIRR;IL6
gsea,negative regulation of cellular catabolic process (GO:0031330),-0.19443442378668463,-0.7290929316708603,0.8627450980392157,1.0,1.0,15/69,30.08%,ATRAID;GOLGA2;BMF;TAB2;EIF4G2;WDR6;DAB2IP;RRAGA;FOXK1;TAB3;MTMR2;CST3;TIMP3;MCL1;RGP1
gsea,positive regulation of interleukin-8 production (GO:0032757),0.23596964917214416,0.7285078427662977,0.7872340425531915,0.9718083893871168,1.0,6/61,19.16%,HMGB1;CD58;PARK7;BCL10;F2RL1;F3
gsea,negative regulation of innate immune response (GO:0045824),0.2114234145901892,0.7280092277017849,0.9230769230769231,0.9715093660297602,1.0,9/38,30.97%,OAS3;TTLL12;LYAR;CNOT7;PTPN2;METTL3;TNFAIP3;YTHDF3;NMI
gsea,positive regulation of translation (GO:0045727),-0.18276564545867668,-0.7278525200686348,0.8085106382978723,1.0,1.0,18/100,19.50%,SOX4;LARP6;EIF3C;ERBB2;COA3;KHDRBS1;NSUN5;CDC123;EEF2;THBS1;YBX3;PYM1;UQCC2;FASTKD3;POLR2G;IL6;BCL3;FXR2
gsea,cellular calcium ion homeostasis (GO:0006874),0.1953857435437641,0.7277562528842063,0.8823529411764706,0.9709875928899746,1.0,14/136,30.44%,YWHAE;MCUB;AFG3L2;MCU;STOML2;ATP1B1;MICU1;ENST00000635371.2;TPT1;STC2;ATP2C1;WFS1;TMEM165;CALB1
gsea,positive regulation of protein metabolic process (GO:0051247),-0.18505704183326452,-0.7268979283153209,0.9545454545454546,1.0,1.0,9/115,8.44%,NR1H3;EGLN2;NDUFA13;RNF41;APP;OAZ2;RAB1A;WNT5A;NR1H2
gsea,epidermal cell differentiation (GO:0009913),-0.2588033498387523,-0.7262469463249394,0.8367346938775511,1.0,1.0,10/53,28.30%,OPN3;WNT5A;TXNIP;GATA6;KRT16;ASAH1;CASP3;OVOL1;ERCC2;CTNNB1
gsea,regulation of heart contraction (GO:0008016),-0.24732720701909097,-0.7255562943801709,0.9090909090909091,1.0,1.0,8/93,23.57%,ATP2A2;TPM1;SRI;SMAD7;P2RX4;ATP2B1;CALM3;RNF207
gsea,positive regulation of phosphorylation (GO:0042327),0.16194515021488157,0.7255178591596907,1.0,0.973046879393396,1.0,29/253,23.69%,HSP90AA1;RYK;TFRC;ADAM17;CCND3;ROCK2;PDE8A;STK4;BCL10;HDAC3;LMO4;PTGES3;RALB;BTBD10;ARNT;RAP2A;ITGA6;ENG;BMP4;PRKAA1;VEGFA;RAD50;HIF1A;AKTIP;LMTK2;KRAS;RASGRP1;CDK2AP1;CRKL
gsea,cell junction assembly (GO:0034329),0.20380305012039257,0.7250176524838265,0.9056603773584906,0.9725803271380133,1.0,9/102,18.56%,RYK;FN1;CAPZA1;FERMT2;NRCAM;CTNND1;RHOA;ITGA6;FARP1
gsea,macromolecule catabolic process (GO:0009057),0.24352109340509165,0.7247483454106133,0.8863636363636364,0.972031224726999,1.0,7/28,24.04%,IDE;LGMN;PIK3R4;CLPX;TRIM24;UCHL3;MTOR
gsea,regulation of cell development (GO:0060284),0.2689600219090211,0.7241743780216661,0.8269230769230769,0.9717752104194954,1.0,10/41,44.78%,DOCK7;HES1;FBXO22;NOTCH2;RPS19;YAP1;BHLHE40;WNT3;RHEB;BHLHE41
gsea,endodermal cell differentiation (GO:0035987),0.23018855491806256,0.723694980508122,0.8367346938775511,0.9713808288678599,1.0,3/32,7.03%,FN1;HMGA2;LEO1
gsea,activation of protein kinase B activity (GO:0032148),-0.228737148617412,-0.7235624416026477,0.8679245283018868,1.0,1.0,4/31,19.12%,GAS6;WNT5A;PDGFB;PINK1
gsea,cellular response to starvation (GO:0009267),0.1858024028092736,0.7230029182986033,0.8913043478260869,0.9711259994986585,1.0,25/158,25.20%,SEH1L;STK26;HSPA8;EIF2AK4;HSPA5;ATP6V1C1;PIK3C3;RALB;TBL2;STK24;PIK3R4;EIF2S1;GCN1;MAPK1;ATP6V0E2;KLF10;EIF2AK2;PRKAA1;XBP1;SFRP1;ATP6V0E1;MAPK8;MTOR;MYBBP1A;FADS1
gsea,negative regulation of insulin receptor signaling pathway (GO:0046627),0.23328351246492227,0.7229421864911976,0.8775510204081632,0.9702063762445173,1.0,1/27,0.95%,PIP4K2A
gsea,potassium ion transmembrane transport (GO:0071805),-0.25334726334313057,-0.7215070800554864,0.8113207547169812,1.0,1.0,4/139,13.13%,SLC9A3;CCDC51;SLC12A7;SLC24A1
gsea,negative regulation of transcription by RNA polymerase II (GO:0000122),-0.1689567411716233,-0.7215023393274089,0.9615384615384616,1.0,1.0,96/684,23.41%,GADD45A;REST;CBX6;MAFK;ENST00000634790.2;NR1H3;ZBED6;DKK1;ENST00000639670.2;IRF2BP1;VPS72;NOP53;NOC2L;ZNF263;NR0B1;HDAC5;MXD4;ZBTB1;MEN1;ZFP36;NFATC3;PAF1;SKIL;PTCH1;ZNF282;CHD3;ZNF219;GLIS2;NR1H2;ZBED2;ZHX2;RARG;ZNF205;VHL;ZNF274;SRF;PURA;ERF;ZGPAT;SOX13;SMAD7;IFI16;MNT;FHL2;HEXIM2;NR2C2;HMBOX1;SIN3B;IRX3;DNMT3A;HEXIM1;FLCN;GATA6;CBX4;CEBPB;CBX8;ZNF75A;WWC1;ZBTB7B;RPL10;RITA1;ZBTB7A;ZFHX3;UBE2I;PDGFB;LDB1;MLX;SMARCA4;UBB;MYC;DLG1;UBC;MAGEA2;GTF2IRD1;SMAD4;MOSPD1;ATF3;DAB2IP;DDIT3;EFNA1;CITED2;RPS14;MTA1;HSBP1;TGIF2;PCGF1;DNAJA3;FAM220A;LIN37;SNCA;HDAC8;MYPOP;MTA3;PLK3;HIVEP1;GPS2
gsea,positive regulation of response to biotic stimulus (GO:0002833),0.2483956950765337,0.720171485628963,0.8333333333333334,0.9724871851166986,1.0,9/45,31.95%,DHX9;PUM2;AKIRIN2;POLR3F;PLSCR1;SLC15A4;NMI;ANKRD17;RIOK3
gsea,transcription by RNA polymerase I (GO:0006360),-0.2333213441317341,-0.720140913036589,0.8372093023255814,1.0,1.0,3/34,7.08%,GTF2H5;MAPK3;POLR2F
gsea,stress granule assembly (GO:0034063),-0.24400225825972116,-0.719987406810306,0.8269230769230769,1.0,1.0,1/21,0.07%,LSM14A
gsea,intracellular protein transmembrane transport (GO:0065002),0.23819765011293875,0.7198090296444497,0.8235294117647058,0.971941525547643,1.0,18/44,35.96%,HSPD1;GRPEL1;TIMM50;SEC63;HSPA5;SEC61G;GRPEL2;AIFM1;TIMM21;TOMM70;C2CD5;DNAJC19;SRP54;PEX2;CHCHD4;PEX26;SEC62;SEC61B
gsea,neuron differentiation (GO:0030182),0.18697439481946604,0.7182642633442776,0.8653846153846154,0.9729999164175362,1.0,6/174,8.62%,ITM2C;UGDH;RYK;ACSL3;MAP2K1;FOXA1
gsea,positive regulation of interferon-gamma production (GO:0032729),0.2809117668973905,0.716851427143362,0.8541666666666666,0.9737248535261575,1.0,2/57,4.06%,HSPD1;SLC7A5
gsea,synaptic vesicle endocytosis (GO:0048488),0.24366594715333895,0.7161543528449296,0.8837209302325582,0.9735657316554988,1.0,6/38,32.86%,DNM2;FCHO2;DNM1;CANX;ITSN1;ITSN2
gsea,regulation of blood vessel endothelial cell migration (GO:0043535),-0.20319960220645164,-0.7138234373928332,0.8888888888888888,1.0,1.0,7/55,17.83%,GADD45A;TMSB4X;JUP;THBS1;MAPK14;PDGFB;P2RX4
gsea,histone H3 acetylation (GO:0043966),0.23075780644930366,0.7133711738363213,0.8372093023255814,0.9763688817411407,1.0,3/42,5.98%,KAT7;DR1;WDR5
gsea,cellular response to glucose starvation (GO:0042149),-0.23638918624210695,-0.7129680397479868,0.92,1.0,1.0,4/43,11.95%,SIK1B;SIK1;IFI16;PRKAG1
gsea,mitochondrial transport (GO:0006839),-0.21609137071721832,-0.7128849095093548,0.7619047619047619,1.0,1.0,18/56,25.08%,STARD3;TOMM7;FIS1;TIMM10;TMEM14C;SPG7;TIMM8B;SLC25A6;BAK1;TIMM9;TOMM22;BAD;TSPO;BCAP31;TMEM14B;AIP;TIMM17A;MAIP1
gsea,cellular response to virus (GO:0098586),0.22418965695316673,0.7122496936078502,0.9230769230769231,0.9767991992085437,1.0,2/35,2.95%,RRP1B;HSP90AA1
gsea,positive regulation of viral transcription (GO:0050434),0.21125133557924952,0.7116447691415196,0.8333333333333334,0.976596208086946,1.0,9/26,29.55%,DHX9;GTF2F2;POLR2B;POLR2K;POLR2L;CCNT1;POLR2C;POLR2E;NELFCD
gsea,ncRNA processing (GO:0034470),0.20318039090507714,0.711626475532828,0.8269230769230769,0.9757068863325747,1.0,61/201,28.54%,NOP58;SSB;RRP36;EXOSC8;TEX10;RRP1B;ENST00000630540.2;WDR75;DGCR8;DDX52;RPL30;DCAF13;HNRNPA2B1;UTP20;WDR43;LYAR;RPL41;NOLC1;DIS3;MRTO4;BMS1;INTS4;INTS7;POP7;WDR3;NOL6;RPF1;INTS10;RPL35A;MPHOSPH6;EXOSC10;RCL1;RPS27;DDX27;DKC1;AGO1;ESF1;WDR12;HEATR1;RPL23;RPL6;FCF1;UTP4;RPS24;UTP18;MTREX;ZCCHC8;UTP15;SBDS;POP5;RPL3;METTL3;SRRT;RPS15;RPP30;UTP14A;DDX10;NVL;PRKRA;TUT7;RPL17
gsea,regulation of cell adhesion (GO:0030155),-0.1866068269404937,-0.7112491323681736,0.9111111111111111,1.0,1.0,22/133,26.76%,STX4;MINK1;TPM1;ERBB2;CYTH1;PLXNB1;MDK;RND1;DUSP1;PTK2B;FLCN;ZFHX3;TFE3;RASA1;EFNA1;ADGRG1;PPP3CA;PPP1CB;RSU1;IL18;MYADM;ADAM8
gsea,establishment of protein localization to extracellular region (GO:0035592),0.22344182868562878,0.711096841954159,0.9302325581395349,0.9754230798263003,1.0,10/46,28.64%,RAB8A;NECAB3;COPG2;GOLPH3;PDIA4;TANGO2;TVP23B;CANX;SEL1L;MON1A
gsea,positive regulation of lipid biosynthetic process (GO:0046889),-0.24212805623649197,-0.7100433531052083,0.8863636363636364,1.0,1.0,4/35,13.82%,NR1H3;NR1H2;SLC27A1;ZBTB20
gsea,cellular response to epidermal growth factor stimulus (GO:0071364),-0.24331354524748858,-0.7098699544957919,0.8,1.0,1.0,10/28,21.56%,EGFR;ZFP36;ERBB2;EEF1A1;ZFP36L1;INPP5K;DAB2IP;DUSP3;ZFP36L2;PTPN12
gsea,positive regulation of organelle organization (GO:0010638),0.22733429830830715,0.7086101916063897,0.8163265306122449,0.9774563520651618,1.0,6/33,29.45%,LNPK;LMAN1;RAB3GAP2;GSK3B;C2CD5;ANXA2
gsea,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.21596496129730813,-0.7084496682007476,0.8478260869565217,1.0,1.0,5/28,17.65%,AAMP;TAB1;TAB2;UBB;UBC
gsea,negative regulation of cellular biosynthetic process (GO:0031327),-0.21372375152301143,-0.7084308449542488,0.9137931034482759,1.0,1.0,7/52,17.37%,RAPGEF2;SIK1;OPN3;SLC27A1;WDTC1;SOGA1;ERLIN2
gsea,rRNA processing (GO:0006364),0.20709018551586475,0.7077021197953548,0.8431372549019608,0.9776506239238824,1.0,49/173,25.24%,RIOK1;NOP58;PRKDC;MRPL1;RRP36;EXOSC8;TEX10;RRP1B;ENST00000630540.2;WDR75;DDX52;RPL30;NOP2;DCAF13;UTP20;WDR43;LYAR;RPL41;NOLC1;DIS3;MRTO4;BMS1;WDR3;MAK16;NOL6;RPF1;RPL35A;MPHOSPH6;EXOSC10;RCL1;RPS27;DDX27;DKC1;ESF1;NAT10;WDR12;SRFBP1;HEATR1;RPL23;RPL6;FCF1;UTP4;RPS24;UTP18;MTREX;UTP15;SBDS;POP5;RPL3
gsea,negative regulation of cellular response to insulin stimulus (GO:1900077),0.22331778464057944,0.7074230621106438,0.8913043478260869,0.9769826910697761,1.0,1/28,0.95%,PIP4K2A
gsea,regulation of keratinocyte differentiation (GO:0045616),-0.22486572370969282,-0.7064527951216089,0.9166666666666666,1.0,1.0,9/34,30.07%,ZFP36;ZBED2;ZFP36L1;GRHL2;AQP3;NME2;CTSL;FOXC1;TRIM16
gsea,positive regulation of TOR signaling (GO:0032008),-0.1987898660252022,-0.705715892538074,0.9322033898305084,1.0,1.0,8/41,25.19%,GAS6;LAMTOR2;RRAGB;FLCN;RRAGA;TELO2;ENST00000639332.2;SEC13
gsea,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.2343140141744723,-0.705233114339964,0.7592592592592593,1.0,1.0,2/36,5.59%,TICAM1;CACTIN
gsea,sodium ion transport (GO:0006814),0.2277202429837183,0.7050283831333062,0.9347826086956522,0.9788716145578098,1.0,6/90,30.04%,ATP1B3;ANO6;ATP1B1;SLC6A6;SLC4A11;NEDD4L
gsea,nucleic acid-templated transcription (GO:0097659),-0.19958523007300033,-0.7047999201819215,0.8958333333333334,1.0,1.0,10/42,22.00%,SCX;POLR2F;POLR3A;XAB2;PWP1;POLR2A;POLR2G;BCL3;RNPS1;FUBP3
gsea,regulation of interleukin-10 production (GO:0032653),-0.26764421167849056,-0.7046614736540786,0.8518518518518519,1.0,1.0,7/48,17.87%,PYCARD;VSIR;LGALS9;PRKCZ;IL23A;IL6;TNFRSF21
gsea,mitochondrion disassembly (GO:0061726),-0.20943151773679947,-0.7039663342986118,0.9285714285714286,1.0,1.0,11/36,26.77%,FIS1;ATG2A;FUNDC2;GABARAPL1;ATG9B;WDR45;PINK1;GABARAP;WIPI2;ULK1;MAP1LC3B
gsea,actin filament bundle organization (GO:0061572),-0.23034805904761033,-0.7033700901362636,0.8125,1.0,1.0,5/33,18.41%,CALD1;MICAL1;BAIAP2L2;CORO1B;NEDD9
gsea,regulation of muscle cell differentiation (GO:0051147),-0.24636028466413296,-0.7024239985321544,0.9333333333333333,1.0,1.0,4/35,16.25%,ZBED6;SRF;MAPK14;MAPK11
gsea,negative regulation of cellular protein localization (GO:1903828),0.2567401647357343,0.7013875874782858,0.7608695652173914,0.9821356159038716,1.0,7/36,25.40%,NSFL1C;SIN3A;ROCK2;MFHAS1;GSK3B;DNAJA1;LEPROTL1
gsea,organonitrogen compound catabolic process (GO:1901565),0.18577910726708075,0.7006483424579385,0.94,0.9819698202638738,1.0,11/63,28.65%,NPEPPS;IDE;ANPEP;CLPX;LNPEP;TRIM24;UCHL3;PNPLA8;MTOR;ADO;ERAP1
gsea,epithelial cell migration (GO:0010631),0.21989969155992012,0.7003933175361632,0.9,0.9813819872013541,1.0,14/41,39.24%,ANLN;STAT1;FERMT1;RHOA;ROCK1;PKN2;LOXL2;PIK3CA;ABL1;PLXND1;PRKX;KANK2;PKN1;CYP1B1
gsea,organelle transport along microtubule (GO:0072384),0.20291668993736559,0.69812034429207,0.851063829787234,0.9829322870724296,1.0,5/31,13.64%,KIF5B;HTT;ENST00000632578.1;LRPPRC;COPG2
gsea,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.19829185949787326,-0.697778801840886,0.8809523809523809,1.0,1.0,4/42,7.01%,TRADD;STX4;LGALS3;CFLAR
gsea,positive regulation of phagocytosis (GO:0050766),-0.23817305383411047,-0.6975637614139056,0.8846153846153846,1.0,1.0,3/53,11.20%,GAS6;PYCARD;LMAN2
gsea,"wound healing, spreading of cells (GO:0044319)",0.24391299637694397,0.697507388295098,0.8135593220338984,0.9826166189000649,1.0,7/24,38.95%,ADAM17;RHOA;FLNA;ITGA5;TOR1A;CD44;RHOC
gsea,histone acetylation (GO:0016573),0.18690289382085284,0.6964423790343183,0.9767441860465116,0.9829807820407406,1.0,4/71,5.98%,KAT7;MSL3;DR1;WDR5
gsea,negative regulation of cell migration (GO:0030336),-0.18369108503732626,-0.696270672760926,0.9111111111111111,1.0,1.0,21/144,22.10%,SRGAP2;DLG5;RNF41;TPM1;CD74;RHOB;SMAD7;MARVELD3;RAP2C;FLCN;DAG1;AFDN;IFITM1;KRT16;HYAL2;EPPK1;DAB2IP;DUSP3;CITED2;FUZ;ADGRG1
gsea,negative regulation of cellular protein metabolic process (GO:0032269),0.1818826170534613,0.6954740580077593,0.9361702127659575,0.9831542322947848,1.0,13/94,20.28%,GAPDH;DHFR;TYMS;CNOT9;SHMT1;LARP1;DNAJC1;SYNCRIP;PUS7;CNOT7;EIF2AK2;NCL;CNOT10
gsea,protein targeting to mitochondrion (GO:0006626),0.20835181392403362,0.695099917420175,0.8545454545454545,0.9824461343101573,1.0,7/55,9.23%,HSPD1;HSP90AA1;TOMM5;HSPA4;GRPEL1;TIMM50;MIPEP
gsea,cellular response to transforming growth factor beta stimulus (GO:0071560),0.1660778431715045,0.6948713322336034,0.9183673469387755,0.9816852715741102,1.0,17/114,25.08%,FERMT2;ID1;FKBP1A;APPL1;RPS27A;ADAM9;TWSG1;RHOA;ITGB1;ENST00000618924.4;ENG;SFRP1;TGFBRAP1;PDE2A;CRKL;NLK;NR3C1
gsea,response to estrogen (GO:0043627),0.22601937604537092,0.6947630713373394,0.7906976744186046,0.9808176813859566,1.0,2/35,6.22%,BRCA1;SRA1
gsea,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.21472459246625017,-0.694030200148897,0.9038461538461539,1.0,1.0,5/24,17.65%,AAMP;TAB1;TAB2;UBB;UBC
gsea,positive regulation of wound healing (GO:0090303),0.24023781985116074,0.6939863439280894,0.9423076923076923,0.9806546763073073,1.0,8/40,31.53%,FERMT2;FERMT1;ITGB1;XBP1;MTOR;ARFGEF1;DMTN;PTK2
gsea,"protein alpha-1,2-demannosylation (GO:0036508)",-0.2444748305727377,-0.693880120037175,0.8571428571428571,1.0,1.0,6/24,17.81%,OS9;TRIM13;RNF5;UBB;UBC;RNF103
gsea,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.18469312052411072,-0.6934400742020025,0.9622641509433962,1.0,1.0,4/58,7.01%,TRADD;GAS6;PYCARD;CFLAR
gsea,protein secretion (GO:0009306),0.22769252603173445,0.6932368199506335,0.8043478260869565,0.9804919946514331,1.0,11/64,25.59%,RAB8A;NECAB3;PARK7;COPG2;GOLPH3;GAL;PDIA4;TANGO2;TVP23B;CANX;SEL1L
gsea,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.23740871706738603,-0.6931738503070278,0.8979591836734694,1.0,1.0,5/35,17.56%,CDKN2B;JADE1;CDKN2A;SUSD2;DLG1
gsea,regulation of TORC1 signaling (GO:1903432),0.26462217014551215,0.6914881816648133,0.8775510204081632,0.9813953284499097,1.0,1/35,0.86%,SEH1L
gsea,negative regulation of nucleic acid-templated transcription (GO:1903507),-0.16384191595043776,-0.6898399413369858,0.9629629629629629,1.0,1.0,48/464,16.81%,PBXIP1;PATZ1;REST;GAS6;ENST00000634790.2;ZBED6;NDUFA13;ENST00000639670.2;RBM15B;KDM5C;ING4;JARID2;NR0B1;HDAC5;COMMD7;PIAS4;MEN1;CCAR2;MBTD1;WNT5A;ZNF282;ZNF219;GLIS2;NR1H2;KHDRBS1;ZHX2;TSC22D4;ATP8B1;CDKN2A;INPP5K;ZGPAT;SOX13;IFI16;TRIM28;HEXIM2;HMBOX1;NACC1;HEXIM1;GATA6;CBX4;PRMT6;CDK5;ZBTB7A;UBE2I;PDGFB;LDB1;MLX;SMARCA4
gsea,regulation of macrophage activation (GO:0043030),-0.2672603313962694,-0.6891593577282881,0.8627450980392157,1.0,1.0,5/30,17.50%,NR1H3;WNT5A;CD74;THBS1;IL6
gsea,regulation of cell size (GO:0008361),0.24436432306793893,0.688395072446385,0.9433962264150944,0.9835636577477213,1.0,5/24,27.70%,MSN;RHOA;MTOR;MTPN;RPTOR
gsea,negative regulation of protein ubiquitination (GO:0031397),-0.18264003987178973,-0.6873214012435996,0.9583333333333334,1.0,1.0,8/51,16.86%,SOX4;UBXN1;SVBP;SMAD7;ARRB2;NXN;ARRB1;U2AF2
gsea,regulation of insulin secretion (GO:0050796),-0.19035857134017017,-0.6868594539899802,0.9615384615384616,1.0,1.0,2/104,0.54%,SOX4;REST
gsea,positive regulation of angiogenesis (GO:0045766),0.18638267829238434,0.6863886881854749,0.9444444444444444,0.9848122068595058,1.0,14/116,21.33%,BRCA1;AGGF1;HMGA2;JAK1;ADAM12;GATA2;ITGB1;RUNX1;VEGFA;F3;XBP1;PKM;HIF1A;PDPK1
gsea,positive regulation of cellular protein metabolic process (GO:0032270),-0.16328456635440863,-0.6859786169437049,1.0,1.0,1.0,17/102,19.50%,SOX4;NR1H3;LARP6;EIF3C;ERBB2;NR1H2;NSUN5;EEF2;THBS1;PYM1;BAK1;CSF1;BAD;PTTG1IP;IL6;BCL3;FXR2
gsea,positive regulation of cellular component organization (GO:0051130),-0.16332099815691786,-0.6852644039916375,0.9791666666666666,1.0,1.0,14/114,21.07%,PPP1R15A;LGALS3;BRK1;BMF;TMED9;BAX;AJUBA;CRB3;CDC42EP2;BAK1;BIK;DAB2IP;SPIDR;DCTN1
gsea,tRNA methylation (GO:0030488),0.22009723364553238,0.6850631886836346,0.9019607843137255,0.9852378509730727,1.0,9/34,32.98%,METTL1;THADA;TRMT1L;THUMPD3;NSUN2;HSD17B10;FTSJ1;METTL2B;TARBP1
gsea,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.21825310258642466,0.684299008011546,0.8627450980392157,0.9850714479288606,1.0,2/37,7.67%,E2F7;CDK6
gsea,negative regulation of actin filament bundle assembly (GO:0032232),-0.2150554593949895,-0.684086476126193,0.9482758620689655,1.0,1.0,3/27,15.29%,ARAP1;INPP5K;ARHGEF18
gsea,negative regulation of stress fiber assembly (GO:0051497),-0.2150554593949895,-0.684086476126193,0.9482758620689655,1.0,1.0,3/24,15.29%,ARAP1;INPP5K;ARHGEF18
gsea,positive regulation of nervous system development (GO:0051962),0.2423952228000788,0.6831158419543857,0.8863636363636364,0.985187261703784,1.0,5/45,22.94%,NAP1L1;FAIM;SNW1;CLSTN1;SPEN
gsea,response to organic cyclic compound (GO:0014070),0.2092292600314433,0.6831075640461048,0.9512195121951219,0.9842166338597409,1.0,4/60,19.95%,DHFR;FOXA1;STAT5B;SFRP1
gsea,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.21513897595626194,-0.6828552913585845,0.9230769230769231,1.0,1.0,6/32,20.37%,CIB1;HDAC5;THBS1;PTGS2;HDAC7;JCAD
gsea,heart morphogenesis (GO:0003007),0.2530161653150642,0.6827163877872371,0.8653846153846154,0.9836766156858295,1.0,7/53,31.53%,FKBP1A;ENG;NOTCH1;VEGFA;NIPBL;HES1;PTK2
gsea,positive regulation of T cell activation (GO:0050870),0.23097510544392685,0.6823501135291463,0.8666666666666667,0.9830573574722224,1.0,3/75,5.90%,HSPD1;TFRC;PNP
gsea,negative regulation of cell-substrate adhesion (GO:0010812),-0.22520239999909047,-0.6817995547781739,0.9347826086956522,1.0,1.0,6/40,20.58%,MELTF;CDKN2A;THBS1;MAP4K4;FZD7;RASA1
gsea,receptor catabolic process (GO:0032801),-0.25806402051596994,-0.6817787409106384,0.8947368421052632,1.0,1.0,2/25,6.80%,MVB12A;AP2S1
gsea,iron ion transport (GO:0006826),0.2029662758424484,0.6803101100036874,0.9423076923076923,0.9844047828107108,1.0,10/50,28.13%,TFRC;HFE;SLC39A14;DNM2;ATP6V1C1;ATP6V0E2;ATP6V0E1;LMTK2;ATP6V0A1;IREB2
gsea,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.20432010280234314,-0.6798257338715139,0.92,1.0,1.0,6/42,18.13%,BAMBI;MDK;GLIPR2;IL6;BCL9L;SMAD4
gsea,regulation of ion transport (GO:0043269),-0.22503959065375473,-0.6795759993219928,0.8909090909090909,1.0,1.0,9/79,25.65%,SIK1;PDZK1;VAMP2;P2RX4;RAB11B;B2M;NKAIN4;SNCA;SYT17
gsea,substrate adhesion-dependent cell spreading (GO:0034446),0.22032008171921766,0.6791603491676155,0.9591836734693877,0.984306964114251,1.0,5/48,16.43%,FN1;FERMT2;KIF14;LAMC1;RHOA
gsea,endoderm formation (GO:0001706),0.22220950046777052,0.6786003278478955,0.8076923076923077,0.9838623852461694,1.0,2/36,4.38%,FN1;HMGA2
gsea,positive regulation of mRNA catabolic process (GO:0061014),0.20646666149150922,0.6782780572416605,0.8222222222222222,0.9831387212744845,1.0,18/44,36.95%,ROCK2;PNPT1;TNRC6A;ZC3HAV1;CNOT7;ROCK1;METTL3;PABPC1;DHX36;AGO2;GTPBP1;YTHDF3;CNOT1;KHSRP;TNRC6B;RIDA;METTL16;FTO
gsea,phosphatidylinositol-mediated signaling (GO:0048015),-0.190980647697051,-0.6776879895517809,0.9285714285714286,1.0,1.0,5/71,11.15%,PIK3CD;ERBB2;PI4KB;IRS2;ZFP36L1
gsea,cell-cell junction assembly (GO:0007043),-0.2043368707015179,-0.6773279220176576,0.9473684210526315,1.0,1.0,8/66,23.06%,PATJ;JUP;ACTG1;SMAD7;FLCN;WDR1;PARD6B;CLDN12
gsea,negative regulation of response to biotic stimulus (GO:0002832),-0.2221388949470119,-0.676629021483365,0.9111111111111111,1.0,1.0,4/31,16.79%,CACTIN;TRAFD1;IFI16;SIGIRR
gsea,prostaglandin metabolic process (GO:0006693),-0.2225680699147355,-0.6758863769470326,0.8793103448275862,1.0,1.0,6/31,23.85%,CD74;PTGR1;CES2;PTGS2;GSTP1;PTGIS
gsea,protein exit from endoplasmic reticulum (GO:0032527),-0.21976946023052987,-0.675605974882127,0.875,1.0,1.0,3/24,9.70%,OS9;TMED9;TMEM129
gsea,regulation of autophagy (GO:0010506),0.1607253117552244,0.6738417893510636,0.975609756097561,0.9866782950910605,1.0,25/231,19.58%,PIP4K2A;SVIP;GAPDH;USP10;UCHL1;HMGB1;WDR41;TRIM14;EIF4E;RAB8A;DNM1L;PIK3CB;VPS35;VPS26A;CISD2;CAPNS1;ATP6V1C1;UFL1;UBQLN1;ATP6V0E2;ROCK1;UBQLN2;DCAF12;PRKAA1;PIK3C2A
gsea,sulfur compound catabolic process (GO:0044273),-0.2558607916502416,-0.6736568714225226,0.8627450980392157,1.0,1.0,5/40,17.01%,TST;GGT1;GGT7;GALNS;GLB1
gsea,regulation of protein transport (GO:0051223),-0.2228890199356002,-0.6722521189010184,0.8888888888888888,1.0,1.0,4/28,10.69%,SNX12;LLGL2;SCFD1;RHBDF1
gsea,chemical synaptic transmission (GO:0007268),-0.16148164655550865,-0.6717324164098748,0.9285714285714286,1.0,1.0,16/306,22.57%,UNC119;MINK1;FCHSD1;SLC12A7;CACNB3;CDK5;DVL1;GIPC1;VAMP2;DLG1;GABRP;CNP;GABARAP;APBA3;SNCG;SNCA
gsea,positive regulation of protein modification process (GO:0031401),0.16384673755529758,0.6701528974757313,1.0,0.9889336522359541,1.0,27/214,23.69%,SVIP;CDCA2;HSP90AA1;TFRC;ADAM17;CCND3;ROCK2;PDE8A;PPP1R7;STK4;HDAC3;RALB;PPP2R5A;SMPD1;PTBP1;RAB3GAP2;RAP2A;ENG;BMP4;VEGFA;TERF2IP;AKTIP;TXN;KRAS;RASGRP1;CDK2AP1;CRKL
gsea,inositol lipid-mediated signaling (GO:0048017),0.20629790335600165,0.6699751800771002,0.9111111111111111,0.9881805716034807,1.0,6/51,20.10%,PIK3CB;PIK3C3;RHOA;PIK3C2A;PI4KA;PTAFR
gsea,cell projection organization (GO:0030030),-0.2520007515501033,-0.6694450484083657,0.8181818181818182,1.0,1.0,2/30,6.32%,GSN;PACSIN2
gsea,response to amino acid starvation (GO:1990928),0.20629748419500082,0.6691221128897312,0.9090909090909091,0.9881062002328345,1.0,12/75,24.04%,SEH1L;EIF2AK4;LARP1;ATP6V1C1;EIF2S1;GCN1;MAPK1;ATP6V0E2;EIF2AK2;ATP6V0E1;MAPK8;MTOR
gsea,regulation of stress fiber assembly (GO:0051492),0.18137891172703385,0.6685652423066097,0.9791666666666666,0.9875543881238156,1.0,11/74,24.45%,FHOD1;ROCK2;PFN2;FERMT2;CARMIL1;PFN1;RHOA;ROCK1;SFRP1;PAK2;PHLDB2
gsea,protein insertion into membrane (GO:0051205),-0.2004706003248787,-0.6680201510819446,0.9791666666666666,1.0,1.0,9/34,32.77%,APP;EGFR;VAMP2;ALDH3A2;WDR83OS;MAIP1;UBE2J2;STX5;GET4
gsea,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.16264254722112437,0.6679603474255321,1.0,0.9870831707382014,1.0,10/64,24.07%,URI1;ARMC10;PARK7;OPA1;ENO1;XBP1;ACKR3;TPT1;NFE2L2;DNAJA1
gsea,regulation of Wnt signaling pathway (GO:0030111),-0.1681162435108629,-0.6676881985526387,1.0,1.0,1.0,23/111,33.13%,FAM53B;DKK1;APP;TAX1BP3;NXN;PTK7;SMARCA4;TMEM237;FZD7;GRB10;TSC2;MDFIC;CDC73;TSKU;CDK14;CTNNB1;TLE1;LRP1;FOLR1;PSEN1;CSNK2A1;AXIN1;ZNF703
gsea,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.23736882519402558,0.6676055939607041,0.9148936170212766,0.9864275036792032,1.0,5/22,26.00%,EEF1E1;DDX5;RPL23;ATR;RPS15
gsea,positive regulation of biomineral tissue development (GO:0070169),0.22794619957876788,0.6666687362150701,0.8679245283018868,0.9863418974792281,1.0,4/41,23.46%,FBXO5;ANO6;BMP4;PTN
gsea,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.1917616405197607,0.6654866156453662,0.95,0.9865471820110018,1.0,10/48,25.88%,HMGB1;ADAM17;GATA2;FGFBP1;VEGFA;PIK3C2A;HIF1A;PDPK1;NUS1;HMOX1
gsea,response to gamma radiation (GO:0010332),0.23058961368884673,0.6649116458502864,0.9302325581395349,0.985973154279475,1.0,5/24,24.50%,XRCC5;MAP3K20;PRKAA1;TMEM109;ATR
gsea,regulation of cell death (GO:0010941),-0.1914078280280235,-0.6634237468519073,0.9375,1.0,1.0,4/102,2.16%,SOX4;SRGAP2;ZBED6;DKK1
gsea,cellular response to type I interferon (GO:0071357),0.19665247924882295,0.6633454202675861,0.9056603773584906,0.9855531334433745,1.0,4/65,13.95%,OAS3;IRF2;JAK1;STAT1
gsea,type I interferon signaling pathway (GO:0060337),0.19665247924882295,0.6633454202675861,0.9056603773584906,0.9855531334433745,1.0,4/65,13.95%,OAS3;IRF2;JAK1;STAT1
gsea,epidermal growth factor receptor signaling pathway (GO:0007173),-0.21168340050570997,-0.6632621647268367,0.9166666666666666,1.0,1.0,4/47,7.72%,AAMP;REPS2;EGFR;BCAR1
gsea,ventricular septum development (GO:0003281),-0.22538190584794882,-0.6632553368491154,0.8666666666666667,1.0,1.0,4/38,20.72%,SOX4;SMAD7;SMAD4;CITED2
gsea,establishment of protein localization to mitochondrion (GO:0072655),-0.19681234140743817,-0.6616543336668526,0.9090909090909091,1.0,1.0,15/48,24.64%,TOMM7;FIS1;TIMM10;TIMM8B;SLC25A6;ROMO1;TIMM9;TOMM22;TSPO;PINK1;BCAP31;DNAJC15;PAM16;AIP;TIMM17A
gsea,negative regulation of secretion by cell (GO:1903531),-0.23990129303627064,-0.6607487394524805,0.7959183673469388,1.0,1.0,3/39,10.69%,VAMP8;ERP29;RHBDF1
gsea,transcription initiation from RNA polymerase II promoter (GO:0006367),0.15305825599593934,0.6603031788366279,1.0,0.9873248585626672,1.0,40/140,37.88%,MED17;DR1;GTF2F2;POLR2B;HDAC3;GTF2H1;POLR2K;TBL1XR1;NOTCH1;E2F3;SNW1;TAF9B;RBPJ;PPARD;TEAD4;GTF2E2;TAF11;TAF9;NR3C1;POLR2L;POLR2C;GTF2E1;POLR2E;MED27;NOTCH3;PPARA;MAZ;TAF2;HDAC10;NOTCH2;VDR;NR2C2AP;WWTR1;TAF6;PPARG;NRBF2;YAP1;CCNH;GTF2B;GTF2A2
gsea,negative regulation of endothelial cell proliferation (GO:0001937),0.2251540695301324,0.6599743706788394,0.8809523809523809,0.9867391470065875,1.0,2/37,13.95%,AIMP1;STAT1
gsea,semaphorin-plexin signaling pathway (GO:0071526),-0.2221258593834327,-0.6596994829328573,0.9375,1.0,1.0,5/35,23.92%,PLXNB1;SEMA7A;SH3BP1;SEMA3B;SEMA4C
gsea,ERAD pathway (GO:0036503),-0.17015844078992123,-0.6582420994868935,0.9464285714285714,1.0,1.0,13/87,17.81%,OS9;UBXN6;USP19;DNAJB2;RNF121;ENST00000635718.1;TMEM129;TMUB1;TRIM13;RNF5;TMUB2;ERLIN2;RNF103
gsea,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.1939971572654804,0.6569417213709041,0.9591836734693877,0.988690242044035,1.0,12/39,37.38%,PLK1;MAPK1;UBE2K;RIPK2;CAB39;EIF4G1;RPTOR;DMTN;SPHK1;TNKS1BP1;CALM1;CALM2
gsea,regulation of protein kinase activity (GO:0045859),-0.16878338174007537,-0.6525372152145229,0.9423076923076923,1.0,1.0,14/110,16.23%,RAPGEF2;GAS6;TARBP2;AKT1S1;TAB1;PRKRIP1;INPP5K;PRKAG1;TAB2;RAP2C;PTK2B;DVL1;JTB;CSF1
gsea,protein localization to cell surface (GO:0034394),0.2623112288642951,0.6524967593076915,0.8695652173913043,0.9911888471171194,1.0,6/28,29.09%,PIGU;VCL;ENST00000618924.4;EMP2;FLNA;MESD
gsea,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.1804737516355115,0.6506580559290641,0.9245283018867925,0.9917812670609366,1.0,13/80,28.30%,BRCA1;HTT;RFFL;RNF34;PARK7;FAIM;ITGA6;BMP4;PHIP;GSK3B;HMOX1;TNFAIP3;TNFRSF10A
gsea,cellular transition metal ion homeostasis (GO:0046916),0.2002537522305976,0.6501316518916324,0.9183673469387755,0.9912459224046373,1.0,22/96,32.12%,BOLA2;TFRC;SLC31A1;HFE;CYBRD1;SLC39A14;CAND1;SLC39A8;GLRX3;MT1A;ACO1;FXN;SKP1;CUL1;SLC30A9;HMOX1;SLC30A5;IREB2;SLC39A10;ATOX1;SOD1;MT1E
gsea,ubiquitin-dependent ERAD pathway (GO:0030433),-0.16879658347307916,-0.6479125668865209,0.9814814814814815,1.0,1.0,12/73,17.81%,OS9;USP19;DNAJB2;RNF121;ENST00000635718.1;TMEM129;TMUB1;TRIM13;RNF5;TMUB2;ERLIN2;RNF103
gsea,regulation of MAP kinase activity (GO:0043405),-0.1951572540827213,-0.6468045594161556,0.92,1.0,1.0,11/97,20.88%,CD24;EGFR;ERBB2;DUSP1;INPP5K;PDGFC;CDK12;PDGFB;HYAL2;DAB2IP;HGS
gsea,iron ion homeostasis (GO:0055072),0.19975074373411966,0.6467953265406582,0.9777777777777777,0.9930673906241754,1.0,11/61,25.88%,BOLA2;TFRC;HFE;CYBRD1;CAND1;GLRX3;ACO1;FXN;SKP1;CUL1;HMOX1
gsea,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.21676544261492983,-0.6462086098011037,0.8703703703703703,1.0,1.0,7/33,21.63%,MFSD6;SEC24C;TAPBPL;HLA-C;TAPBP;BCAP31;B2M
gsea,maturation of LSU-rRNA (GO:0000470),0.20184673911020468,0.6462019163682429,0.9464285714285714,0.9924795385659583,1.0,6/26,20.37%,MRPL1;NOP2;MAK16;RPF1;ZNHIT6;WDR12
gsea,long-chain fatty acid metabolic process (GO:0001676),0.20110924677237116,0.645758489572835,0.9245283018867925,0.992036503038228,1.0,3/83,6.05%,ELOVL6;ELOVL5;ACSL3
gsea,regulation of neurogenesis (GO:0050767),0.19246953725228055,0.6453127830220735,0.9787234042553191,0.9915421168872088,1.0,6/62,22.94%,NAP1L1;DOCK7;FAIM;NOTCH1;SNW1;SPEN
gsea,positive regulation of vasculature development (GO:1904018),0.17815978814010638,0.6440495412256777,0.9444444444444444,0.9917005548852545,1.0,12/102,21.33%,BRCA1;AGGF1;HMGA2;ADAM12;GATA2;ITGB1;RUNX1;VEGFA;F3;XBP1;HIF1A;PDPK1
gsea,regulation of response to external stimulus (GO:0032101),0.167300477340514,0.6432727437813153,0.9777777777777777,0.9913376870579861,1.0,29/130,40.95%,CYLD;PARK7;SHPK;APPL1;STK24;UFL1;METAP2;BRD4;F2RL1;METAP1;ELMOD2;EFNB2;ZMPSTE24;PSMA6;ERAP1;BCL6;EPHB2;FNTA;BIRC2;BIRC3;XIAP;APPL2;CALM1;CAV1;TRAF3;AREL1;CASP8;SETD6;SPATA2
gsea,response to growth factor (GO:0070848),-0.18379262123289547,-0.6430663293722461,0.9130434782608695,1.0,1.0,5/41,17.05%,CIB1;ERBB2;GATA6;PDGFB;MYC
gsea,RNA phosphodiester bond hydrolysis (GO:0090501),0.2233019660240737,0.6429372877727372,0.9056603773584906,0.9906111598976719,1.0,4/28,18.46%,CPSF3;POP7;CSTF3;TOE1
gsea,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.17323190124038376,-0.6426373153575049,0.9622641509433962,1.0,1.0,18/185,11.20%,TMEM115;GAS6;TRAPPC6A;GOLGA2;CUL3;ERGIC3;SEC24C;TMED9;RAB1A;ARFGAP1;KLHL12;CD59;TRAPPC2L;GORASP1;SCFD1;BET1L;PROC;LMAN2
gsea,cholesterol homeostasis (GO:0042632),0.2100311385422043,0.6412268714691071,0.9302325581395349,0.9910170365833373,1.0,7/71,19.54%,INSIG1;TMEM97;MALL;SOAT1;LDLR;NPC1;XBP1
gsea,ERBB2 signaling pathway (GO:0038128),0.20184644741687457,0.64028179173413,0.9069767441860465,0.9907078108294746,1.0,4/32,19.20%,HSP90AA1;SOS1;STUB1;CUL5
gsea,regulation of interferon-gamma production (GO:0032649),0.21296618427494995,0.6384945435826209,0.9433962264150944,0.990957116764196,1.0,3/86,4.06%,HSPD1;HMGB1;SLC7A5
gsea,clathrin-dependent endocytosis (GO:0072583),-0.20481683742095977,-0.6382352000004196,0.9636363636363636,1.0,1.0,2/26,6.80%,CLTB;AP2S1
gsea,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.22986388558657958,-0.6380948341462296,0.8723404255319149,1.0,1.0,2/17,9.70%,OS9;TMEM129
gsea,"DNA-templated transcription, initiation (GO:0006352)",-0.15022832890729304,-0.6354524468035944,0.9642857142857143,1.0,1.0,11/168,9.16%,GTF2H5;ESRRA;NR1H3;NAT14;MAPK3;NR0B1;HDAC5;POLR2F;NR1H2;GTF2F1;RARG
gsea,Golgi to plasma membrane transport (GO:0006893),0.19137810428013965,0.6325266165942548,0.8863636363636364,0.9942392993657327,1.0,17/48,36.50%,CCDC93;BLZF1;RABEP1;EXOC2;GCC2;GOLPH3;GOLGA4;STXBP6;SPTBN1;ARFGEF2;EXOC1;NSF;SYS1;GOLPH3L;PREPL;OPTN;EXOC6B
gsea,axonogenesis (GO:0007409),-0.15726625921416926,-0.6308312002197393,0.9807692307692307,1.0,1.0,28/240,24.07%,LYPLA2;EPHB4;PIK3CD;MAPK3;APP;RAB10;TAOK2;WNT5A;EFNA4;DOK4;IRS2;IGSF9;VASP;DCC;DAG1;CDK5;PTPRA;SH3KBP1;SIAH1;SEMA7A;EFNA1;GRB10;SEMA3B;PARD6B;GAB2;GRB2;SEMA4C;ARHGAP35
gsea,regulation of angiogenesis (GO:0045765),0.1606881210928336,0.6296207195400345,1.0,0.9954560737672256,1.0,20/203,21.33%,BRCA1;AGGF1;HMGA2;ROCK2;PGK1;ADAM12;NAXE;GATA2;STAT1;ITGB1;ROCK1;RUNX1;VEGFA;F3;XBP1;AGO1;SFRP1;FOXJ2;HIF1A;PDPK1
gsea,blood vessel morphogenesis (GO:0048514),-0.18481231128230394,-0.6295084956691438,1.0,1.0,1.0,6/56,20.58%,SERPINF2;CUL7;SMAD7;EGFL7;ADM;RASA1
gsea,positive regulation of macromolecule metabolic process (GO:0010604),-0.13941863816780395,-0.6277619908618284,1.0,1.0,1.0,30/384,17.50%,GSN;DDRGK1;GAS6;CD63;DKK1;TICAM1;RPL11;PIK3CD;MAPK3;APP;SCX;WNT5A;VSIR;CELF1;CD74;ERP29;ACTG1;PRKAG1;TRIM28;ARRB2;MAPK14;ZBTB7B;AFDN;LGALS9;PDGFB;CSF1;MAPK11;ARRB1;MYC;IL6
gsea,aminoglycan catabolic process (GO:0006026),-0.306816061772211,-0.626832431684233,0.9090909090909091,1.0,1.0,4/31,18.76%,AGRN;GLB1;SDC4;HYAL2
gsea,glycoprotein metabolic process (GO:0009100),0.20676767845867347,0.6266610609321732,0.9777777777777777,0.9964376437780731,1.0,7/55,24.15%,MAN2A1;ERP44;PARK7;TNIP1;GOLPH3;HIF1A;MAN1A1
gsea,Notch signaling pathway (GO:0007219),0.17360775310517665,0.6265528115442078,0.9574468085106383,0.9955818419791435,1.0,19/60,40.96%,ADAM17;DTX4;STAT1;DLGAP5;NRARP;NOTCH1;SNW1;RBPJ;POFUT1;NOTCH3;HES1;NOTCH2;JAG1;PLXND1;DTX3L;EP300;YBX1;GMDS;PSENEN
gsea,fatty acid catabolic process (GO:0009062),0.18305048501978674,0.6260193238299082,0.96,0.9948697163891782,1.0,17/70,33.78%,LPIN1;ACAT2;ABCD3;HADHA;HADH;PEX13;PPARD;ACAT1;HSD17B10;SLC25A17;ECI2;ACADM;NUDT19;MMUT;ECHDC1;PEX2;SLC27A4
gsea,response to amino acid (GO:0043200),-0.20428100011519895,-0.6257861560501897,0.9622641509433962,1.0,1.0,3/32,20.67%,LAMTOR2;RRAGB;RRAGA
gsea,purine ribonucleotide biosynthetic process (GO:0009152),0.20495979835121744,0.6242251552351866,0.9019607843137255,0.9950491515133779,1.0,11/48,39.46%,ACOT7;SLC26A1;ADCY3;GMPS;PANK3;ACAT1;ADSL;PAPSS1;IMPDH1;DCAKD;COASY
gsea,axon guidance (GO:0007411),-0.15923808866028605,-0.623118402239448,0.9791666666666666,1.0,1.0,25/203,24.07%,LYPLA2;EPHB4;PIK3CD;MAPK3;WNT5A;EFNA4;DOK4;PLXNB1;IRS2;IGSF9;VASP;DCC;DAG1;PTPRA;SH3KBP1;SIAH1;PTPRM;SEMA7A;EFNA1;GRB10;SEMA3B;GAB2;GRB2;SEMA4C;ARHGAP35
gsea,endoplasmic reticulum to cytosol transport (GO:1903513),-0.23571067485863811,-0.6225315254838032,0.8444444444444444,1.0,1.0,2/15,9.70%,OS9;TMEM129
gsea,interferon-gamma-mediated signaling pathway (GO:0060333),0.20824485233136703,0.6225075717892933,0.94,0.9951380210885687,1.0,4/68,13.95%,OAS3;IRF2;JAK1;STAT1
gsea,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.20641225347021586,-0.622209113952223,0.9375,1.0,1.0,4/46,17.50%,SERPINF2;THBS1;PDGFB;IL6
gsea,regulation of wound healing (GO:0061041),-0.19270783981337164,-0.6220172598201397,1.0,1.0,1.0,4/47,13.43%,TNFRSF12A;CADM4;ACTG1;CLDN4
gsea,regulation of BMP signaling pathway (GO:0030510),0.17381910715276544,0.6217960874410544,0.9803921568627451,0.9946472488335419,1.0,16/76,37.47%,FOXD1;TWSG1;ITGA3;ENG;BMP4;NOTCH1;LEMD3;RBPJ;TRIM33;RBPMS2;SMURF2;SMAD5;XIAP;UBE2D1;PPARG;BMPR2
gsea,neural crest cell development (GO:0014032),0.242838292462507,0.620980058282104,0.9375,0.9942345944435705,1.0,2/45,10.98%,CORO1C;NOLC1
gsea,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.19372254427404176,0.619458302779763,0.9574468085106383,0.9944525101719327,1.0,6/40,27.07%,USP10;STAT1;TNIP1;PPM1A;TRIM59;TNFAIP3
gsea,sulfur compound biosynthetic process (GO:0044272),-0.16426485756911416,-0.6162063214603929,0.9772727272727273,1.0,1.0,8/113,12.49%,DSE;GSTZ1;CHPF;GGT1;GGT7;CHPF2;MGST2;MGST3
gsea,regulation of proteolysis (GO:0030162),0.17815030651456845,0.6152896551364625,0.9534883720930233,0.9961081785046574,1.0,6/54,18.86%,PLK1;DNAJC1;STUB1;SPOP;ASPH;HDAC2
gsea,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.21262533412123885,0.6146111828873293,0.9230769230769231,0.995567027513022,1.0,3/29,19.75%,HSPD1;RPS27A;TNIP1
gsea,histone monoubiquitination (GO:0010390),0.2072605316956481,0.6132830147626896,0.9523809523809523,0.9952063275581035,1.0,8/24,29.64%,RNF20;LEO1;DDB2;CTR9;SKP1;CUL4B;DDB1;TRIM37
gsea,hemopoiesis (GO:0030097),-0.17614359332684823,-0.611677780826436,1.0,1.0,1.0,8/94,16.18%,WNT5A;ARIH2;FSTL3;TMEM190;RRAS;IFI16;FLCN;PDGFB
gsea,sterol homeostasis (GO:0055092),0.20628564039043099,0.6111749988846584,0.9767441860465116,0.9954993361939828,1.0,7/72,19.54%,INSIG1;TMEM97;MALL;SOAT1;LDLR;NPC1;XBP1
gsea,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.1996452563472969,-0.6107569641086003,0.94,1.0,1.0,2/26,4.35%,UNC119;APP
gsea,establishment of protein localization to plasma membrane (GO:0061951),-0.2088571899172736,-0.6088926308242611,0.9152542372881356,1.0,1.0,7/36,17.53%,RAB10;GGA1;GORASP1;KIF13A;RAB34;AFDN;VAMP2
gsea,rRNA metabolic process (GO:0016072),0.18258685910605413,0.6086949537878852,0.9245283018867925,0.9958301714850195,1.0,49/162,27.87%,NOP58;RRP36;EXOSC8;TEX10;RRP1B;ENST00000630540.2;WDR75;DDX52;DIS3L;RPL30;DCAF13;UTP20;WDR43;LYAR;RPL41;NOLC1;DIS3;MRTO4;BMS1;WDR3;NOL6;RPF1;RPL35A;MPHOSPH6;EXOSC10;RCL1;RPS27;DDX27;DKC1;ESF1;WDR12;HEATR1;RPL23;RPL6;FCF1;UTP4;RPS24;UTP18;MTREX;UTP15;SBDS;POP5;RPL3;SLFN13;RPS15;UTP14A;DDX10;NVL;NIFK
gsea,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.18436709886896227,0.6081116467967643,0.975,0.9951379484723033,1.0,17/67,32.48%,HSP90AA1;NCKAP1;ROCK2;PIK3CB;BAIAP2;CRK;RHOA;ROCK1;VEGFA;MAPKAPK3;CYFIP1;PAK2;PIK3CA;NCF2;PTK2;SH2D2A;VEGFC
gsea,morphogenesis of an epithelium (GO:0002009),0.19678925258880797,0.6080883989340294,1.0,0.9942427286129102,1.0,9/30,38.21%,TIMELESS;VCL;ARHGAP12;LAMA5;LAMA3;LIN7C;ACTB;KRT6A;PRKX
gsea,inositol phosphate metabolic process (GO:0043647),-0.19831763165303978,-0.608082685451721,0.9433962264150944,1.0,1.0,7/48,25.93%,IP6K1;INPPL1;ISYNA1;INPP4A;PLCD3;INPP5B;ITPKC
gsea,polyol metabolic process (GO:0019751),-0.19831763165303978,-0.608082685451721,0.9433962264150944,1.0,1.0,7/47,25.93%,IP6K1;INPPL1;ISYNA1;INPP4A;PLCD3;INPP5B;ITPKC
gsea,carbohydrate homeostasis (GO:0033500),0.1681080253165978,0.6069418076518874,0.9318181818181818,0.9939104730668461,1.0,11/70,31.92%,ENST00000645126.2;PARK7;CRY1;MCU;PRKAA1;PTPN2;TENT4B;ADIPOR1;WFS1;PDK2;SELENOT
gsea,neuron migration (GO:0001764),0.2457143829686532,0.6062400991809005,0.9767441860465116,0.9934641386593721,1.0,7/50,23.30%,NRCAM;PEX13;VEGFA;MARK2;TUBB2A;PAFAH1B1;POMGNT2
gsea,negative regulation of wound healing (GO:0061045),0.19323646693830576,0.6039116508315154,0.9444444444444444,0.9939863199867754,1.0,4/29,31.05%,CRK;PHLDB2;CLASP1;SERPINE2
gsea,cellular response to misfolded protein (GO:0071218),-0.20149932048425717,-0.6027876079989536,0.9649122807017544,1.0,1.0,2/20,5.77%,CUL3;RNF126
gsea,cation transport (GO:0006812),0.18469336506748463,0.6025668033796096,0.9777777777777777,0.9937697223008444,1.0,10/174,30.04%,ANO6;ANO1;SLC3A2;NDFIP2;ATP1B1;SLC7A1;TRPM7;SLC6A6;SLC4A11;NEDD4L
gsea,cellular response to amino acid stimulus (GO:0071230),-0.19565680221417414,-0.6025126677332169,0.9807692307692307,1.0,1.0,18/34,80.48%,LAMTOR2;RRAGB;RRAGA;CASTOR2;LAMTOR1;SH3BP4;LAMTOR5;LAMTOR4;LAMTOR3;SLC38A9;FYN;IPO5;CAPN2;RRAGC;NSMF;RPTOR;MTOR;XBP1
gsea,negative regulation of defense response (GO:0031348),0.15214013381949332,0.6015264786873082,1.0,0.9934772759115081,1.0,13/85,30.97%,C1QBP;LYAR;VPS35;RB1;MFHAS1;RNF26;PTPN2;LPCAT3;PPARD;OTULIN;TNFAIP3;PPARA;NMI
gsea,regulation of receptor-mediated endocytosis (GO:0048259),-0.2101871771937219,-0.6013862866096522,0.96,1.0,1.0,3/39,7.33%,DKK1;TNK2;HIP1R
gsea,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.20365752290720596,-0.6010660872640524,0.9615384615384616,1.0,1.0,5/45,16.81%,REST;NFATC3;SRF;PDGFB;SMARCA4
gsea,cellular response to peptide (GO:1901653),0.17436684130047406,0.6006470318593478,0.9795918367346939,0.9930457080409478,1.0,7/57,24.83%,TIMELESS;LGMN;XBP1;RPL23;RIPK2;GSK3B;DDX11
gsea,protein transport (GO:0015031),-0.14241778198096644,-0.6002175876072943,1.0,1.0,1.0,52/369,20.90%,SNX8;SNX33;ENST00000639909.2;MYH9;ARRDC2;RAB43;RAB13;ATP6V0B;UNC119;UNC93B1;STX4;CHMP1B;RAB10;SVBP;TMED9;RAB20;GGA1;RAB1A;SNX15;SCAMP2;ATP6V1G1;TBC1D3L;CD74;ERP29;STX16;TXNIP;SCFD1;KIF13A;TBC1D22A;VMP1;STEAP3;RAB34;IFT27;IFT22;TMED3;TBC1D16;TBC1D2;CTSA;TBC1D1;RAB1B;ARL4C;VAMP2;SIL1;VPS26B;UNC119B;RAB3D;TMEM167A;LAMP2;RAB11B;TBC1D17;ARL4A;BBS1
gsea,cellular lipid catabolic process (GO:0044242),0.24974334782814298,0.5996830612492218,0.9814814814814815,0.9926276297589501,1.0,6/27,34.00%,LPIN1;PLBD1;PPARD;NUDT19;LIPG;PLBD2
gsea,regulation of signal transduction (GO:0009966),-0.14428422182014972,-0.5986607634597109,0.9814814814814815,1.0,1.0,22/198,23.16%,CD63;CD24;FBXL17;MFNG;APP;DHRS3;IGFBP6;PTCH1;ZFAND2B;LLGL2;GIT1;ZDHHC7;PXN;TMEM237;DGKQ;RFNG;FUZ;DYNLT1;TSC2;MDFIC;AMFR;NCK1
gsea,positive regulation of signal transduction (GO:0009967),0.1331835912015232,0.5970698452937201,1.0,0.9930847921276305,1.0,31/252,30.32%,PRKCI;CTBP2;TEDC2;HTT;SLC39A14;KLK5;P2RY6;VPS35;DEPDC1B;PTPN11;NEPRO;ARNT;TSPAN5;NOTCH1;F3;XBP1;SNW1;SFRP1;HIF1A;PHIP;SULF2;RBPJ;EMP2;TNFAIP3;FLNA;ROBO1;ITGA5;IL6ST;DMTN;KLF2;SPIN1
gsea,regulation of mitochondrial membrane potential (GO:0051881),0.1822403556985905,0.5969779695151843,0.9019607843137255,0.9922369617691104,1.0,12/41,33.40%,NDUFS1;PARK7;PRELID1;STOML2;VCP;PRDX3;SLC25A36;PPA2;SLC4A11;PYCR1;SOD1;ABL1
gsea,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.1813505382349671,0.5957704147687181,0.9818181818181818,0.9919852482522998,1.0,6/26,24.81%,ING2;MUC1;ACKR3;TAF9B;TPT1;TAF9
gsea,intracellular pH reduction (GO:0051452),0.21553366368288232,0.5945224956015598,0.9534883720930233,0.9916328976739687,1.0,14/35,42.38%,CLCN3;ATP6V1C1;ATP6V0E2;ATP6V0E1;RAB7A;ATP6V0A1;RAB38;ATP6V1E1;ATP6V1D;ATP6V1A;ATP6V0D1;GPR89A;ATP6V0C;ATP6V1B2
gsea,regulation of gluconeogenesis (GO:0006111),0.18566169991678413,0.5921482195731174,0.9583333333333334,0.9916473646206497,1.0,7/29,31.51%,ARPP19;PGP;CRY1;PTPN2;DDB1;PDK2;SDHAF3
gsea,negative regulation of catabolic process (GO:0009895),0.17886780581814155,0.5907988641296021,0.9038461538461539,0.9915104291138271,1.0,8/49,29.78%,SF3B3;MAD2L1;CYP51A1;PRKAA1;APOC1;AZIN1;FLNA;PPARA
gsea,cellular response to acid chemical (GO:0071229),-0.19033425590802178,-0.5894181153003009,0.96,1.0,1.0,18/28,81.01%,LAMTOR2;RRAGB;RRAGA;LAMTOR1;SH3BP4;LAMTOR5;LAMTOR4;LAMTOR3;SLC38A9;IPO5;CAPN2;RRAGC;NSMF;KLF2;RPTOR;MTOR;XBP1;VEGFA
gsea,maintenance of blood-brain barrier (GO:0035633),-0.18957331873334485,-0.5885320736511588,0.9811320754716981,1.0,1.0,8/30,32.30%,ACTG1;IL6;TJP2;CLDN12;LSR;CLDN3;TJP1;F11R
gsea,Golgi to plasma membrane protein transport (GO:0043001),-0.1926487424985784,-0.5884410940170067,0.9122807017543859,1.0,1.0,8/30,26.72%,RAB10;GGA1;KIF13A;RAB34;VAMP2;BBS1;GOLGA7;KRT18
gsea,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.20190501636596545,-0.5882328050874116,0.94,1.0,1.0,10/35,32.69%,PTPN6;DUSP1;DUSP3;PTPN12;DUSP18;PTPRF;PTPRB;PTPN1;PTPRJ;DUSP22
gsea,embryonic limb morphogenesis (GO:0030326),-0.22955878124150028,-0.5877738880238825,0.9482758620689655,1.0,1.0,4/36,15.94%,PTCH1;FBXW4;RARG;MEGF8
gsea,mRNA destabilization (GO:0061157),0.19921620696697367,0.5866375474531016,0.9583333333333334,0.9924449984753939,1.0,16/38,36.95%,ROCK2;TARDBP;RC3H2;ROCK1;METTL3;DIS3L2;DHX36;TUT7;YTHDF3;CNOT1;PDE12;TUT4;KHSRP;RIDA;METTL16;FTO
gsea,myelination (GO:0042552),0.17682865726725977,0.5862682335479069,0.9782608695652174,0.9916906048655404,1.0,2/48,9.97%,MALL;ADGRG6
gsea,regulation of interleukin-2 production (GO:0032663),0.17981626674784196,0.585640104851398,1.0,0.9910005040016683,1.0,9/48,37.81%,PNP;STOML2;RUNX1;TNFAIP3;LAPTM5;SPTBN1;MAP3K7;PRKD2;RPS3
gsea,negative regulation of epithelial cell apoptotic process (GO:1904036),0.1978520128243701,0.5855970152707946,0.9166666666666666,0.9900980207964832,1.0,11/37,39.68%,GATA2;TNIP2;PDPK1;NFE2L2;TNFAIP3;WFS1;PPARA;GATA3;PAK4;YAP1;MAPK7
gsea,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.18641541573511872,-0.5851435608549552,0.9787234042553191,1.0,1.0,19/34,81.41%,MAPKAPK2;MAPK14;DAB2IP;FOXC1;NRP1;ITGB1BP1;MT1G;HSPB1;MAP2K3;RELA;ANXA1;VEGFB;PRKD2;VEGFC;SPHK1;PIK3CA;NUS1;VEGFA;NOTCH1
gsea,regulation of filopodium assembly (GO:0051489),-0.20625052626752657,-0.5848747504258622,0.9183673469387755,1.0,1.0,2/41,6.73%,ARAP1;AGRN
gsea,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.21355618630154577,-0.5811218680154157,0.9629629629629629,1.0,1.0,5/31,18.73%,FSTL3;SMAD7;LTBP4;SMAD4;BCL9
gsea,cellular response to amino acid starvation (GO:0034198),0.18318096688723756,0.5787324849020005,0.9767441860465116,0.9922484202605918,1.0,11/74,24.04%,SEH1L;EIF2AK4;ATP6V1C1;EIF2S1;GCN1;MAPK1;ATP6V0E2;EIF2AK2;ATP6V0E1;MAPK8;MTOR
gsea,negative regulation of epithelial cell proliferation (GO:0050680),0.16933849583476604,0.5768657874451144,0.9791666666666666,0.9920238738854706,1.0,13/72,35.64%,AIMP1;CDK6;STAT1;WDR77;ENST00000618924.4;SFRP1;SYNJ2BP;ROBO1;MAGED1;PEX2;VDR;CAV2;GATA3
gsea,regulation of cytokine production (GO:0001817),-0.14904524951256068,-0.574658238854024,0.9791666666666666,1.0,1.0,18/150,26.94%,PIK3CD;TRIM56;MAPKAPK2;HILPDA;IFI16;BTN3A3;MAPK14;LGALS9;TREX1;AGPAT2;IL6;ATP2B1;ASB1;VTCN1;BATF;SIRPA;BTN3A1;SNAI2
gsea,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.16232493089343739,-0.5738102574026688,0.9767441860465116,1.0,1.0,14/170,26.70%,OBSL1;IGSF9;IGFN1;CLDN4;CLDN7;CLDN23;NECTIN4;PTPRM;ITGAM;CLDN12;PTPRF;LRFN4;AMIGO2;ICAM1
gsea,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.19210488816609977,0.5731528336908329,0.9347826086956522,0.9925266739876637,1.0,3/22,19.54%,PARK7;OPA1;XBP1
gsea,negative regulation of MAPK cascade (GO:0043409),0.14598083625884106,0.5724633104368014,1.0,0.9917638475290156,1.0,10/94,24.72%,UCHL1;FOXM1;PIK3CB;SMPD1;PSMD10;BMP4;TNIP1;PTPN2;RANBP9;SYNJ2BP
gsea,positive regulation of mitotic cell cycle (GO:0045931),0.19436833854351995,0.5719779947849855,0.9090909090909091,0.9910649747623248,1.0,9/27,34.18%,EIF4E;FOXA1;LGMN;CCNB1;PKN2;HES1;SPHK1;RPS6KB1;ASNS
gsea,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.20263591259244634,-0.5617699229303726,0.9782608695652174,1.0,1.0,5/52,22.68%,JPH2;SRI;PTK2B;SNCA;CALM3
gsea,cell-cell junction organization (GO:0045216),0.1537519300176559,0.5594286915327945,0.9607843137254902,0.9950794329653488,1.0,12/82,37.18%,PRKCI;DSG2;CTNND1;F2RL1;CDH1;CSK;NECTIN3;GJC1;LIMS1;PKP2;OCLN;NECTIN1
gsea,skin development (GO:0043588),-0.1783947194261324,-0.5589687985186139,0.92,1.0,1.0,11/80,25.27%,OPN3;WNT5A;TXNIP;CLDN4;GATA6;KDF1;KRT16;ASAH1;SLC2A10;LSR;CASP3
gsea,actin filament bundle assembly (GO:0051017),0.18009817981879422,0.5586642133357208,1.0,0.9944662120423297,1.0,3/33,14.27%,HSP90B1;BAIAP2;PLS3
gsea,regulation of sodium ion transport (GO:0002028),-0.17462345909508595,-0.5578519338146193,0.9661016949152542,1.0,1.0,5/36,22.47%,SIK1;DLG1;P2RX4;PRSS8;NKAIN4
gsea,termination of RNA polymerase I transcription (GO:0006363),-0.1859189843214421,-0.5566432852094055,0.9772727272727273,1.0,1.0,7/30,27.28%,GTF2H5;POLR2F;POLR1C;TAF1D;CAVIN1;MNAT1;ERCC2
gsea,positive regulation of immune response (GO:0050778),0.21042295696183072,0.5547697350514217,0.9090909090909091,0.9949020897773367,1.0,12/75,31.95%,DHX9;EIF2AK4;AKIRIN2;POLR3F;F2RL1;XBP1;PLSCR1;CD46;SLC15A4;IL6ST;NMI;RIOK3
gsea,collagen fibril organization (GO:0030199),0.16833328744245568,0.5537543821989521,0.9821428571428571,0.9943150832962653,1.0,8/89,19.82%,PLOD2;P4HB;P4HA1;COLGALT1;ITGA6;P3H1;DST;ITGB4
gsea,negative regulation of response to external stimulus (GO:0032102),0.14422426849162817,0.5529456596721207,1.0,0.9936793387015768,1.0,12/118,24.17%,C1QBP;LYAR;CERS2;VPS35;CRK;RB1;MFHAS1;RNF26;PTPN2;LPCAT3;PPARD;OTULIN
gsea,keratan sulfate metabolic process (GO:0042339),-0.18085743048858133,-0.5517493403593614,0.9166666666666666,1.0,1.0,8/33,33.56%,GALNS;ST3GAL1;GLB1;B4GALT3;HEXA;B3GNT7;B3GNT3;SLC35D2
gsea,negative regulation of protein localization to membrane (GO:1905476),-0.1870244650290837,-0.5512902238283359,0.9622641509433962,1.0,1.0,2/26,11.21%,NUMB;INPP5K
gsea,ribosomal large subunit assembly (GO:0000027),-0.18564672886656225,-0.5498640450473808,0.9777777777777777,1.0,1.0,4/25,14.63%,RPL11;NOP53;RPL23A;RPL10
gsea,negative regulation of cell-matrix adhesion (GO:0001953),-0.19256724634728892,-0.548772308803387,1.0,1.0,1.0,4/32,20.58%,CDKN2A;THBS1;MAP4K4;RASA1
gsea,response to cytokine (GO:0034097),-0.14594423691362907,-0.545735525620609,0.9803921568627451,1.0,1.0,9/150,10.78%,PTPN6;RELB;APP;TRIM56;MAPKAPK2;GGT1;CD74;SRF;GGT7
gsea,epithelial tube morphogenesis (GO:0060562),-0.17622645525166866,-0.5455849869617106,0.9791666666666666,1.0,1.0,15/34,82.42%,RHOB;MEGF8;SCRIB;GLI2;CTNNB1;PKD1;MET;PAK1;PRKX;PRKD2;CCM2;GATA3;HES1;BMP4;PODXL
gsea,regulation of macroautophagy (GO:0016241),0.13698830520401228,0.5453576239749423,1.0,0.9951473994726073,1.0,24/112,31.87%,GAPDH;UCHL1;LARP1;VPS35;VPS26A;TBK1;CAPNS1;ATP6V1C1;UBQLN1;ATP6V0E2;UBQLN2;PRKAA1;ATP6V0E1;SCOC;MAPK8;MTOR;ATP6V0A1;USP36;RPTOR;PIK3CA;EXOC1;NEDD4;EXOC7;PAFAH1B2
gsea,embryonic organ development (GO:0048568),0.18068395545568977,0.5450977867417282,0.9622641509433962,0.9943256012534589,1.0,6/66,23.92%,STIL;KITLG;IFT122;RBPJ;NES;TEAD4
gsea,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.17759948071567747,0.5449243850535618,0.98,0.9934680457515358,1.0,9/53,26.80%,YWHAE;ARL6IP1;PCID2;VEGFA;DHCR24;USP47;RPS6KA3;SFN;RAF1
gsea,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.17154722606751366,0.5447884333148284,0.9615384615384616,0.9926120537054047,1.0,21/59,82.88%,ARL2BP;VEGFA;IL6ST;HES1;PARP14;LYN;LIF;TNFRSF1A;TNFRSF18;SOCS3;PARP9;STAP2;JAK2;STAT3;CD40;PTK6;IL18;CLCF1;IL6;IL23A;CTF1
gsea,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.20585326311223906,0.5445486777751717,0.9795918367346939,0.9918072062451007,1.0,8/30,36.69%,LRRC59;NOTCH1;SHOC2;RASGRP1;CRKL;NOTCH2;ERBIN;TGM2
gsea,negative regulation of cell adhesion (GO:0007162),-0.1648175805419198,-0.5416108399237464,0.9811320754716981,1.0,1.0,38/73,83.60%,PLXNB1;MDK;RND1;DUSP1;FZD7;RASA1;SPINT2;SNAI2;FBLN1;ERBB3;SERPINE1;NF2;SIPA1;CBLL1;PLXNA3;ITGB1BP1;ARHGDIB;SPOCK1;ARHGDIA;MIA3;ADAM10;CYP1B1;PLXND1;TBCD;JAG1;PLXNB2;PLXNA1;PTK2;GTPBP4;EPHB2;DMTN;TGFBI;CD164;CDH1;MUC1;NOTCH1;PODXL;RHOA
gsea,cellular protein catabolic process (GO:0044257),-0.14506289636368705,-0.5411862182799585,1.0,1.0,1.0,9/60,20.26%,CTSF;RNF123;AP2S1;CTSZ;RNF5;MAGEA2;LONP1;RIPK1;DAB2IP
gsea,positive regulation of osteoblast differentiation (GO:0045669),0.18425866039693545,0.5403930003130987,1.0,0.9921432499870465,1.0,2/44,8.31%,FBXO5;FERMT2
gsea,regulation of apoptotic signaling pathway (GO:2001233),0.16086101791370858,0.5395835275249823,1.0,0.9915258992453201,1.0,6/38,31.81%,CYLD;RB1;BCL2L12;MAZ;PPIA;SGMS1
gsea,adherens junction organization (GO:0034332),0.18154933277536464,0.5384530775671217,0.9807692307692307,0.9909838453775283,1.0,7/49,27.62%,FERMT2;VCL;CTNND1;CDH1;PAK2;CSK;NECTIN3
gsea,histone H3-K4 methylation (GO:0051568),-0.22085008937027106,-0.5383560110400306,0.9807692307692307,1.0,1.0,6/30,27.24%,PAGR1;MEN1;KMT2B;WDR61;SETMAR;KMT2D
gsea,kidney development (GO:0001822),0.15171447536452046,0.5354699099635042,1.0,0.9907268564297217,1.0,1/70,0.40%,CENPF
gsea,calcium ion homeostasis (GO:0055074),-0.15620002132423613,-0.5300789841794402,1.0,1.0,1.0,33/97,84.45%,JPH2;ATP2A2;SLC24A1;TMEM203;ATP2B1;SNCA;CD40;SELENON;NPTN;STIM2;RMDN3;STIM1;EDN1;TMCO1;ATP13A3;ATP13A2;CALR;SLC30A1;ATP2B4;DMPK;SLC8B1;ATP13A1;VAPB;CAV1;CHERP;S100A14;TMEM165;WFS1;ATP2C1;STC2;TPT1;ATP1B1;STOML2
gsea,positive regulation of signaling (GO:0023056),-0.20381013197104525,-0.5214005293661655,0.9803921568627451,1.0,1.0,16/38,79.66%,KCTD13;SCRIB;SNCA;ILK;CLSTN3;NMU;EDN1;PTPN23;ECE1;NMB;WLS;GATA3;VAMP3;NSF;ANXA2;CLSTN1
gsea,negative regulation of fat cell differentiation (GO:0045599),-0.20228989351452265,-0.516872881702688,0.9807692307692307,1.0,1.0,7/36,23.41%,WNT5A;TRIO;ZADH2;FLCN;IL6;ZFP36L2;GPS2
gsea,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.19495480866124995,-0.5141297749640715,1.0,1.0,1.0,2/25,3.87%,FBXL17;CUL3
gsea,cell morphogenesis involved in differentiation (GO:0000904),0.15174916767879684,0.5134350282866548,1.0,0.9951842733045025,1.0,6/72,16.90%,FN1;FERMT2;KIF14;LAMC1;RHOA;RB1
gsea,negative regulation of kinase activity (GO:0033673),-0.1486133154756946,-0.5130135941818732,1.0,1.0,1.0,6/62,11.21%,TARBP2;AKT1S1;TAB1;PRKRIP1;IRS2;INPP5K
gsea,regulation of mitochondrial translation (GO:0070129),0.178416605032196,0.5023728173346469,1.0,0.996502054489515,1.0,2/21,11.00%,C1QBP;MTG2
gsea,integrin-mediated signaling pathway (GO:0007229),-0.14295879315164783,-0.4991303704651858,1.0,1.0,1.0,12/75,26.42%,MYH9;CUL3;BCAR1;PTK2B;PTPRA;NEDD9;SEMA7A;ENST00000646695.2;NME2;ILK;ITGB5;PLPP3
gsea,positive regulation of lymphocyte proliferation (GO:0050671),0.16474187761452158,0.49611919430029433,1.0,0.996634939683697,1.0,2/75,5.90%,TFRC;PNP
gsea,protein insertion into ER membrane (GO:0045048),-0.14068745743565672,-0.49370252964609684,1.0,1.0,1.0,2/37,4.35%,EMC4;APP
gsea,negative regulation of proteolysis (GO:0045861),-0.1522460271896893,-0.49286937741303316,1.0,1.0,1.0,4/43,14.89%,SNX12;CLN3;CSTB;CDK5
gsea,positive regulation of axon extension (GO:0045773),-0.19027349153984482,-0.49233937000943484,1.0,1.0,1.0,15/22,81.01%,DBN1;MEGF8;SEMA7A;NTN1;ZFYVE27;NRP1;LIMK1;L1CAM;MACF1;TWF2;DBNL;MAP3K13;SHTN1;GOLGA4;VEGFA
gsea,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.1605040539940106,-0.48538601024772143,1.0,1.0,1.0,10/26,37.78%,RPL11;EFNA1;PRKCG;CSNK2A2;CSNK2A1;ALAD;PML;PSMF1;F8A1;RPS7
gsea,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.17975507365175986,-0.48517852275861895,1.0,1.0,1.0,2/20,9.57%,TARBP2;ZC3H7B
gsea,regulation of amyloid-beta formation (GO:1902003),0.14589860657671505,0.4830375767135248,1.0,0.9975552123714987,1.0,3/34,21.71%,ROCK2;ROCK1;RTN4
gsea,unsaturated fatty acid metabolic process (GO:0033559),-0.16853810087485785,-0.47972474868845033,0.9743589743589743,1.0,1.0,2/54,3.41%,GPX4;FAAH2
gsea,regulation of response to biotic stimulus (GO:0002831),0.19356794941055697,0.474068109359509,1.0,0.9979082263298049,1.0,10/29,40.35%,APPL1;ELMOD2;ZMPSTE24;ERAP1;BIRC2;BIRC3;XIAP;APPL2;TRAF3;CASP8
gsea,positive regulation of cell junction assembly (GO:1901890),0.1476294598361073,0.4721204044567773,1.0,0.9971795697167004,1.0,9/57,33.40%,FERMT2;ROCK1;VEGFA;SFRP1;CLSTN1;EPHB2;EPHA2;LIMS1;ABL1
gsea,regulation of cell adhesion mediated by integrin (GO:0033628),-0.16833383894622356,-0.47152388786789484,0.9795918367346939,1.0,1.0,1/34,2.27%,CIB1
gsea,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.17189868081976406,-0.46873953786885664,0.9574468085106383,1.0,1.0,5/30,23.91%,TICAM1;UBB;UBC;RIPK1;FADD
gsea,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.17189868081976406,-0.46873953786885664,0.9574468085106383,1.0,1.0,5/31,23.91%,TICAM1;UBB;UBC;RIPK1;FADD
gsea,positive regulation of cellular component movement (GO:0051272),-0.15519767620894487,-0.4585692376774245,1.0,1.0,1.0,3/27,16.51%,SPOCK2;PHPT1;AKT2
gsea,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.1700439125703193,-0.45468280531941424,1.0,1.0,1.0,4/27,23.11%,APP;ZGPAT;GPRC5A;CHMP6
gsea,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.16497693045210432,-0.450138275777969,0.9811320754716981,1.0,1.0,5/45,20.88%,VHL;OCIAD2;IL6;BCL3;HGS
gsea,positive regulation of receptor-mediated endocytosis (GO:0048260),0.12902270117203904,0.4294416356852412,1.0,0.9995696689926679,1.0,9/44,35.61%,HFE;WASL;VEGFA;HIP1;RAB21;ANXA2;FMR1;CBL;PCSK9
gsea,positive regulation of developmental growth (GO:0048639),-0.14219403642552708,-0.4236901396382549,1.0,1.0,1.0,2/52,9.41%,AGRN;DBN1
gsea,regulation of immune response (GO:0050776),-0.126070905893395,-0.411171039677068,1.0,1.0,1.0,13/179,27.03%,TKFC;HLA-C;CD99;IFITM1;NPDC1;SLAMF7;B2M;GPR108;PILRB;ADCY7;IRF1;ICAM1;C3
gsea,rRNA methylation (GO:0031167),0.15143508389840074,0.39280588968950386,1.0,1.0,1.0,3/22,23.49%,NOP2;NSUN4;DIMT1
gsea,glycosaminoglycan catabolic process (GO:0006027),-0.16683549138179826,-0.3769669758614585,1.0,1.0,1.0,5/56,18.76%,AGRN;GALNS;GLB1;SDC4;HYAL2
gsea,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.12914243378305645,-0.37586050228659845,1.0,1.0,1.0,2/37,16.18%,TPM1;PDGFB
gsea,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.13512937919284404,-0.3622092563133466,1.0,0.9996530829363061,1.0,21/34,86.53%,SRF;PDGFB;SMARCA4;TP53;STAT3;FOXO3;TEAD1;JUN;TGFB2;SMAD3;FOSL1;KLF4;RELA;KLF5;ETS1;PPARG;GATA3;GNL3;NR3C1;HIF1A;GATA2
gsea,epidermis development (GO:0008544),0.11373745802157292,0.30783253370002256,1.0,0.9999509948054494,1.0,15/83,45.81%,FABP5;KLK5;HDAC2;CRABP2;LAMA3;ATP2C1;LAMC2;COL17A1;YBX1;EMP1;PLOD1;KRT5;DSP;EVPL;LAMB3
